Pharm~Hosp|ATC1|ATC2|ATC3|ATC4|Crp|MIDAS~Crp|Mnf|Prd|Str|Pck|NFC~1|NFC~2|NFC~3|RX/OTC|Launch~Year|Launch~Date|DDD~Fact|DDD~Unit|Mono~Combi|MOL|[DCKey 1]|[Latest MNF Price]|[Latest Price]|EURO Sales Period|EURO Sales Value|USD Sales Period|USD Sales Value|LC Sales Period|LC Sales Value|Units Period|Units Value|DOT Period|DOT Value
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|KENALOG ORABASE|00.1%|PASTE .1 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX STATUS UNKNOWN|1973|1973/12|0.00|0.00|MONO|TRIAMCINOLONE ACETONIDE|1|52.6|71.2|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Nov/01|196|USD Sales Nov/01|174|LC Sales Nov/01|6518|Units Nov/01|109|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Dec/01|196|USD Sales Dec/01|175|LC Sales Dec/01|6349|Units Dec/01|106|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jan/02|286|USD Sales Jan/02|253|LC Sales Jan/02|9180|Units Jan/02|153|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Feb/02|172|USD Sales Feb/02|150|LC Sales Feb/02|5460|Units Feb/02|91|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Mar/02|193|USD Sales Mar/02|169|LC Sales Mar/02|6070|Units Mar/02|101|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Apr/02|241|USD Sales Apr/02|213|LC Sales Apr/02|7320|Units Apr/02|122|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales May/02|281|USD Sales May/02|258|LC Sales May/02|8594|Units May/02|143|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jun/02|244|USD Sales Jun/02|233|LC Sales Jun/02|7380|Units Jun/02|123|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jul/02|277|USD Sales Jul/02|275|LC Sales Jul/02|8252|Units Jul/02|138|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Aug/02|232|USD Sales Aug/02|226|LC Sales Aug/02|7140|Units Aug/02|119|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Sep/02|163|USD Sales Sep/02|160|LC Sales Sep/02|4920|Units Sep/02|82|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Oct/02|197|USD Sales Oct/02|193|LC Sales Oct/02|6020|Units Oct/02|101|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Nov/02|133|USD Sales Nov/02|133|LC Sales Nov/02|4094|Units Nov/02|68|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Dec/02|209|USD Sales Dec/02|212|LC Sales Dec/02|6502|Units Dec/02|108|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jan/03|196|USD Sales Jan/03|208|LC Sales Jan/03|6171|Units Jan/03|101|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Feb/03|144|USD Sales Feb/03|156|LC Sales Feb/03|4566|Units Feb/03|74|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Mar/03|176|USD Sales Mar/03|190|LC Sales Mar/03|5571|Units Mar/03|90|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Apr/03|159|USD Sales Apr/03|172|LC Sales Apr/03|5022|Units Apr/03|81|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales May/03|182|USD Sales May/03|210|LC Sales May/03|5704|Units May/03|92|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jun/03|225|USD Sales Jun/03|262|LC Sales Jun/03|7068|Units Jun/03|114|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jul/03|187|USD Sales Jul/03|213|LC Sales Jul/03|5966|Units Jul/03|95|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Aug/03|167|USD Sales Aug/03|186|LC Sales Aug/03|5398|Units Aug/03|85|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Sep/03|132|USD Sales Sep/03|148|LC Sales Sep/03|4268|Units Sep/03|67|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Oct/03|164|USD Sales Oct/03|192|LC Sales Oct/03|5256|Units Oct/03|82|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Nov/03|146|USD Sales Nov/03|171|LC Sales Nov/03|4679|Units Nov/03|73|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Dec/03|143|USD Sales Dec/03|175|LC Sales Dec/03|4615|Units Dec/03|72|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jan/04|194|USD Sales Jan/04|245|LC Sales Jan/04|6346|Units Jan/04|99|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Feb/04|129|USD Sales Feb/04|163|LC Sales Feb/04|4231|Units Feb/04|66|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Mar/04|157|USD Sales Mar/04|193|LC Sales Mar/04|5192|Units Mar/04|81|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Apr/04|225|USD Sales Apr/04|270|LC Sales Apr/04|7319|Units Apr/04|114|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales May/04|126|USD Sales May/04|152|LC Sales May/04|4045|Units May/04|63|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jun/04|223|USD Sales Jun/04|271|LC Sales Jun/04|7062|Units Jun/04|110|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jul/04|138|USD Sales Jul/04|170|LC Sales Jul/04|4366|Units Jul/04|68|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Aug/04|114|USD Sales Aug/04|138|LC Sales Aug/04|3595|Units Aug/04|56|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Sep/04|150|USD Sales Sep/04|184|LC Sales Sep/04|4751|Units Sep/04|74|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Oct/04|179|USD Sales Oct/04|224|LC Sales Oct/04|5650|Units Oct/04|88|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Nov/04|185|USD Sales Nov/04|240|LC Sales Nov/04|5778|Units Nov/04|90|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Dec/04|128|USD Sales Dec/04|171|LC Sales Dec/04|3916|Units Dec/04|61|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jan/05|222|USD Sales Jan/05|292|LC Sales Jan/05|6741|Units Jan/05|105|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Feb/05|150|USD Sales Feb/05|195|LC Sales Feb/05|4494|Units Feb/05|70|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Mar/05|201|USD Sales Mar/05|265|LC Sales Mar/05|5971|Units Mar/05|93|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Apr/05|126|USD Sales Apr/05|163|LC Sales Apr/05|3788|Units Apr/05|59|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales May/05|183|USD Sales May/05|232|LC Sales May/05|5521|Units May/05|86|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jun/05|165|USD Sales Jun/05|200|LC Sales Jun/05|4943|Units Jun/05|77|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jul/05|191|USD Sales Jul/05|231|LC Sales Jul/05|5778|Units Jul/05|90|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Aug/05|138|USD Sales Aug/05|170|LC Sales Aug/05|4083|Units Aug/05|64|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Sep/05|174|USD Sales Sep/05|213|LC Sales Sep/05|5088|Units Sep/05|80|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Oct/05|128|USD Sales Oct/05|153|LC Sales Oct/05|3788|Units Oct/05|59|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Nov/05|136|USD Sales Nov/05|160|LC Sales Nov/05|3980|Units Nov/05|62|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Dec/05|188|USD Sales Dec/05|224|LC Sales Dec/05|5457|Units Dec/05|85|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jan/06|168|USD Sales Jan/06|203|LC Sales Jan/06|4815|Units Jan/06|75|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Feb/06|182|USD Sales Feb/06|217|LC Sales Feb/06|5166|Units Feb/06|82|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Mar/06|194|USD Sales Mar/06|234|LC Sales Mar/06|5570|Units Mar/06|88|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Apr/06|160|USD Sales Apr/06|196|LC Sales Apr/06|4558|Units Apr/06|71|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales May/06|235|USD Sales May/06|301|LC Sales May/06|6657|Units May/06|105|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jun/06|209|USD Sales Jun/06|265|LC Sales Jun/06|5941|Units Jun/06|94|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Jul/06|104|USD Sales Jul/06|132|LC Sales Jul/06|2953|Units Jul/06|46|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Aug/06|241|USD Sales Aug/06|308|LC Sales Aug/06|6782|Units Aug/06|108|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Sep/06|131|USD Sales Sep/06|167|LC Sales Sep/06|3724|Units Sep/06|58|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CALCIDENT|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1991|1991/10|0.00|0.00|MONO|DENTURE POWDER|2|64.2|89.7|EURO Sales Oct/06|145|USD Sales Oct/06|183|LC Sales Oct/06|4109|Units Oct/06|64|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|CHLUMSKEHO|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|COMBI|CAMPHOR;ETHANOL;PHENOL|3|6.6|8.9|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|SINDOLOR|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1997|1997/03|0.00|0.00|MONO|TANNIN(S)|4|67.7|91.6|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTAL PRAHA|DENTAL PRAHA|DENTAL PRAHA|TRIKRESOLFORMALI|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1999|1999/06|0.00|0.00|COMBI|FORMALDEHYDE;M-CRESOL|5|44.9|60.7|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|DENTINOX|DENTINOX|DENTINOX|DENTINOX GEL N|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1997|1997/02|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|6|79.8|108|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|FERROSAN|FERROSAN|FERROSAN|SPONGOSTAN DENTAL|0000|SPONGE 20 X15|K ORAL TOPICAL|KW ORAL TOP MEDIC DRESSINGS|KWH ORAL TOP SPONGES WITH SUBST|NON-RX BOUND|1990|1990/01|0.00|0.00|MONO|ABSORBABLE GELATIN/COLLAGEN SPONGE|7|186|251.7|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Nov/01|317|USD Sales Nov/01|281|LC Sales Nov/01|10520|Units Nov/01|133|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Dec/01|197|USD Sales Dec/01|176|LC Sales Dec/01|6376|Units Dec/01|80|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jan/02|384|USD Sales Jan/02|339|LC Sales Jan/02|12335|Units Jan/02|154|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Feb/02|223|USD Sales Feb/02|194|LC Sales Feb/02|7084|Units Feb/02|89|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Mar/02|271|USD Sales Mar/02|237|LC Sales Mar/02|8507|Units Mar/02|107|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Apr/02|362|USD Sales Apr/02|320|LC Sales Apr/02|10985|Units Apr/02|138|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales May/02|392|USD Sales May/02|359|LC Sales May/02|11989|Units May/02|151|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jun/02|286|USD Sales Jun/02|273|LC Sales Jun/02|8655|Units Jun/02|109|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jul/02|288|USD Sales Jul/02|286|LC Sales Jul/02|8586|Units Jul/02|108|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Aug/02|232|USD Sales Aug/02|226|LC Sales Aug/02|7137|Units Aug/02|90|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Sep/02|316|USD Sales Sep/02|309|LC Sales Sep/02|9528|Units Sep/02|120|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Oct/02|375|USD Sales Oct/02|368|LC Sales Oct/02|11477|Units Oct/02|144|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Nov/02|402|USD Sales Nov/02|403|LC Sales Nov/02|12354|Units Nov/02|155|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Dec/02|230|USD Sales Dec/02|233|LC Sales Dec/02|7146|Units Dec/02|90|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jan/03|422|USD Sales Jan/03|448|LC Sales Jan/03|13260|Units Jan/03|167|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Feb/03|270|USD Sales Feb/03|291|LC Sales Feb/03|8549|Units Feb/03|107|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Mar/03|275|USD Sales Mar/03|297|LC Sales Mar/03|8726|Units Mar/03|108|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Apr/03|364|USD Sales Apr/03|395|LC Sales Apr/03|11524|Units Apr/03|134|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales May/03|397|USD Sales May/03|460|LC Sales May/03|12471|Units May/03|127|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jun/03|551|USD Sales Jun/03|643|LC Sales Jun/03|17303|Units Jun/03|172|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jul/03|246|USD Sales Jul/03|280|LC Sales Jul/03|7831|Units Jul/03|77|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Aug/03|288|USD Sales Aug/03|321|LC Sales Aug/03|9292|Units Aug/03|92|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Sep/03|459|USD Sales Sep/03|514|LC Sales Sep/03|14844|Units Sep/03|148|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Oct/03|448|USD Sales Oct/03|524|LC Sales Oct/03|14314|Units Oct/03|142|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Nov/03|435|USD Sales Nov/03|509|LC Sales Nov/03|13900|Units Nov/03|139|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Dec/03|527|USD Sales Dec/03|647|LC Sales Dec/03|17028|Units Dec/03|172|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jan/04|478|USD Sales Jan/04|603|LC Sales Jan/04|15637|Units Jan/04|157|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Feb/04|310|USD Sales Feb/04|393|LC Sales Feb/04|10197|Units Feb/04|103|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Mar/04|489|USD Sales Mar/04|601|LC Sales Mar/04|16137|Units Mar/04|163|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Apr/04|496|USD Sales Apr/04|595|LC Sales Apr/04|16137|Units Apr/04|163|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales May/04|418|USD Sales May/04|501|LC Sales May/04|13365|Units May/04|135|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jun/04|532|USD Sales Jun/04|646|LC Sales Jun/04|16830|Units Jun/04|170|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jul/04|420|USD Sales Jul/04|516|LC Sales Jul/04|13260|Units Jul/04|133|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Aug/04|352|USD Sales Aug/04|429|LC Sales Aug/04|11133|Units Aug/04|112|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Sep/04|489|USD Sales Sep/04|597|LC Sales Sep/04|15444|Units Sep/04|156|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Oct/04|589|USD Sales Oct/04|735|LC Sales Oct/04|18537|Units Oct/04|188|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Nov/04|451|USD Sales Nov/04|586|LC Sales Nov/04|14114|Units Nov/04|143|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Dec/04|450|USD Sales Dec/04|603|LC Sales Dec/04|13804|Units Dec/04|140|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jan/05|661|USD Sales Jan/05|868|LC Sales Jan/05|20036|Units Jan/05|203|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Feb/05|636|USD Sales Feb/05|827|LC Sales Feb/05|19049|Units Feb/05|193|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Mar/05|631|USD Sales Mar/05|834|LC Sales Mar/05|18791|Units Mar/05|190|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Apr/05|799|USD Sales Apr/05|1033|LC Sales Apr/05|24057|Units Apr/05|243|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales May/05|802|USD Sales May/05|1018|LC Sales May/05|24256|Units May/05|246|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jun/05|572|USD Sales Jun/05|696|LC Sales Jun/05|17191|Units Jun/05|174|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jul/05|467|USD Sales Jul/05|563|LC Sales Jul/05|14104|Units Jul/05|146|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Aug/05|517|USD Sales Aug/05|636|LC Sales Aug/05|15299|Units Aug/05|155|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Sep/05|573|USD Sales Sep/05|702|LC Sales Sep/05|16796|Units Sep/05|170|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Oct/05|789|USD Sales Oct/05|949|LC Sales Oct/05|23416|Units Oct/05|237|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Nov/05|722|USD Sales Nov/05|851|LC Sales Nov/05|21143|Units Nov/05|214|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Dec/05|646|USD Sales Dec/05|766|LC Sales Dec/05|18711|Units Dec/05|189|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jan/06|897|USD Sales Jan/06|1085|LC Sales Jan/06|25749|Units Jan/06|266|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Feb/06|857|USD Sales Feb/06|1024|LC Sales Feb/06|24354|Units Feb/06|246|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Mar/06|916|USD Sales Mar/06|1102|LC Sales Mar/06|26235|Units Mar/06|265|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Apr/06|688|USD Sales Apr/06|843|LC Sales Apr/06|19602|Units Apr/06|198|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales May/06|966|USD Sales May/06|1234|LC Sales May/06|27324|Units May/06|276|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jun/06|750|USD Sales Jun/06|950|LC Sales Jun/06|21285|Units Jun/06|215|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Jul/06|662|USD Sales Jul/06|840|LC Sales Jul/06|18837|Units Jul/06|194|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Aug/06|506|USD Sales Aug/06|648|LC Sales Aug/06|14259|Units Aug/06|147|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Sep/06|834|USD Sales Sep/06|1062|LC Sales Sep/06|23661|Units Sep/06|239|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;FLUORINE;OLAFLUR|8|99|138.3|EURO Sales Oct/06|889|USD Sales Oct/06|1122|LC Sales Oct/06|25146|Units Oct/06|254|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Nov/01|33|USD Sales Nov/01|29|LC Sales Nov/01|1081|Units Nov/01|9|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Dec/01|41|USD Sales Dec/01|37|LC Sales Dec/01|1332|Units Dec/01|11|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jan/02|34|USD Sales Jan/02|30|LC Sales Jan/02|1084|Units Jan/02|9|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Feb/02|45|USD Sales Feb/02|39|LC Sales Feb/02|1435|Units Feb/02|12|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Mar/02|49|USD Sales Mar/02|43|LC Sales Mar/02|1530|Units Mar/02|13|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Apr/02|64|USD Sales Apr/02|56|LC Sales Apr/02|1934|Units Apr/02|16|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales May/02|91|USD Sales May/02|83|LC Sales May/02|2774|Units May/02|23|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jun/02|20|USD Sales Jun/02|19|LC Sales Jun/02|599|Units Jun/02|5|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jul/02|16|USD Sales Jul/02|16|LC Sales Jul/02|482|Units Jul/02|4|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Aug/02|19|USD Sales Aug/02|19|LC Sales Aug/02|592|Units Aug/02|5|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Sep/02|4|USD Sales Sep/02|4|LC Sales Sep/02|120|Units Sep/02|1|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Oct/02|31|USD Sales Oct/02|31|LC Sales Oct/02|958|Units Oct/02|8|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Nov/02|61|USD Sales Nov/02|62|LC Sales Nov/02|1888|Units Nov/02|16|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Dec/02|51|USD Sales Dec/02|51|LC Sales Dec/02|1572|Units Dec/02|13|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jan/03|61|USD Sales Jan/03|65|LC Sales Jan/03|1934|Units Jan/03|16|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Feb/03|42|USD Sales Feb/03|45|LC Sales Feb/03|1330|Units Feb/03|11|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Mar/03|57|USD Sales Mar/03|62|LC Sales Mar/03|1814|Units Mar/03|15|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Apr/03|66|USD Sales Apr/03|71|LC Sales Apr/03|2083|Units Apr/03|17|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales May/03|40|USD Sales May/03|47|LC Sales May/03|1262|Units May/03|9|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jun/03|49|USD Sales Jun/03|57|LC Sales Jun/03|1530|Units Jun/03|11|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jul/03|63|USD Sales Jul/03|72|LC Sales Jul/03|2009|Units Jul/03|14|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Aug/03|26|USD Sales Aug/03|29|LC Sales Aug/03|834|Units Aug/03|6|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Sep/03|126|USD Sales Sep/03|141|LC Sales Sep/03|4082|Units Sep/03|27|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Oct/03|65|USD Sales Oct/03|76|LC Sales Oct/03|2085|Units Oct/03|14|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Nov/03|43|USD Sales Nov/03|50|LC Sales Nov/03|1359|Units Nov/03|9|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Dec/03|65|USD Sales Dec/03|79|LC Sales Dec/03|2090|Units Dec/03|14|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jan/04|23|USD Sales Jan/04|29|LC Sales Jan/04|752|Units Jan/04|5|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Feb/04|73|USD Sales Feb/04|92|LC Sales Feb/04|2382|Units Feb/04|16|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Mar/04|27|USD Sales Mar/04|33|LC Sales Mar/04|890|Units Mar/04|6|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Apr/04|18|USD Sales Apr/04|22|LC Sales Apr/04|594|Units Apr/04|4|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales May/04|28|USD Sales May/04|33|LC Sales May/04|891|Units May/04|6|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jun/04|19|USD Sales Jun/04|23|LC Sales Jun/04|594|Units Jun/04|4|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jul/04|33|USD Sales Jul/04|40|LC Sales Jul/04|1040|Units Jul/04|7|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Aug/04|23|USD Sales Aug/04|29|LC Sales Aug/04|743|Units Aug/04|5|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Sep/04|28|USD Sales Sep/04|34|LC Sales Sep/04|889|Units Sep/04|6|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Oct/04|75|USD Sales Oct/04|94|LC Sales Oct/04|2365|Units Oct/04|16|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Nov/04|24|USD Sales Nov/04|31|LC Sales Nov/04|738|Units Nov/04|5|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Dec/04|29|USD Sales Dec/04|39|LC Sales Dec/04|889|Units Dec/04|6|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jan/05|24|USD Sales Jan/05|32|LC Sales Jan/05|740|Units Jan/05|5|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Feb/05|64|USD Sales Feb/05|83|LC Sales Feb/05|1921|Units Feb/05|13|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Mar/05|35|USD Sales Mar/05|46|LC Sales Mar/05|1035|Units Mar/05|7|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Apr/05|59|USD Sales Apr/05|77|LC Sales Apr/05|1781|Units Apr/05|12|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales May/05|49|USD Sales May/05|62|LC Sales May/05|1487|Units May/05|10|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jun/05|49|USD Sales Jun/05|60|LC Sales Jun/05|1483|Units Jun/05|10|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jul/05|15|USD Sales Jul/05|18|LC Sales Jul/05|443|Units Jul/05|3|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Aug/05|60|USD Sales Aug/05|74|LC Sales Aug/05|1786|Units Aug/05|12|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Sep/05|66|USD Sales Sep/05|81|LC Sales Sep/05|1932|Units Sep/05|13|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Oct/05|130|USD Sales Oct/05|156|LC Sales Oct/05|3856|Units Oct/05|26|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Nov/05|30|USD Sales Nov/05|36|LC Sales Nov/05|890|Units Nov/05|6|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Dec/05|10|USD Sales Dec/05|12|LC Sales Dec/05|297|Units Dec/05|2|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jan/06|72|USD Sales Jan/06|88|LC Sales Jan/06|2079|Units Jan/06|14|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Feb/06|73|USD Sales Feb/06|87|LC Sales Feb/06|2079|Units Feb/06|14|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Mar/06|78|USD Sales Mar/06|94|LC Sales Mar/06|2228|Units Mar/06|15|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Apr/06|31|USD Sales Apr/06|38|LC Sales Apr/06|891|Units Apr/06|6|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales May/06|5|USD Sales May/06|7|LC Sales May/06|149|Units May/06|1|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jun/06|58|USD Sales Jun/06|73|LC Sales Jun/06|1634|Units Jun/06|11|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Jul/06|52|USD Sales Jul/06|66|LC Sales Jul/06|1485|Units Jul/06|10|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Aug/06|26|USD Sales Aug/06|34|LC Sales Aug/06|743|Units Aug/06|5|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Sep/06|68|USD Sales Sep/06|87|LC Sales Sep/06|1931|Units Sep/06|13|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GABA|COLGATE-PALMOLIVE|GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1982|1982/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|9|145.5|203.2|EURO Sales Oct/06|72|USD Sales Oct/06|91|LC Sales Oct/06|2037|Units Oct/06|14|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|JEL. 1 25 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1996|1996/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|10|61.8|83.6|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|SOLUT. 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/01|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|11|93.2|126.2|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Dec/01|11|USD Sales Dec/01|10|LC Sales Dec/01|346|Units Dec/01|8|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Feb/02|13|USD Sales Feb/02|12|LC Sales Feb/02|424|Units Feb/02|10|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Mar/02|4|USD Sales Mar/02|3|LC Sales Mar/02|124|Units Mar/02|3|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Apr/02|7|USD Sales Apr/02|6|LC Sales Apr/02|204|Units Apr/02|5|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales May/02|3|USD Sales May/02|2|LC Sales May/02|81|Units May/02|2|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jun/02|7|USD Sales Jun/02|6|LC Sales Jun/02|203|Units Jun/02|5|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jul/02|8|USD Sales Jul/02|8|LC Sales Jul/02|243|Units Jul/02|6|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Aug/02|4|USD Sales Aug/02|4|LC Sales Aug/02|123|Units Aug/02|3|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GALENA GABA|TEVA|GALENA GABA|ELMEX|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1995|1995/10|0.00|0.00|COMBI|DECTAFLUR;OLAFLUR|12|41.5|56.2|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Nov/01|1950|USD Sales Nov/01|1732|LC Sales Nov/01|64811|Units Nov/01|654|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Dec/01|1198|USD Sales Dec/01|1070|LC Sales Dec/01|38847|Units Dec/01|392|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jan/02|1864|USD Sales Jan/02|1646|LC Sales Jan/02|59796|Units Jan/02|604|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Feb/02|1542|USD Sales Feb/02|1341|LC Sales Feb/02|48955|Units Feb/02|494|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Mar/02|1452|USD Sales Mar/02|1271|LC Sales Mar/02|45540|Units Mar/02|460|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Apr/02|2016|USD Sales Apr/02|1786|LC Sales Apr/02|61244|Units Apr/02|618|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales May/02|1855|USD Sales May/02|1702|LC Sales May/02|56784|Units May/02|573|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jun/02|1790|USD Sales Jun/02|1711|LC Sales Jun/02|54208|Units Jun/02|547|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jul/02|2155|USD Sales Jul/02|2138|LC Sales Jul/02|64217|Units Jul/02|648|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Aug/02|1409|USD Sales Aug/02|1377|LC Sales Aug/02|43406|Units Aug/02|438|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Sep/02|2616|USD Sales Sep/02|2565|LC Sales Sep/02|78983|Units Sep/02|797|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Oct/02|2017|USD Sales Oct/02|1978|LC Sales Oct/02|61739|Units Oct/02|623|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Nov/02|1806|USD Sales Nov/02|1809|LC Sales Nov/02|55496|Units Nov/02|560|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Dec/02|1558|USD Sales Dec/02|1583|LC Sales Dec/02|48460|Units Dec/02|489|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jan/03|2026|USD Sales Jan/03|2151|LC Sales Jan/03|63721|Units Jan/03|643|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Feb/03|2163|USD Sales Feb/03|2330|LC Sales Feb/03|68379|Units Feb/03|690|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Mar/03|1709|USD Sales Mar/03|1846|LC Sales Mar/03|54208|Units Mar/03|547|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Apr/03|1724|USD Sales Apr/03|1870|LC Sales Apr/03|54505|Units Apr/03|550|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales May/03|1712|USD Sales May/03|1980|LC Sales May/03|53712|Units May/03|542|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jun/03|1830|USD Sales Jun/03|2134|LC Sales Jun/03|57469|Units Jun/03|569|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jul/03|1739|USD Sales Jul/03|1978|LC Sales Jul/03|55372|Units Jul/03|545|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Aug/03|1753|USD Sales Aug/03|1952|LC Sales Aug/03|56555|Units Aug/03|555|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Sep/03|1617|USD Sales Sep/03|1811|LC Sales Sep/03|52326|Units Sep/03|513|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Oct/03|2087|USD Sales Oct/03|2441|LC Sales Oct/03|66708|Units Oct/03|654|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Nov/03|1792|USD Sales Nov/03|2097|LC Sales Nov/03|57268|Units Nov/03|562|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Dec/03|1826|USD Sales Dec/03|2241|LC Sales Dec/03|58956|Units Dec/03|578|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jan/04|2082|USD Sales Jan/04|2626|LC Sales Jan/04|68136|Units Jan/04|668|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Feb/04|2059|USD Sales Feb/04|2603|LC Sales Feb/04|67626|Units Feb/04|663|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Mar/04|2271|USD Sales Mar/04|2786|LC Sales Mar/04|74868|Units Mar/04|734|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Apr/04|1848|USD Sales Apr/04|2215|LC Sales Apr/04|60078|Units Apr/04|589|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales May/04|2503|USD Sales May/04|3004|LC Sales May/04|80070|Units May/04|785|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jun/04|2239|USD Sales Jun/04|2718|LC Sales Jun/04|70788|Units Jun/04|694|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jul/04|1672|USD Sales Jul/04|2051|LC Sales Jul/04|52734|Units Jul/04|517|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Aug/04|1719|USD Sales Aug/04|2093|LC Sales Aug/04|54366|Units Aug/04|533|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Sep/04|2954|USD Sales Sep/04|3608|LC Sales Sep/04|93330|Units Sep/04|915|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Oct/04|1885|USD Sales Oct/04|2355|LC Sales Oct/04|59364|Units Oct/04|582|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Nov/04|2360|USD Sales Nov/04|3066|LC Sales Nov/04|73848|Units Nov/04|724|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Dec/04|1880|USD Sales Dec/04|2519|LC Sales Dec/04|57630|Units Dec/04|565|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jan/05|2905|USD Sales Jan/05|3814|LC Sales Jan/05|88026|Units Jan/05|863|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Feb/05|3434|USD Sales Feb/05|4470|LC Sales Feb/05|102918|Units Feb/05|1009|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Mar/05|2440|USD Sales Mar/05|3223|LC Sales Mar/05|72655|Units Mar/05|713|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Apr/05|2357|USD Sales Apr/05|3050|LC Sales Apr/05|70992|Units Apr/05|696|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales May/05|2401|USD Sales May/05|3047|LC Sales May/05|72624|Units May/05|712|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jun/05|2477|USD Sales Jun/05|3014|LC Sales Jun/05|74401|Units Jun/05|747|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jul/05|2029|USD Sales Jul/05|2443|LC Sales Jul/05|61219|Units Jul/05|619|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Aug/05|2644|USD Sales Aug/05|3250|LC Sales Aug/05|78210|Units Aug/05|790|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Sep/05|3033|USD Sales Sep/05|3717|LC Sales Sep/05|88911|Units Sep/05|899|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Oct/05|3006|USD Sales Oct/05|3614|LC Sales Oct/05|89208|Units Oct/05|902|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Nov/05|2424|USD Sales Nov/05|2857|LC Sales Nov/05|70938|Units Nov/05|718|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Dec/05|2470|USD Sales Dec/05|2930|LC Sales Dec/05|71531|Units Dec/05|724|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jan/06|3015|USD Sales Jan/06|3649|LC Sales Jan/06|86571|Units Jan/06|878|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Feb/06|3052|USD Sales Feb/06|3647|LC Sales Feb/06|86779|Units Feb/06|881|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Mar/06|2930|USD Sales Mar/06|3523|LC Sales Mar/06|83909|Units Mar/06|851|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Apr/06|2657|USD Sales Apr/06|3258|LC Sales Apr/06|75747|Units Apr/06|769|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales May/06|3320|USD Sales May/06|4238|LC Sales May/06|93879|Units May/06|956|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jun/06|2696|USD Sales Jun/06|3414|LC Sales Jun/06|76496|Units Jun/06|796|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Jul/06|2047|USD Sales Jul/06|2597|LC Sales Jul/06|58228|Units Jul/06|611|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Aug/06|3068|USD Sales Aug/06|3931|LC Sales Aug/06|86507|Units Aug/06|903|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Sep/06|3648|USD Sales Sep/06|4646|LC Sales Sep/06|103560|Units Sep/06|1081|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|CORSODYL|0200MG|LIQUID 200 MG 1 300 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1999|1999/05|0.00|0.00|MONO|CHLORHEXIDINE|13|95.8|133.8|EURO Sales Oct/06|4051|USD Sales Oct/06|5111|LC Sales Oct/06|114577|Units Oct/06|1196|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Nov/01|135|USD Sales Nov/01|120|LC Sales Nov/01|4485|Units Nov/01|65|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Dec/01|121|USD Sales Dec/01|108|LC Sales Dec/01|3933|Units Dec/01|57|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jan/02|60|USD Sales Jan/02|53|LC Sales Jan/02|1932|Units Jan/02|28|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Feb/02|46|USD Sales Feb/02|40|LC Sales Feb/02|1449|Units Feb/02|21|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Mar/02|132|USD Sales Mar/02|115|LC Sales Mar/02|4134|Units Mar/02|60|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Apr/02|102|USD Sales Apr/02|90|LC Sales Apr/02|3092|Units Apr/02|45|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales May/02|138|USD Sales May/02|126|LC Sales May/02|4209|Units May/02|61|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jun/02|100|USD Sales Jun/02|96|LC Sales Jun/02|3036|Units Jun/02|44|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jul/02|134|USD Sales Jul/02|133|LC Sales Jul/02|4002|Units Jul/02|58|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Aug/02|38|USD Sales Aug/02|37|LC Sales Aug/02|1173|Units Aug/02|17|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Oct/02|144|USD Sales Oct/02|141|LC Sales Oct/02|4416|Units Oct/02|64|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Nov/02|144|USD Sales Nov/02|144|LC Sales Nov/02|4416|Units Nov/02|64|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Dec/02|73|USD Sales Dec/02|74|LC Sales Dec/02|2277|Units Dec/02|33|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jan/03|97|USD Sales Jan/03|103|LC Sales Jan/03|3036|Units Jan/03|44|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Feb/03|79|USD Sales Feb/03|85|LC Sales Feb/03|2484|Units Feb/03|36|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Mar/03|109|USD Sales Mar/03|118|LC Sales Mar/03|3450|Units Mar/03|50|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Apr/03|116|USD Sales Apr/03|125|LC Sales Apr/03|3657|Units Apr/03|53|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales May/03|128|USD Sales May/03|148|LC Sales May/03|4002|Units May/03|58|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jun/03|174|USD Sales Jun/03|202|LC Sales Jun/03|5451|Units Jun/03|79|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jul/03|115|USD Sales Jul/03|131|LC Sales Jul/03|3657|Units Jul/03|53|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Aug/03|64|USD Sales Aug/03|71|LC Sales Aug/03|2070|Units Aug/03|30|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Sep/03|98|USD Sales Sep/03|110|LC Sales Sep/03|3174|Units Sep/03|46|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Oct/03|140|USD Sales Oct/03|164|LC Sales Oct/03|4485|Units Oct/03|65|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Nov/03|50|USD Sales Nov/03|58|LC Sales Nov/03|1587|Units Nov/03|23|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Dec/03|113|USD Sales Dec/03|139|LC Sales Dec/03|3657|Units Dec/03|53|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jan/04|129|USD Sales Jan/04|162|LC Sales Jan/04|4209|Units Jan/04|61|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Feb/04|92|USD Sales Feb/04|117|LC Sales Feb/04|3036|Units Feb/04|44|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Mar/04|149|USD Sales Mar/04|182|LC Sales Mar/04|4899|Units Mar/04|71|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Apr/04|136|USD Sales Apr/04|163|LC Sales Apr/04|4416|Units Apr/04|64|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales May/04|108|USD Sales May/04|129|LC Sales May/04|3450|Units May/04|50|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jun/04|72|USD Sales Jun/04|87|LC Sales Jun/04|2277|Units Jun/04|33|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jul/04|7|USD Sales Jul/04|8|LC Sales Jul/04|207|Units Jul/04|3|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|INFUSIA|INFUSIA|INFUSIA|SYSTOGEN|0000|PWDR SOLUBL 1 20 G|K ORAL TOPICAL|KE ORAL TOP POWDERS/GRANULES|KEK ORAL TOP SOLUBLE POWDER|NON-RX BOUND|1990|1990/01|0.00|0.00|COMBI|CARMELLOSE;CELLULOSE|14|70|94.8|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|CHIRON MEDICOM|SALAGEN|0005MG|C.TAB 5 MG 84|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/03|28.00|15.00 MG|MONO|PILOCARPINE|15|2804.5|3795.5|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Nov/01|117|USD Sales Nov/01|104|LC Sales Nov/01|3888|Units Nov/01|54|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Dec/01|82|USD Sales Dec/01|73|LC Sales Dec/01|2664|Units Dec/01|37|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jan/02|76|USD Sales Jan/02|67|LC Sales Jan/02|2448|Units Jan/02|34|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Feb/02|79|USD Sales Feb/02|69|LC Sales Feb/02|2520|Units Feb/02|35|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Mar/02|165|USD Sales Mar/02|145|LC Sales Mar/02|5184|Units Mar/02|72|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Apr/02|161|USD Sales Apr/02|143|LC Sales Apr/02|4896|Units Apr/02|68|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales May/02|111|USD Sales May/02|101|LC Sales May/02|3384|Units May/02|47|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jun/02|197|USD Sales Jun/02|189|LC Sales Jun/02|5976|Units Jun/02|83|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jul/02|159|USD Sales Jul/02|158|LC Sales Jul/02|4752|Units Jul/02|66|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Aug/02|103|USD Sales Aug/02|100|LC Sales Aug/02|3168|Units Aug/02|44|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Sep/02|131|USD Sales Sep/02|129|LC Sales Sep/02|3960|Units Sep/02|55|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Oct/02|157|USD Sales Oct/02|154|LC Sales Oct/02|4796|Units Oct/02|69|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Nov/02|104|USD Sales Nov/02|104|LC Sales Nov/02|3185|Units Nov/02|49|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Dec/02|58|USD Sales Dec/02|59|LC Sales Dec/02|1792|Units Dec/02|28|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jan/03|129|USD Sales Jan/03|137|LC Sales Jan/03|4070|Units Jan/03|64|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Feb/03|95|USD Sales Feb/03|102|LC Sales Feb/03|2989|Units Feb/03|47|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Mar/03|80|USD Sales Mar/03|87|LC Sales Mar/03|2544|Units Mar/03|40|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Apr/03|127|USD Sales Apr/03|137|LC Sales Apr/03|4007|Units Apr/03|63|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales May/03|249|USD Sales May/03|288|LC Sales May/03|7823|Units May/03|123|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jun/03|137|USD Sales Jun/03|160|LC Sales Jun/03|4311|Units Jun/03|68|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jul/03|136|USD Sales Jul/03|154|LC Sales Jul/03|4325|Units Jul/03|68|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Aug/03|93|USD Sales Aug/03|103|LC Sales Aug/03|2989|Units Aug/03|47|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Sep/03|102|USD Sales Sep/03|114|LC Sales Sep/03|3307|Units Sep/03|52|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Oct/03|92|USD Sales Oct/03|107|LC Sales Oct/03|2926|Units Oct/03|46|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Nov/03|70|USD Sales Nov/03|82|LC Sales Nov/03|2226|Units Nov/03|35|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Dec/03|61|USD Sales Dec/03|75|LC Sales Dec/03|1975|Units Dec/03|31|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jan/04|72|USD Sales Jan/04|91|LC Sales Jan/04|2357|Units Jan/04|37|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Feb/04|58|USD Sales Feb/04|73|LC Sales Feb/04|1908|Units Feb/04|30|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Mar/04|106|USD Sales Mar/04|130|LC Sales Mar/04|3504|Units Mar/04|55|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Apr/04|94|USD Sales Apr/04|113|LC Sales Apr/04|3053|Units Apr/04|48|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales May/04|72|USD Sales May/04|86|LC Sales May/04|2290|Units May/04|36|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jun/04|111|USD Sales Jun/04|134|LC Sales Jun/04|3498|Units Jun/04|55|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jul/04|85|USD Sales Jul/04|104|LC Sales Jul/04|2671|Units Jul/04|42|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Aug/04|66|USD Sales Aug/04|81|LC Sales Aug/04|2099|Units Aug/04|33|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Sep/04|58|USD Sales Sep/04|71|LC Sales Sep/04|1844|Units Sep/04|29|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Oct/04|85|USD Sales Oct/04|106|LC Sales Oct/04|2671|Units Oct/04|42|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Nov/04|53|USD Sales Nov/04|69|LC Sales Nov/04|1654|Units Nov/04|26|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Dec/04|100|USD Sales Dec/04|133|LC Sales Dec/04|3053|Units Dec/04|48|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jan/05|128|USD Sales Jan/05|168|LC Sales Jan/05|3880|Units Jan/05|61|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Feb/05|83|USD Sales Feb/05|108|LC Sales Feb/05|2480|Units Feb/05|39|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Mar/05|94|USD Sales Mar/05|124|LC Sales Mar/05|2798|Units Mar/05|44|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Apr/05|84|USD Sales Apr/05|109|LC Sales Apr/05|2544|Units Apr/05|40|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales May/05|103|USD Sales May/05|131|LC Sales May/05|3116|Units May/05|49|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jun/05|59|USD Sales Jun/05|72|LC Sales Jun/05|1781|Units Jun/05|28|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jul/05|51|USD Sales Jul/05|61|LC Sales Jul/05|1526|Units Jul/05|24|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Aug/05|80|USD Sales Aug/05|98|LC Sales Aug/05|2353|Units Aug/05|37|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Sep/05|69|USD Sales Sep/05|85|LC Sales Sep/05|2035|Units Sep/05|32|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Oct/05|34|USD Sales Oct/05|41|LC Sales Oct/05|1018|Units Oct/05|16|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Nov/05|76|USD Sales Nov/05|90|LC Sales Nov/05|2226|Units Nov/05|35|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Dec/05|75|USD Sales Dec/05|89|LC Sales Dec/05|2162|Units Dec/05|34|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jan/06|78|USD Sales Jan/06|94|LC Sales Jan/06|2226|Units Jan/06|35|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Feb/06|86|USD Sales Feb/06|103|LC Sales Feb/06|2441|Units Feb/06|39|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Mar/06|77|USD Sales Mar/06|92|LC Sales Mar/06|2198|Units Mar/06|35|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Apr/06|58|USD Sales Apr/06|71|LC Sales Apr/06|1654|Units Apr/06|26|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales May/06|69|USD Sales May/06|88|LC Sales May/06|1944|Units May/06|31|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jun/06|29|USD Sales Jun/06|36|LC Sales Jun/06|815|Units Jun/06|13|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Jul/06|69|USD Sales Jul/06|88|LC Sales Jul/06|1972|Units Jul/06|31|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Aug/06|85|USD Sales Aug/06|109|LC Sales Aug/06|2399|Units Aug/06|39|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Sep/06|62|USD Sales Sep/06|79|LC Sales Sep/06|1753|Units Sep/06|28|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEDICOM INT.*|MEDICOM|MEDICOM|TANTUM VERDE|00.5%|TOOTHPASTE .5 % 1 40 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|2001|2001/09|0.00|0.00|MONO|BENZYDAMINE|16|62.2|86.9|EURO Sales Oct/06|64|USD Sales Oct/06|80|LC Sales Oct/06|1804|Units Oct/06|29|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Nov/01|282|USD Sales Nov/01|251|LC Sales Nov/01|9379|Units Nov/01|539|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Dec/01|262|USD Sales Dec/01|234|LC Sales Dec/01|8501|Units Dec/01|483|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jan/02|394|USD Sales Jan/02|348|LC Sales Jan/02|12637|Units Jan/02|739|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Feb/02|307|USD Sales Feb/02|267|LC Sales Feb/02|9741|Units Feb/02|510|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Mar/02|436|USD Sales Mar/02|382|LC Sales Mar/02|13672|Units Mar/02|694|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Apr/02|439|USD Sales Apr/02|389|LC Sales Apr/02|13333|Units Apr/02|670|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales May/02|437|USD Sales May/02|400|LC Sales May/02|13360|Units May/02|668|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jun/02|412|USD Sales Jun/02|394|LC Sales Jun/02|12477|Units Jun/02|627|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jul/02|495|USD Sales Jul/02|491|LC Sales Jul/02|14740|Units Jul/02|737|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Aug/02|311|USD Sales Aug/02|304|LC Sales Aug/02|9572|Units Aug/02|481|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Sep/02|429|USD Sales Sep/02|421|LC Sales Sep/02|12963|Units Sep/02|658|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Oct/02|395|USD Sales Oct/02|388|LC Sales Oct/02|12099|Units Oct/02|608|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Nov/02|389|USD Sales Nov/02|389|LC Sales Nov/02|11940|Units Nov/02|597|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Dec/02|397|USD Sales Dec/02|403|LC Sales Dec/02|12342|Units Dec/02|611|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jan/03|510|USD Sales Jan/03|542|LC Sales Jan/03|16059|Units Jan/03|795|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Feb/03|282|USD Sales Feb/03|303|LC Sales Feb/03|8904|Units Feb/03|443|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Mar/03|417|USD Sales Mar/03|450|LC Sales Mar/03|13215|Units Mar/03|651|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Apr/03|394|USD Sales Apr/03|427|LC Sales Apr/03|12461|Units Apr/03|569|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales May/03|420|USD Sales May/03|486|LC Sales May/03|13179|Units May/03|573|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jun/03|397|USD Sales Jun/03|463|LC Sales Jun/03|12480|Units Jun/03|520|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jul/03|462|USD Sales Jul/03|526|LC Sales Jul/03|14722|Units Jul/03|616|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Aug/03|380|USD Sales Aug/03|423|LC Sales Aug/03|12253|Units Aug/03|517|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Sep/03|442|USD Sales Sep/03|495|LC Sales Sep/03|14291|Units Sep/03|603|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Oct/03|363|USD Sales Oct/03|424|LC Sales Oct/03|11589|Units Oct/03|489|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Nov/03|357|USD Sales Nov/03|418|LC Sales Nov/03|11423|Units Nov/03|482|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Dec/03|453|USD Sales Dec/03|556|LC Sales Dec/03|14623|Units Dec/03|617|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jan/04|475|USD Sales Jan/04|599|LC Sales Jan/04|15552|Units Jan/04|648|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Feb/04|407|USD Sales Feb/04|515|LC Sales Feb/04|13383|Units Feb/04|553|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Mar/04|547|USD Sales Mar/04|671|LC Sales Mar/04|18025|Units Mar/04|721|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Apr/04|480|USD Sales Apr/04|576|LC Sales Apr/04|15610|Units Apr/04|617|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales May/04|453|USD Sales May/04|544|LC Sales May/04|14508|Units May/04|558|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jun/04|531|USD Sales Jun/04|645|LC Sales Jun/04|16796|Units Jun/04|651|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jul/04|483|USD Sales Jul/04|593|LC Sales Jul/04|15242|Units Jul/04|584|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Aug/04|487|USD Sales Aug/04|593|LC Sales Aug/04|15391|Units Aug/04|583|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Sep/04|536|USD Sales Sep/04|654|LC Sales Sep/04|16926|Units Sep/04|651|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Oct/04|493|USD Sales Oct/04|615|LC Sales Oct/04|15510|Units Oct/04|592|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Nov/04|559|USD Sales Nov/04|727|LC Sales Nov/04|17502|Units Nov/04|668|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Dec/04|616|USD Sales Dec/04|826|LC Sales Dec/04|18896|Units Dec/04|724|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jan/05|673|USD Sales Jan/05|883|LC Sales Jan/05|20384|Units Jan/05|781|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Feb/05|598|USD Sales Feb/05|779|LC Sales Feb/05|17935|Units Feb/05|636|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Mar/05|618|USD Sales Mar/05|817|LC Sales Mar/05|18406|Units Mar/05|655|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Apr/05|592|USD Sales Apr/05|766|LC Sales Apr/05|17841|Units Apr/05|626|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales May/05|604|USD Sales May/05|766|LC Sales May/05|18269|Units May/05|641|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jun/05|633|USD Sales Jun/05|770|LC Sales Jun/05|19000|Units Jun/05|669|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jul/05|547|USD Sales Jul/05|658|LC Sales Jul/05|16502|Units Jul/05|577|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Aug/05|662|USD Sales Aug/05|814|LC Sales Aug/05|19591|Units Aug/05|685|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Sep/05|647|USD Sales Sep/05|793|LC Sales Sep/05|18962|Units Sep/05|663|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Oct/05|535|USD Sales Oct/05|643|LC Sales Oct/05|15876|Units Oct/05|559|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Nov/05|576|USD Sales Nov/05|678|LC Sales Nov/05|16845|Units Nov/05|589|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Dec/05|609|USD Sales Dec/05|723|LC Sales Dec/05|17646|Units Dec/05|617|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jan/06|754|USD Sales Jan/06|913|LC Sales Jan/06|21660|Units Jan/06|760|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Feb/06|816|USD Sales Feb/06|975|LC Sales Feb/06|23209|Units Feb/06|756|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Mar/06|902|USD Sales Mar/06|1084|LC Sales Mar/06|25826|Units Mar/06|844|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Apr/06|734|USD Sales Apr/06|900|LC Sales Apr/06|20919|Units Apr/06|677|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales May/06|707|USD Sales May/06|903|LC Sales May/06|19992|Units May/06|647|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jun/06|802|USD Sales Jun/06|1015|LC Sales Jun/06|22754|Units Jun/06|734|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Jul/06|608|USD Sales Jul/06|771|LC Sales Jul/06|17294|Units Jul/06|567|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Aug/06|813|USD Sales Aug/06|1041|LC Sales Aug/06|22921|Units Aug/06|737|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Sep/06|708|USD Sales Sep/06|901|LC Sales Sep/06|20088|Units Sep/06|648|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MEMSEP|MEMSEP|MEMSEP|HERBADENT|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|COMBI|BENZOCAINE;BORIC ACID;CITRIC ACID;RUTA GRAVEOLENS;SALICYLIC ACID|17|31|43.3|EURO Sales Oct/06|742|USD Sales Oct/06|936|LC Sales Oct/06|20987|Units Oct/06|677|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Nov/01|197|USD Sales Nov/01|175|LC Sales Nov/01|6555|Units Nov/01|115|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Dec/01|279|USD Sales Dec/01|249|LC Sales Dec/01|9048|Units Dec/01|156|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jan/02|256|USD Sales Jan/02|226|LC Sales Jan/02|8208|Units Jan/02|143|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Feb/02|287|USD Sales Feb/02|250|LC Sales Feb/02|9127|Units Feb/02|159|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Mar/02|271|USD Sales Mar/02|237|LC Sales Mar/02|8495|Units Mar/02|148|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Apr/02|371|USD Sales Apr/02|328|LC Sales Apr/02|11263|Units Apr/02|199|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales May/02|344|USD Sales May/02|315|LC Sales May/02|10519|Units May/02|193|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jun/02|430|USD Sales Jun/02|411|LC Sales Jun/02|13013|Units Jun/02|246|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jul/02|421|USD Sales Jul/02|417|LC Sales Jul/02|12536|Units Jul/02|242|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Aug/02|293|USD Sales Aug/02|286|LC Sales Aug/02|9027|Units Aug/02|177|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Sep/02|315|USD Sales Sep/02|309|LC Sales Sep/02|9507|Units Sep/02|189|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Oct/02|282|USD Sales Oct/02|277|LC Sales Oct/02|8630|Units Oct/02|174|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Nov/02|290|USD Sales Nov/02|290|LC Sales Nov/02|8903|Units Nov/02|177|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Dec/02|344|USD Sales Dec/02|349|LC Sales Dec/02|10698|Units Dec/02|211|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jan/03|374|USD Sales Jan/03|398|LC Sales Jan/03|11781|Units Jan/03|231|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Feb/03|214|USD Sales Feb/03|230|LC Sales Feb/03|6756|Units Feb/03|133|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Mar/03|272|USD Sales Mar/03|294|LC Sales Mar/03|8626|Units Mar/03|164|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Apr/03|280|USD Sales Apr/03|304|LC Sales Apr/03|8856|Units Apr/03|164|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales May/03|426|USD Sales May/03|493|LC Sales May/03|13371|Units May/03|249|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jun/03|373|USD Sales Jun/03|435|LC Sales Jun/03|11713|Units Jun/03|221|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jul/03|375|USD Sales Jul/03|426|LC Sales Jul/03|11933|Units Jul/03|226|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Aug/03|296|USD Sales Aug/03|329|LC Sales Aug/03|9539|Units Aug/03|181|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Sep/03|343|USD Sales Sep/03|384|LC Sales Sep/03|11107|Units Sep/03|208|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Oct/03|349|USD Sales Oct/03|408|LC Sales Oct/03|11149|Units Oct/03|208|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Nov/03|269|USD Sales Nov/03|315|LC Sales Nov/03|8592|Units Nov/03|160|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Dec/03|344|USD Sales Dec/03|423|LC Sales Dec/03|11116|Units Dec/03|207|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jan/04|330|USD Sales Jan/04|416|LC Sales Jan/04|10794|Units Jan/04|201|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Feb/04|340|USD Sales Feb/04|431|LC Sales Feb/04|11185|Units Feb/04|203|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Mar/04|418|USD Sales Mar/04|512|LC Sales Mar/04|13770|Units Mar/04|249|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Apr/04|407|USD Sales Apr/04|488|LC Sales Apr/04|13241|Units Apr/04|239|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales May/04|544|USD Sales May/04|653|LC Sales May/04|17403|Units May/04|313|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jun/04|592|USD Sales Jun/04|718|LC Sales Jun/04|18707|Units Jun/04|342|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jul/04|536|USD Sales Jul/04|657|LC Sales Jul/04|16895|Units Jul/04|310|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Aug/04|555|USD Sales Aug/04|676|LC Sales Aug/04|17550|Units Aug/04|325|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Sep/04|571|USD Sales Sep/04|697|LC Sales Sep/04|18036|Units Sep/04|334|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Oct/04|462|USD Sales Oct/04|577|LC Sales Oct/04|14553|Units Oct/04|271|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Nov/04|594|USD Sales Nov/04|771|LC Sales Nov/04|18580|Units Nov/04|346|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Dec/04|613|USD Sales Dec/04|822|LC Sales Dec/04|18797|Units Dec/04|352|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jan/05|582|USD Sales Jan/05|764|LC Sales Jan/05|17642|Units Jan/05|331|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Feb/05|532|USD Sales Feb/05|692|LC Sales Feb/05|15937|Units Feb/05|299|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Mar/05|521|USD Sales Mar/05|688|LC Sales Mar/05|15514|Units Mar/05|303|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Apr/05|580|USD Sales Apr/05|751|LC Sales Apr/05|17475|Units Apr/05|344|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales May/05|641|USD Sales May/05|813|LC Sales May/05|19388|Units May/05|375|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jun/05|759|USD Sales Jun/05|923|LC Sales Jun/05|22794|Units Jun/05|393|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jul/05|730|USD Sales Jul/05|879|LC Sales Jul/05|22037|Units Jul/05|371|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Aug/05|808|USD Sales Aug/05|994|LC Sales Aug/05|23919|Units Aug/05|402|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Sep/05|738|USD Sales Sep/05|905|LC Sales Sep/05|21635|Units Sep/05|363|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Oct/05|620|USD Sales Oct/05|745|LC Sales Oct/05|18388|Units Oct/05|308|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Nov/05|636|USD Sales Nov/05|749|LC Sales Nov/05|18602|Units Nov/05|309|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Dec/05|728|USD Sales Dec/05|863|LC Sales Dec/05|21074|Units Dec/05|353|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jan/06|843|USD Sales Jan/06|1021|LC Sales Jan/06|24217|Units Jan/06|407|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Feb/06|695|USD Sales Feb/06|830|LC Sales Feb/06|19747|Units Feb/06|333|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Mar/06|934|USD Sales Mar/06|1124|LC Sales Mar/06|26760|Units Mar/06|459|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Apr/06|897|USD Sales Apr/06|1101|LC Sales Apr/06|25585|Units Apr/06|412|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales May/06|1034|USD Sales May/06|1320|LC Sales May/06|29240|Units May/06|430|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jun/06|1001|USD Sales Jun/06|1267|LC Sales Jun/06|28400|Units Jun/06|411|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Jul/06|455|USD Sales Jul/06|577|LC Sales Jul/06|12931|Units Jul/06|191|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Aug/06|280|USD Sales Aug/06|359|LC Sales Aug/06|7897|Units Aug/06|123|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Sep/06|1131|USD Sales Sep/06|1440|LC Sales Sep/06|32096|Units Sep/06|472|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|MUNDIPHARMA|MUNDI INT|MUNDIPHARMA|MUNDISAL|0000|JEL. 1 8 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1994|1994/07|0.00|0.00|MONO|SALICYLIC ACID|18|67.8|94.7|EURO Sales Oct/06|829|USD Sales Oct/06|1047|LC Sales Oct/06|23459|Units Oct/06|346|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Nov/01|221|USD Sales Nov/01|197|LC Sales Nov/01|7360|Units Nov/01|12|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Dec/01|247|USD Sales Dec/01|220|LC Sales Dec/01|7992|Units Dec/01|13|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jan/02|307|USD Sales Jan/02|271|LC Sales Jan/02|9837|Units Jan/02|16|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Feb/02|232|USD Sales Feb/02|202|LC Sales Feb/02|7362|Units Feb/02|12|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Mar/02|314|USD Sales Mar/02|275|LC Sales Mar/02|9837|Units Mar/02|16|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Apr/02|162|USD Sales Apr/02|143|LC Sales Apr/02|4918|Units Apr/02|8|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales May/02|341|USD Sales May/02|313|LC Sales May/02|10452|Units May/02|17|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jun/02|203|USD Sales Jun/02|194|LC Sales Jun/02|6147|Units Jun/02|10|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jul/02|407|USD Sales Jul/02|404|LC Sales Jul/02|12122|Units Jul/02|20|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Aug/02|236|USD Sales Aug/02|231|LC Sales Aug/02|7273|Units Aug/02|12|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Sep/02|482|USD Sales Sep/02|472|LC Sales Sep/02|14546|Units Sep/02|24|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Oct/02|297|USD Sales Oct/02|291|LC Sales Oct/02|9092|Units Oct/02|15|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Nov/02|316|USD Sales Nov/02|316|LC Sales Nov/02|9698|Units Nov/02|16|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Dec/02|234|USD Sales Dec/02|238|LC Sales Dec/02|7273|Units Dec/02|12|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jan/03|135|USD Sales Jan/03|143|LC Sales Jan/03|4243|Units Jan/03|7|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Feb/03|230|USD Sales Feb/03|248|LC Sales Feb/03|7273|Units Feb/03|12|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Mar/03|153|USD Sales Mar/03|165|LC Sales Mar/03|4849|Units Mar/03|8|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Apr/03|115|USD Sales Apr/03|125|LC Sales Apr/03|3637|Units Apr/03|6|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales May/03|251|USD Sales May/03|291|LC Sales May/03|7879|Units May/03|13|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jun/03|184|USD Sales Jun/03|214|LC Sales Jun/03|5775|Units Jun/03|10|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jul/03|212|USD Sales Jul/03|241|LC Sales Jul/03|6760|Units Jul/03|13|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Aug/03|193|USD Sales Aug/03|215|LC Sales Aug/03|6240|Units Aug/03|12|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Sep/03|161|USD Sales Sep/03|180|LC Sales Sep/03|5200|Units Sep/03|10|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Oct/03|81|USD Sales Oct/03|95|LC Sales Oct/03|2600|Units Oct/03|5|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Nov/03|163|USD Sales Nov/03|190|LC Sales Nov/03|5200|Units Nov/03|10|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Dec/03|113|USD Sales Dec/03|138|LC Sales Dec/03|3640|Units Dec/03|7|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jan/04|175|USD Sales Jan/04|220|LC Sales Jan/04|5720|Units Jan/04|11|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Feb/04|190|USD Sales Feb/04|240|LC Sales Feb/04|6240|Units Feb/04|12|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Mar/04|142|USD Sales Mar/04|174|LC Sales Mar/04|4680|Units Mar/04|9|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Apr/04|64|USD Sales Apr/04|77|LC Sales Apr/04|2080|Units Apr/04|4|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales May/04|98|USD Sales May/04|117|LC Sales May/04|3120|Units May/04|6|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jun/04|114|USD Sales Jun/04|138|LC Sales Jun/04|3589|Units Jun/04|7|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jul/04|129|USD Sales Jul/04|158|LC Sales Jul/04|4058|Units Jul/04|8|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Aug/04|127|USD Sales Aug/04|154|LC Sales Aug/04|4010|Units Aug/04|8|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Sep/04|112|USD Sales Sep/04|137|LC Sales Sep/04|3540|Units Sep/04|7|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Oct/04|96|USD Sales Oct/04|119|LC Sales Oct/04|3010|Units Oct/04|6|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Nov/04|93|USD Sales Nov/04|121|LC Sales Nov/04|2903|Units Nov/04|6|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Dec/04|205|USD Sales Dec/04|275|LC Sales Dec/04|6291|Units Dec/04|13|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jan/05|527|USD Sales Jan/05|692|LC Sales Jan/05|15969|Units Jan/05|33|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Feb/05|274|USD Sales Feb/05|357|LC Sales Feb/05|8226|Units Feb/05|17|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Mar/05|423|USD Sales Mar/05|558|LC Sales Mar/05|12581|Units Mar/05|26|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Apr/05|400|USD Sales Apr/05|518|LC Sales Apr/05|12058|Units Apr/05|25|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales May/05|159|USD Sales May/05|202|LC Sales May/05|4807|Units May/05|10|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jun/05|272|USD Sales Jun/05|331|LC Sales Jun/05|8176|Units Jun/05|18|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jul/05|89|USD Sales Jul/05|107|LC Sales Jul/05|2694|Units Jul/05|6|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Aug/05|76|USD Sales Aug/05|93|LC Sales Aug/05|2237|Units Aug/05|5|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Sep/05|153|USD Sales Sep/05|187|LC Sales Sep/05|4473|Units Sep/05|10|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Oct/05|30|USD Sales Oct/05|36|LC Sales Oct/05|895|Units Oct/05|2|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Nov/05|367|USD Sales Nov/05|432|LC Sales Nov/05|10735|Units Nov/05|24|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Dec/05|77|USD Sales Dec/05|92|LC Sales Dec/05|2237|Units Dec/05|5|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jan/06|93|USD Sales Jan/06|113|LC Sales Jan/06|2684|Units Jan/06|6|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Feb/06|94|USD Sales Feb/06|113|LC Sales Feb/06|2684|Units Feb/06|6|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Mar/06|203|USD Sales Mar/06|244|LC Sales Mar/06|5815|Units Mar/06|13|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Apr/06|94|USD Sales Apr/06|115|LC Sales Apr/06|2684|Units Apr/06|6|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales May/06|380|USD Sales May/06|485|LC Sales May/06|10735|Units May/06|24|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jun/06|126|USD Sales Jun/06|160|LC Sales Jun/06|3578|Units Jun/06|8|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Jul/06|60|USD Sales Jul/06|76|LC Sales Jul/06|1714|Units Jul/06|4|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Aug/06|213|USD Sales Aug/06|272|LC Sales Aug/06|5996|Units Aug/06|14|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Sep/06|359|USD Sales Sep/06|457|LC Sales Sep/06|10188|Units Sep/06|24|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0000|PASTE 10 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|1995|1995/10|0.00|0.00|MONO|DEXAMETHASONE|19|426.5|587.4|EURO Sales Oct/06|90|USD Sales Oct/06|114|LC Sales Oct/06|2559|Units Oct/06|6|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Dec/02|22|USD Sales Dec/02|22|LC Sales Dec/02|683|Units Dec/02|9|DOT Dec/02|90
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jan/03|87|USD Sales Jan/03|92|LC Sales Jan/03|2732|Units Jan/03|36|DOT Jan/03|360
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Feb/03|72|USD Sales Feb/03|78|LC Sales Feb/03|2277|Units Feb/03|30|DOT Feb/03|300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Mar/03|95|USD Sales Mar/03|103|LC Sales Mar/03|3020|Units Mar/03|45|DOT Mar/03|450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Apr/03|66|USD Sales Apr/03|71|LC Sales Apr/03|2080|Units Apr/03|31|DOT Apr/03|310
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales May/03|190|USD Sales May/03|220|LC Sales May/03|5972|Units May/03|89|DOT May/03|890
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jun/03|96|USD Sales Jun/03|112|LC Sales Jun/03|3020|Units Jun/03|45|DOT Jun/03|450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jul/03|107|USD Sales Jul/03|122|LC Sales Jul/03|3408|Units Jul/03|53|DOT Jul/03|530
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Aug/03|59|USD Sales Aug/03|65|LC Sales Aug/03|1888|Units Aug/03|29|DOT Aug/03|290
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Sep/03|95|USD Sales Sep/03|106|LC Sales Sep/03|3060|Units Sep/03|47|DOT Sep/03|470
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Oct/03|92|USD Sales Oct/03|107|LC Sales Oct/03|2930|Units Oct/03|45|DOT Oct/03|450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Nov/03|24|USD Sales Nov/03|29|LC Sales Nov/03|781|Units Nov/03|12|DOT Nov/03|120
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Dec/03|48|USD Sales Dec/03|59|LC Sales Dec/03|1562|Units Dec/03|24|DOT Dec/03|240
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jan/04|80|USD Sales Jan/04|100|LC Sales Jan/04|2604|Units Jan/04|40|DOT Jan/04|400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Feb/04|10|USD Sales Feb/04|13|LC Sales Feb/04|326|Units Feb/04|5|DOT Feb/04|50
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Mar/04|156|USD Sales Mar/04|191|LC Sales Mar/04|5143|Units Mar/04|79|DOT Mar/04|790
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Apr/04|182|USD Sales Apr/04|218|LC Sales Apr/04|5924|Units Apr/04|91|DOT Apr/04|910
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales May/04|173|USD Sales May/04|208|LC Sales May/04|5534|Units May/04|85|DOT May/04|850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jun/04|161|USD Sales Jun/04|195|LC Sales Jun/04|5079|Units Jun/04|81|DOT Jun/04|810
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jul/04|150|USD Sales Jul/04|184|LC Sales Jul/04|4727|Units Jul/04|78|DOT Jul/04|780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Aug/04|113|USD Sales Aug/04|138|LC Sales Aug/04|3575|Units Aug/04|59|DOT Aug/04|590
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Sep/04|109|USD Sales Sep/04|134|LC Sales Sep/04|3454|Units Sep/04|57|DOT Sep/04|570
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Oct/04|158|USD Sales Oct/04|197|LC Sales Oct/04|4969|Units Oct/04|82|DOT Oct/04|820
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Nov/04|159|USD Sales Nov/04|207|LC Sales Nov/04|4977|Units Nov/04|82|DOT Nov/04|820
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Dec/04|123|USD Sales Dec/04|164|LC Sales Dec/04|3763|Units Dec/04|62|DOT Dec/04|620
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jan/05|24|USD Sales Jan/05|31|LC Sales Jan/05|727|Units Jan/05|12|DOT Jan/05|120
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales May/05|291|USD Sales May/05|369|LC Sales May/05|8787|Units May/05|145|DOT May/05|1450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jun/05|224|USD Sales Jun/05|273|LC Sales Jun/05|6738|Units Jun/05|118|DOT Jun/05|1180
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jul/05|119|USD Sales Jul/05|143|LC Sales Jul/05|3585|Units Jul/05|63|DOT Jul/05|630
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Aug/05|184|USD Sales Aug/05|226|LC Sales Aug/05|5432|Units Aug/05|97|DOT Aug/05|970
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Sep/05|203|USD Sales Sep/05|248|LC Sales Sep/05|5936|Units Sep/05|106|DOT Sep/05|1060
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Oct/05|166|USD Sales Oct/05|200|LC Sales Oct/05|4928|Units Oct/05|88|DOT Oct/05|880
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Nov/05|155|USD Sales Nov/05|183|LC Sales Nov/05|4536|Units Nov/05|81|DOT Nov/05|810
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Dec/05|168|USD Sales Dec/05|200|LC Sales Dec/05|4872|Units Dec/05|87|DOT Dec/05|870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jan/06|216|USD Sales Jan/06|262|LC Sales Jan/06|6216|Units Jan/06|111|DOT Jan/06|1110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Feb/06|152|USD Sales Feb/06|181|LC Sales Feb/06|4312|Units Feb/06|77|DOT Feb/06|770
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Mar/06|182|USD Sales Mar/06|219|LC Sales Mar/06|5208|Units Mar/06|93|DOT Mar/06|930
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Apr/06|210|USD Sales Apr/06|258|LC Sales Apr/06|5992|Units Apr/06|107|DOT Apr/06|1070
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales May/06|212|USD Sales May/06|271|LC Sales May/06|5992|Units May/06|107|DOT May/06|1070
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jun/06|213|USD Sales Jun/06|270|LC Sales Jun/06|6048|Units Jun/06|108|DOT Jun/06|1080
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Jul/06|167|USD Sales Jul/06|212|LC Sales Jul/06|4753|Units Jul/06|89|DOT Jul/06|890
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Aug/06|63|USD Sales Aug/06|80|LC Sales Aug/06|1766|Units Aug/06|32|DOT Aug/06|320
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Sep/06|172|USD Sales Sep/06|219|LC Sales Sep/06|4885|Units Sep/06|92|DOT Sep/06|920
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NIPPON KAYAKO|NIPPON KAYAKU|NIPPON KAYAKO|DEXALTIN|0005MG|PASTE 5 MG 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|RX BOUND|2000|2000/07|10.00|0.50 G|MONO|DEXAMETHASONE|20|52.9|73.9|EURO Sales Oct/06|206|USD Sales Oct/06|260|LC Sales Oct/06|5819|Units Oct/06|110|DOT Oct/06|1100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Nov/01|398|USD Sales Nov/01|354|LC Sales Nov/01|13229|Units Nov/01|208|DOT Nov/01|20800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Dec/01|306|USD Sales Dec/01|273|LC Sales Dec/01|9906|Units Dec/01|156|DOT Dec/01|15600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jan/02|537|USD Sales Jan/02|474|LC Sales Jan/02|17236|Units Jan/02|271|DOT Jan/02|27100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Feb/02|402|USD Sales Feb/02|350|LC Sales Feb/02|12764|Units Feb/02|201|DOT Feb/02|20100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Mar/02|487|USD Sales Mar/02|426|LC Sales Mar/02|15264|Units Mar/02|240|DOT Mar/02|24000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Apr/02|458|USD Sales Apr/02|406|LC Sales Apr/02|13928|Units Apr/02|219|DOT Apr/02|21900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales May/02|754|USD Sales May/02|692|LC Sales May/02|23087|Units May/02|363|DOT May/02|36300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jun/02|386|USD Sales Jun/02|369|LC Sales Jun/02|11702|Units Jun/02|184|DOT Jun/02|18400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jul/02|412|USD Sales Jul/02|409|LC Sales Jul/02|12275|Units Jul/02|193|DOT Jul/02|19300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Aug/02|299|USD Sales Aug/02|293|LC Sales Aug/02|9222|Units Aug/02|145|DOT Aug/02|14500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Sep/02|506|USD Sales Sep/02|496|LC Sales Sep/02|15272|Units Sep/02|239|DOT Sep/02|23900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Oct/02|524|USD Sales Oct/02|514|LC Sales Oct/02|16039|Units Oct/02|251|DOT Oct/02|25100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Nov/02|368|USD Sales Nov/02|369|LC Sales Nov/02|11310|Units Nov/02|177|DOT Nov/02|17700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Dec/02|253|USD Sales Dec/02|257|LC Sales Dec/02|7872|Units Dec/02|123|DOT Dec/02|12300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jan/03|626|USD Sales Jan/03|665|LC Sales Jan/03|19686|Units Jan/03|317|DOT Jan/03|31700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Feb/03|438|USD Sales Feb/03|472|LC Sales Feb/03|13848|Units Feb/03|223|DOT Feb/03|22300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Mar/03|414|USD Sales Mar/03|448|LC Sales Mar/03|13145|Units Mar/03|211|DOT Mar/03|21100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Apr/03|408|USD Sales Apr/03|442|LC Sales Apr/03|12896|Units Apr/03|207|DOT Apr/03|20700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales May/03|518|USD Sales May/03|600|LC Sales May/03|16260|Units May/03|261|DOT May/03|26100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jun/03|464|USD Sales Jun/03|541|LC Sales Jun/03|14578|Units Jun/03|234|DOT Jun/03|23400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jul/03|376|USD Sales Jul/03|427|LC Sales Jul/03|11970|Units Jul/03|190|DOT Jul/03|19000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Aug/03|345|USD Sales Aug/03|384|LC Sales Aug/03|11123|Units Aug/03|176|DOT Aug/03|17600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Sep/03|464|USD Sales Sep/03|519|LC Sales Sep/03|15002|Units Sep/03|237|DOT Sep/03|23700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Oct/03|487|USD Sales Oct/03|570|LC Sales Oct/03|15572|Units Oct/03|246|DOT Oct/03|24600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Nov/03|422|USD Sales Nov/03|494|LC Sales Nov/03|13483|Units Nov/03|213|DOT Nov/03|21300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Dec/03|392|USD Sales Dec/03|481|LC Sales Dec/03|12660|Units Dec/03|200|DOT Dec/03|20000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jan/04|375|USD Sales Jan/04|473|LC Sales Jan/04|12280|Units Jan/04|194|DOT Jan/04|19400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Feb/04|516|USD Sales Feb/04|653|LC Sales Feb/04|16964|Units Feb/04|268|DOT Feb/04|26800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Mar/04|392|USD Sales Mar/04|481|LC Sales Mar/04|12913|Units Mar/04|204|DOT Mar/04|20400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Apr/04|423|USD Sales Apr/04|506|LC Sales Apr/04|13736|Units Apr/04|217|DOT Apr/04|21700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales May/04|647|USD Sales May/04|777|LC Sales May/04|20699|Units May/04|327|DOT May/04|32700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jun/04|416|USD Sales Jun/04|505|LC Sales Jun/04|13166|Units Jun/04|208|DOT Jun/04|20800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jul/04|321|USD Sales Jul/04|394|LC Sales Jul/04|10128|Units Jul/04|160|DOT Jul/04|16000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Aug/04|310|USD Sales Aug/04|378|LC Sales Aug/04|9812|Units Aug/04|155|DOT Aug/04|15500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Sep/04|547|USD Sales Sep/04|668|LC Sales Sep/04|17281|Units Sep/04|273|DOT Sep/04|27300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Oct/04|527|USD Sales Oct/04|658|LC Sales Oct/04|16585|Units Oct/04|262|DOT Oct/04|26200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Nov/04|544|USD Sales Nov/04|707|LC Sales Nov/04|17028|Units Nov/04|269|DOT Nov/04|26900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Dec/04|483|USD Sales Dec/04|647|LC Sales Dec/04|14812|Units Dec/04|234|DOT Dec/04|23400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jan/05|622|USD Sales Jan/05|817|LC Sales Jan/05|18863|Units Jan/05|298|DOT Jan/05|29800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Feb/05|587|USD Sales Feb/05|764|LC Sales Feb/05|17597|Units Feb/05|278|DOT Feb/05|27800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Mar/05|629|USD Sales Mar/05|831|LC Sales Mar/05|18737|Units Mar/05|296|DOT Mar/05|29600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Apr/05|498|USD Sales Apr/05|644|LC Sales Apr/05|15000|Units Apr/05|240|DOT Apr/05|24000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales May/05|479|USD Sales May/05|607|LC Sales May/05|14476|Units May/05|235|DOT May/05|23500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jun/05|571|USD Sales Jun/05|695|LC Sales Jun/05|17153|Units Jun/05|278|DOT Jun/05|27800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jul/05|427|USD Sales Jul/05|514|LC Sales Jul/05|12874|Units Jul/05|209|DOT Jul/05|20900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Aug/05|448|USD Sales Aug/05|550|LC Sales Aug/05|13244|Units Aug/05|215|DOT Aug/05|21500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Sep/05|474|USD Sales Sep/05|580|LC Sales Sep/05|13882|Units Sep/05|220|DOT Sep/05|22000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Oct/05|573|USD Sales Oct/05|689|LC Sales Oct/05|17013|Units Oct/05|265|DOT Oct/05|26500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Nov/05|594|USD Sales Nov/05|700|LC Sales Nov/05|17388|Units Nov/05|270|DOT Nov/05|27000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Dec/05|413|USD Sales Dec/05|490|LC Sales Dec/05|11960|Units Dec/05|186|DOT Dec/05|18600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jan/06|596|USD Sales Jan/06|722|LC Sales Jan/06|17130|Units Jan/06|266|DOT Jan/06|26600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Feb/06|433|USD Sales Feb/06|517|LC Sales Feb/06|12300|Units Feb/06|191|DOT Feb/06|19100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Mar/06|695|USD Sales Mar/06|836|LC Sales Mar/06|19900|Units Mar/06|309|DOT Mar/06|30900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Apr/06|398|USD Sales Apr/06|488|LC Sales Apr/06|11334|Units Apr/06|176|DOT Apr/06|17600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales May/06|476|USD Sales May/06|608|LC Sales May/06|13460|Units May/06|209|DOT May/06|20900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jun/06|420|USD Sales Jun/06|532|LC Sales Jun/06|11914|Units Jun/06|185|DOT Jun/06|18500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Jul/06|299|USD Sales Jul/06|380|LC Sales Jul/06|8512|Units Jul/06|140|DOT Jul/06|14000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Aug/06|466|USD Sales Aug/06|597|LC Sales Aug/06|13145|Units Aug/06|218|DOT Aug/06|21800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Sep/06|554|USD Sales Sep/06|706|LC Sales Sep/06|15734|Units Sep/06|255|DOT Sep/06|25500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 200|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1999|1999/10|100.00|1.10 MG|MONO|FLUORINE|21|59.9|83.7|EURO Sales Oct/06|377|USD Sales Oct/06|476|LC Sales Oct/06|10662|Units Oct/06|178|DOT Oct/06|17800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|NOVARTIS*|NOVARTIS|NOVARTIS CON.HEALT|ZYMAFLUOR|0.25MG|TABS .25 MG 400|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1998|1998/04|200.00|1.10 MG|MONO|FLUORINE|22|130|175.9|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Nov/01|151|USD Sales Nov/01|134|LC Sales Nov/01|5022|Units Nov/01|93|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Dec/01|173|USD Sales Dec/01|155|LC Sales Dec/01|5616|Units Dec/01|104|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jan/02|234|USD Sales Jan/02|207|LC Sales Jan/02|7506|Units Jan/02|139|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Feb/02|136|USD Sales Feb/02|118|LC Sales Feb/02|4320|Units Feb/02|80|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Mar/02|195|USD Sales Mar/02|170|LC Sales Mar/02|6102|Units Mar/02|113|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Apr/02|124|USD Sales Apr/02|110|LC Sales Apr/02|3780|Units Apr/02|70|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales May/02|143|USD Sales May/02|131|LC Sales May/02|4374|Units May/02|81|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jun/02|159|USD Sales Jun/02|152|LC Sales Jun/02|4806|Units Jun/02|89|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jul/02|196|USD Sales Jul/02|194|LC Sales Jul/02|5832|Units Jul/02|108|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Aug/02|200|USD Sales Aug/02|195|LC Sales Aug/02|6156|Units Aug/02|114|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Sep/02|292|USD Sales Sep/02|286|LC Sales Sep/02|8802|Units Sep/02|163|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Oct/02|155|USD Sales Oct/02|152|LC Sales Oct/02|4752|Units Oct/02|88|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Nov/02|125|USD Sales Nov/02|125|LC Sales Nov/02|3834|Units Nov/02|71|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Dec/02|179|USD Sales Dec/02|182|LC Sales Dec/02|5562|Units Dec/02|103|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jan/03|209|USD Sales Jan/03|222|LC Sales Jan/03|6588|Units Jan/03|122|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Feb/03|161|USD Sales Feb/03|173|LC Sales Feb/03|5076|Units Feb/03|94|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Mar/03|117|USD Sales Mar/03|127|LC Sales Mar/03|3726|Units Mar/03|69|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Apr/03|157|USD Sales Apr/03|170|LC Sales Apr/03|4968|Units Apr/03|92|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales May/03|212|USD Sales May/03|245|LC Sales May/03|6642|Units May/03|123|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jun/03|175|USD Sales Jun/03|204|LC Sales Jun/03|5504|Units Jun/03|99|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jul/03|188|USD Sales Jul/03|213|LC Sales Jul/03|5975|Units Jul/03|105|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Aug/03|136|USD Sales Aug/03|152|LC Sales Aug/03|4393|Units Aug/03|76|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Sep/03|213|USD Sales Sep/03|239|LC Sales Sep/03|6902|Units Sep/03|119|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Oct/03|170|USD Sales Oct/03|199|LC Sales Oct/03|5443|Units Oct/03|94|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Nov/03|142|USD Sales Nov/03|166|LC Sales Nov/03|4540|Units Nov/03|78|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Dec/03|245|USD Sales Dec/03|301|LC Sales Dec/03|7915|Units Dec/03|136|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jan/04|148|USD Sales Jan/04|186|LC Sales Jan/04|4831|Units Jan/04|83|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Feb/04|131|USD Sales Feb/04|166|LC Sales Feb/04|4307|Units Feb/04|74|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Mar/04|139|USD Sales Mar/04|171|LC Sales Mar/04|4590|Units Mar/04|79|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Apr/04|156|USD Sales Apr/04|187|LC Sales Apr/04|5063|Units Apr/04|87|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales May/04|153|USD Sales May/04|183|LC Sales May/04|4889|Units May/04|84|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jun/04|162|USD Sales Jun/04|197|LC Sales Jun/04|5122|Units Jun/04|88|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jul/04|155|USD Sales Jul/04|190|LC Sales Jul/04|4889|Units Jul/04|84|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Aug/04|217|USD Sales Aug/04|264|LC Sales Aug/04|6868|Units Aug/04|118|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Sep/04|169|USD Sales Sep/04|207|LC Sales Sep/04|5354|Units Sep/04|92|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Oct/04|118|USD Sales Oct/04|148|LC Sales Oct/04|3725|Units Oct/04|64|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Nov/04|234|USD Sales Nov/04|304|LC Sales Nov/04|7333|Units Nov/04|126|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Dec/04|178|USD Sales Dec/04|239|LC Sales Dec/04|5471|Units Dec/04|94|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jan/05|184|USD Sales Jan/05|242|LC Sales Jan/05|5587|Units Jan/05|96|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Feb/05|159|USD Sales Feb/05|207|LC Sales Feb/05|4772|Units Feb/05|82|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Mar/05|184|USD Sales Mar/05|243|LC Sales Mar/05|5471|Units Mar/05|94|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Apr/05|182|USD Sales Apr/05|235|LC Sales Apr/05|5471|Units Apr/05|94|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales May/05|212|USD Sales May/05|269|LC Sales May/05|6402|Units May/05|110|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jun/05|163|USD Sales Jun/05|198|LC Sales Jun/05|4889|Units Jun/05|84|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jul/05|179|USD Sales Jul/05|216|LC Sales Jul/05|5413|Units Jul/05|93|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Aug/05|199|USD Sales Aug/05|244|LC Sales Aug/05|5878|Units Aug/05|101|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Sep/05|185|USD Sales Sep/05|226|LC Sales Sep/05|5413|Units Sep/05|93|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Oct/05|212|USD Sales Oct/05|255|LC Sales Oct/05|6286|Units Oct/05|108|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Nov/05|175|USD Sales Nov/05|206|LC Sales Nov/05|5122|Units Nov/05|88|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Dec/05|195|USD Sales Dec/05|231|LC Sales Dec/05|5645|Units Dec/05|97|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jan/06|227|USD Sales Jan/06|275|LC Sales Jan/06|6518|Units Jan/06|112|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Feb/06|170|USD Sales Feb/06|203|LC Sales Feb/06|4831|Units Feb/06|83|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Mar/06|246|USD Sales Mar/06|296|LC Sales Mar/06|7042|Units Mar/06|121|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Apr/06|204|USD Sales Apr/06|250|LC Sales Apr/06|5810|Units Apr/06|100|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales May/06|242|USD Sales May/06|310|LC Sales May/06|6856|Units May/06|118|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jun/06|123|USD Sales Jun/06|156|LC Sales Jun/06|3486|Units Jun/06|60|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Jul/06|173|USD Sales Jul/06|220|LC Sales Jul/06|4933|Units Jul/06|87|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Aug/06|309|USD Sales Aug/06|396|LC Sales Aug/06|8715|Units Aug/06|150|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Sep/06|157|USD Sales Sep/06|200|LC Sales Sep/06|4458|Units Sep/06|77|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PFIZER*|PFIZER|PFIZER|CALGEL|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|RX BOUND|1998|1998/10|0.00|0.00|COMBI|CETYLPYRIDINIUM;LIDOCAINE|23|57.1|79.7|EURO Sales Oct/06|291|USD Sales Oct/06|367|LC Sales Oct/06|8222|Units Oct/06|144|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales May/04|28|USD Sales May/04|34|LC Sales May/04|898|Units May/04|8|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jun/04|46|USD Sales Jun/04|56|LC Sales Jun/04|1459|Units Jun/04|13|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jul/04|14|USD Sales Jul/04|17|LC Sales Jul/04|449|Units Jul/04|4|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Aug/04|14|USD Sales Aug/04|17|LC Sales Aug/04|449|Units Aug/04|4|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Sep/04|7|USD Sales Sep/04|9|LC Sales Sep/04|224|Units Sep/04|2|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Oct/04|21|USD Sales Oct/04|27|LC Sales Oct/04|673|Units Oct/04|6|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Nov/04|18|USD Sales Nov/04|23|LC Sales Nov/04|561|Units Nov/04|5|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Dec/04|7|USD Sales Dec/04|10|LC Sales Dec/04|224|Units Dec/04|2|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jan/05|19|USD Sales Jan/05|24|LC Sales Jan/05|561|Units Jan/05|5|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Feb/05|7|USD Sales Feb/05|10|LC Sales Feb/05|224|Units Feb/05|2|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Mar/05|4|USD Sales Mar/05|5|LC Sales Mar/05|112|Units Mar/05|1|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Apr/05|26|USD Sales Apr/05|34|LC Sales Apr/05|785|Units Apr/05|7|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales May/05|7|USD Sales May/05|9|LC Sales May/05|224|Units May/05|2|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jul/05|4|USD Sales Jul/05|4|LC Sales Jul/05|112|Units Jul/05|1|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Nov/05|4|USD Sales Nov/05|5|LC Sales Nov/05|112|Units Nov/05|1|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|METHYLROSANIL.CHLO|0002%|SOLUT. 2 % 1 800 G|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|2004|2004/05|0.00|0.00|MONO|CRYSTAL VIOLET|24|114.9|155.5|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ROCHE*|ROCHE|SYNTEX|INSADOL|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1995|1995/10|0.00|0.00|MONO|ZEA MAIS|25|179|242.3|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Nov/01|7|USD Sales Nov/01|6|LC Sales Nov/01|228|Units Nov/01|3|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Dec/01|9|USD Sales Dec/01|8|LC Sales Dec/01|305|Units Dec/01|4|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jan/02|17|USD Sales Jan/02|15|LC Sales Jan/02|533|Units Jan/02|7|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales May/02|2|USD Sales May/02|2|LC Sales May/02|76|Units May/02|1|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jul/02|8|USD Sales Jul/02|8|LC Sales Jul/02|229|Units Jul/02|3|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|MOUTH SOLUT. 1 200 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1992|1992/01|0.00|0.00|COMBI|FLUORINE;MONOFLUOROPHOSPHORIC ACID|26|77.4|104.7|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 100 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1997|1997/09|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|27|36.3|49.1|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 50 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|28|18.3|24.7|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Nov/01|55|USD Sales Nov/01|49|LC Sales Nov/01|1815|Units Nov/01|58|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Dec/01|25|USD Sales Dec/01|23|LC Sales Dec/01|822|Units Dec/01|26|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jan/02|60|USD Sales Jan/02|53|LC Sales Jan/02|1928|Units Jan/02|61|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Feb/02|21|USD Sales Feb/02|18|LC Sales Feb/02|664|Units Feb/02|21|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Mar/02|50|USD Sales Mar/02|44|LC Sales Mar/02|1580|Units Mar/02|50|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Apr/02|4|USD Sales Apr/02|4|LC Sales Apr/02|126|Units Apr/02|4|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Nov/02|2|USD Sales Nov/02|2|LC Sales Nov/02|63|Units Nov/02|2|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SANOFI AVENTIS*|SANOFI-AVENTIS|GOUPIL|FLUOCARIL BI-FLUOR|0000|TOOTHPASTE 1 75 ML|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1991|1991/10|0.00|0.00|COMBI|BENZOIC ACID;EUGENOL;FLUORINE;MONOFLUOROPHOSPHORIC ACID|29|32.1|43.4|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Nov/01|10885|USD Sales Nov/01|9670|LC Sales Nov/01|361813|Units Nov/01|4489|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Dec/01|10358|USD Sales Dec/01|9248|LC Sales Dec/01|335762|Units Dec/01|4135|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jan/02|10979|USD Sales Jan/02|9696|LC Sales Jan/02|352268|Units Jan/02|4376|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Feb/02|11025|USD Sales Feb/02|9588|LC Sales Feb/02|350083|Units Feb/02|4387|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Mar/02|8621|USD Sales Mar/02|7548|LC Sales Mar/02|270442|Units Mar/02|3432|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Apr/02|10143|USD Sales Apr/02|8985|LC Sales Apr/02|308140|Units Apr/02|3976|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales May/02|8157|USD Sales May/02|7483|LC Sales May/02|249650|Units May/02|3213|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jun/02|7145|USD Sales Jun/02|6829|LC Sales Jun/02|216386|Units Jun/02|2753|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jul/02|6953|USD Sales Jul/02|6896|LC Sales Jul/02|207157|Units Jul/02|2583|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Aug/02|6304|USD Sales Aug/02|6161|LC Sales Aug/02|194246|Units Aug/02|2419|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Sep/02|9751|USD Sales Sep/02|9560|LC Sales Sep/02|294412|Units Sep/02|3694|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Oct/02|10908|USD Sales Oct/02|10697|LC Sales Oct/02|333863|Units Oct/02|4189|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Nov/02|10746|USD Sales Nov/02|10760|LC Sales Nov/02|330147|Units Nov/02|4132|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Dec/02|9936|USD Sales Dec/02|10098|LC Sales Dec/02|309096|Units Dec/02|3816|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jan/03|12595|USD Sales Jan/03|13378|LC Sales Jan/03|396237|Units Jan/03|4910|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Feb/03|13624|USD Sales Feb/03|14680|LC Sales Feb/03|430758|Units Feb/03|5318|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Mar/03|11212|USD Sales Mar/03|12115|LC Sales Mar/03|355671|Units Mar/03|4391|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Apr/03|10513|USD Sales Apr/03|11403|LC Sales Apr/03|332394|Units Apr/03|4124|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales May/03|7870|USD Sales May/03|9105|LC Sales May/03|246942|Units May/03|3060|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jun/03|7021|USD Sales Jun/03|8188|LC Sales Jun/03|220482|Units Jun/03|2722|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jul/03|7312|USD Sales Jul/03|8315|LC Sales Jul/03|232820|Units Jul/03|2885|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Aug/03|5918|USD Sales Aug/03|6591|LC Sales Aug/03|190917|Units Aug/03|2357|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Sep/03|9615|USD Sales Sep/03|10770|LC Sales Sep/03|311202|Units Sep/03|3842|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Oct/03|12198|USD Sales Oct/03|14270|LC Sales Oct/03|389942|Units Oct/03|4832|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Nov/03|9615|USD Sales Nov/03|11252|LC Sales Nov/03|307314|Units Nov/03|3794|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Dec/03|11800|USD Sales Dec/03|14483|LC Sales Dec/03|381024|Units Dec/03|4704|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jan/04|12549|USD Sales Jan/04|15830|LC Sales Jan/04|410670|Units Jan/04|5070|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Feb/04|10142|USD Sales Feb/04|12824|LC Sales Feb/04|333153|Units Feb/04|4113|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Mar/04|10218|USD Sales Mar/04|12537|LC Sales Mar/04|336879|Units Mar/04|4159|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Apr/04|9381|USD Sales Apr/04|11245|LC Sales Apr/04|304965|Units Apr/04|3765|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales May/04|9934|USD Sales May/04|11926|LC Sales May/04|317844|Units May/04|3924|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jun/04|9470|USD Sales Jun/04|11493|LC Sales Jun/04|299376|Units Jun/04|3696|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jul/04|6488|USD Sales Jul/04|7959|LC Sales Jul/04|204677|Units Jul/04|2530|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Aug/04|6574|USD Sales Aug/04|8007|LC Sales Aug/04|207927|Units Aug/04|2567|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Sep/04|7742|USD Sales Sep/04|9457|LC Sales Sep/04|244642|Units Sep/04|3024|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Oct/04|11582|USD Sales Oct/04|14466|LC Sales Oct/04|364669|Units Oct/04|4491|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Nov/04|11584|USD Sales Nov/04|15047|LC Sales Nov/04|362467|Units Nov/04|4442|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Dec/04|12714|USD Sales Dec/04|17034|LC Sales Dec/04|389722|Units Dec/04|4776|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jan/05|8138|USD Sales Jan/05|10684|LC Sales Jan/05|246619|Units Jan/05|3026|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Feb/05|18887|USD Sales Feb/05|24586|LC Sales Feb/05|566018|Units Feb/05|6928|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Mar/05|11885|USD Sales Mar/05|15698|LC Sales Mar/05|353843|Units Mar/05|4331|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Apr/05|11012|USD Sales Apr/05|14250|LC Sales Apr/05|331702|Units Apr/05|4060|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales May/05|9877|USD Sales May/05|12531|LC Sales May/05|298686|Units May/05|3715|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jun/05|9084|USD Sales Jun/05|11050|LC Sales Jun/05|272813|Units Jun/05|3423|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jul/05|6780|USD Sales Jul/05|8164|LC Sales Jul/05|204594|Units Jul/05|2580|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Aug/05|7463|USD Sales Aug/05|9176|LC Sales Aug/05|220805|Units Aug/05|2795|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Sep/05|10253|USD Sales Sep/05|12565|LC Sales Sep/05|300516|Units Sep/05|3804|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Oct/05|10858|USD Sales Oct/05|13055|LC Sales Oct/05|322241|Units Oct/05|4079|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Nov/05|10384|USD Sales Nov/05|12238|LC Sales Nov/05|303913|Units Nov/05|3847|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Dec/05|10667|USD Sales Dec/05|12651|LC Sales Dec/05|308890|Units Dec/05|3910|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jan/06|10861|USD Sales Jan/06|13146|LC Sales Jan/06|311888|Units Jan/06|4014|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Feb/06|9901|USD Sales Feb/06|11830|LC Sales Feb/06|281477|Units Feb/06|3563|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Mar/06|12444|USD Sales Mar/06|14962|LC Sales Mar/06|356369|Units Mar/06|4511|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Apr/06|8205|USD Sales Apr/06|10062|LC Sales Apr/06|233919|Units Apr/06|2961|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales May/06|9522|USD Sales May/06|12155|LC Sales May/06|269232|Units May/06|3408|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jun/06|8981|USD Sales Jun/06|11373|LC Sales Jun/06|254848|Units Jun/06|3327|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Jul/06|5714|USD Sales Jul/06|7251|LC Sales Jul/06|162550|Units Jul/06|2136|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Aug/06|7436|USD Sales Aug/06|9525|LC Sales Aug/06|209645|Units Aug/06|2799|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Sep/06|8783|USD Sales Sep/06|11185|LC Sales Sep/06|249304|Units Sep/06|3276|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|SOLVAY*|SOLVAY|SOLVAY PHARMA|IMUDON|0050MG|TABS 50 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1994|1994/07|0.00|0.00|COMBI|CANDIDA ALBICANS;CORYNEBACTERIUM PARVUM;KLEBSIELLA PNEUMONIAE;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS LACTIS;STAPHYLOCOCCUS AUREUS;STREPTOCOCCUS|30|76.1|106.3|EURO Sales Oct/06|10564|USD Sales Oct/06|13328|LC Sales Oct/06|298769|Units Oct/06|3926|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Nov/01|25|USD Sales Nov/01|23|LC Sales Nov/01|846|Units Nov/01|13|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Dec/01|6|USD Sales Dec/01|5|LC Sales Dec/01|198|Units Dec/01|3|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jan/02|31|USD Sales Jan/02|27|LC Sales Jan/02|986|Units Jan/02|15|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Feb/02|25|USD Sales Feb/02|21|LC Sales Feb/02|782|Units Feb/02|12|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Mar/02|12|USD Sales Mar/02|11|LC Sales Mar/02|388|Units Mar/02|6|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Apr/02|36|USD Sales Apr/02|32|LC Sales Apr/02|1100|Units Apr/02|17|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales May/02|36|USD Sales May/02|33|LC Sales May/02|1098|Units May/02|17|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jun/02|66|USD Sales Jun/02|63|LC Sales Jun/02|1996|Units Jun/02|31|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jul/02|45|USD Sales Jul/02|45|LC Sales Jul/02|1352|Units Jul/02|21|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Aug/02|42|USD Sales Aug/02|41|LC Sales Aug/02|1288|Units Aug/02|20|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Sep/02|36|USD Sales Sep/02|36|LC Sales Sep/02|1095|Units Sep/02|17|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Oct/02|6|USD Sales Oct/02|6|LC Sales Oct/02|193|Units Oct/02|3|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Nov/02|4|USD Sales Nov/02|4|LC Sales Nov/02|128|Units Nov/02|2|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jan/03|13|USD Sales Jan/03|13|LC Sales Jan/03|397|Units Jan/03|5|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Feb/03|125|USD Sales Feb/03|135|LC Sales Feb/03|3952|Units Feb/03|52|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Mar/03|103|USD Sales Mar/03|111|LC Sales Mar/03|3268|Units Mar/03|43|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Apr/03|171|USD Sales Apr/03|186|LC Sales Apr/03|5410|Units Apr/03|71|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales May/03|126|USD Sales May/03|146|LC Sales May/03|3957|Units May/03|52|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jun/03|124|USD Sales Jun/03|144|LC Sales Jun/03|3881|Units Jun/03|51|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jul/03|115|USD Sales Jul/03|130|LC Sales Jul/03|3648|Units Jul/03|48|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Aug/03|130|USD Sales Aug/03|144|LC Sales Aug/03|4180|Units Aug/03|55|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Sep/03|120|USD Sales Sep/03|134|LC Sales Sep/03|3876|Units Sep/03|51|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Oct/03|97|USD Sales Oct/03|114|LC Sales Oct/03|3116|Units Oct/03|41|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Nov/03|83|USD Sales Nov/03|97|LC Sales Nov/03|2660|Units Nov/03|35|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Dec/03|212|USD Sales Dec/03|260|LC Sales Dec/03|6840|Units Dec/03|90|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jan/04|137|USD Sales Jan/04|173|LC Sales Jan/04|4484|Units Jan/04|59|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Feb/04|111|USD Sales Feb/04|140|LC Sales Feb/04|3648|Units Feb/04|48|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Mar/04|157|USD Sales Mar/04|192|LC Sales Mar/04|5168|Units Mar/04|68|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Apr/04|161|USD Sales Apr/04|193|LC Sales Apr/04|5244|Units Apr/04|69|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales May/04|197|USD Sales May/04|237|LC Sales May/04|6308|Units May/04|83|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jun/04|190|USD Sales Jun/04|230|LC Sales Jun/04|6004|Units Jun/04|79|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jul/04|159|USD Sales Jul/04|195|LC Sales Jul/04|5016|Units Jul/04|66|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Aug/04|207|USD Sales Aug/04|252|LC Sales Aug/04|6536|Units Aug/04|86|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Sep/04|327|USD Sales Sep/04|400|LC Sales Sep/04|10336|Units Sep/04|136|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Oct/04|183|USD Sales Oct/04|229|LC Sales Oct/04|5776|Units Oct/04|76|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Nov/04|267|USD Sales Nov/04|347|LC Sales Nov/04|8360|Units Nov/04|110|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Dec/04|159|USD Sales Dec/04|213|LC Sales Dec/04|4864|Units Dec/04|64|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jan/05|364|USD Sales Jan/05|477|LC Sales Jan/05|11020|Units Jan/05|145|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Feb/05|218|USD Sales Feb/05|284|LC Sales Feb/05|6536|Units Feb/05|86|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Mar/05|276|USD Sales Mar/05|364|LC Sales Mar/05|8208|Units Mar/05|108|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Apr/05|267|USD Sales Apr/05|346|LC Sales Apr/05|8056|Units Apr/05|106|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales May/05|362|USD Sales May/05|459|LC Sales May/05|10944|Units May/05|144|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jun/05|334|USD Sales Jun/05|406|LC Sales Jun/05|10032|Units Jun/05|132|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jul/05|315|USD Sales Jul/05|379|LC Sales Jul/05|9500|Units Jul/05|125|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Aug/05|380|USD Sales Aug/05|467|LC Sales Aug/05|11248|Units Aug/05|148|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Sep/05|526|USD Sales Sep/05|645|LC Sales Sep/05|15428|Units Sep/05|203|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Oct/05|238|USD Sales Oct/05|286|LC Sales Oct/05|7068|Units Oct/05|93|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Nov/05|236|USD Sales Nov/05|278|LC Sales Nov/05|6916|Units Nov/05|91|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Dec/05|239|USD Sales Dec/05|283|LC Sales Dec/05|6916|Units Dec/05|91|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jan/06|331|USD Sales Jan/06|400|LC Sales Jan/06|9500|Units Jan/06|125|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Feb/06|251|USD Sales Feb/06|300|LC Sales Feb/06|7144|Units Feb/06|94|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Mar/06|284|USD Sales Mar/06|341|LC Sales Mar/06|8132|Units Mar/06|107|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Apr/06|309|USD Sales Apr/06|379|LC Sales Apr/06|8816|Units Apr/06|116|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales May/06|317|USD Sales May/06|405|LC Sales May/06|8968|Units May/06|118|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jun/06|367|USD Sales Jun/06|465|LC Sales Jun/06|10412|Units Jun/06|137|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Jul/06|352|USD Sales Jul/06|447|LC Sales Jul/06|10010|Units Jul/06|134|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Aug/06|731|USD Sales Aug/06|936|LC Sales Aug/06|20596|Units Aug/06|271|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Sep/06|632|USD Sales Sep/06|805|LC Sales Sep/06|17936|Units Sep/06|236|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|STADA*|STADA|STADA|KAMISTAD|0000|JEL. 1 10 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1999|1999/02|0.00|0.00|COMBI|LIDOCAINE;MATRICARIA CHAMOMILLA;THYMOL|31|76|106.1|EURO Sales Oct/06|365|USD Sales Oct/06|461|LC Sales Oct/06|10336|Units Oct/06|136|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Nov/01|437|USD Sales Nov/01|388|LC Sales Nov/01|14516|Units Nov/01|764|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Dec/01|440|USD Sales Dec/01|393|LC Sales Dec/01|14269|Units Dec/01|751|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jan/02|519|USD Sales Jan/02|459|LC Sales Jan/02|16663|Units Jan/02|877|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Feb/02|399|USD Sales Feb/02|347|LC Sales Feb/02|12673|Units Feb/02|667|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Mar/02|548|USD Sales Mar/02|480|LC Sales Mar/02|17195|Units Mar/02|905|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Apr/02|556|USD Sales Apr/02|492|LC Sales Apr/02|16887|Units Apr/02|866|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales May/02|688|USD Sales May/02|631|LC Sales May/02|21048|Units May/02|1042|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jun/02|576|USD Sales Jun/02|550|LC Sales Jun/02|17438|Units Jun/02|859|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jul/02|566|USD Sales Jul/02|561|LC Sales Jul/02|16851|Units Jul/02|822|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Aug/02|444|USD Sales Aug/02|434|LC Sales Aug/02|13694|Units Aug/02|668|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Sep/02|488|USD Sales Sep/02|479|LC Sales Sep/02|14740|Units Sep/02|719|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Oct/02|508|USD Sales Oct/02|498|LC Sales Oct/02|15539|Units Oct/02|758|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Nov/02|508|USD Sales Nov/02|508|LC Sales Nov/02|15601|Units Nov/02|761|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Dec/02|484|USD Sales Dec/02|492|LC Sales Dec/02|15068|Units Dec/02|735|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jan/03|486|USD Sales Jan/03|516|LC Sales Jan/03|15293|Units Jan/03|746|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Feb/03|481|USD Sales Feb/03|518|LC Sales Feb/03|15211|Units Feb/03|742|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Mar/03|469|USD Sales Mar/03|507|LC Sales Mar/03|14883|Units Mar/03|726|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Apr/03|484|USD Sales Apr/03|525|LC Sales Apr/03|15293|Units Apr/03|746|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales May/03|442|USD Sales May/03|511|LC Sales May/03|13858|Units May/03|676|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jun/03|341|USD Sales Jun/03|398|LC Sales Jun/03|10722|Units Jun/03|523|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jul/03|473|USD Sales Jul/03|538|LC Sales Jul/03|15064|Units Jul/03|691|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Aug/03|519|USD Sales Aug/03|578|LC Sales Aug/03|16734|Units Aug/03|683|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Sep/03|519|USD Sales Sep/03|581|LC Sales Sep/03|16789|Units Sep/03|661|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Oct/03|501|USD Sales Oct/03|586|LC Sales Oct/03|16021|Units Oct/03|646|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Nov/03|312|USD Sales Nov/03|365|LC Sales Nov/03|9979|Units Nov/03|378|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Dec/03|411|USD Sales Dec/03|504|LC Sales Dec/03|13268|Units Dec/03|479|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jan/04|534|USD Sales Jan/04|673|LC Sales Jan/04|17472|Units Jan/04|624|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Feb/04|538|USD Sales Feb/04|681|LC Sales Feb/04|17681|Units Feb/04|627|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Mar/04|628|USD Sales Mar/04|771|LC Sales Mar/04|20720|Units Mar/04|740|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Apr/04|523|USD Sales Apr/04|627|LC Sales Apr/04|16993|Units Apr/04|588|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales May/04|745|USD Sales May/04|894|LC Sales May/04|23838|Units May/04|822|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jun/04|696|USD Sales Jun/04|845|LC Sales Jun/04|22011|Units Jun/04|759|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jul/04|523|USD Sales Jul/04|642|LC Sales Jul/04|16501|Units Jul/04|569|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Aug/04|475|USD Sales Aug/04|579|LC Sales Aug/04|15034|Units Aug/04|522|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Sep/04|573|USD Sales Sep/04|700|LC Sales Sep/04|18096|Units Sep/04|624|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Oct/04|556|USD Sales Oct/04|695|LC Sales Oct/04|17518|Units Oct/04|602|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Nov/04|539|USD Sales Nov/04|701|LC Sales Nov/04|16878|Units Nov/04|582|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Dec/04|570|USD Sales Dec/04|764|LC Sales Dec/04|17487|Units Dec/04|603|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jan/05|672|USD Sales Jan/05|882|LC Sales Jan/05|20358|Units Jan/05|702|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Feb/05|638|USD Sales Feb/05|830|LC Sales Feb/05|19111|Units Feb/05|659|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Mar/05|662|USD Sales Mar/05|875|LC Sales Mar/05|19720|Units Mar/05|680|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Apr/05|603|USD Sales Apr/05|780|LC Sales Apr/05|18154|Units Apr/05|626|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales May/05|1013|USD Sales May/05|1285|LC Sales May/05|30631|Units May/05|858|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jun/05|904|USD Sales Jun/05|1100|LC Sales Jun/05|27158|Units Jun/05|736|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jul/05|585|USD Sales Jul/05|704|LC Sales Jul/05|17649|Units Jul/05|477|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Aug/05|635|USD Sales Aug/05|781|LC Sales Aug/05|18782|Units Aug/05|509|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Sep/05|677|USD Sales Sep/05|830|LC Sales Sep/05|19853|Units Sep/05|528|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Oct/05|685|USD Sales Oct/05|823|LC Sales Oct/05|20322|Units Oct/05|532|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Nov/05|830|USD Sales Nov/05|978|LC Sales Nov/05|24295|Units Nov/05|636|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Dec/05|627|USD Sales Dec/05|743|LC Sales Dec/05|18145|Units Dec/05|475|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jan/06|750|USD Sales Jan/06|907|LC Sales Jan/06|21527|Units Jan/06|571|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Feb/06|825|USD Sales Feb/06|986|LC Sales Feb/06|23455|Units Feb/06|614|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Mar/06|800|USD Sales Mar/06|961|LC Sales Mar/06|22898|Units Mar/06|601|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Apr/06|519|USD Sales Apr/06|636|LC Sales Apr/06|14783|Units Apr/06|387|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales May/06|878|USD Sales May/06|1121|LC Sales May/06|24830|Units May/06|650|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jun/06|967|USD Sales Jun/06|1224|LC Sales Jun/06|27428|Units Jun/06|718|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Jul/06|722|USD Sales Jul/06|916|LC Sales Jul/06|20533|Units Jul/06|549|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Aug/06|768|USD Sales Aug/06|984|LC Sales Aug/06|21655|Units Aug/06|579|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Sep/06|571|USD Sales Sep/06|727|LC Sales Sep/06|16197|Units Sep/06|424|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|CHAMOMILLA|0000|LIQUID 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1969|1969/12|0.00|0.00|MONO|MATRICARIA CHAMOMILLA|32|38.2|53.4|EURO Sales Oct/06|812|USD Sales Oct/06|1024|LC Sales Oct/06|22958|Units Oct/06|601|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Nov/01|3986|USD Sales Nov/01|3541|LC Sales Nov/01|132500|Units Nov/01|1060|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Dec/01|2404|USD Sales Dec/01|2147|LC Sales Dec/01|77938|Units Dec/01|625|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jan/02|4126|USD Sales Jan/02|3643|LC Sales Jan/02|132375|Units Jan/02|1059|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Feb/02|2441|USD Sales Feb/02|2123|LC Sales Feb/02|77500|Units Feb/02|620|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Mar/02|3937|USD Sales Mar/02|3447|LC Sales Mar/02|123515|Units Mar/02|956|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Apr/02|4311|USD Sales Apr/02|3819|LC Sales Apr/02|130965|Units Apr/02|817|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales May/02|4433|USD Sales May/02|4067|LC Sales May/02|135678|Units May/02|837|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jun/02|3940|USD Sales Jun/02|3765|LC Sales Jun/02|119314|Units Jun/02|706|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jul/02|4330|USD Sales Jul/02|4295|LC Sales Jul/02|129021|Units Jul/02|826|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Aug/02|3783|USD Sales Aug/02|3698|LC Sales Aug/02|116572|Units Aug/02|691|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Sep/02|4559|USD Sales Sep/02|4470|LC Sales Sep/02|137659|Units Sep/02|816|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Oct/02|4875|USD Sales Oct/02|4781|LC Sales Oct/02|149219|Units Oct/02|884|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Nov/02|4128|USD Sales Nov/02|4133|LC Sales Nov/02|126805|Units Nov/02|753|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Dec/02|3814|USD Sales Dec/02|3876|LC Sales Dec/02|118638|Units Dec/02|702|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jan/03|4464|USD Sales Jan/03|4741|LC Sales Jan/03|140439|Units Jan/03|831|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Feb/03|3047|USD Sales Feb/03|3283|LC Sales Feb/03|96330|Units Feb/03|570|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Mar/03|3639|USD Sales Mar/03|3932|LC Sales Mar/03|115427|Units Mar/03|683|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Apr/03|3629|USD Sales Apr/03|3937|LC Sales Apr/03|114751|Units Apr/03|679|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales May/03|3237|USD Sales May/03|3745|LC Sales May/03|101569|Units May/03|601|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jun/03|3778|USD Sales Jun/03|4406|LC Sales Jun/03|118638|Units Jun/03|702|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jul/03|3524|USD Sales Jul/03|4008|LC Sales Jul/03|112216|Units Jul/03|664|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Aug/03|3400|USD Sales Aug/03|3786|LC Sales Aug/03|109681|Units Aug/03|649|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Sep/03|2297|USD Sales Sep/03|2573|LC Sales Sep/03|74360|Units Sep/03|440|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Oct/03|2574|USD Sales Oct/03|3012|LC Sales Oct/03|82303|Units Oct/03|487|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Nov/03|3056|USD Sales Nov/03|3576|LC Sales Nov/03|97682|Units Nov/03|578|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Dec/03|2256|USD Sales Dec/03|2769|LC Sales Dec/03|72839|Units Dec/03|431|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jan/04|3202|USD Sales Jan/04|4039|LC Sales Jan/04|104780|Units Jan/04|620|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Feb/04|2974|USD Sales Feb/04|3760|LC Sales Feb/04|97682|Units Feb/04|578|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Mar/04|2589|USD Sales Mar/04|3176|LC Sales Mar/04|85345|Units Mar/04|505|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Apr/04|2189|USD Sales Apr/04|2623|LC Sales Apr/04|71149|Units Apr/04|421|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales May/04|1680|USD Sales May/04|2016|LC Sales May/04|53742|Units May/04|318|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jun/04|2721|USD Sales Jun/04|3302|LC Sales Jun/04|86021|Units Jun/04|509|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jul/04|2518|USD Sales Jul/04|3089|LC Sales Jul/04|79430|Units Jul/04|470|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Aug/04|1651|USD Sales Aug/04|2011|LC Sales Aug/04|52221|Units Aug/04|309|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Sep/04|1594|USD Sales Sep/04|1947|LC Sales Sep/04|50362|Units Sep/04|298|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Oct/04|1728|USD Sales Oct/04|2159|LC Sales Oct/04|54418|Units Oct/04|322|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Nov/04|2571|USD Sales Nov/04|3339|LC Sales Nov/04|80444|Units Nov/04|476|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Dec/04|2354|USD Sales Dec/04|3154|LC Sales Dec/04|72163|Units Dec/04|427|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jan/05|582|USD Sales Jan/05|765|LC Sales Jan/05|17651|Units Jan/05|105|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Feb/05|6|USD Sales Feb/05|7|LC Sales Feb/05|169|Units Feb/05|1|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|33|173.1|234.2|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|TEVA*|TEVA|IVAX CR|DESIGALIN SINE COL|0000|LIQUID 1 250 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX STATUS UNKNOWN|1990|1990/07|0.00|0.00|COMBI|ALKONIUM HYDROXIDE;CHLORHEXIDINE;UREA|34|62.6|84.7|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Nov/01|315|USD Sales Nov/01|280|LC Sales Nov/01|10478|Units Nov/01|127|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Dec/01|324|USD Sales Dec/01|289|LC Sales Dec/01|10503|Units Dec/01|127|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jan/02|336|USD Sales Jan/02|297|LC Sales Jan/02|10777|Units Jan/02|130|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Feb/02|324|USD Sales Feb/02|282|LC Sales Feb/02|10300|Units Feb/02|125|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Mar/02|301|USD Sales Mar/02|264|LC Sales Mar/02|9453|Units Mar/02|115|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Apr/02|475|USD Sales Apr/02|421|LC Sales Apr/02|14438|Units Apr/02|175|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales May/02|430|USD Sales May/02|395|LC Sales May/02|13165|Units May/02|169|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jun/02|356|USD Sales Jun/02|340|LC Sales Jun/02|10778|Units Jun/02|138|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jul/02|470|USD Sales Jul/02|466|LC Sales Jul/02|14004|Units Jul/02|180|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Aug/02|275|USD Sales Aug/02|269|LC Sales Aug/02|8480|Units Aug/02|109|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Sep/02|377|USD Sales Sep/02|370|LC Sales Sep/02|11397|Units Sep/02|145|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Oct/02|326|USD Sales Oct/02|319|LC Sales Oct/02|9970|Units Oct/02|127|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Nov/02|322|USD Sales Nov/02|323|LC Sales Nov/02|9904|Units Nov/02|126|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Dec/02|276|USD Sales Dec/02|281|LC Sales Dec/02|8600|Units Dec/02|109|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jan/03|437|USD Sales Jan/03|465|LC Sales Jan/03|13763|Units Jan/03|174|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Feb/03|295|USD Sales Feb/03|318|LC Sales Feb/03|9334|Units Feb/03|118|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Mar/03|501|USD Sales Mar/03|541|LC Sales Mar/03|15880|Units Mar/03|200|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Apr/03|440|USD Sales Apr/03|477|LC Sales Apr/03|13913|Units Apr/03|175|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales May/03|420|USD Sales May/03|486|LC Sales May/03|13176|Units May/03|167|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jun/03|388|USD Sales Jun/03|453|LC Sales Jun/03|12199|Units Jun/03|155|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jul/03|420|USD Sales Jul/03|478|LC Sales Jul/03|13389|Units Jul/03|171|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Aug/03|369|USD Sales Aug/03|411|LC Sales Aug/03|11914|Units Aug/03|151|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Sep/03|359|USD Sales Sep/03|402|LC Sales Sep/03|11628|Units Sep/03|147|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Oct/03|434|USD Sales Oct/03|508|LC Sales Oct/03|13878|Units Oct/03|175|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Nov/03|254|USD Sales Nov/03|297|LC Sales Nov/03|8116|Units Nov/03|103|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Dec/03|420|USD Sales Dec/03|516|LC Sales Dec/03|13577|Units Dec/03|171|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jan/04|337|USD Sales Jan/04|425|LC Sales Jan/04|11037|Units Jan/04|139|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Feb/04|270|USD Sales Feb/04|341|LC Sales Feb/04|8870|Units Feb/04|112|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Mar/04|409|USD Sales Mar/04|501|LC Sales Mar/04|13475|Units Mar/04|171|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Apr/04|143|USD Sales Apr/04|171|LC Sales Apr/04|4643|Units Apr/04|59|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales May/04|562|USD Sales May/04|675|LC Sales May/04|17989|Units May/04|228|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jun/04|552|USD Sales Jun/04|670|LC Sales Jun/04|17454|Units Jun/04|219|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jul/04|453|USD Sales Jul/04|556|LC Sales Jul/04|14292|Units Jul/04|180|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Aug/04|321|USD Sales Aug/04|391|LC Sales Aug/04|10165|Units Aug/04|129|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Sep/04|357|USD Sales Sep/04|436|LC Sales Sep/04|11286|Units Sep/04|146|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Oct/04|228|USD Sales Oct/04|285|LC Sales Oct/04|7180|Units Oct/04|93|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Nov/04|12|USD Sales Nov/04|16|LC Sales Nov/04|386|Units Nov/04|5|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Dec/04|401|USD Sales Dec/04|538|LC Sales Dec/04|12305|Units Dec/04|154|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jan/05|524|USD Sales Jan/05|688|LC Sales Jan/05|15879|Units Jan/05|201|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Feb/05|388|USD Sales Feb/05|505|LC Sales Feb/05|11628|Units Feb/05|147|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Mar/05|324|USD Sales Mar/05|428|LC Sales Mar/05|9650|Units Mar/05|122|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Apr/05|278|USD Sales Apr/05|359|LC Sales Apr/05|8363|Units Apr/05|106|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales May/05|426|USD Sales May/05|541|LC Sales May/05|12893|Units May/05|163|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jun/05|319|USD Sales Jun/05|388|LC Sales Jun/05|9571|Units Jun/05|121|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jul/05|302|USD Sales Jul/05|364|LC Sales Jul/05|9120|Units Jul/05|115|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Aug/05|356|USD Sales Aug/05|437|LC Sales Aug/05|10520|Units Aug/05|133|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Sep/05|429|USD Sales Sep/05|526|LC Sales Sep/05|12577|Units Sep/05|159|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Oct/05|394|USD Sales Oct/05|474|LC Sales Oct/05|11707|Units Oct/05|148|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Nov/05|334|USD Sales Nov/05|394|LC Sales Nov/05|9779|Units Nov/05|123|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Dec/05|280|USD Sales Dec/05|332|LC Sales Dec/05|8099|Units Dec/05|102|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jan/06|453|USD Sales Jan/06|549|LC Sales Jan/06|13022|Units Jan/06|164|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Feb/06|600|USD Sales Feb/06|717|LC Sales Feb/06|17056|Units Feb/06|214|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Mar/06|367|USD Sales Mar/06|442|LC Sales Mar/06|10520|Units Mar/06|132|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Apr/06|444|USD Sales Apr/06|545|LC Sales Apr/06|12665|Units Apr/06|163|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales May/06|477|USD Sales May/06|608|LC Sales May/06|13477|Units May/06|173|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jun/06|459|USD Sales Jun/06|581|LC Sales Jun/06|13030|Units Jun/06|169|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Jul/06|417|USD Sales Jul/06|529|LC Sales Jul/06|11866|Units Jul/06|158|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Aug/06|522|USD Sales Aug/06|669|LC Sales Aug/06|14723|Units Aug/06|195|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Sep/06|394|USD Sales Sep/06|502|LC Sales Sep/06|11194|Units Sep/06|145|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|VALEANT PHARMA*|VALEANT PHARMA|VALEANT CZECH|SOLCOSERYL|.213%|PASTE DENTAL .213 % 1 5 G|K ORAL TOPICAL|KS ORAL TOP OINTMENTS|KSB ORAL TOP PASTES N O S|NON-RX BOUND|1986|1986/01|0.00|0.00|MONO|BLOOD|35|77.2|107.8|EURO Sales Oct/06|415|USD Sales Oct/06|523|LC Sales Oct/06|11734|Units Oct/06|152|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Nov/01|115|USD Sales Nov/01|102|LC Sales Nov/01|3823|Units Nov/01|43|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Dec/01|30|USD Sales Dec/01|27|LC Sales Dec/01|974|Units Dec/01|11|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jan/02|72|USD Sales Jan/02|63|LC Sales Jan/02|2298|Units Jan/02|26|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Feb/02|47|USD Sales Feb/02|41|LC Sales Feb/02|1496|Units Feb/02|17|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Mar/02|67|USD Sales Mar/02|59|LC Sales Mar/02|2105|Units Mar/02|24|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Apr/02|91|USD Sales Apr/02|81|LC Sales Apr/02|2765|Units Apr/02|32|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales May/02|91|USD Sales May/02|84|LC Sales May/02|2798|Units May/02|33|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jun/02|132|USD Sales Jun/02|126|LC Sales Jun/02|3985|Units Jun/02|27|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jul/02|73|USD Sales Jul/02|72|LC Sales Jul/02|2176|Units Jul/02|14|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Aug/02|84|USD Sales Aug/02|83|LC Sales Aug/02|2601|Units Aug/02|17|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Sep/02|220|USD Sales Sep/02|215|LC Sales Sep/02|6636|Units Sep/02|42|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Oct/02|43|USD Sales Oct/02|42|LC Sales Oct/02|1306|Units Oct/02|8|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Nov/02|143|USD Sales Nov/02|143|LC Sales Nov/02|4396|Units Nov/02|27|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Dec/02|132|USD Sales Dec/02|134|LC Sales Dec/02|4110|Units Dec/02|25|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jan/03|136|USD Sales Jan/03|144|LC Sales Jan/03|4274|Units Jan/03|26|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Feb/03|146|USD Sales Feb/03|157|LC Sales Feb/03|4603|Units Feb/03|28|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Mar/03|57|USD Sales Mar/03|62|LC Sales Mar/03|1816|Units Mar/03|11|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Apr/03|83|USD Sales Apr/03|90|LC Sales Apr/03|2634|Units Apr/03|16|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales May/03|90|USD Sales May/03|104|LC Sales May/03|2822|Units May/03|17|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jun/03|153|USD Sales Jun/03|179|LC Sales Jun/03|4817|Units Jun/03|29|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jul/03|42|USD Sales Jul/03|47|LC Sales Jul/03|1327|Units Jul/03|8|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Aug/03|82|USD Sales Aug/03|92|LC Sales Aug/03|2659|Units Aug/03|16|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Sep/03|118|USD Sales Sep/03|132|LC Sales Sep/03|3820|Units Sep/03|23|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Oct/03|42|USD Sales Oct/03|49|LC Sales Oct/03|1330|Units Oct/03|8|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Nov/03|166|USD Sales Nov/03|194|LC Sales Nov/03|5309|Units Nov/03|32|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Dec/03|98|USD Sales Dec/03|120|LC Sales Dec/03|3152|Units Dec/03|19|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jan/04|91|USD Sales Jan/04|115|LC Sales Jan/04|2986|Units Jan/04|18|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Feb/04|86|USD Sales Feb/04|109|LC Sales Feb/04|2822|Units Feb/04|17|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Mar/04|45|USD Sales Mar/04|56|LC Sales Mar/04|1493|Units Mar/04|9|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Apr/04|51|USD Sales Apr/04|61|LC Sales Apr/04|1659|Units Apr/04|10|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales May/04|52|USD Sales May/04|62|LC Sales May/04|1662|Units May/04|10|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jun/04|68|USD Sales Jun/04|82|LC Sales Jun/04|2149|Units Jun/04|13|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jul/04|27|USD Sales Jul/04|34|LC Sales Jul/04|864|Units Jul/04|5|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Aug/04|47|USD Sales Aug/04|58|LC Sales Aug/04|1498|Units Aug/04|9|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Sep/04|52|USD Sales Sep/04|64|LC Sales Sep/04|1649|Units Sep/04|10|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Oct/04|69|USD Sales Oct/04|86|LC Sales Oct/04|2165|Units Oct/04|13|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Nov/04|58|USD Sales Nov/04|76|LC Sales Nov/04|1828|Units Nov/04|11|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Dec/04|50|USD Sales Dec/04|68|LC Sales Dec/04|1546|Units Dec/04|9|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jan/05|6|USD Sales Jan/05|7|LC Sales Jan/05|171|Units Jan/05|1|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales May/05|148|USD Sales May/05|188|LC Sales May/05|4480|Units May/05|25|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jun/05|36|USD Sales Jun/05|44|LC Sales Jun/05|1089|Units Jun/05|6|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jul/05|66|USD Sales Jul/05|80|LC Sales Jul/05|1997|Units Jul/05|11|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Aug/05|91|USD Sales Aug/05|112|LC Sales Aug/05|2702|Units Aug/05|15|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Sep/05|31|USD Sales Sep/05|38|LC Sales Sep/05|908|Units Sep/05|5|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Oct/05|12|USD Sales Oct/05|15|LC Sales Oct/05|360|Units Oct/05|2|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Nov/05|31|USD Sales Nov/05|37|LC Sales Nov/05|908|Units Nov/05|5|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Dec/05|25|USD Sales Dec/05|30|LC Sales Dec/05|726|Units Dec/05|4|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jan/06|57|USD Sales Jan/06|69|LC Sales Jan/06|1634|Units Jan/06|9|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Feb/06|89|USD Sales Feb/06|106|LC Sales Feb/06|2534|Units Feb/06|14|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Mar/06|164|USD Sales Mar/06|197|LC Sales Mar/06|4690|Units Mar/06|26|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Apr/06|19|USD Sales Apr/06|23|LC Sales Apr/06|539|Units Apr/06|3|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales May/06|45|USD Sales May/06|57|LC Sales May/06|1263|Units May/06|7|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jun/06|102|USD Sales Jun/06|129|LC Sales Jun/06|2882|Units Jun/06|16|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Jul/06|13|USD Sales Jul/06|16|LC Sales Jul/06|361|Units Jul/06|2|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Aug/06|38|USD Sales Aug/06|49|LC Sales Aug/06|1085|Units Aug/06|6|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Sep/06|57|USD Sales Sep/06|73|LC Sales Sep/06|1628|Units Sep/06|9|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 100 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/10|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|36|181.5|253.1|EURO Sales Oct/06|77|USD Sales Oct/06|97|LC Sales Oct/06|2178|Units Oct/06|12|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Nov/01|84|USD Sales Nov/01|75|LC Sales Nov/01|2797|Units Nov/01|71|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Dec/01|39|USD Sales Dec/01|35|LC Sales Dec/01|1280|Units Dec/01|32|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jan/02|74|USD Sales Jan/02|66|LC Sales Jan/02|2388|Units Jan/02|60|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Feb/02|114|USD Sales Feb/02|99|LC Sales Feb/02|3622|Units Feb/02|91|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Mar/02|25|USD Sales Mar/02|22|LC Sales Mar/02|792|Units Mar/02|20|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Apr/02|77|USD Sales Apr/02|68|LC Sales Apr/02|2325|Units Apr/02|59|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales May/02|116|USD Sales May/02|106|LC Sales May/02|3543|Units May/02|65|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jun/02|70|USD Sales Jun/02|67|LC Sales Jun/02|2126|Units Jun/02|39|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jul/02|99|USD Sales Jul/02|98|LC Sales Jul/02|2948|Units Jul/02|54|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Aug/02|66|USD Sales Aug/02|64|LC Sales Aug/02|2020|Units Aug/02|37|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Sep/02|135|USD Sales Sep/02|133|LC Sales Sep/02|4088|Units Sep/02|75|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Oct/02|142|USD Sales Oct/02|140|LC Sales Oct/02|4360|Units Oct/02|80|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Nov/02|106|USD Sales Nov/02|106|LC Sales Nov/02|3264|Units Nov/02|60|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Dec/02|120|USD Sales Dec/02|122|LC Sales Dec/02|3720|Units Dec/02|68|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jan/03|170|USD Sales Jan/03|181|LC Sales Jan/03|5361|Units Jan/03|98|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Feb/03|145|USD Sales Feb/03|156|LC Sales Feb/03|4586|Units Feb/03|84|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Mar/03|140|USD Sales Mar/03|151|LC Sales Mar/03|4447|Units Mar/03|81|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Apr/03|88|USD Sales Apr/03|96|LC Sales Apr/03|2790|Units Apr/03|51|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales May/03|107|USD Sales May/03|124|LC Sales May/03|3355|Units May/03|61|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jun/03|135|USD Sales Jun/03|157|LC Sales Jun/03|4235|Units Jun/03|77|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jul/03|136|USD Sales Jul/03|155|LC Sales Jul/03|4337|Units Jul/03|79|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Aug/03|124|USD Sales Aug/03|138|LC Sales Aug/03|4008|Units Aug/03|73|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Sep/03|119|USD Sales Sep/03|133|LC Sales Sep/03|3857|Units Sep/03|70|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Oct/03|113|USD Sales Oct/03|132|LC Sales Oct/03|3614|Units Oct/03|65|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Nov/03|98|USD Sales Nov/03|114|LC Sales Nov/03|3125|Units Nov/03|56|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Dec/03|114|USD Sales Dec/03|140|LC Sales Dec/03|3670|Units Dec/03|66|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jan/04|165|USD Sales Jan/04|208|LC Sales Jan/04|5403|Units Jan/04|97|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Feb/04|141|USD Sales Feb/04|178|LC Sales Feb/04|4631|Units Feb/04|83|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Mar/04|129|USD Sales Mar/04|158|LC Sales Mar/04|4241|Units Mar/04|76|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Apr/04|178|USD Sales Apr/04|213|LC Sales Apr/04|5782|Units Apr/04|104|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales May/04|169|USD Sales May/04|203|LC Sales May/04|5413|Units May/04|97|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jun/04|170|USD Sales Jun/04|206|LC Sales Jun/04|5374|Units Jun/04|97|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jul/04|14|USD Sales Jul/04|17|LC Sales Jul/04|450|Units Jul/04|8|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Aug/04|176|USD Sales Aug/04|215|LC Sales Aug/04|5580|Units Aug/04|100|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Sep/04|164|USD Sales Sep/04|201|LC Sales Sep/04|5189|Units Sep/04|93|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Oct/04|152|USD Sales Oct/04|190|LC Sales Oct/04|4790|Units Oct/04|86|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Nov/04|149|USD Sales Nov/04|193|LC Sales Nov/04|4648|Units Nov/04|83|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Dec/04|37|USD Sales Dec/04|49|LC Sales Dec/04|1122|Units Dec/04|20|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales May/05|152|USD Sales May/05|193|LC Sales May/05|4598|Units May/05|76|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jun/05|109|USD Sales Jun/05|132|LC Sales Jun/05|3267|Units Jun/05|54|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jul/05|102|USD Sales Jul/05|123|LC Sales Jul/05|3086|Units Jul/05|51|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Aug/05|90|USD Sales Aug/05|111|LC Sales Aug/05|2662|Units Aug/05|44|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Sep/05|54|USD Sales Sep/05|66|LC Sales Sep/05|1573|Units Sep/05|26|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Oct/05|71|USD Sales Oct/05|86|LC Sales Oct/05|2120|Units Oct/05|36|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Nov/05|67|USD Sales Nov/05|79|LC Sales Nov/05|1955|Units Nov/05|32|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Dec/05|67|USD Sales Dec/05|79|LC Sales Dec/05|1936|Units Dec/05|32|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jan/06|95|USD Sales Jan/06|115|LC Sales Jan/06|2719|Units Jan/06|46|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Feb/06|87|USD Sales Feb/06|104|LC Sales Feb/06|2472|Units Feb/06|41|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Mar/06|84|USD Sales Mar/06|101|LC Sales Mar/06|2408|Units Mar/06|40|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Apr/06|125|USD Sales Apr/06|153|LC Sales Apr/06|3564|Units Apr/06|59|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales May/06|132|USD Sales May/06|169|LC Sales May/06|3745|Units May/06|62|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jun/06|115|USD Sales Jun/06|146|LC Sales Jun/06|3262|Units Jun/06|54|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Jul/06|66|USD Sales Jul/06|84|LC Sales Jul/06|1876|Units Jul/06|31|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Aug/06|90|USD Sales Aug/06|115|LC Sales Aug/06|2541|Units Aug/06|43|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Sep/06|112|USD Sales Sep/06|143|LC Sales Sep/06|3177|Units Sep/06|52|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|WERNIGERODE|PHARMA WERNIGERODE|WERNIGERODE|PARODONTAL F5|0000|LIQUID 1 20 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|RX BOUND|1995|1995/09|0.00|0.00|COMBI|8-QUINOLINOL;XENYSALATE|37|60.5|84.5|EURO Sales Oct/06|98|USD Sales Oct/06|124|LC Sales Oct/06|2783|Units Oct/06|46|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Nov/01|18|USD Sales Nov/01|16|LC Sales Nov/01|606|Units Nov/01|30|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Dec/01|22|USD Sales Dec/01|20|LC Sales Dec/01|714|Units Dec/01|35|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jan/02|27|USD Sales Jan/02|23|LC Sales Jan/02|853|Units Jan/02|42|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Feb/02|9|USD Sales Feb/02|8|LC Sales Feb/02|284|Units Feb/02|14|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Mar/02|28|USD Sales Mar/02|24|LC Sales Mar/02|873|Units Mar/02|43|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Apr/02|23|USD Sales Apr/02|20|LC Sales Apr/02|687|Units Apr/02|34|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales May/02|2|USD Sales May/02|2|LC Sales May/02|61|Units May/02|3|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|BUKOSAN|0000|SOLUT. 1 25 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1993|1993/04|0.00|0.00|COMBI|RHEUM OFFICINALE;SALICYLIC ACID|38|20.5|27.8|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Nov/01|805|USD Sales Nov/01|715|LC Sales Nov/01|26765|Units Nov/01|1325|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Dec/01|656|USD Sales Dec/01|586|LC Sales Dec/01|21271|Units Dec/01|1053|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jan/02|1049|USD Sales Jan/02|926|LC Sales Jan/02|33653|Units Jan/02|1666|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Feb/02|419|USD Sales Feb/02|364|LC Sales Feb/02|13306|Units Feb/02|662|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Apr/02|37|USD Sales Apr/02|32|LC Sales Apr/02|1111|Units Apr/02|55|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales May/02|144|USD Sales May/02|132|LC Sales May/02|4404|Units May/02|218|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jun/02|505|USD Sales Jun/02|483|LC Sales Jun/02|15291|Units Jun/02|757|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jul/02|527|USD Sales Jul/02|523|LC Sales Jul/02|15716|Units Jul/02|778|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Aug/02|5|USD Sales Aug/02|5|LC Sales Aug/02|162|Units Aug/02|8|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Dec/02|434|USD Sales Dec/02|441|LC Sales Dec/02|13494|Units Dec/02|668|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jan/03|440|USD Sales Jan/03|467|LC Sales Jan/03|13837|Units Jan/03|685|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Feb/03|954|USD Sales Feb/03|1029|LC Sales Feb/03|30179|Units Feb/03|1494|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Mar/03|685|USD Sales Mar/03|740|LC Sales Mar/03|21715|Units Mar/03|1075|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Apr/03|444|USD Sales Apr/03|482|LC Sales Apr/03|14039|Units Apr/03|695|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales May/03|474|USD Sales May/03|548|LC Sales May/03|14867|Units May/03|736|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jun/03|472|USD Sales Jun/03|550|LC Sales Jun/03|14807|Units Jun/03|733|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jul/03|711|USD Sales Jul/03|808|LC Sales Jul/03|22630|Units Jul/03|884|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Aug/03|617|USD Sales Aug/03|687|LC Sales Aug/03|19908|Units Aug/03|701|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Sep/03|754|USD Sales Sep/03|844|LC Sales Sep/03|24396|Units Sep/03|853|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Oct/03|806|USD Sales Oct/03|943|LC Sales Oct/03|25761|Units Oct/03|930|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Nov/03|633|USD Sales Nov/03|740|LC Sales Nov/03|20218|Units Nov/03|702|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Dec/03|886|USD Sales Dec/03|1087|LC Sales Dec/03|28605|Units Dec/03|983|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jan/04|424|USD Sales Jan/04|534|LC Sales Jan/04|13860|Units Jan/04|504|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Feb/04|869|USD Sales Feb/04|1099|LC Sales Feb/04|28557|Units Feb/04|1002|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Mar/04|689|USD Sales Mar/04|845|LC Sales Mar/04|22712|Units Mar/04|835|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Apr/04|808|USD Sales Apr/04|968|LC Sales Apr/04|26261|Units Apr/04|915|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales May/04|688|USD Sales May/04|825|LC Sales May/04|22000|Units May/04|800|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jun/04|814|USD Sales Jun/04|987|LC Sales Jun/04|25718|Units Jun/04|893|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jul/04|692|USD Sales Jul/04|849|LC Sales Jul/04|21828|Units Jul/04|788|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Aug/04|560|USD Sales Aug/04|682|LC Sales Aug/04|17719|Units Aug/04|642|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Sep/04|732|USD Sales Sep/04|894|LC Sales Sep/04|23128|Units Sep/04|841|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Oct/04|752|USD Sales Oct/04|940|LC Sales Oct/04|23687|Units Oct/04|814|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Nov/04|600|USD Sales Nov/04|780|LC Sales Nov/04|18782|Units Nov/04|688|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Dec/04|902|USD Sales Dec/04|1209|LC Sales Dec/04|27655|Units Dec/04|1013|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jan/05|703|USD Sales Jan/05|923|LC Sales Jan/05|21302|Units Jan/05|951|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Feb/05|959|USD Sales Feb/05|1249|LC Sales Feb/05|28751|Units Feb/05|988|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Mar/05|918|USD Sales Mar/05|1212|LC Sales Mar/05|27325|Units Mar/05|939|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Apr/05|705|USD Sales Apr/05|913|LC Sales Apr/05|21243|Units Apr/05|730|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales May/05|779|USD Sales May/05|989|LC Sales May/05|23571|Units May/05|810|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jun/05|859|USD Sales Jun/05|1044|LC Sales Jun/05|25783|Units Jun/05|886|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jul/05|754|USD Sales Jul/05|908|LC Sales Jul/05|22747|Units Jul/05|671|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Aug/05|893|USD Sales Aug/05|1098|LC Sales Aug/05|26426|Units Aug/05|730|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Sep/05|1072|USD Sales Sep/05|1314|LC Sales Sep/05|31420|Units Sep/05|772|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Oct/05|1131|USD Sales Oct/05|1360|LC Sales Oct/05|33578|Units Oct/05|825|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Nov/05|1072|USD Sales Nov/05|1264|LC Sales Nov/05|31380|Units Nov/05|771|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Dec/05|1110|USD Sales Dec/05|1317|LC Sales Dec/05|32153|Units Dec/05|790|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jan/06|1291|USD Sales Jan/06|1563|LC Sales Jan/06|37078|Units Jan/06|911|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Feb/06|1273|USD Sales Feb/06|1521|LC Sales Feb/06|36182|Units Feb/06|889|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Mar/06|1316|USD Sales Mar/06|1582|LC Sales Mar/06|37688|Units Mar/06|926|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Apr/06|1192|USD Sales Apr/06|1462|LC Sales Apr/06|33985|Units Apr/06|835|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales May/06|1196|USD Sales May/06|1527|LC Sales May/06|33822|Units May/06|831|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jun/06|1562|USD Sales Jun/06|1978|LC Sales Jun/06|44332|Units Jun/06|892|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Jul/06|1301|USD Sales Jul/06|1650|LC Sales Jul/06|37001|Units Jul/06|743|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Aug/06|1430|USD Sales Aug/06|1832|LC Sales Aug/06|40313|Units Aug/06|792|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Sep/06|1312|USD Sales Sep/06|1671|LC Sales Sep/06|37248|Units Sep/06|742|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|FLORSALMIN|0000|DROPS 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGB ORAL TOP DROPS|NON-RX BOUND|1989|1989/01|0.00|0.00|MONO|SALVIA OFFICINALIS|39|51|71.2|EURO Sales Oct/06|1659|USD Sales Oct/06|2093|LC Sales Oct/06|46920|Units Oct/06|920|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Nov/01|154|USD Sales Nov/01|137|LC Sales Nov/01|5124|Units Nov/01|183|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Dec/01|128|USD Sales Dec/01|114|LC Sales Dec/01|4144|Units Dec/01|148|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jan/02|205|USD Sales Jan/02|181|LC Sales Jan/02|6580|Units Jan/02|235|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Feb/02|179|USD Sales Feb/02|156|LC Sales Feb/02|5684|Units Feb/02|203|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Mar/02|151|USD Sales Mar/02|132|LC Sales Mar/02|4732|Units Mar/02|169|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Apr/02|132|USD Sales Apr/02|117|LC Sales Apr/02|4004|Units Apr/02|143|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales May/02|176|USD Sales May/02|161|LC Sales May/02|5376|Units May/02|192|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jun/02|120|USD Sales Jun/02|115|LC Sales Jun/02|3640|Units Jun/02|130|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jul/02|130|USD Sales Jul/02|129|LC Sales Jul/02|3864|Units Jul/02|138|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Aug/02|104|USD Sales Aug/02|101|LC Sales Aug/02|3197|Units Aug/02|115|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Sep/02|151|USD Sales Sep/02|148|LC Sales Sep/02|4548|Units Sep/02|163|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Oct/02|223|USD Sales Oct/02|219|LC Sales Oct/02|6832|Units Oct/02|244|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Nov/02|113|USD Sales Nov/02|113|LC Sales Nov/02|3475|Units Nov/02|125|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Dec/02|143|USD Sales Dec/02|145|LC Sales Dec/02|4452|Units Dec/02|159|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jan/03|180|USD Sales Jan/03|191|LC Sales Jan/03|5651|Units Jan/03|204|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Feb/03|118|USD Sales Feb/03|127|LC Sales Feb/03|3724|Units Feb/03|133|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Mar/03|155|USD Sales Mar/03|168|LC Sales Mar/03|4928|Units Mar/03|176|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Apr/03|153|USD Sales Apr/03|166|LC Sales Apr/03|4844|Units Apr/03|173|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales May/03|120|USD Sales May/03|139|LC Sales May/03|3780|Units May/03|135|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jun/03|174|USD Sales Jun/03|203|LC Sales Jun/03|5460|Units Jun/03|195|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jul/03|161|USD Sales Jul/03|183|LC Sales Jul/03|5124|Units Jul/03|183|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Aug/03|130|USD Sales Aug/03|145|LC Sales Aug/03|4200|Units Aug/03|150|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Sep/03|126|USD Sales Sep/03|141|LC Sales Sep/03|4088|Units Sep/03|146|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Oct/03|146|USD Sales Oct/03|171|LC Sales Oct/03|4676|Units Oct/03|167|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Nov/03|103|USD Sales Nov/03|120|LC Sales Nov/03|3276|Units Nov/03|117|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Dec/03|156|USD Sales Dec/03|192|LC Sales Dec/03|5040|Units Dec/03|180|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jan/04|205|USD Sales Jan/04|259|LC Sales Jan/04|6720|Units Jan/04|240|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Feb/04|178|USD Sales Feb/04|225|LC Sales Feb/04|5852|Units Feb/04|209|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Mar/04|129|USD Sales Mar/04|158|LC Sales Mar/04|4256|Units Mar/04|152|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Apr/04|1|USD Sales Apr/04|1|LC Sales Apr/04|28|Units Apr/04|1|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jun/04|2|USD Sales Jun/04|2|LC Sales Jun/04|56|Units Jun/04|2|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|PARADENTOL|0000|JEL. 1 45 G|K ORAL TOPICAL|KV ORAL TOP GELS/SOLS|KVA ORAL TOP GELS/SOLS|NON-RX BOUND|1979|1979/01|0.00|0.00|MONO|ALKONIUM HYDROXIDE|40|28.7|38.8|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Nov/01|21|USD Sales Nov/01|18|LC Sales Nov/01|688|Units Nov/01|36|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Dec/01|24|USD Sales Dec/01|22|LC Sales Dec/01|783|Units Dec/01|41|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jan/02|36|USD Sales Jan/02|32|LC Sales Jan/02|1152|Units Jan/02|60|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Feb/02|17|USD Sales Feb/02|15|LC Sales Feb/02|554|Units Feb/02|29|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Mar/02|10|USD Sales Mar/02|9|LC Sales Mar/02|326|Units Mar/02|17|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jun/02|45|USD Sales Jun/02|43|LC Sales Jun/02|1370|Units Jun/02|71|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jul/02|36|USD Sales Jul/02|36|LC Sales Jul/02|1081|Units Jul/02|56|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01A STOMATOLOGICALS|A01A0 STOMATOLOGICALS|ZENTIVA*|ZENTIVA|ZENTIVA|STOMATOSAN|0000|TINC 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGA ORAL TOP LIQUIDS|NON-RX BOUND|1989|1989/01|0.00|0.00|COMBI|ACHILLEA MILLEFOLIUM;ALLIARIA PETIOLATA;CARYOPHYLLATA VULGARIS;POTENTILLA TORMENTILLA;PRUNELLA VULGARIS;SALVIA OFFICINALIS;SYMPHYTUM OFFICINALE;SYZYGIUM AROMATICUM;THYMUS VULGARE;VERBENA OFFICINALIS|41|19.6|26.5|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Dec/03|44|USD Sales Dec/03|54|LC Sales Dec/03|1433|Units Dec/03|2|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jan/06|25|USD Sales Jan/06|31|LC Sales Jan/06|727|Units Jan/06|1|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Mar/06|338|USD Sales Mar/06|406|LC Sales Mar/06|9675|Units Mar/06|11|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Apr/06|122|USD Sales Apr/06|150|LC Sales Apr/06|3489|Units Apr/06|4|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales May/06|1281|USD Sales May/06|1635|LC Sales May/06|36225|Units May/06|42|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jun/06|400|USD Sales Jun/06|507|LC Sales Jun/06|11358|Units Jun/06|13|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Jul/06|734|USD Sales Jul/06|932|LC Sales Jul/06|20885|Units Jul/06|24|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Aug/06|398|USD Sales Aug/06|510|LC Sales Aug/06|11218|Units Aug/06|13|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Sep/06|367|USD Sales Sep/06|467|LC Sales Sep/06|10412|Units Sep/06|12|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A01 STOMATOLOGICALS|A01B MOUTH ANTIFUNGALS|A01B0 MOUTH ANTIFUNGALS|BRISTOL MYERS SQB*|BRISTOL-MYERS SQB.|BRISTOL MYERS SQUI|AMPHO MORONAL|0005G|SUSP 5 G 1 50 ML|K ORAL TOPICAL|KG ORAL TOP LIQUIDS|KGK ORAL TOP SUSPENSIONS|RX BOUND|2003|2003/10|0.00|0.00|MONO|AMPHOTERICIN B|42|860.3|1159.1|EURO Sales Oct/06|913|USD Sales Oct/06|1151|LC Sales Oct/06|25809|Units Oct/06|30|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Mar/06|9|USD Sales Mar/06|10|LC Sales Mar/06|246|Units Mar/06|5|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Apr/06|415|USD Sales Apr/06|509|LC Sales Apr/06|11832|Units Apr/06|240|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales May/06|322|USD Sales May/06|411|LC Sales May/06|9108|Units May/06|184|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jun/06|251|USD Sales Jun/06|317|LC Sales Jun/06|7114|Units Jun/06|144|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Jul/06|109|USD Sales Jul/06|138|LC Sales Jul/06|3100|Units Jul/06|63|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Aug/06|300|USD Sales Aug/06|384|LC Sales Aug/06|8445|Units Aug/06|172|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Sep/06|227|USD Sales Sep/06|289|LC Sales Sep/06|6451|Units Sep/06|133|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TAB CH.SPEAR 36 DIA|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/03|0.00|0.00|COMBI|CALCIUM;MAGNESIUM|43|49|68.4|EURO Sales Oct/06|288|USD Sales Oct/06|363|LC Sales Oct/06|8134|Units Oct/06|166|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Nov/01|306|USD Sales Nov/01|272|LC Sales Nov/01|10160|Units Nov/01|359|DOT Nov/01|861.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Dec/01|322|USD Sales Dec/01|288|LC Sales Dec/01|10447|Units Dec/01|364|DOT Dec/01|873.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jan/02|453|USD Sales Jan/02|400|LC Sales Jan/02|14544|Units Jan/02|505|DOT Jan/02|1212
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Feb/02|369|USD Sales Feb/02|321|LC Sales Feb/02|11722|Units Feb/02|407|DOT Feb/02|976.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Mar/02|323|USD Sales Mar/02|283|LC Sales Mar/02|10138|Units Mar/02|352|DOT Mar/02|844.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Apr/02|399|USD Sales Apr/02|354|LC Sales Apr/02|12125|Units Apr/02|421|DOT Apr/02|1010.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales May/02|440|USD Sales May/02|404|LC Sales May/02|13478|Units May/02|468|DOT May/02|1123.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jun/02|360|USD Sales Jun/02|344|LC Sales Jun/02|10915|Units Jun/02|379|DOT Jun/02|909.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jul/02|425|USD Sales Jul/02|421|LC Sales Jul/02|12658|Units Jul/02|438|DOT Jul/02|1051.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Aug/02|334|USD Sales Aug/02|326|LC Sales Aug/02|10288|Units Aug/02|356|DOT Aug/02|854.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Sep/02|444|USD Sales Sep/02|435|LC Sales Sep/02|13410|Units Sep/02|464|DOT Sep/02|1113.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Oct/02|487|USD Sales Oct/02|478|LC Sales Oct/02|14912|Units Oct/02|516|DOT Oct/02|1238.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Nov/02|434|USD Sales Nov/02|434|LC Sales Nov/02|13323|Units Nov/02|461|DOT Nov/02|1106.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Dec/02|552|USD Sales Dec/02|561|LC Sales Dec/02|17165|Units Dec/02|596|DOT Dec/02|1430.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jan/03|574|USD Sales Jan/03|610|LC Sales Jan/03|18063|Units Jan/03|625|DOT Jan/03|1500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Feb/03|458|USD Sales Feb/03|494|LC Sales Feb/03|14492|Units Feb/03|498|DOT Feb/03|1195.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Mar/03|360|USD Sales Mar/03|390|LC Sales Mar/03|11436|Units Mar/03|393|DOT Mar/03|943.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Apr/03|595|USD Sales Apr/03|645|LC Sales Apr/03|18799|Units Apr/03|646|DOT Apr/03|1550.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales May/03|425|USD Sales May/03|491|LC Sales May/03|13328|Units May/03|458|DOT May/03|1099.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jun/03|402|USD Sales Jun/03|469|LC Sales Jun/03|12629|Units Jun/03|434|DOT Jun/03|1041.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jul/03|460|USD Sales Jul/03|523|LC Sales Jul/03|14652|Units Jul/03|507|DOT Jul/03|1216.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Aug/03|346|USD Sales Aug/03|386|LC Sales Aug/03|11174|Units Aug/03|384|DOT Aug/03|921.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Sep/03|474|USD Sales Sep/03|531|LC Sales Sep/03|15336|Units Sep/03|527|DOT Sep/03|1264.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Oct/03|539|USD Sales Oct/03|630|LC Sales Oct/03|17227|Units Oct/03|592|DOT Oct/03|1420.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Nov/03|445|USD Sales Nov/03|521|LC Sales Nov/03|14230|Units Nov/03|489|DOT Nov/03|1173.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Dec/03|637|USD Sales Dec/03|782|LC Sales Dec/03|20574|Units Dec/03|707|DOT Dec/03|1696.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jan/04|584|USD Sales Jan/04|737|LC Sales Jan/04|19119|Units Jan/04|657|DOT Jan/04|1576.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Feb/04|460|USD Sales Feb/04|581|LC Sales Feb/04|15103|Units Feb/04|519|DOT Feb/04|1245.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Mar/04|628|USD Sales Mar/04|770|LC Sales Mar/04|20690|Units Mar/04|711|DOT Mar/04|1706.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Apr/04|809|USD Sales Apr/04|970|LC Sales Apr/04|26306|Units Apr/04|904|DOT Apr/04|2169.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales May/04|740|USD Sales May/04|889|LC Sales May/04|23687|Units May/04|814|DOT May/04|1953.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jun/04|626|USD Sales Jun/04|760|LC Sales Jun/04|19788|Units Jun/04|680|DOT Jun/04|1632
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jul/04|557|USD Sales Jul/04|684|LC Sales Jul/04|17582|Units Jul/04|590|DOT Jul/04|1416
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Aug/04|569|USD Sales Aug/04|693|LC Sales Aug/04|17999|Units Aug/04|604|DOT Aug/04|1449.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Sep/04|808|USD Sales Sep/04|987|LC Sales Sep/04|25530|Units Sep/04|851|DOT Sep/04|2042.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Oct/04|914|USD Sales Oct/04|1141|LC Sales Oct/04|28770|Units Oct/04|959|DOT Oct/04|2301.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Nov/04|865|USD Sales Nov/04|1123|LC Sales Nov/04|27060|Units Nov/04|902|DOT Nov/04|2164.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Dec/04|977|USD Sales Dec/04|1309|LC Sales Dec/04|29940|Units Dec/04|998|DOT Dec/04|2395.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jan/05|862|USD Sales Jan/05|1132|LC Sales Jan/05|26130|Units Jan/05|871|DOT Jan/05|2090.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Feb/05|655|USD Sales Feb/05|852|LC Sales Feb/05|19620|Units Feb/05|654|DOT Feb/05|1569.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Mar/05|926|USD Sales Mar/05|1223|LC Sales Mar/05|27568|Units Mar/05|922|DOT Mar/05|2212.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Apr/05|879|USD Sales Apr/05|1138|LC Sales Apr/05|26491|Units Apr/05|886|DOT Apr/05|2126.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales May/05|799|USD Sales May/05|1014|LC Sales May/05|24159|Units May/05|808|DOT May/05|1939.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jun/05|744|USD Sales Jun/05|904|LC Sales Jun/05|22329|Units Jun/05|778|DOT Jun/05|1867.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jul/05|620|USD Sales Jul/05|747|LC Sales Jul/05|18720|Units Jul/05|650|DOT Jul/05|1560
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Aug/05|839|USD Sales Aug/05|1032|LC Sales Aug/05|24825|Units Aug/05|868|DOT Aug/05|2083.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Sep/05|788|USD Sales Sep/05|966|LC Sales Sep/05|23098|Units Sep/05|802|DOT Sep/05|1924.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Oct/05|1138|USD Sales Oct/05|1368|LC Sales Oct/05|33777|Units Oct/05|1181|DOT Oct/05|2834.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Nov/05|666|USD Sales Nov/05|785|LC Sales Nov/05|19505|Units Nov/05|682|DOT Nov/05|1636.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Dec/05|970|USD Sales Dec/05|1151|LC Sales Dec/05|28095|Units Dec/05|1007|DOT Dec/05|2416.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jan/06|1207|USD Sales Jan/06|1461|LC Sales Jan/06|34663|Units Jan/06|1212|DOT Jan/06|2908.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Feb/06|918|USD Sales Feb/06|1096|LC Sales Feb/06|26088|Units Feb/06|909|DOT Feb/06|2181.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Mar/06|977|USD Sales Mar/06|1175|LC Sales Mar/06|27983|Units Mar/06|975|DOT Mar/06|2340
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Apr/06|971|USD Sales Apr/06|1191|LC Sales Apr/06|27696|Units Apr/06|965|DOT Apr/06|2316
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales May/06|1173|USD Sales May/06|1497|LC Sales May/06|33158|Units May/06|1180|DOT May/06|2832
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jun/06|839|USD Sales Jun/06|1062|LC Sales Jun/06|23800|Units Jun/06|850|DOT Jun/06|2040
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Jul/06|654|USD Sales Jul/06|830|LC Sales Jul/06|18618|Units Jul/06|677|DOT Jul/06|1624.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Aug/06|1038|USD Sales Aug/06|1329|LC Sales Aug/06|29260|Units Aug/06|1064|DOT Aug/06|2553.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Sep/06|963|USD Sales Sep/06|1226|LC Sales Sep/06|27336|Units Sep/06|1005|DOT Sep/06|2412
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 24|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/01|2.40|10.00 DF|COMBI|CALCIUM;MAGNESIUM|44|27.9|39|EURO Sales Oct/06|1116|USD Sales Oct/06|1408|LC Sales Oct/06|31555|Units Oct/06|1131|DOT Oct/06|2714.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 36|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1994|1994/10|3.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|45|46.1|62.4|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Nov/01|37|USD Sales Nov/01|33|LC Sales Nov/01|1235|Units Nov/01|25|DOT Nov/01|120
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Dec/01|95|USD Sales Dec/01|85|LC Sales Dec/01|3088|Units Dec/01|62|DOT Dec/01|297.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jan/02|169|USD Sales Jan/02|149|LC Sales Jan/02|5428|Units Jan/02|109|DOT Jan/02|523.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Feb/02|163|USD Sales Feb/02|142|LC Sales Feb/02|5179|Units Feb/02|104|DOT Feb/02|499.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Mar/02|60|USD Sales Mar/02|53|LC Sales Mar/02|1892|Units Mar/02|38|DOT Mar/02|182.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Apr/02|110|USD Sales Apr/02|97|LC Sales Apr/02|3337|Units Apr/02|67|DOT Apr/02|321.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales May/02|119|USD Sales May/02|109|LC Sales May/02|3635|Units May/02|73|DOT May/02|350.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jun/02|113|USD Sales Jun/02|108|LC Sales Jun/02|3436|Units Jun/02|69|DOT Jun/02|331.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jul/02|258|USD Sales Jul/02|256|LC Sales Jul/02|7685|Units Jul/02|154|DOT Jul/02|739.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Aug/02|138|USD Sales Aug/02|135|LC Sales Aug/02|4259|Units Aug/02|85|DOT Aug/02|408
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Sep/02|179|USD Sales Sep/02|176|LC Sales Sep/02|5411|Units Sep/02|108|DOT Sep/02|518.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Oct/02|198|USD Sales Oct/02|194|LC Sales Oct/02|6062|Units Oct/02|121|DOT Oct/02|580.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Nov/02|175|USD Sales Nov/02|175|LC Sales Nov/02|5361|Units Nov/02|107|DOT Nov/02|513.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Dec/02|166|USD Sales Dec/02|169|LC Sales Dec/02|5179|Units Dec/02|104|DOT Dec/02|499.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jan/03|178|USD Sales Jan/03|189|LC Sales Jan/03|5611|Units Jan/03|112|DOT Jan/03|537.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Feb/03|135|USD Sales Feb/03|145|LC Sales Feb/03|4259|Units Feb/03|85|DOT Feb/03|408
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Mar/03|128|USD Sales Mar/03|138|LC Sales Mar/03|4058|Units Mar/03|81|DOT Mar/03|388.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Apr/03|226|USD Sales Apr/03|245|LC Sales Apr/03|7136|Units Apr/03|143|DOT Apr/03|686.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales May/03|224|USD Sales May/03|259|LC Sales May/03|7014|Units May/03|140|DOT May/03|672
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jun/03|137|USD Sales Jun/03|160|LC Sales Jun/03|4309|Units Jun/03|86|DOT Jun/03|412.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jul/03|184|USD Sales Jul/03|209|LC Sales Jul/03|5862|Units Jul/03|117|DOT Jul/03|561.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Aug/03|151|USD Sales Aug/03|168|LC Sales Aug/03|4860|Units Aug/03|97|DOT Aug/03|465.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Sep/03|218|USD Sales Sep/03|244|LC Sales Sep/03|7064|Units Sep/03|141|DOT Sep/03|676.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Oct/03|255|USD Sales Oct/03|299|LC Sales Oct/03|8166|Units Oct/03|163|DOT Oct/03|782.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Nov/03|237|USD Sales Nov/03|277|LC Sales Nov/03|7565|Units Nov/03|151|DOT Nov/03|724.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Dec/03|310|USD Sales Dec/03|381|LC Sales Dec/03|10020|Units Dec/03|200|DOT Dec/03|960
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jan/04|343|USD Sales Jan/04|433|LC Sales Jan/04|11222|Units Jan/04|224|DOT Jan/04|1075.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Feb/04|310|USD Sales Feb/04|391|LC Sales Feb/04|10170|Units Feb/04|203|DOT Feb/04|974.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Mar/04|401|USD Sales Mar/04|492|LC Sales Mar/04|13226|Units Mar/04|264|DOT Mar/04|1267.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Apr/04|535|USD Sales Apr/04|641|LC Sales Apr/04|17385|Units Apr/04|347|DOT Apr/04|1665.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales May/04|573|USD Sales May/04|688|LC Sales May/04|18337|Units May/04|366|DOT May/04|1756.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jun/04|480|USD Sales Jun/04|583|LC Sales Jun/04|15180|Units Jun/04|303|DOT Jun/04|1454.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jul/04|464|USD Sales Jul/04|570|LC Sales Jul/04|14649|Units Jul/04|285|DOT Jul/04|1368
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Aug/04|431|USD Sales Aug/04|525|LC Sales Aug/04|13621|Units Aug/04|265|DOT Aug/04|1272
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Sep/04|461|USD Sales Sep/04|563|LC Sales Sep/04|14556|Units Sep/04|281|DOT Sep/04|1348.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Oct/04|694|USD Sales Oct/04|867|LC Sales Oct/04|21860|Units Oct/04|422|DOT Oct/04|2025.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Nov/04|548|USD Sales Nov/04|712|LC Sales Nov/04|17146|Units Nov/04|331|DOT Nov/04|1588.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Dec/04|747|USD Sales Dec/04|1001|LC Sales Dec/04|22896|Units Dec/04|442|DOT Dec/04|2121.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jan/05|648|USD Sales Jan/05|851|LC Sales Jan/05|19646|Units Jan/05|380|DOT Jan/05|1824
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Feb/05|597|USD Sales Feb/05|778|LC Sales Feb/05|17905|Units Feb/05|347|DOT Feb/05|1665.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Mar/05|785|USD Sales Mar/05|1037|LC Sales Mar/05|23381|Units Mar/05|454|DOT Mar/05|2179.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Apr/05|671|USD Sales Apr/05|868|LC Sales Apr/05|20215|Units Apr/05|391|DOT Apr/05|1876.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales May/05|687|USD Sales May/05|872|LC Sales May/05|20783|Units May/05|402|DOT May/05|1929.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jun/05|585|USD Sales Jun/05|711|LC Sales Jun/05|17558|Units Jun/05|347|DOT Jun/05|1665.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jul/05|559|USD Sales Jul/05|673|LC Sales Jul/05|16866|Units Jul/05|338|DOT Jul/05|1622.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Aug/05|595|USD Sales Aug/05|731|LC Sales Aug/05|17594|Units Aug/05|354|DOT Aug/05|1699.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Sep/05|616|USD Sales Sep/05|755|LC Sales Sep/05|18064|Units Sep/05|362|DOT Sep/05|1737.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Oct/05|782|USD Sales Oct/05|940|LC Sales Oct/05|23207|Units Oct/05|466|DOT Oct/05|2236.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Nov/05|616|USD Sales Nov/05|726|LC Sales Nov/05|18041|Units Nov/05|363|DOT Nov/05|1742.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Dec/05|1005|USD Sales Dec/05|1192|LC Sales Dec/05|29111|Units Dec/05|599|DOT Dec/05|2875.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jan/06|1089|USD Sales Jan/06|1318|LC Sales Jan/06|31261|Units Jan/06|629|DOT Jan/06|3019.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Feb/06|659|USD Sales Feb/06|787|LC Sales Feb/06|18737|Units Feb/06|377|DOT Feb/06|1809.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Mar/06|970|USD Sales Mar/06|1167|LC Sales Mar/06|27788|Units Mar/06|558|DOT Mar/06|2678.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Apr/06|847|USD Sales Apr/06|1039|LC Sales Apr/06|24152|Units Apr/06|484|DOT Apr/06|2323.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales May/06|1039|USD Sales May/06|1327|LC Sales May/06|29389|Units May/06|601|DOT May/06|2884.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jun/06|817|USD Sales Jun/06|1035|LC Sales Jun/06|23183|Units Jun/06|478|DOT Jun/06|2294.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Jul/06|569|USD Sales Jul/06|722|LC Sales Jul/06|16190|Units Jul/06|338|DOT Jul/06|1622.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Aug/06|795|USD Sales Aug/06|1019|LC Sales Aug/06|22420|Units Aug/06|472|DOT Aug/06|2265.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Sep/06|854|USD Sales Sep/06|1087|LC Sales Sep/06|24237|Units Sep/06|506|DOT Sep/06|2428.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 48|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2000|2000/10|4.80|10.00 DF|COMBI|CALCIUM;MAGNESIUM|46|48.1|67.2|EURO Sales Oct/06|1077|USD Sales Oct/06|1358|LC Sales Oct/06|30447|Units Oct/06|633|DOT Oct/06|3038.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jan/04|534|USD Sales Jan/04|674|LC Sales Jan/04|17490|Units Jan/04|173|DOT Jan/04|1660.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Feb/04|598|USD Sales Feb/04|756|LC Sales Feb/04|19633|Units Feb/04|194|DOT Feb/04|1862.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Mar/04|638|USD Sales Mar/04|783|LC Sales Mar/04|21050|Units Mar/04|208|DOT Mar/04|1996.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Apr/04|598|USD Sales Apr/04|716|LC Sales Apr/04|19430|Units Apr/04|192|DOT Apr/04|1843.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales May/04|797|USD Sales May/04|957|LC Sales May/04|25502|Units May/04|252|DOT May/04|2419.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jun/04|509|USD Sales Jun/04|618|LC Sales Jun/04|16091|Units Jun/04|159|DOT Jun/04|1526.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jul/04|421|USD Sales Jul/04|516|LC Sales Jul/04|13279|Units Jul/04|132|DOT Jul/04|1267.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Aug/04|470|USD Sales Aug/04|572|LC Sales Aug/04|14859|Units Aug/04|148|DOT Aug/04|1420.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Sep/04|731|USD Sales Sep/04|893|LC Sales Sep/04|23092|Units Sep/04|230|DOT Sep/04|2208
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Oct/04|730|USD Sales Oct/04|912|LC Sales Oct/04|22992|Units Oct/04|229|DOT Oct/04|2198.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Nov/04|615|USD Sales Nov/04|799|LC Sales Nov/04|19258|Units Nov/04|192|DOT Nov/04|1843.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Dec/04|864|USD Sales Dec/04|1157|LC Sales Dec/04|26479|Units Dec/04|264|DOT Dec/04|2534.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jan/05|744|USD Sales Jan/05|976|LC Sales Jan/05|22534|Units Jan/05|224|DOT Jan/05|2150.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Feb/05|734|USD Sales Feb/05|955|LC Sales Feb/05|21988|Units Feb/05|219|DOT Feb/05|2102.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Mar/05|826|USD Sales Mar/05|1091|LC Sales Mar/05|24600|Units Mar/05|240|DOT Mar/05|2304
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Apr/05|805|USD Sales Apr/05|1042|LC Sales Apr/05|24255|Units Apr/05|233|DOT Apr/05|2236.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales May/05|740|USD Sales May/05|939|LC Sales May/05|22387|Units May/05|212|DOT May/05|2035.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jun/05|649|USD Sales Jun/05|790|LC Sales Jun/05|19505|Units Jun/05|189|DOT Jun/05|1814.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jul/05|716|USD Sales Jul/05|862|LC Sales Jul/05|21606|Units Jul/05|211|DOT Jul/05|2025.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Aug/05|719|USD Sales Aug/05|884|LC Sales Aug/05|21276|Units Aug/05|209|DOT Aug/05|2006.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Sep/05|704|USD Sales Sep/05|862|LC Sales Sep/05|20624|Units Sep/05|202|DOT Sep/05|1939.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Oct/05|956|USD Sales Oct/05|1150|LC Sales Oct/05|28386|Units Oct/05|285|DOT Oct/05|2736
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Nov/05|848|USD Sales Nov/05|999|LC Sales Nov/05|24812|Units Nov/05|255|DOT Nov/05|2448
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Dec/05|389|USD Sales Dec/05|461|LC Sales Dec/05|11267|Units Dec/05|111|DOT Dec/05|1065.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jan/06|1294|USD Sales Jan/06|1566|LC Sales Jan/06|37157|Units Jan/06|365|DOT Jan/06|3504
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Feb/06|942|USD Sales Feb/06|1125|LC Sales Feb/06|26773|Units Feb/06|263|DOT Feb/06|2524.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Mar/06|1018|USD Sales Mar/06|1224|LC Sales Mar/06|29143|Units Mar/06|286|DOT Mar/06|2745.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Apr/06|931|USD Sales Apr/06|1142|LC Sales Apr/06|26546|Units Apr/06|260|DOT Apr/06|2496
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales May/06|1007|USD Sales May/06|1285|LC Sales May/06|28458|Units May/06|279|DOT May/06|2678.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jun/06|1013|USD Sales Jun/06|1283|LC Sales Jun/06|28741|Units Jun/06|284|DOT Jun/06|2726.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Jul/06|665|USD Sales Jul/06|844|LC Sales Jul/06|18928|Units Jul/06|191|DOT Jul/06|1833.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Aug/06|845|USD Sales Aug/06|1083|LC Sales Aug/06|23833|Units Aug/06|248|DOT Aug/06|2380.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Sep/06|1021|USD Sales Sep/06|1300|LC Sales Sep/06|28978|Units Sep/06|296|DOT Sep/06|2841.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|RENNIE|0000|TABS CHEW 96|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2004|2004/01|9.60|10.00 DF|COMBI|CALCIUM;MAGNESIUM|47|98.4|137.4|EURO Sales Oct/06|1086|USD Sales Oct/06|1370|LC Sales Oct/06|30701|Units Oct/06|312|DOT Oct/06|2995.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Nov/01|24|USD Sales Nov/01|21|LC Sales Nov/01|798|Units Nov/01|13|DOT Nov/01|26
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Dec/01|28|USD Sales Dec/01|25|LC Sales Dec/01|923|Units Dec/01|15|DOT Dec/01|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jan/02|38|USD Sales Jan/02|33|LC Sales Jan/02|1212|Units Jan/02|20|DOT Jan/02|40
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Feb/02|38|USD Sales Feb/02|33|LC Sales Feb/02|1196|Units Feb/02|20|DOT Feb/02|40
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Mar/02|26|USD Sales Mar/02|23|LC Sales Mar/02|830|Units Mar/02|14|DOT Mar/02|28
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Apr/02|41|USD Sales Apr/02|37|LC Sales Apr/02|1252|Units Apr/02|21|DOT Apr/02|42
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0001G|TABS CHEW 1 G FORT 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1999|1999/10|2.00|10.00 DF|MONO|HYDROTALCITE|48|65.3|88.4|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Nov/01|223|USD Sales Nov/01|198|LC Sales Nov/01|7404|Units Nov/01|223|DOT Nov/01|446
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Dec/01|210|USD Sales Dec/01|188|LC Sales Dec/01|6810|Units Dec/01|207|DOT Dec/01|414
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jan/02|292|USD Sales Jan/02|258|LC Sales Jan/02|9367|Units Jan/02|290|DOT Jan/02|580
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Feb/02|328|USD Sales Feb/02|285|LC Sales Feb/02|10400|Units Feb/02|320|DOT Feb/02|640
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Mar/02|259|USD Sales Mar/02|227|LC Sales Mar/02|8134|Units Mar/02|248|DOT Mar/02|496
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Apr/02|299|USD Sales Apr/02|264|LC Sales Apr/02|9068|Units Apr/02|279|DOT Apr/02|558
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales May/02|354|USD Sales May/02|324|LC Sales May/02|10823|Units May/02|333|DOT May/02|666
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jun/02|242|USD Sales Jun/02|231|LC Sales Jun/02|7329|Units Jun/02|210|DOT Jun/02|420
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jul/02|248|USD Sales Jul/02|246|LC Sales Jul/02|7399|Units Jul/02|212|DOT Jul/02|424
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Aug/02|235|USD Sales Aug/02|230|LC Sales Aug/02|7237|Units Aug/02|205|DOT Aug/02|410
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Sep/02|333|USD Sales Sep/02|326|LC Sales Sep/02|10039|Units Sep/02|282|DOT Sep/02|564
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Oct/02|268|USD Sales Oct/02|263|LC Sales Oct/02|8211|Units Oct/02|230|DOT Oct/02|460
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Nov/02|221|USD Sales Nov/02|221|LC Sales Nov/02|6785|Units Nov/02|189|DOT Nov/02|378
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Dec/02|336|USD Sales Dec/02|341|LC Sales Dec/02|10440|Units Dec/02|290|DOT Dec/02|580
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jan/03|417|USD Sales Jan/03|442|LC Sales Jan/03|13104|Units Jan/03|359|DOT Jan/03|718
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Feb/03|269|USD Sales Feb/03|290|LC Sales Feb/03|8514|Units Feb/03|232|DOT Feb/03|464
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Mar/03|263|USD Sales Mar/03|284|LC Sales Mar/03|8331|Units Mar/03|227|DOT Mar/03|454
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Apr/03|311|USD Sales Apr/03|337|LC Sales Apr/03|9832|Units Apr/03|265|DOT Apr/03|530
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales May/03|269|USD Sales May/03|311|LC Sales May/03|8436|Units May/03|228|DOT May/03|456
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jun/03|264|USD Sales Jun/03|307|LC Sales Jun/03|8280|Units Jun/03|225|DOT Jun/03|450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jul/03|289|USD Sales Jul/03|328|LC Sales Jul/03|9188|Units Jul/03|249|DOT Jul/03|498
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Aug/03|256|USD Sales Aug/03|285|LC Sales Aug/03|8258|Units Aug/03|222|DOT Aug/03|444
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Sep/03|335|USD Sales Sep/03|375|LC Sales Sep/03|10829|Units Sep/03|288|DOT Sep/03|576
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Oct/03|268|USD Sales Oct/03|313|LC Sales Oct/03|8565|Units Oct/03|229|DOT Oct/03|458
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Nov/03|255|USD Sales Nov/03|298|LC Sales Nov/03|8138|Units Nov/03|217|DOT Nov/03|434
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Dec/03|309|USD Sales Dec/03|379|LC Sales Dec/03|9975|Units Dec/03|266|DOT Dec/03|532
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jan/04|354|USD Sales Jan/04|446|LC Sales Jan/04|11581|Units Jan/04|308|DOT Jan/04|616
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Feb/04|245|USD Sales Feb/04|310|LC Sales Feb/04|8046|Units Feb/04|214|DOT Feb/04|428
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Mar/04|327|USD Sales Mar/04|402|LC Sales Mar/04|10791|Units Mar/04|287|DOT Mar/04|574
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Apr/04|264|USD Sales Apr/04|316|LC Sales Apr/04|8573|Units Apr/04|228|DOT Apr/04|456
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales May/04|322|USD Sales May/04|387|LC Sales May/04|10302|Units May/04|274|DOT May/04|548
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jun/04|323|USD Sales Jun/04|392|LC Sales Jun/04|10221|Units Jun/04|277|DOT Jun/04|554
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jul/04|297|USD Sales Jul/04|364|LC Sales Jul/04|9373|Units Jul/04|254|DOT Jul/04|508
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Aug/04|342|USD Sales Aug/04|416|LC Sales Aug/04|10812|Units Aug/04|293|DOT Aug/04|586
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Sep/04|293|USD Sales Sep/04|358|LC Sales Sep/04|9262|Units Sep/04|251|DOT Sep/04|502
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Oct/04|333|USD Sales Oct/04|416|LC Sales Oct/04|10496|Units Oct/04|286|DOT Oct/04|572
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Nov/04|281|USD Sales Nov/04|365|LC Sales Nov/04|8795|Units Nov/04|239|DOT Nov/04|478
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Dec/04|279|USD Sales Dec/04|373|LC Sales Dec/04|8543|Units Dec/04|236|DOT Dec/04|472
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jan/05|356|USD Sales Jan/05|467|LC Sales Jan/05|10787|Units Jan/05|303|DOT Jan/05|606
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Feb/05|264|USD Sales Feb/05|344|LC Sales Feb/05|7920|Units Feb/05|225|DOT Feb/05|450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Mar/05|302|USD Sales Mar/05|399|LC Sales Mar/05|9004|Units Mar/05|244|DOT Mar/05|488
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Apr/05|341|USD Sales Apr/05|441|LC Sales Apr/05|10267|Units Apr/05|279|DOT Apr/05|558
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales May/05|361|USD Sales May/05|457|LC Sales May/05|10904|Units May/05|290|DOT May/05|580
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jun/05|287|USD Sales Jun/05|349|LC Sales Jun/05|8607|Units Jun/05|232|DOT Jun/05|464
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jul/05|312|USD Sales Jul/05|376|LC Sales Jul/05|9417|Units Jul/05|258|DOT Jul/05|516
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Aug/05|367|USD Sales Aug/05|451|LC Sales Aug/05|10847|Units Aug/05|298|DOT Aug/05|596
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Sep/05|352|USD Sales Sep/05|432|LC Sales Sep/05|10330|Units Sep/05|283|DOT Sep/05|566
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Oct/05|399|USD Sales Oct/05|479|LC Sales Oct/05|11830|Units Oct/05|325|DOT Oct/05|650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Nov/05|424|USD Sales Nov/05|500|LC Sales Nov/05|12418|Units Nov/05|344|DOT Nov/05|688
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Dec/05|356|USD Sales Dec/05|423|LC Sales Dec/05|10317|Units Dec/05|285|DOT Dec/05|570
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jan/06|468|USD Sales Jan/06|566|LC Sales Jan/06|13432|Units Jan/06|367|DOT Jan/06|734
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Feb/06|613|USD Sales Feb/06|732|LC Sales Feb/06|17422|Units Feb/06|476|DOT Feb/06|952
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Mar/06|530|USD Sales Mar/06|638|LC Sales Mar/06|15189|Units Mar/06|415|DOT Mar/06|830
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Apr/06|472|USD Sales Apr/06|579|LC Sales Apr/06|13469|Units Apr/06|368|DOT Apr/06|736
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales May/06|403|USD Sales May/06|514|LC Sales May/06|11388|Units May/06|312|DOT May/06|624
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jun/06|384|USD Sales Jun/06|486|LC Sales Jun/06|10899|Units Jun/06|307|DOT Jun/06|614
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Jul/06|326|USD Sales Jul/06|413|LC Sales Jul/06|9266|Units Jul/06|261|DOT Jul/06|522
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Aug/06|439|USD Sales Aug/06|563|LC Sales Aug/06|12390|Units Aug/06|354|DOT Aug/06|708
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Sep/06|359|USD Sales Sep/06|457|LC Sales Sep/06|10182|Units Sep/06|296|DOT Sep/06|592
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|BAYER*|BAYER|BAYER|TALCID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/10|2.00|10.00 DF|MONO|HYDROTALCITE|49|35.2|49.2|EURO Sales Oct/06|489|USD Sales Oct/06|617|LC Sales Oct/06|13834|Units Oct/06|393|DOT Oct/06|786
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Nov/01|92|USD Sales Nov/01|82|LC Sales Nov/01|3055|Units Nov/01|51|DOT Nov/01|849.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Dec/01|80|USD Sales Dec/01|71|LC Sales Dec/01|2584|Units Dec/01|43|DOT Dec/01|716.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jan/02|173|USD Sales Jan/02|153|LC Sales Jan/02|5557|Units Jan/02|92|DOT Jan/02|1532.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Feb/02|53|USD Sales Feb/02|46|LC Sales Feb/02|1677|Units Feb/02|28|DOT Feb/02|466.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Mar/02|38|USD Sales Mar/02|33|LC Sales Mar/02|1196|Units Mar/02|20|DOT Mar/02|333.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Apr/02|140|USD Sales Apr/02|124|LC Sales Apr/02|4267|Units Apr/02|71|DOT Apr/02|1182.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales May/02|161|USD Sales May/02|148|LC Sales May/02|4925|Units May/02|81|DOT May/02|1349.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jun/02|115|USD Sales Jun/02|110|LC Sales Jun/02|3471|Units Jun/02|57|DOT Jun/02|949.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jul/02|182|USD Sales Jul/02|180|LC Sales Jul/02|5420|Units Jul/02|89|DOT Jul/02|1482.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Aug/02|156|USD Sales Aug/02|153|LC Sales Aug/02|4819|Units Aug/02|79|DOT Aug/02|1316.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Sep/02|87|USD Sales Sep/02|85|LC Sales Sep/02|2614|Units Sep/02|43|DOT Sep/02|716.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Oct/02|109|USD Sales Oct/02|107|LC Sales Oct/02|3350|Units Oct/02|55|DOT Oct/02|916.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Nov/02|89|USD Sales Nov/02|89|LC Sales Nov/02|2741|Units Nov/02|45|DOT Nov/02|749.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Dec/02|158|USD Sales Dec/02|161|LC Sales Dec/02|4917|Units Dec/02|81|DOT Dec/02|1349.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jan/03|193|USD Sales Jan/03|205|LC Sales Jan/03|6060|Units Jan/03|100|DOT Jan/03|1666
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Feb/03|299|USD Sales Feb/03|323|LC Sales Feb/03|9469|Units Feb/03|156|DOT Feb/03|2598.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Mar/03|156|USD Sales Mar/03|169|LC Sales Mar/03|4961|Units Mar/03|82|DOT Mar/03|1366.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Apr/03|358|USD Sales Apr/03|388|LC Sales Apr/03|11314|Units Apr/03|187|DOT Apr/03|3115.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales May/03|162|USD Sales May/03|187|LC Sales May/03|5082|Units May/03|84|DOT May/03|1399.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jun/03|168|USD Sales Jun/03|196|LC Sales Jun/03|5272|Units Jun/03|87|DOT Jun/03|1449.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jul/03|211|USD Sales Jul/03|240|LC Sales Jul/03|6727|Units Jul/03|111|DOT Jul/03|1849.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Aug/03|177|USD Sales Aug/03|197|LC Sales Aug/03|5696|Units Aug/03|94|DOT Aug/03|1566
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Sep/03|64|USD Sales Sep/03|71|LC Sales Sep/03|2060|Units Sep/03|34|DOT Sep/03|566.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Oct/03|182|USD Sales Oct/03|213|LC Sales Oct/03|5827|Units Oct/03|96|DOT Oct/03|1599.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Nov/03|199|USD Sales Nov/03|233|LC Sales Nov/03|6374|Units Nov/03|105|DOT Nov/03|1749.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Dec/03|179|USD Sales Dec/03|219|LC Sales Dec/03|5767|Units Dec/03|95|DOT Dec/03|1582.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jan/04|154|USD Sales Jan/04|194|LC Sales Jan/04|5038|Units Jan/04|83|DOT Jan/04|1382.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Feb/04|72|USD Sales Feb/04|91|LC Sales Feb/04|2367|Units Feb/04|39|DOT Feb/04|649.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Mar/04|166|USD Sales Mar/04|203|LC Sales Mar/04|5463|Units Mar/04|90|DOT Mar/04|1499.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Apr/04|164|USD Sales Apr/04|197|LC Sales Apr/04|5342|Units Apr/04|88|DOT Apr/04|1466
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales May/04|295|USD Sales May/04|355|LC Sales May/04|9454|Units May/04|156|DOT May/04|2598.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jun/04|127|USD Sales Jun/04|154|LC Sales Jun/04|4006|Units Jun/04|66|DOT Jun/04|1099.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jul/04|112|USD Sales Jul/04|138|LC Sales Jul/04|3538|Units Jul/04|58|DOT Jul/04|966.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Aug/04|29|USD Sales Aug/04|35|LC Sales Aug/04|915|Units Aug/04|15|DOT Aug/04|249.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Sep/04|90|USD Sales Sep/04|110|LC Sales Sep/04|2853|Units Sep/04|47|DOT Sep/04|783
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Oct/04|118|USD Sales Oct/04|148|LC Sales Oct/04|3721|Units Oct/04|61|DOT Oct/04|1016.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Nov/04|175|USD Sales Nov/04|228|LC Sales Nov/04|5490|Units Nov/04|90|DOT Nov/04|1499.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Dec/04|174|USD Sales Dec/04|233|LC Sales Dec/04|5342|Units Dec/04|88|DOT Dec/04|1466
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jan/05|112|USD Sales Jan/05|147|LC Sales Jan/05|3388|Units Jan/05|56|DOT Jan/05|932.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Feb/05|105|USD Sales Feb/05|137|LC Sales Feb/05|3146|Units Feb/05|52|DOT Feb/05|866.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Mar/05|102|USD Sales Mar/05|135|LC Sales Mar/05|3035|Units Mar/05|50|DOT Mar/05|833
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Apr/05|151|USD Sales Apr/05|196|LC Sales Apr/05|4560|Units Apr/05|75|DOT Apr/05|1249.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales May/05|152|USD Sales May/05|193|LC Sales May/05|4606|Units May/05|76|DOT May/05|1266.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jun/05|249|USD Sales Jun/05|303|LC Sales Jun/05|7478|Units Jun/05|123|DOT Jun/05|2049.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jul/05|253|USD Sales Jul/05|305|LC Sales Jul/05|7648|Units Jul/05|126|DOT Jul/05|2099.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Aug/05|164|USD Sales Aug/05|202|LC Sales Aug/05|4856|Units Aug/05|80|DOT Aug/05|1332.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Sep/05|170|USD Sales Sep/05|208|LC Sales Sep/05|4977|Units Sep/05|82|DOT Sep/05|1366.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Oct/05|100|USD Sales Oct/05|120|LC Sales Oct/05|2969|Units Oct/05|49|DOT Oct/05|816.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Nov/05|280|USD Sales Nov/05|331|LC Sales Nov/05|8208|Units Nov/05|135|DOT Nov/05|2249.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Dec/05|302|USD Sales Dec/05|359|LC Sales Dec/05|8755|Units Dec/05|144|DOT Dec/05|2399
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jan/06|146|USD Sales Jan/06|177|LC Sales Jan/06|4188|Units Jan/06|69|DOT Jan/06|1149.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Feb/06|367|USD Sales Feb/06|439|LC Sales Feb/06|10440|Units Feb/06|172|DOT Feb/06|2865.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Mar/06|379|USD Sales Mar/06|456|LC Sales Mar/06|10865|Units Mar/06|179|DOT Mar/06|2982.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Apr/06|239|USD Sales Apr/06|293|LC Sales Apr/06|6810|Units Apr/06|112|DOT Apr/06|1865.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales May/06|328|USD Sales May/06|419|LC Sales May/06|9287|Units May/06|153|DOT May/06|2548.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jun/06|688|USD Sales Jun/06|871|LC Sales Jun/06|19517|Units Jun/06|321|DOT Jun/06|5347.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Jul/06|517|USD Sales Jul/06|656|LC Sales Jul/06|14714|Units Jul/06|242|DOT Jul/06|4031.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Aug/06|516|USD Sales Aug/06|661|LC Sales Aug/06|14544|Units Aug/06|240|DOT Aug/06|3998.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Sep/06|426|USD Sales Sep/06|542|LC Sales Sep/06|12079|Units Sep/06|199|DOT Sep/06|3315.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|GALENICKA LAB.OSTR|CALCII CARBONICI|00.5MG|TABS .5 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/10|16.66|3.00 G|MONO|CALCIUM|50|60.7|84.8|EURO Sales Oct/06|747|USD Sales Oct/06|942|LC Sales Oct/06|21124|Units Oct/06|348|DOT Oct/06|5797.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Nov/01|444|USD Sales Nov/01|395|LC Sales Nov/01|14772|Units Nov/01|449|DOT Nov/01|1347
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Dec/01|592|USD Sales Dec/01|529|LC Sales Dec/01|19206|Units Dec/01|582|DOT Dec/01|1746
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jan/02|914|USD Sales Jan/02|807|LC Sales Jan/02|29337|Units Jan/02|889|DOT Jan/02|2667
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Feb/02|586|USD Sales Feb/02|510|LC Sales Feb/02|18612|Units Feb/02|564|DOT Feb/02|1692
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Mar/02|529|USD Sales Mar/02|463|LC Sales Mar/02|16582|Units Mar/02|504|DOT Mar/02|1512
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Apr/02|575|USD Sales Apr/02|510|LC Sales Apr/02|17477|Units Apr/02|528|DOT Apr/02|1584
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales May/02|581|USD Sales May/02|533|LC Sales May/02|17775|Units May/02|537|DOT May/02|1611
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jun/02|478|USD Sales Jun/02|456|LC Sales Jun/02|14465|Units Jun/02|437|DOT Jun/02|1311
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jul/02|682|USD Sales Jul/02|677|LC Sales Jul/02|20323|Units Jul/02|614|DOT Jul/02|1842
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Aug/02|438|USD Sales Aug/02|428|LC Sales Aug/02|13505|Units Aug/02|408|DOT Aug/02|1224
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Sep/02|1050|USD Sales Sep/02|1030|LC Sales Sep/02|31710|Units Sep/02|958|DOT Sep/02|2874
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Oct/02|497|USD Sales Oct/02|488|LC Sales Oct/02|15226|Units Oct/02|460|DOT Oct/02|1380
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Nov/02|534|USD Sales Nov/02|535|LC Sales Nov/02|16418|Units Nov/02|496|DOT Nov/02|1488
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Dec/02|555|USD Sales Dec/02|564|LC Sales Dec/02|17278|Units Dec/02|522|DOT Dec/02|1566
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jan/03|758|USD Sales Jan/03|805|LC Sales Jan/03|23832|Units Jan/03|720|DOT Jan/03|2160
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Feb/03|581|USD Sales Feb/03|626|LC Sales Feb/03|18371|Units Feb/03|555|DOT Feb/03|1665
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Mar/03|543|USD Sales Mar/03|586|LC Sales Mar/03|17212|Units Mar/03|520|DOT Mar/03|1560
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Apr/03|601|USD Sales Apr/03|652|LC Sales Apr/03|19008|Units Apr/03|576|DOT Apr/03|1728
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales May/03|599|USD Sales May/03|694|LC Sales May/03|18810|Units May/03|570|DOT May/03|1710
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jun/03|587|USD Sales Jun/03|685|LC Sales Jun/03|18448|Units Jun/03|554|DOT Jun/03|1662
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jul/03|507|USD Sales Jul/03|576|LC Sales Jul/03|16142|Units Jul/03|479|DOT Jul/03|1437
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Aug/03|419|USD Sales Aug/03|467|LC Sales Aug/03|13526|Units Aug/03|399|DOT Aug/03|1197
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Sep/03|685|USD Sales Sep/03|767|LC Sales Sep/03|22165|Units Sep/03|650|DOT Sep/03|1950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Oct/03|807|USD Sales Oct/03|945|LC Sales Oct/03|25814|Units Oct/03|757|DOT Oct/03|2271
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Nov/03|480|USD Sales Nov/03|562|LC Sales Nov/03|15345|Units Nov/03|450|DOT Nov/03|1350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Dec/03|501|USD Sales Dec/03|614|LC Sales Dec/03|16163|Units Dec/03|474|DOT Dec/03|1422
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jan/04|549|USD Sales Jan/04|693|LC Sales Jan/04|17967|Units Jan/04|530|DOT Jan/04|1590
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Feb/04|528|USD Sales Feb/04|668|LC Sales Feb/04|17357|Units Feb/04|512|DOT Feb/04|1536
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Mar/04|591|USD Sales Mar/04|725|LC Sales Mar/04|19471|Units Mar/04|571|DOT Mar/04|1713
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Apr/04|587|USD Sales Apr/04|704|LC Sales Apr/04|19096|Units Apr/04|560|DOT Apr/04|1680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales May/04|551|USD Sales May/04|661|LC Sales May/04|17630|Units May/04|517|DOT May/04|1551
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jun/04|514|USD Sales Jun/04|623|LC Sales Jun/04|16238|Units Jun/04|479|DOT Jun/04|1437
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jul/04|443|USD Sales Jul/04|544|LC Sales Jul/04|13981|Units Jul/04|410|DOT Jul/04|1230
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Aug/04|550|USD Sales Aug/04|670|LC Sales Aug/04|17391|Units Aug/04|510|DOT Aug/04|1530
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Sep/04|991|USD Sales Sep/04|1210|LC Sales Sep/04|31304|Units Sep/04|918|DOT Sep/04|2754
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Oct/04|535|USD Sales Oct/04|668|LC Sales Oct/04|16845|Units Oct/04|494|DOT Oct/04|1482
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Nov/04|526|USD Sales Nov/04|684|LC Sales Nov/04|16470|Units Nov/04|483|DOT Nov/04|1449
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Dec/04|554|USD Sales Dec/04|742|LC Sales Dec/04|16982|Units Dec/04|498|DOT Dec/04|1494
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jan/05|798|USD Sales Jan/05|1047|LC Sales Jan/05|24174|Units Jan/05|711|DOT Jan/05|2133
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Feb/05|632|USD Sales Feb/05|823|LC Sales Feb/05|18938|Units Feb/05|557|DOT Feb/05|1671
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Mar/05|756|USD Sales Mar/05|998|LC Sales Mar/05|22506|Units Mar/05|660|DOT Mar/05|1980
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Apr/05|502|USD Sales Apr/05|649|LC Sales Apr/05|15106|Units Apr/05|443|DOT Apr/05|1329
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales May/05|524|USD Sales May/05|665|LC Sales May/05|15857|Units May/05|465|DOT May/05|1395
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jun/05|467|USD Sales Jun/05|568|LC Sales Jun/05|14015|Units Jun/05|411|DOT Jun/05|1233
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jul/05|399|USD Sales Jul/05|480|LC Sales Jul/05|12037|Units Jul/05|353|DOT Jul/05|1059
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Aug/05|659|USD Sales Aug/05|811|LC Sales Aug/05|19505|Units Aug/05|572|DOT Aug/05|1716
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Sep/05|1016|USD Sales Sep/05|1245|LC Sales Sep/05|29769|Units Sep/05|873|DOT Sep/05|2619
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Oct/05|792|USD Sales Oct/05|952|LC Sales Oct/05|23495|Units Oct/05|689|DOT Oct/05|2067
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Nov/05|679|USD Sales Nov/05|801|LC Sales Nov/05|19880|Units Nov/05|583|DOT Nov/05|1749
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Dec/05|579|USD Sales Dec/05|687|LC Sales Dec/05|16777|Units Dec/05|492|DOT Dec/05|1476
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jan/06|722|USD Sales Jan/06|874|LC Sales Jan/06|20733|Units Jan/06|608|DOT Jan/06|1824
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Feb/06|473|USD Sales Feb/06|565|LC Sales Feb/06|13435|Units Feb/06|394|DOT Feb/06|1182
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Mar/06|535|USD Sales Mar/06|643|LC Sales Mar/06|15311|Units Mar/06|449|DOT Mar/06|1347
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Apr/06|492|USD Sales Apr/06|604|LC Sales Apr/06|14035|Units Apr/06|414|DOT Apr/06|1242
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales May/06|570|USD Sales May/06|728|LC Sales May/06|16123|Units May/06|477|DOT May/06|1431
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jun/06|401|USD Sales Jun/06|508|LC Sales Jun/06|11390|Units Jun/06|336|DOT Jun/06|1008
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Jul/06|343|USD Sales Jul/06|435|LC Sales Jul/06|9753|Units Jul/06|292|DOT Jul/06|876
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Aug/06|586|USD Sales Aug/06|751|LC Sales Aug/06|16524|Units Aug/06|486|DOT Aug/06|1458
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Sep/06|930|USD Sales Sep/06|1184|LC Sales Sep/06|26384|Units Sep/06|776|DOT Sep/06|2328
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1996|1996/04|3.00|10.00 DF|MONO|CALCIUM|51|34|47.5|EURO Sales Oct/06|708|USD Sales Oct/06|893|LC Sales Oct/06|20026|Units Oct/06|589|DOT Oct/06|1767
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TAB.CHEW POM 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/07|6.00|10.00 DF|MONO|CALCIUM|52|57.9|78.4|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Nov/01|259|USD Sales Nov/01|231|LC Sales Nov/01|8625|Units Nov/01|259|DOT Nov/01|777
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Dec/01|410|USD Sales Dec/01|366|LC Sales Dec/01|13283|Units Dec/01|393|DOT Dec/01|1179
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jan/02|553|USD Sales Jan/02|488|LC Sales Jan/02|17741|Units Jan/02|528|DOT Jan/02|1584
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Feb/02|408|USD Sales Feb/02|355|LC Sales Feb/02|12970|Units Feb/02|386|DOT Feb/02|1158
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Mar/02|248|USD Sales Mar/02|218|LC Sales Mar/02|7795|Units Mar/02|232|DOT Mar/02|696
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Apr/02|427|USD Sales Apr/02|378|LC Sales Apr/02|12970|Units Apr/02|386|DOT Apr/02|1158
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales May/02|329|USD Sales May/02|302|LC Sales May/02|10080|Units May/02|300|DOT May/02|900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jun/02|338|USD Sales Jun/02|323|LC Sales Jun/02|10248|Units Jun/02|305|DOT Jun/02|915
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jul/02|316|USD Sales Jul/02|313|LC Sales Jul/02|9408|Units Jul/02|280|DOT Jul/02|840
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Aug/02|303|USD Sales Aug/02|296|LC Sales Aug/02|9341|Units Aug/02|278|DOT Aug/02|834
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Sep/02|730|USD Sales Sep/02|716|LC Sales Sep/02|22038|Units Sep/02|652|DOT Sep/02|1956
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Oct/02|367|USD Sales Oct/02|360|LC Sales Oct/02|11222|Units Oct/02|332|DOT Oct/02|996
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Nov/02|285|USD Sales Nov/02|285|LC Sales Nov/02|8754|Units Nov/02|259|DOT Nov/02|777
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Dec/02|330|USD Sales Dec/02|336|LC Sales Dec/02|10275|Units Dec/02|304|DOT Dec/02|912
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jan/03|441|USD Sales Jan/03|469|LC Sales Jan/03|13884|Units Jan/03|412|DOT Jan/03|1236
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Feb/03|470|USD Sales Feb/03|507|LC Sales Feb/03|14872|Units Feb/03|440|DOT Feb/03|1320
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Mar/03|326|USD Sales Mar/03|352|LC Sales Mar/03|10343|Units Mar/03|306|DOT Mar/03|918
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Apr/03|478|USD Sales Apr/03|518|LC Sales Apr/03|15109|Units Apr/03|447|DOT Apr/03|1341
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales May/03|360|USD Sales May/03|416|LC Sales May/03|11290|Units May/03|336|DOT May/03|1008
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jun/03|290|USD Sales Jun/03|339|LC Sales Jun/03|9119|Units Jun/03|269|DOT Jun/03|807
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jul/03|273|USD Sales Jul/03|311|LC Sales Jul/03|8704|Units Jul/03|256|DOT Jul/03|768
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Aug/03|267|USD Sales Aug/03|297|LC Sales Aug/03|8602|Units Aug/03|253|DOT Aug/03|759
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Sep/03|532|USD Sales Sep/03|596|LC Sales Sep/03|17221|Units Sep/03|505|DOT Sep/03|1515
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Oct/03|573|USD Sales Oct/03|670|LC Sales Oct/03|18312|Units Oct/03|537|DOT Oct/03|1611
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Nov/03|287|USD Sales Nov/03|336|LC Sales Nov/03|9173|Units Nov/03|269|DOT Nov/03|807
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Dec/03|332|USD Sales Dec/03|407|LC Sales Dec/03|10712|Units Dec/03|316|DOT Dec/03|948
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jan/04|394|USD Sales Jan/04|497|LC Sales Jan/04|12882|Units Jan/04|380|DOT Jan/04|1140
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Feb/04|266|USD Sales Feb/04|337|LC Sales Feb/04|8746|Units Feb/04|258|DOT Feb/04|774
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Mar/04|370|USD Sales Mar/04|454|LC Sales Mar/04|12208|Units Mar/04|358|DOT Mar/04|1074
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Apr/04|372|USD Sales Apr/04|446|LC Sales Apr/04|12107|Units Apr/04|354|DOT Apr/04|1062
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales May/04|314|USD Sales May/04|377|LC Sales May/04|10055|Units May/04|294|DOT May/04|882
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jun/04|273|USD Sales Jun/04|331|LC Sales Jun/04|8618|Units Jun/04|252|DOT Jun/04|756
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jul/04|292|USD Sales Jul/04|358|LC Sales Jul/04|9200|Units Jul/04|269|DOT Jul/04|807
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Aug/04|329|USD Sales Aug/04|400|LC Sales Aug/04|10397|Units Aug/04|304|DOT Aug/04|912
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Sep/04|838|USD Sales Sep/04|1023|LC Sales Sep/04|26471|Units Sep/04|774|DOT Sep/04|2322
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Oct/04|434|USD Sales Oct/04|543|LC Sales Oct/04|13680|Units Oct/04|400|DOT Oct/04|1200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Nov/04|366|USD Sales Nov/04|476|LC Sales Nov/04|11457|Units Nov/04|335|DOT Nov/04|1005
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Dec/04|377|USD Sales Dec/04|505|LC Sales Dec/04|11560|Units Dec/04|339|DOT Dec/04|1017
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jan/05|561|USD Sales Jan/05|737|LC Sales Jan/05|17016|Units Jan/05|499|DOT Jan/05|1497
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Feb/05|415|USD Sales Feb/05|541|LC Sales Feb/05|12444|Units Feb/05|366|DOT Feb/05|1098
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Mar/05|446|USD Sales Mar/05|589|LC Sales Mar/05|13270|Units Mar/05|388|DOT Mar/05|1164
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Apr/05|288|USD Sales Apr/05|373|LC Sales Apr/05|8687|Units Apr/05|254|DOT Apr/05|762
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales May/05|385|USD Sales May/05|488|LC Sales May/05|11628|Units May/05|340|DOT May/05|1020
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jun/05|247|USD Sales Jun/05|301|LC Sales Jun/05|7421|Units Jun/05|217|DOT Jun/05|651
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jul/05|245|USD Sales Jul/05|295|LC Sales Jul/05|7387|Units Jul/05|216|DOT Jul/05|648
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Aug/05|440|USD Sales Aug/05|541|LC Sales Aug/05|13030|Units Aug/05|381|DOT Aug/05|1143
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Sep/05|841|USD Sales Sep/05|1031|LC Sales Sep/05|24658|Units Sep/05|721|DOT Sep/05|2163
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Oct/05|597|USD Sales Oct/05|718|LC Sales Oct/05|17716|Units Oct/05|518|DOT Oct/05|1554
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Nov/05|424|USD Sales Nov/05|500|LC Sales Nov/05|12412|Units Nov/05|364|DOT Nov/05|1092
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Dec/05|398|USD Sales Dec/05|472|LC Sales Dec/05|11526|Units Dec/05|338|DOT Dec/05|1014
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jan/06|513|USD Sales Jan/06|621|LC Sales Jan/06|14731|Units Jan/06|432|DOT Jan/06|1296
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Feb/06|355|USD Sales Feb/06|424|LC Sales Feb/06|10094|Units Feb/06|296|DOT Feb/06|888
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Mar/06|351|USD Sales Mar/06|422|LC Sales Mar/06|10050|Units Mar/06|293|DOT Mar/06|879
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Apr/06|364|USD Sales Apr/06|446|LC Sales Apr/06|10373|Units Apr/06|306|DOT Apr/06|918
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales May/06|398|USD Sales May/06|508|LC Sales May/06|11255|Units May/06|332|DOT May/06|996
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jun/06|259|USD Sales Jun/06|328|LC Sales Jun/06|7356|Units Jun/06|217|DOT Jun/06|651
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Jul/06|237|USD Sales Jul/06|301|LC Sales Jul/06|6746|Units Jul/06|199|DOT Jul/06|597
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Aug/06|398|USD Sales Aug/06|510|LC Sales Aug/06|11218|Units Aug/06|328|DOT Aug/06|984
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Sep/06|834|USD Sales Sep/06|1062|LC Sales Sep/06|23666|Units Sep/06|692|DOT Sep/06|2076
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 30|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|3.00|10.00 DF|MONO|CALCIUM|53|34.2|47.8|EURO Sales Oct/06|560|USD Sales Oct/06|706|LC Sales Oct/06|15835|Units Oct/06|463|DOT Oct/06|1389
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|TUMS|0000|TABS CH.CITR 60|A ORAL SOLID ORDINARY|AD ORAL S ORD SPECIAL FORMS|ADF ORAL S ORD CHEWING GUM|NON-RX BOUND|1997|1997/09|6.00|10.00 DF|MONO|CALCIUM|54|59|79.8|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Sep/02|98|USD Sales Sep/02|96|LC Sales Sep/02|2970|Units Sep/02|79|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Oct/02|66|USD Sales Oct/02|64|LC Sales Oct/02|2009|Units Oct/02|54|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Nov/02|16|USD Sales Nov/02|16|LC Sales Nov/02|486|Units Nov/02|13|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Dec/02|57|USD Sales Dec/02|58|LC Sales Dec/02|1763|Units Dec/02|47|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jan/03|21|USD Sales Jan/03|23|LC Sales Jan/03|675|Units Jan/03|18|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Feb/03|33|USD Sales Feb/03|36|LC Sales Feb/03|1050|Units Feb/03|28|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Mar/03|24|USD Sales Mar/03|26|LC Sales Mar/03|750|Units Mar/03|20|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Apr/03|46|USD Sales Apr/03|50|LC Sales Apr/03|1463|Units Apr/03|39|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales May/03|57|USD Sales May/03|66|LC Sales May/03|1800|Units May/03|48|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jun/03|74|USD Sales Jun/03|86|LC Sales Jun/03|2326|Units Jun/03|68|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jul/03|62|USD Sales Jul/03|70|LC Sales Jul/03|1965|Units Jul/03|59|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Aug/03|59|USD Sales Aug/03|66|LC Sales Aug/03|1898|Units Aug/03|57|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Sep/03|69|USD Sales Sep/03|77|LC Sales Sep/03|2231|Units Sep/03|67|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Oct/03|30|USD Sales Oct/03|35|LC Sales Oct/03|966|Units Oct/03|29|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Nov/03|18|USD Sales Nov/03|21|LC Sales Nov/03|566|Units Nov/03|17|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Dec/03|72|USD Sales Dec/03|89|LC Sales Dec/03|2331|Units Dec/03|70|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jan/04|61|USD Sales Jan/04|77|LC Sales Jan/04|1998|Units Jan/04|60|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Feb/04|40|USD Sales Feb/04|50|LC Sales Feb/04|1299|Units Feb/04|39|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Mar/04|42|USD Sales Mar/04|52|LC Sales Mar/04|1399|Units Mar/04|42|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Apr/04|38|USD Sales Apr/04|45|LC Sales Apr/04|1225|Units Apr/04|37|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales May/04|63|USD Sales May/04|75|LC Sales May/04|2004|Units May/04|60|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jun/04|55|USD Sales Jun/04|67|LC Sales Jun/04|1744|Units Jun/04|54|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jul/04|33|USD Sales Jul/04|41|LC Sales Jul/04|1046|Units Jul/04|33|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Aug/04|35|USD Sales Aug/04|43|LC Sales Aug/04|1110|Units Aug/04|35|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Sep/04|54|USD Sales Sep/04|66|LC Sales Sep/04|1712|Units Sep/04|54|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Oct/04|19|USD Sales Oct/04|24|LC Sales Oct/04|602|Units Oct/04|19|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Nov/04|40|USD Sales Nov/04|51|LC Sales Nov/04|1236|Units Nov/04|39|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Dec/04|59|USD Sales Dec/04|79|LC Sales Dec/04|1807|Units Dec/04|57|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jan/05|53|USD Sales Jan/05|70|LC Sales Jan/05|1617|Units Jan/05|51|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Feb/05|34|USD Sales Feb/05|44|LC Sales Feb/05|1011|Units Feb/05|32|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Mar/05|44|USD Sales Mar/05|58|LC Sales Mar/05|1300|Units Mar/05|41|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Apr/05|27|USD Sales Apr/05|35|LC Sales Apr/05|824|Units Apr/05|26|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales May/05|25|USD Sales May/05|32|LC Sales May/05|761|Units May/05|24|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jun/05|49|USD Sales Jun/05|60|LC Sales Jun/05|1478|Units Jun/05|48|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jul/05|41|USD Sales Jul/05|49|LC Sales Jul/05|1224|Units Jul/05|40|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Aug/05|44|USD Sales Aug/05|55|LC Sales Aug/05|1312|Units Aug/05|43|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Sep/05|32|USD Sales Sep/05|40|LC Sales Sep/05|946|Units Sep/05|31|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Oct/05|41|USD Sales Oct/05|50|LC Sales Oct/05|1224|Units Oct/05|40|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Nov/05|39|USD Sales Nov/05|46|LC Sales Nov/05|1132|Units Nov/05|37|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Dec/05|40|USD Sales Dec/05|48|LC Sales Dec/05|1163|Units Dec/05|38|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jan/06|49|USD Sales Jan/06|59|LC Sales Jan/06|1408|Units Jan/06|46|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Feb/06|54|USD Sales Feb/06|64|LC Sales Feb/06|1530|Units Feb/06|50|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Mar/06|51|USD Sales Mar/06|62|LC Sales Mar/06|1469|Units Mar/06|48|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Apr/06|38|USD Sales Apr/06|46|LC Sales Apr/06|1071|Units Apr/06|35|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales May/06|32|USD Sales May/06|41|LC Sales May/06|918|Units May/06|30|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jun/06|35|USD Sales Jun/06|44|LC Sales Jun/06|990|Units Jun/06|33|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Jul/06|24|USD Sales Jul/06|31|LC Sales Jul/06|696|Units Jul/06|24|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Aug/06|27|USD Sales Aug/06|35|LC Sales Aug/06|770|Units Aug/06|26|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Sep/06|22|USD Sales Sep/06|28|LC Sales Sep/06|622|Units Sep/06|21|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|KRKA*|KRKA|KRKA|RUTACID|0500MG|TABS CHEW 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2002|2002/08|0.00|0.00|MONO|HYDROTALCITE|55|29.6|41.3|EURO Sales Oct/06|21|USD Sales Oct/06|26|LC Sales Oct/06|592|Units Oct/06|20|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Nov/01|399|USD Sales Nov/01|354|LC Sales Nov/01|13253|Units Nov/01|25|DOT Nov/01|4166.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Dec/01|523|USD Sales Dec/01|467|LC Sales Dec/01|16963|Units Dec/01|32|DOT Dec/01|5333.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jan/02|529|USD Sales Jan/02|467|LC Sales Jan/02|16963|Units Jan/02|32|DOT Jan/02|5333.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Feb/02|1068|USD Sales Feb/02|929|LC Sales Feb/02|33926|Units Feb/02|64|DOT Feb/02|10666.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Mar/02|321|USD Sales Mar/02|281|LC Sales Mar/02|10072|Units Mar/02|19|DOT Mar/02|3166.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Apr/02|1047|USD Sales Apr/02|927|LC Sales Apr/02|31806|Units Apr/02|60|DOT Apr/02|9999.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales May/02|727|USD Sales May/02|667|LC Sales May/02|22264|Units May/02|42|DOT May/02|6999.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jun/02|508|USD Sales Jun/02|485|LC Sales Jun/02|15373|Units Jun/02|29|DOT Jun/02|4833.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jul/02|747|USD Sales Jul/02|741|LC Sales Jul/02|22264|Units Jul/02|42|DOT Jul/02|6999.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Aug/02|1222|USD Sales Aug/02|1194|LC Sales Aug/02|37637|Units Aug/02|71|DOT Aug/02|11832.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Sep/02|808|USD Sales Sep/02|792|LC Sales Sep/02|24385|Units Sep/02|46|DOT Sep/02|7666.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Oct/02|450|USD Sales Oct/02|442|LC Sales Oct/02|13783|Units Oct/02|26|DOT Oct/02|4333.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Nov/02|794|USD Sales Nov/02|795|LC Sales Nov/02|24385|Units Nov/02|46|DOT Nov/02|7666.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Dec/02|613|USD Sales Dec/02|623|LC Sales Dec/02|19084|Units Dec/02|36|DOT Dec/02|5999.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jan/03|489|USD Sales Jan/03|519|LC Sales Jan/03|15373|Units Jan/03|29|DOT Jan/03|4833.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Feb/03|1610|USD Sales Feb/03|1734|LC Sales Feb/03|50890|Units Feb/03|96|DOT Feb/03|15999.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Mar/03|485|USD Sales Mar/03|524|LC Sales Mar/03|15373|Units Mar/03|29|DOT Mar/03|4833.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Apr/03|486|USD Sales Apr/03|527|LC Sales Apr/03|15373|Units Apr/03|29|DOT Apr/03|4833.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales May/03|1673|USD Sales May/03|1935|LC Sales May/03|52480|Units May/03|99|DOT May/03|16499.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jun/03|658|USD Sales Jun/03|768|LC Sales Jun/03|20674|Units Jun/03|39|DOT Jun/03|6499.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jul/03|250|USD Sales Jul/03|284|LC Sales Jul/03|7952|Units Jul/03|15|DOT Jul/03|2499.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Aug/03|427|USD Sales Aug/03|476|LC Sales Aug/03|13783|Units Aug/03|26|DOT Aug/03|4333.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Sep/03|770|USD Sales Sep/03|862|LC Sales Sep/03|24915|Units Sep/03|47|DOT Sep/03|7833
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Oct/03|796|USD Sales Oct/03|931|LC Sales Oct/03|25445|Units Oct/03|48|DOT Oct/03|7999.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Nov/03|448|USD Sales Nov/03|524|LC Sales Nov/03|14313|Units Nov/03|27|DOT Nov/03|4499.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Dec/03|772|USD Sales Dec/03|947|LC Sales Dec/03|24915|Units Dec/03|47|DOT Dec/03|7833
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jan/04|956|USD Sales Jan/04|1206|LC Sales Jan/04|31276|Units Jan/04|59|DOT Jan/04|9832.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Feb/04|371|USD Sales Feb/04|469|LC Sales Feb/04|12192|Units Feb/04|23|DOT Feb/04|3833.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Mar/04|788|USD Sales Mar/04|967|LC Sales Mar/04|25975|Units Mar/04|49|DOT Mar/04|8166.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Apr/04|734|USD Sales Apr/04|880|LC Sales Apr/04|23855|Units Apr/04|45|DOT Apr/04|7499.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales May/04|497|USD Sales May/04|597|LC Sales May/04|15903|Units May/04|30|DOT May/04|4999.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jun/04|604|USD Sales Jun/04|733|LC Sales Jun/04|19084|Units Jun/04|36|DOT Jun/04|5999.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jul/04|521|USD Sales Jul/04|639|LC Sales Jul/04|16433|Units Jul/04|31|DOT Jul/04|5166.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Aug/04|721|USD Sales Aug/04|878|LC Sales Aug/04|22790|Units Aug/04|43|DOT Aug/04|7166.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Sep/04|688|USD Sales Sep/04|840|LC Sales Sep/04|21730|Units Sep/04|41|DOT Sep/04|6833
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Oct/04|875|USD Sales Oct/04|1093|LC Sales Oct/04|27560|Units Oct/04|52|DOT Oct/04|8666.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Nov/04|474|USD Sales Nov/04|616|LC Sales Nov/04|14840|Units Nov/04|28|DOT Nov/04|4666.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Dec/04|121|USD Sales Dec/04|162|LC Sales Dec/04|3710|Units Dec/04|7|DOT Dec/04|1166.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jan/05|700|USD Sales Jan/05|918|LC Sales Jan/05|21200|Units Jan/05|40|DOT Jan/05|6666.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Feb/05|1079|USD Sales Feb/05|1404|LC Sales Feb/05|32330|Units Feb/05|61|DOT Feb/05|10166.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Mar/05|587|USD Sales Mar/05|776|LC Sales Mar/05|17490|Units Mar/05|33|DOT Mar/05|5499.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Apr/05|405|USD Sales Apr/05|524|LC Sales Apr/05|12190|Units Apr/05|23|DOT Apr/05|3833.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales May/05|456|USD Sales May/05|578|LC Sales May/05|13780|Units May/05|26|DOT May/05|4333.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jun/05|953|USD Sales Jun/05|1159|LC Sales Jun/05|28620|Units Jun/05|54|DOT Jun/05|8999.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jul/05|808|USD Sales Jul/05|973|LC Sales Jul/05|24380|Units Jul/05|46|DOT Jul/05|7666.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Aug/05|985|USD Sales Aug/05|1211|LC Sales Aug/05|29150|Units Aug/05|55|DOT Aug/05|9166.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Sep/05|778|USD Sales Sep/05|953|LC Sales Sep/05|22790|Units Sep/05|43|DOT Sep/05|7166.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Oct/05|625|USD Sales Oct/05|752|LC Sales Oct/05|18550|Units Oct/05|35|DOT Oct/05|5833.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Nov/05|724|USD Sales Nov/05|854|LC Sales Nov/05|21200|Units Nov/05|40|DOT Nov/05|6666.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Dec/05|549|USD Sales Dec/05|651|LC Sales Dec/05|15900|Units Dec/05|30|DOT Dec/05|4999.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jan/06|1218|USD Sales Jan/06|1474|LC Sales Jan/06|34980|Units Jan/06|66|DOT Jan/06|10999.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Feb/06|1175|USD Sales Feb/06|1403|LC Sales Feb/06|33390|Units Feb/06|63|DOT Feb/06|10499.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Mar/06|981|USD Sales Mar/06|1179|LC Sales Mar/06|28090|Units Mar/06|53|DOT Mar/06|8832.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Apr/06|1190|USD Sales Apr/06|1459|LC Sales Apr/06|33920|Units Apr/06|64|DOT Apr/06|10666.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales May/06|1050|USD Sales May/06|1340|LC Sales May/06|29680|Units May/06|56|DOT May/06|9332.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jun/06|542|USD Sales Jun/06|686|LC Sales Jun/06|15370|Units Jun/06|29|DOT Jun/06|4833.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Jul/06|932|USD Sales Jul/06|1182|LC Sales Jul/06|26500|Units Jul/06|50|DOT Jul/06|8333
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Aug/06|808|USD Sales Aug/06|1035|LC Sales Aug/06|22790|Units Aug/06|43|DOT Aug/06|7166.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Sep/06|878|USD Sales Sep/06|1118|LC Sales Sep/06|24910|Units Sep/06|47|DOT Sep/06|7833
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 1000|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/10|166.66|3.00 G|MONO|CALCIUM|56|530|725.6|EURO Sales Oct/06|1068|USD Sales Oct/06|1348|LC Sales Oct/06|30210|Units Oct/06|57|DOT Oct/06|9499.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Nov/01|2553|USD Sales Nov/01|2267|LC Sales Nov/01|84842|Units Nov/01|2001|DOT Nov/01|16668.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Dec/01|2827|USD Sales Dec/01|2524|LC Sales Dec/01|91634|Units Dec/01|2136|DOT Dec/01|17792.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jan/02|2433|USD Sales Jan/02|2149|LC Sales Jan/02|78078|Units Jan/02|1820|DOT Jan/02|15160.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Feb/02|2248|USD Sales Feb/02|1955|LC Sales Feb/02|71386|Units Feb/02|1664|DOT Feb/02|13861.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Mar/02|2672|USD Sales Mar/02|2340|LC Sales Mar/02|83827|Units Mar/02|1954|DOT Mar/02|16276.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Apr/02|2550|USD Sales Apr/02|2259|LC Sales Apr/02|77477|Units Apr/02|1806|DOT Apr/02|15043.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales May/02|2300|USD Sales May/02|2110|LC Sales May/02|70399|Units May/02|1641|DOT May/02|13669.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jun/02|2516|USD Sales Jun/02|2404|LC Sales Jun/02|76190|Units Jun/02|1776|DOT Jun/02|14794
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jul/02|2943|USD Sales Jul/02|2919|LC Sales Jul/02|87688|Units Jul/02|2044|DOT Jul/02|17026.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Aug/02|2304|USD Sales Aug/02|2252|LC Sales Aug/02|71000|Units Aug/02|1655|DOT Aug/02|13786.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Sep/02|2710|USD Sales Sep/02|2657|LC Sales Sep/02|81810|Units Sep/02|1907|DOT Sep/02|15885.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Oct/02|2659|USD Sales Oct/02|2608|LC Sales Oct/02|81386|Units Oct/02|1906|DOT Oct/02|15876.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Nov/02|2120|USD Sales Nov/02|2122|LC Sales Nov/02|65118|Units Nov/02|1525|DOT Nov/02|12703.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Dec/02|2484|USD Sales Dec/02|2524|LC Sales Dec/02|77263|Units Dec/02|1801|DOT Dec/02|15002.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jan/03|2921|USD Sales Jan/03|3102|LC Sales Jan/03|91892|Units Jan/03|2142|DOT Jan/03|17842.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Feb/03|2239|USD Sales Feb/03|2412|LC Sales Feb/03|70785|Units Feb/03|1650|DOT Feb/03|13744.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Mar/03|2621|USD Sales Mar/03|2832|LC Sales Mar/03|83140|Units Mar/03|1938|DOT Mar/03|16143.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Apr/03|2168|USD Sales Apr/03|2352|LC Sales Apr/03|68554|Units Apr/03|1598|DOT Apr/03|13311.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales May/03|2625|USD Sales May/03|3037|LC Sales May/03|82368|Units May/03|1920|DOT May/03|15993.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jun/03|2817|USD Sales Jun/03|3285|LC Sales Jun/03|88460|Units Jun/03|2062|DOT Jun/03|17176.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jul/03|2875|USD Sales Jul/03|3270|LC Sales Jul/03|91549|Units Jul/03|2134|DOT Jul/03|17776.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Aug/03|2508|USD Sales Aug/03|2793|LC Sales Aug/03|80909|Units Aug/03|1886|DOT Aug/03|15710.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Sep/03|2601|USD Sales Sep/03|2913|LC Sales Sep/03|84170|Units Sep/03|1962|DOT Sep/03|16343.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Oct/03|2279|USD Sales Oct/03|2666|LC Sales Oct/03|72844|Units Oct/03|1698|DOT Oct/03|14144.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Nov/03|2438|USD Sales Nov/03|2852|LC Sales Nov/03|77906|Units Nov/03|1816|DOT Nov/03|15127.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Dec/03|2508|USD Sales Dec/03|3078|LC Sales Dec/03|80969|Units Dec/03|1883|DOT Dec/03|15685.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jan/04|2608|USD Sales Jan/04|3290|LC Sales Jan/04|85355|Units Jan/04|1985|DOT Jan/04|16535
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Feb/04|1982|USD Sales Feb/04|2506|LC Sales Feb/04|65102|Units Feb/04|1514|DOT Feb/04|12611.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Mar/04|2539|USD Sales Mar/04|3116|LC Sales Mar/04|83721|Units Mar/04|1947|DOT Mar/04|16218.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Apr/04|2505|USD Sales Apr/04|3002|LC Sales Apr/04|81424|Units Apr/04|1898|DOT Apr/04|15810.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales May/04|2662|USD Sales May/04|3195|LC Sales May/04|85157|Units May/04|1985|DOT May/04|16535
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jun/04|2871|USD Sales Jun/04|3485|LC Sales Jun/04|90776|Units Jun/04|2116|DOT Jun/04|17626.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jul/04|2582|USD Sales Jul/04|3168|LC Sales Jul/04|81467|Units Jul/04|1899|DOT Jul/04|15818.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Aug/04|2661|USD Sales Aug/04|3241|LC Sales Aug/04|84170|Units Aug/04|1962|DOT Aug/04|16343.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Sep/04|2738|USD Sales Sep/04|3345|LC Sales Sep/04|86529|Units Sep/04|2017|DOT Sep/04|16801.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Oct/04|2804|USD Sales Oct/04|3502|LC Sales Oct/04|88288|Units Oct/04|2058|DOT Oct/04|17143.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Nov/04|2605|USD Sales Nov/04|3384|LC Sales Nov/04|81510|Units Nov/04|1900|DOT Nov/04|15827
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Dec/04|2365|USD Sales Dec/04|3169|LC Sales Dec/04|72501|Units Dec/04|1690|DOT Dec/04|14077.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jan/05|2687|USD Sales Jan/05|3528|LC Sales Jan/05|81424|Units Jan/05|1898|DOT Jan/05|15810.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Feb/05|2718|USD Sales Feb/05|3539|LC Sales Feb/05|81467|Units Feb/05|1899|DOT Feb/05|15818.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Mar/05|3291|USD Sales Mar/05|4347|LC Sales Mar/05|97984|Units Mar/05|2284|DOT Mar/05|19025.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Apr/05|2886|USD Sales Apr/05|3734|LC Sales Apr/05|86915|Units Apr/05|2026|DOT Apr/05|16876.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales May/05|2824|USD Sales May/05|3583|LC Sales May/05|85414|Units May/05|1991|DOT May/05|16585
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jun/05|3064|USD Sales Jun/05|3727|LC Sales Jun/05|92021|Units Jun/05|2145|DOT Jun/05|17867.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jul/05|2697|USD Sales Jul/05|3247|LC Sales Jul/05|81381|Units Jul/05|1897|DOT Jul/05|15802
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Aug/05|3537|USD Sales Aug/05|4348|LC Sales Aug/05|104633|Units Aug/05|2439|DOT Aug/05|20316.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Sep/05|2652|USD Sales Sep/05|3250|LC Sales Sep/05|77735|Units Sep/05|1812|DOT Sep/05|15093.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Oct/05|2491|USD Sales Oct/05|2995|LC Sales Oct/05|73917|Units Oct/05|1723|DOT Oct/05|14352.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Nov/05|2732|USD Sales Nov/05|3220|LC Sales Nov/05|79966|Units Nov/05|1864|DOT Nov/05|15527.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Dec/05|2796|USD Sales Dec/05|3316|LC Sales Dec/05|80952|Units Dec/05|1887|DOT Dec/05|15718.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jan/06|2867|USD Sales Jan/06|3470|LC Sales Jan/06|82325|Units Jan/06|1919|DOT Jan/06|15985.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Feb/06|2967|USD Sales Feb/06|3545|LC Sales Feb/06|84341|Units Feb/06|1966|DOT Feb/06|16376.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Mar/06|3487|USD Sales Mar/06|4193|LC Sales Mar/06|99871|Units Mar/06|2328|DOT Mar/06|19392.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Apr/06|2590|USD Sales Apr/06|3176|LC Sales Apr/06|73831|Units Apr/06|1721|DOT Apr/06|14335.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales May/06|3217|USD Sales May/06|4106|LC Sales May/06|90948|Units May/06|2120|DOT May/06|17659.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jun/06|3604|USD Sales Jun/06|4564|LC Sales Jun/06|102274|Units Jun/06|2384|DOT Jun/06|19858.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Jul/06|2478|USD Sales Jul/06|3144|LC Sales Jul/06|70485|Units Jul/06|1643|DOT Jul/06|13686.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Aug/06|3414|USD Sales Aug/06|4374|LC Sales Aug/06|96265|Units Aug/06|2303|DOT Aug/06|19183.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Sep/06|3178|USD Sales Sep/06|4048|LC Sales Sep/06|90219|Units Sep/06|2103|DOT Sep/06|17517.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|CALCII CARBON PRAE|00.5MG|TABS .5 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1996|1996/11|8.33|3.00 G|MONO|CALCIUM|57|42.9|59.9|EURO Sales Oct/06|3239|USD Sales Oct/06|4086|LC Sales Oct/06|91592|Units Oct/06|2135|DOT Oct/06|17784.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|PFIZER*|PFIZER|PFIZER|GELUSIL|0500MG|TABS 500 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1992|1992/07|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|58|33.3|45.1|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Nov/01|1070|USD Sales Nov/01|950|LC Sales Nov/01|35561|Units Nov/01|792|DOT Nov/01|3960
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Dec/01|963|USD Sales Dec/01|860|LC Sales Dec/01|31209|Units Dec/01|692|DOT Dec/01|3460
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jan/02|1113|USD Sales Jan/02|983|LC Sales Jan/02|35708|Units Jan/02|790|DOT Jan/02|3950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Feb/02|972|USD Sales Feb/02|845|LC Sales Feb/02|30870|Units Feb/02|686|DOT Feb/02|3430
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Mar/02|920|USD Sales Mar/02|805|LC Sales Mar/02|28845|Units Mar/02|641|DOT Mar/02|3205
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Apr/02|1029|USD Sales Apr/02|911|LC Sales Apr/02|31254|Units Apr/02|693|DOT Apr/02|3465
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales May/02|894|USD Sales May/02|820|LC Sales May/02|27356|Units May/02|612|DOT May/02|3060
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jun/02|822|USD Sales Jun/02|786|LC Sales Jun/02|24898|Units Jun/02|557|DOT Jun/02|2785
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jul/02|733|USD Sales Jul/02|727|LC Sales Jul/02|21835|Units Jul/02|482|DOT Jul/02|2410
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Aug/02|846|USD Sales Aug/02|827|LC Sales Aug/02|26060|Units Aug/02|574|DOT Aug/02|2870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Sep/02|1290|USD Sales Sep/02|1264|LC Sales Sep/02|38936|Units Sep/02|852|DOT Sep/02|4260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Oct/02|1377|USD Sales Oct/02|1350|LC Sales Oct/02|42134|Units Oct/02|924|DOT Oct/02|4620
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Nov/02|971|USD Sales Nov/02|972|LC Sales Nov/02|29822|Units Nov/02|654|DOT Nov/02|3270
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Dec/02|912|USD Sales Dec/02|927|LC Sales Dec/02|28366|Units Dec/02|618|DOT Dec/02|3090
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jan/03|953|USD Sales Jan/03|1012|LC Sales Jan/03|29979|Units Jan/03|656|DOT Jan/03|3280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Feb/03|1041|USD Sales Feb/03|1122|LC Sales Feb/03|32910|Units Feb/03|717|DOT Feb/03|3585
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Mar/03|774|USD Sales Mar/03|836|LC Sales Mar/03|24557|Units Mar/03|535|DOT Mar/03|2675
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Apr/03|929|USD Sales Apr/03|1008|LC Sales Apr/03|29376|Units Apr/03|640|DOT Apr/03|3200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales May/03|810|USD Sales May/03|938|LC Sales May/03|25429|Units May/03|554|DOT May/03|2770
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jun/03|728|USD Sales Jun/03|849|LC Sales Jun/03|22858|Units Jun/03|498|DOT Jun/03|2490
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jul/03|575|USD Sales Jul/03|654|LC Sales Jul/03|18302|Units Jul/03|397|DOT Jul/03|1985
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Aug/03|619|USD Sales Aug/03|689|LC Sales Aug/03|19961|Units Aug/03|433|DOT Aug/03|2165
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Sep/03|755|USD Sales Sep/03|846|LC Sales Sep/03|24433|Units Sep/03|530|DOT Sep/03|2650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Oct/03|823|USD Sales Oct/03|962|LC Sales Oct/03|26301|Units Oct/03|573|DOT Oct/03|2865
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Nov/03|873|USD Sales Nov/03|1021|LC Sales Nov/03|27891|Units Nov/03|605|DOT Nov/03|3025
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Dec/03|682|USD Sales Dec/03|838|LC Sales Dec/03|22036|Units Dec/03|478|DOT Dec/03|2390
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jan/04|866|USD Sales Jan/04|1093|LC Sales Jan/04|28352|Units Jan/04|615|DOT Jan/04|3075
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Feb/04|749|USD Sales Feb/04|948|LC Sales Feb/04|24617|Units Feb/04|534|DOT Feb/04|2670
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Mar/04|610|USD Sales Mar/04|748|LC Sales Mar/04|20100|Units Mar/04|436|DOT Mar/04|2180
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Apr/04|841|USD Sales Apr/04|1008|LC Sales Apr/04|27324|Units Apr/04|594|DOT Apr/04|2970
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales May/04|676|USD Sales May/04|811|LC Sales May/04|21621|Units May/04|469|DOT May/04|2345
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jun/04|605|USD Sales Jun/04|734|LC Sales Jun/04|19110|Units Jun/04|455|DOT Jun/04|2275
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jul/04|605|USD Sales Jul/04|742|LC Sales Jul/04|19081|Units Jul/04|413|DOT Jul/04|2065
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Aug/04|734|USD Sales Aug/04|894|LC Sales Aug/04|23204|Units Aug/04|499|DOT Aug/04|2495
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Sep/04|653|USD Sales Sep/04|798|LC Sales Sep/04|20646|Units Sep/04|444|DOT Sep/04|2220
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Oct/04|679|USD Sales Oct/04|848|LC Sales Oct/04|21390|Units Oct/04|461|DOT Oct/04|2305
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Nov/04|783|USD Sales Nov/04|1017|LC Sales Nov/04|24506|Units Nov/04|527|DOT Nov/04|2635
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Dec/04|754|USD Sales Dec/04|1010|LC Sales Dec/04|23111|Units Dec/04|497|DOT Dec/04|2485
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jan/05|867|USD Sales Jan/05|1138|LC Sales Jan/05|26273|Units Jan/05|565|DOT Jan/05|2825
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Feb/05|683|USD Sales Feb/05|889|LC Sales Feb/05|20460|Units Feb/05|440|DOT Feb/05|2200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Mar/05|800|USD Sales Mar/05|1056|LC Sales Mar/05|23808|Units Mar/05|512|DOT Mar/05|2560
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Apr/05|553|USD Sales Apr/05|715|LC Sales Apr/05|16647|Units Apr/05|358|DOT Apr/05|1790
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales May/05|621|USD Sales May/05|788|LC Sales May/05|18786|Units May/05|404|DOT May/05|2020
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jun/05|586|USD Sales Jun/05|713|LC Sales Jun/05|17609|Units Jun/05|387|DOT Jun/05|1935
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jul/05|538|USD Sales Jul/05|647|LC Sales Jul/05|16227|Units Jul/05|359|DOT Jul/05|1795
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Aug/05|558|USD Sales Aug/05|686|LC Sales Aug/05|16515|Units Aug/05|367|DOT Aug/05|1835
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Sep/05|607|USD Sales Sep/05|743|LC Sales Sep/05|17780|Units Sep/05|396|DOT Sep/05|1980
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Oct/05|492|USD Sales Oct/05|591|LC Sales Oct/05|14593|Units Oct/05|325|DOT Oct/05|1625
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Nov/05|617|USD Sales Nov/05|727|LC Sales Nov/05|18050|Units Nov/05|402|DOT Nov/05|2010
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Dec/05|606|USD Sales Dec/05|719|LC Sales Dec/05|17556|Units Dec/05|391|DOT Dec/05|1955
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jan/06|679|USD Sales Jan/06|821|LC Sales Jan/06|19487|Units Jan/06|434|DOT Jan/06|2170
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Feb/06|395|USD Sales Feb/06|472|LC Sales Feb/06|11225|Units Feb/06|250|DOT Feb/06|1250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Mar/06|720|USD Sales Mar/06|865|LC Sales Mar/06|20609|Units Mar/06|459|DOT Mar/06|2295
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Apr/06|534|USD Sales Apr/06|655|LC Sales Apr/06|15221|Units Apr/06|339|DOT Apr/06|1695
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales May/06|653|USD Sales May/06|833|LC Sales May/06|18454|Units May/06|411|DOT May/06|2055
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jun/06|497|USD Sales Jun/06|630|LC Sales Jun/06|14112|Units Jun/06|320|DOT Jun/06|1600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Jul/06|351|USD Sales Jul/06|445|LC Sales Jul/06|9972|Units Jul/06|233|DOT Jul/06|1165
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Aug/06|481|USD Sales Aug/06|616|LC Sales Aug/06|13558|Units Aug/06|319|DOT Aug/06|1595
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Sep/06|547|USD Sales Sep/06|697|LC Sales Sep/06|15537|Units Sep/06|358|DOT Sep/06|1790
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP 400 MG 1 250 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1993|1993/01|5.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|59|42.5|59.4|EURO Sales Oct/06|508|USD Sales Oct/06|641|LC Sales Oct/06|14365|Units Oct/06|338|DOT Oct/06|1690
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Nov/01|1869|USD Sales Nov/01|1661|LC Sales Nov/01|62134|Units Nov/01|715|DOT Nov/01|6435
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Dec/01|1483|USD Sales Dec/01|1324|LC Sales Dec/01|48079|Units Dec/01|552|DOT Dec/01|4968
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jan/02|1973|USD Sales Jan/02|1742|LC Sales Jan/02|63291|Units Jan/02|730|DOT Jan/02|6570
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Feb/02|1876|USD Sales Feb/02|1631|LC Sales Feb/02|59563|Units Feb/02|687|DOT Feb/02|6183
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Mar/02|1644|USD Sales Mar/02|1439|LC Sales Mar/02|51559|Units Mar/02|594|DOT Mar/02|5346
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Apr/02|2017|USD Sales Apr/02|1786|LC Sales Apr/02|61265|Units Apr/02|705|DOT Apr/02|6345
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales May/02|2033|USD Sales May/02|1865|LC Sales May/02|62220|Units May/02|716|DOT May/02|6444
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jun/02|1424|USD Sales Jun/02|1361|LC Sales Jun/02|43114|Units Jun/02|499|DOT Jun/02|4491
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jul/02|1418|USD Sales Jul/02|1407|LC Sales Jul/02|42250|Units Jul/02|489|DOT Jul/02|4401
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Aug/02|1057|USD Sales Aug/02|1033|LC Sales Aug/02|32562|Units Aug/02|376|DOT Aug/02|3384
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Sep/02|9|USD Sales Sep/02|8|LC Sales Sep/02|258|Units Sep/02|3|DOT Sep/02|27
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Oct/02|801|USD Sales Oct/02|786|LC Sales Oct/02|24531|Units Oct/02|291|DOT Oct/02|2619
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Nov/02|1723|USD Sales Nov/02|1725|LC Sales Nov/02|52919|Units Nov/02|627|DOT Nov/02|5643
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Dec/02|1204|USD Sales Dec/02|1223|LC Sales Dec/02|37447|Units Dec/02|439|DOT Dec/02|3951
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jan/03|1527|USD Sales Jan/03|1621|LC Sales Jan/03|48024|Units Jan/03|563|DOT Jan/03|5067
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Feb/03|1160|USD Sales Feb/03|1250|LC Sales Feb/03|36679|Units Feb/03|430|DOT Feb/03|3870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Mar/03|1094|USD Sales Mar/03|1183|LC Sales Mar/03|34717|Units Mar/03|407|DOT Mar/03|3663
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Apr/03|1410|USD Sales Apr/03|1530|LC Sales Apr/03|44595|Units Apr/03|529|DOT Apr/03|4761
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales May/03|1395|USD Sales May/03|1613|LC Sales May/03|43759|Units May/03|513|DOT May/03|4617
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jun/03|1023|USD Sales Jun/03|1192|LC Sales Jun/03|32110|Units Jun/03|376|DOT Jun/03|3384
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jul/03|1093|USD Sales Jul/03|1244|LC Sales Jul/03|34819|Units Jul/03|403|DOT Jul/03|3627
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Aug/03|876|USD Sales Aug/03|976|LC Sales Aug/03|28264|Units Aug/03|326|DOT Aug/03|2934
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Sep/03|1391|USD Sales Sep/03|1558|LC Sales Sep/03|45032|Units Sep/03|520|DOT Sep/03|4680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Oct/03|1143|USD Sales Oct/03|1337|LC Sales Oct/03|36545|Units Oct/03|422|DOT Oct/03|3798
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Nov/03|1276|USD Sales Nov/03|1494|LC Sales Nov/03|40796|Units Nov/03|470|DOT Nov/03|4230
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Dec/03|930|USD Sales Dec/03|1141|LC Sales Dec/03|30015|Units Dec/03|345|DOT Dec/03|3105
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jan/04|1242|USD Sales Jan/04|1566|LC Sales Jan/04|40629|Units Jan/04|467|DOT Jan/04|4203
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Feb/04|1094|USD Sales Feb/04|1383|LC Sales Feb/04|35931|Units Feb/04|413|DOT Feb/04|3717
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Mar/04|1348|USD Sales Mar/04|1654|LC Sales Mar/04|44457|Units Mar/04|511|DOT Mar/04|4599
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Apr/04|1013|USD Sales Apr/04|1214|LC Sales Apr/04|32935|Units Apr/04|379|DOT Apr/04|3411
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales May/04|1179|USD Sales May/04|1415|LC Sales May/04|37715|Units May/04|434|DOT May/04|3906
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jun/04|1078|USD Sales Jun/04|1308|LC Sales Jun/04|34065|Units Jun/04|392|DOT Jun/04|3528
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jul/04|1083|USD Sales Jul/04|1328|LC Sales Jul/04|34154|Units Jul/04|389|DOT Jul/04|3501
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Aug/04|1005|USD Sales Aug/04|1223|LC Sales Aug/04|31773|Units Aug/04|357|DOT Aug/04|3213
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Sep/04|1183|USD Sales Sep/04|1445|LC Sales Sep/04|37380|Units Sep/04|420|DOT Sep/04|3780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Oct/04|1097|USD Sales Oct/04|1370|LC Sales Oct/04|34532|Units Oct/04|388|DOT Oct/04|3492
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Nov/04|1232|USD Sales Nov/04|1600|LC Sales Nov/04|38539|Units Nov/04|434|DOT Nov/04|3906
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Dec/04|1344|USD Sales Dec/04|1801|LC Sales Dec/04|41207|Units Dec/04|463|DOT Dec/04|4167
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jan/05|1210|USD Sales Jan/05|1589|LC Sales Jan/05|36668|Units Jan/05|412|DOT Jan/05|3708
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Feb/05|944|USD Sales Feb/05|1229|LC Sales Feb/05|28302|Units Feb/05|318|DOT Feb/05|2862
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Mar/05|1256|USD Sales Mar/05|1658|LC Sales Mar/05|37380|Units Mar/05|420|DOT Mar/05|3780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Apr/05|1061|USD Sales Apr/05|1373|LC Sales Apr/05|31951|Units Apr/05|359|DOT Apr/05|3231
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales May/05|977|USD Sales May/05|1240|LC Sales May/05|29548|Units May/05|332|DOT May/05|2988
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jun/05|758|USD Sales Jun/05|922|LC Sales Jun/05|22768|Units Jun/05|262|DOT Jun/05|2358
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jul/05|793|USD Sales Jul/05|955|LC Sales Jul/05|23929|Units Jul/05|276|DOT Jul/05|2484
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Aug/05|814|USD Sales Aug/05|1001|LC Sales Aug/05|24080|Units Aug/05|280|DOT Aug/05|2520
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Sep/05|959|USD Sales Sep/05|1176|LC Sales Sep/05|28122|Units Sep/05|327|DOT Sep/05|2943
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Oct/05|1046|USD Sales Oct/05|1258|LC Sales Oct/05|31046|Units Oct/05|361|DOT Oct/05|3249
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Nov/05|873|USD Sales Nov/05|1029|LC Sales Nov/05|25542|Units Nov/05|297|DOT Nov/05|2673
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Dec/05|936|USD Sales Dec/05|1110|LC Sales Dec/05|27090|Units Dec/05|315|DOT Dec/05|2835
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jan/06|1141|USD Sales Jan/06|1381|LC Sales Jan/06|32766|Units Jan/06|381|DOT Jan/06|3429
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Feb/06|947|USD Sales Feb/06|1131|LC Sales Feb/06|26918|Units Feb/06|313|DOT Feb/06|2817
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Mar/06|934|USD Sales Mar/06|1123|LC Sales Mar/06|26746|Units Mar/06|311|DOT Mar/06|2799
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Apr/06|846|USD Sales Apr/06|1037|LC Sales Apr/06|24108|Units Apr/06|287|DOT Apr/06|2583
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales May/06|958|USD Sales May/06|1223|LC Sales May/06|27090|Units May/06|315|DOT May/06|2835
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jun/06|814|USD Sales Jun/06|1031|LC Sales Jun/06|23100|Units Jun/06|275|DOT Jun/06|2475
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Jul/06|586|USD Sales Jul/06|744|LC Sales Jul/06|16680|Units Jul/06|200|DOT Jul/06|1800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Aug/06|772|USD Sales Aug/06|989|LC Sales Aug/06|21776|Units Aug/06|263|DOT Aug/06|2367
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Sep/06|782|USD Sales Sep/06|996|LC Sales Sep/06|22190|Units Sep/06|268|DOT Sep/06|2412
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|SUSP SACH 400 MG 30 15 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1993|1993/01|9.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|60|82.8|115.6|EURO Sales Oct/06|834|USD Sales Oct/06|1053|LC Sales Oct/06|23598|Units Oct/06|285|DOT Oct/06|2565
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Nov/01|991|USD Sales Nov/01|881|LC Sales Nov/01|32951|Units Nov/01|761|DOT Nov/01|3044
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Dec/01|815|USD Sales Dec/01|728|LC Sales Dec/01|26413|Units Dec/01|610|DOT Dec/01|2440
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jan/02|1431|USD Sales Jan/02|1264|LC Sales Jan/02|45922|Units Jan/02|1063|DOT Jan/02|4252
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Feb/02|1057|USD Sales Feb/02|919|LC Sales Feb/02|33566|Units Feb/02|777|DOT Feb/02|3108
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Mar/02|1244|USD Sales Mar/02|1089|LC Sales Mar/02|39020|Units Mar/02|897|DOT Mar/02|3588
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Apr/02|75|USD Sales Apr/02|66|LC Sales Apr/02|2272|Units Apr/02|52|DOT Apr/02|208
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales May/02|1737|USD Sales May/02|1594|LC Sales May/02|53171|Units May/02|1257|DOT May/02|5028
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jun/02|972|USD Sales Jun/02|929|LC Sales Jun/02|29437|Units Jun/02|683|DOT Jun/02|2732
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jul/02|851|USD Sales Jul/02|844|LC Sales Jul/02|25362|Units Jul/02|601|DOT Jul/02|2404
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Aug/02|820|USD Sales Aug/02|802|LC Sales Aug/02|25278|Units Aug/02|592|DOT Aug/02|2368
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Sep/02|927|USD Sales Sep/02|909|LC Sales Sep/02|27988|Units Sep/02|657|DOT Sep/02|2628
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Oct/02|1118|USD Sales Oct/02|1096|LC Sales Oct/02|34208|Units Oct/02|803|DOT Oct/02|3212
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Nov/02|960|USD Sales Nov/02|961|LC Sales Nov/02|29479|Units Nov/02|692|DOT Nov/02|2768
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Dec/02|707|USD Sales Dec/02|718|LC Sales Dec/02|21991|Units Dec/02|515|DOT Dec/02|2060
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jan/03|1262|USD Sales Jan/03|1341|LC Sales Jan/03|39711|Units Jan/03|930|DOT Jan/03|3720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Feb/03|895|USD Sales Feb/03|965|LC Sales Feb/03|28310|Units Feb/03|663|DOT Feb/03|2652
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Mar/03|975|USD Sales Mar/03|1053|LC Sales Mar/03|30915|Units Mar/03|724|DOT Mar/03|2896
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Apr/03|782|USD Sales Apr/03|848|LC Sales Apr/03|24723|Units Apr/03|579|DOT Apr/03|2316
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales May/03|988|USD Sales May/03|1143|LC Sales May/03|31000|Units May/03|726|DOT May/03|2904
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jun/03|708|USD Sales Jun/03|826|LC Sales Jun/03|22247|Units Jun/03|521|DOT Jun/03|2084
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jul/03|796|USD Sales Jul/03|905|LC Sales Jul/03|25354|Units Jul/03|591|DOT Jul/03|2364
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Aug/03|667|USD Sales Aug/03|743|LC Sales Aug/03|21513|Units Aug/03|505|DOT Aug/03|2020
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Sep/03|993|USD Sales Sep/03|1112|LC Sales Sep/03|32132|Units Sep/03|749|DOT Sep/03|2996
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Oct/03|849|USD Sales Oct/03|994|LC Sales Oct/03|27156|Units Oct/03|633|DOT Oct/03|2532
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Nov/03|915|USD Sales Nov/03|1071|LC Sales Nov/03|29258|Units Nov/03|682|DOT Nov/03|2728
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Dec/03|848|USD Sales Dec/03|1040|LC Sales Dec/03|27370|Units Dec/03|638|DOT Dec/03|2552
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jan/04|1034|USD Sales Jan/04|1305|LC Sales Jan/04|33848|Units Jan/04|789|DOT Jan/04|3156
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Feb/04|683|USD Sales Feb/04|864|LC Sales Feb/04|22437|Units Feb/04|523|DOT Feb/04|2092
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Mar/04|938|USD Sales Mar/04|1151|LC Sales Mar/04|30931|Units Mar/04|721|DOT Mar/04|2884
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Apr/04|878|USD Sales Apr/04|1052|LC Sales Apr/04|28529|Units Apr/04|665|DOT Apr/04|2660
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales May/04|956|USD Sales May/04|1148|LC Sales May/04|30588|Units May/04|713|DOT May/04|2852
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jun/04|837|USD Sales Jun/04|1016|LC Sales Jun/04|26469|Units Jun/04|617|DOT Jun/04|2468
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jul/04|723|USD Sales Jul/04|886|LC Sales Jul/04|22794|Units Jul/04|524|DOT Jul/04|2096
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Aug/04|787|USD Sales Aug/04|958|LC Sales Aug/04|24885|Units Aug/04|563|DOT Aug/04|2252
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Sep/04|860|USD Sales Sep/04|1051|LC Sales Sep/04|27183|Units Sep/04|615|DOT Sep/04|2460
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Oct/04|915|USD Sales Oct/04|1143|LC Sales Oct/04|28818|Units Oct/04|652|DOT Oct/04|2608
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Nov/04|990|USD Sales Nov/04|1286|LC Sales Nov/04|30984|Units Nov/04|701|DOT Nov/04|2804
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Dec/04|983|USD Sales Dec/04|1318|LC Sales Dec/04|30144|Units Dec/04|682|DOT Dec/04|2728
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jan/05|1075|USD Sales Jan/05|1411|LC Sales Jan/05|32575|Units Jan/05|737|DOT Jan/05|2948
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Feb/05|866|USD Sales Feb/05|1127|LC Sales Feb/05|25945|Units Feb/05|587|DOT Feb/05|2348
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Mar/05|943|USD Sales Mar/05|1245|LC Sales Mar/05|28067|Units Mar/05|635|DOT Mar/05|2540
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Apr/05|989|USD Sales Apr/05|1280|LC Sales Apr/05|29791|Units Apr/05|674|DOT Apr/05|2696
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales May/05|699|USD Sales May/05|886|LC Sales May/05|21128|Units May/05|478|DOT May/05|1912
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jun/05|848|USD Sales Jun/05|1031|LC Sales Jun/05|25456|Units Jun/05|592|DOT Jun/05|2368
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jul/05|729|USD Sales Jul/05|878|LC Sales Jul/05|22006|Units Jul/05|519|DOT Jul/05|2076
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Aug/05|918|USD Sales Aug/05|1128|LC Sales Aug/05|27156|Units Aug/05|633|DOT Aug/05|2532
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Sep/05|927|USD Sales Sep/05|1135|LC Sales Sep/05|27157|Units Sep/05|636|DOT Sep/05|2544
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Oct/05|960|USD Sales Oct/05|1154|LC Sales Oct/05|28481|Units Oct/05|667|DOT Oct/05|2668
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Nov/05|970|USD Sales Nov/05|1143|LC Sales Nov/05|28396|Units Nov/05|665|DOT Nov/05|2660
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Dec/05|923|USD Sales Dec/05|1095|LC Sales Dec/05|26730|Units Dec/05|626|DOT Dec/05|2504
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jan/06|1106|USD Sales Jan/06|1339|LC Sales Jan/06|31769|Units Jan/06|744|DOT Jan/06|2976
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Feb/06|943|USD Sales Feb/06|1126|LC Sales Feb/06|26796|Units Feb/06|638|DOT Feb/06|2552
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Mar/06|1215|USD Sales Mar/06|1461|LC Sales Mar/06|34801|Units Mar/06|815|DOT Mar/06|3260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Apr/06|1117|USD Sales Apr/06|1370|LC Sales Apr/06|31854|Units Apr/06|746|DOT Apr/06|2984
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales May/06|1044|USD Sales May/06|1332|LC Sales May/06|29506|Units May/06|691|DOT May/06|2764
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jun/06|901|USD Sales Jun/06|1141|LC Sales Jun/06|25578|Units Jun/06|609|DOT Jun/06|2436
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Jul/06|584|USD Sales Jul/06|741|LC Sales Jul/06|16606|Units Jul/06|408|DOT Jul/06|1632
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Aug/06|922|USD Sales Aug/06|1181|LC Sales Aug/06|26001|Units Aug/06|642|DOT Aug/06|2568
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Sep/06|787|USD Sales Sep/06|1002|LC Sales Sep/06|22343|Units Sep/06|541|DOT Sep/06|2164
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|SANOFI AVENTIS*|SANOFI-AVENTIS|SANOFI-AVENTIS|MAALOX|0400MG|TABS CHEW 400 MG 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1993|1993/01|4.00|10.00 DF|COMBI|ALUMINIUM;MAGNESIUM|61|41.3|57.7|EURO Sales Oct/06|866|USD Sales Oct/06|1093|LC Sales Oct/06|24491|Units Oct/06|593|DOT Oct/06|2372
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Nov/01|504|USD Sales Nov/01|448|LC Sales Nov/01|16746|Units Nov/01|829|DOT Nov/01|994.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Dec/01|561|USD Sales Dec/01|501|LC Sales Dec/01|18195|Units Dec/01|879|DOT Dec/01|1054.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jan/02|675|USD Sales Jan/02|596|LC Sales Jan/02|21653|Units Jan/02|1041|DOT Jan/02|1249.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Feb/02|554|USD Sales Feb/02|482|LC Sales Feb/02|17597|Units Feb/02|846|DOT Feb/02|1015.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Mar/02|644|USD Sales Mar/02|564|LC Sales Mar/02|20197|Units Mar/02|971|DOT Mar/02|1165.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Apr/02|602|USD Sales Apr/02|533|LC Sales Apr/02|18293|Units Apr/02|888|DOT Apr/02|1065.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales May/02|743|USD Sales May/02|682|LC Sales May/02|22742|Units May/02|1104|DOT May/02|1324.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jun/02|431|USD Sales Jun/02|412|LC Sales Jun/02|13062|Units Jun/02|631|DOT Jun/02|757.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jul/02|456|USD Sales Jul/02|452|LC Sales Jul/02|13592|Units Jul/02|663|DOT Jul/02|795.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Aug/02|504|USD Sales Aug/02|492|LC Sales Aug/02|15525|Units Aug/02|750|DOT Aug/02|900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Sep/02|429|USD Sales Sep/02|421|LC Sales Sep/02|12956|Units Sep/02|632|DOT Sep/02|758.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Oct/02|449|USD Sales Oct/02|441|LC Sales Oct/02|13756|Units Oct/02|671|DOT Oct/02|805.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Nov/02|547|USD Sales Nov/02|548|LC Sales Nov/02|16810|Units Nov/02|816|DOT Nov/02|979.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Dec/02|515|USD Sales Dec/02|523|LC Sales Dec/02|16016|Units Dec/02|770|DOT Dec/02|924
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jan/03|564|USD Sales Jan/03|599|LC Sales Jan/03|17742|Units Jan/03|853|DOT Jan/03|1023.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Feb/03|464|USD Sales Feb/03|500|LC Sales Feb/03|14685|Units Feb/03|706|DOT Feb/03|847.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Mar/03|414|USD Sales Mar/03|447|LC Sales Mar/03|13125|Units Mar/03|631|DOT Mar/03|757.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Apr/03|466|USD Sales Apr/03|505|LC Sales Apr/03|14726|Units Apr/03|708|DOT Apr/03|849.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales May/03|434|USD Sales May/03|502|LC Sales May/03|13624|Units May/03|655|DOT May/03|786
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jun/03|405|USD Sales Jun/03|473|LC Sales Jun/03|12730|Units Jun/03|612|DOT Jun/03|734.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jul/03|542|USD Sales Jul/03|616|LC Sales Jul/03|17262|Units Jul/03|822|DOT Jul/03|986.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Aug/03|441|USD Sales Aug/03|492|LC Sales Aug/03|14243|Units Aug/03|675|DOT Aug/03|810
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Sep/03|464|USD Sales Sep/03|520|LC Sales Sep/03|15023|Units Sep/03|712|DOT Sep/03|854.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Oct/03|468|USD Sales Oct/03|547|LC Sales Oct/03|14960|Units Oct/03|709|DOT Oct/03|850.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Nov/03|375|USD Sales Nov/03|439|LC Sales Nov/03|11985|Units Nov/03|568|DOT Nov/03|681.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Dec/03|487|USD Sales Dec/03|598|LC Sales Dec/03|15741|Units Dec/03|746|DOT Dec/03|895.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jan/04|498|USD Sales Jan/04|628|LC Sales Jan/04|16289|Units Jan/04|772|DOT Jan/04|926.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Feb/04|422|USD Sales Feb/04|534|LC Sales Feb/04|13863|Units Feb/04|657|DOT Feb/04|788.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Mar/04|480|USD Sales Mar/04|589|LC Sales Mar/04|15825|Units Mar/04|750|DOT Mar/04|900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Apr/04|464|USD Sales Apr/04|556|LC Sales Apr/04|15073|Units Apr/04|711|DOT Apr/04|853.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales May/04|454|USD Sales May/04|545|LC Sales May/04|14522|Units May/04|685|DOT May/04|822
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jun/04|533|USD Sales Jun/04|647|LC Sales Jun/04|16854|Units Jun/04|795|DOT Jun/04|954
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jul/04|384|USD Sales Jul/04|472|LC Sales Jul/04|12126|Units Jul/04|572|DOT Jul/04|686.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Aug/04|446|USD Sales Aug/04|544|LC Sales Aug/04|14116|Units Aug/04|669|DOT Aug/04|802.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Sep/04|412|USD Sales Sep/04|503|LC Sales Sep/04|13019|Units Sep/04|617|DOT Sep/04|740.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Oct/04|443|USD Sales Oct/04|553|LC Sales Oct/04|13947|Units Oct/04|661|DOT Oct/04|793.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Nov/04|575|USD Sales Nov/04|747|LC Sales Nov/04|17998|Units Nov/04|853|DOT Nov/04|1023.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Dec/04|566|USD Sales Dec/04|758|LC Sales Dec/04|17344|Units Dec/04|822|DOT Dec/04|986.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jan/05|643|USD Sales Jan/05|844|LC Sales Jan/05|19475|Units Jan/05|923|DOT Jan/05|1107.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Feb/05|529|USD Sales Feb/05|689|LC Sales Feb/05|15867|Units Feb/05|752|DOT Feb/05|902.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Mar/05|452|USD Sales Mar/05|597|LC Sales Mar/05|13462|Units Mar/05|638|DOT Mar/05|765.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Apr/05|391|USD Sales Apr/05|506|LC Sales Apr/05|11774|Units Apr/05|558|DOT Apr/05|669.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales May/05|650|USD Sales May/05|825|LC Sales May/05|19665|Units May/05|932|DOT May/05|1118.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jun/05|443|USD Sales Jun/05|538|LC Sales Jun/05|13293|Units Jun/05|630|DOT Jun/05|756
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jul/05|344|USD Sales Jul/05|414|LC Sales Jul/05|10373|Units Jul/05|487|DOT Jul/05|584.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Aug/05|443|USD Sales Aug/05|544|LC Sales Aug/05|13100|Units Aug/05|615|DOT Aug/05|738
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Sep/05|540|USD Sales Sep/05|662|LC Sales Sep/05|15833|Units Sep/05|733|DOT Sep/05|879.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Oct/05|390|USD Sales Oct/05|469|LC Sales Oct/05|11566|Units Oct/05|533|DOT Oct/05|639.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Nov/05|521|USD Sales Nov/05|615|LC Sales Nov/05|15260|Units Nov/05|700|DOT Nov/05|840
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Dec/05|549|USD Sales Dec/05|651|LC Sales Dec/05|15892|Units Dec/05|729|DOT Dec/05|874.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jan/06|537|USD Sales Jan/06|650|LC Sales Jan/06|15413|Units Jan/06|707|DOT Jan/06|848.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Feb/06|546|USD Sales Feb/06|652|LC Sales Feb/06|15522|Units Feb/06|712|DOT Feb/06|854.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Mar/06|613|USD Sales Mar/06|737|LC Sales Mar/06|17549|Units Mar/06|805|DOT Mar/06|966
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Apr/06|370|USD Sales Apr/06|454|LC Sales Apr/06|10551|Units Apr/06|484|DOT Apr/06|580.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales May/06|625|USD Sales May/06|798|LC Sales May/06|17680|Units May/06|811|DOT May/06|973.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jun/06|530|USD Sales Jun/06|671|LC Sales Jun/06|15042|Units Jun/06|690|DOT Jun/06|828
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Jul/06|356|USD Sales Jul/06|452|LC Sales Jul/06|10139|Units Jul/06|476|DOT Jul/06|571.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Aug/06|496|USD Sales Aug/06|635|LC Sales Aug/06|13973|Units Aug/06|656|DOT Aug/06|787.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Sep/06|635|USD Sales Sep/06|809|LC Sales Sep/06|18020|Units Sep/06|846|DOT Sep/06|1015.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 12 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/12|1.20|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|62|21.8|30.4|EURO Sales Oct/06|600|USD Sales Oct/06|757|LC Sales Oct/06|16960|Units Oct/06|778|DOT Oct/06|933.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Nov/01|3255|USD Sales Nov/01|2892|LC Sales Nov/01|108202|Units Nov/01|2534|DOT Nov/01|7602
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Dec/01|3148|USD Sales Dec/01|2811|LC Sales Dec/01|102053|Units Dec/01|2390|DOT Dec/01|7170
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jan/02|4080|USD Sales Jan/02|3603|LC Sales Jan/02|130892|Units Jan/02|3044|DOT Jan/02|9132
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Feb/02|2778|USD Sales Feb/02|2416|LC Sales Feb/02|88226|Units Feb/02|2047|DOT Feb/02|6141
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Mar/02|3582|USD Sales Mar/02|3136|LC Sales Mar/02|112359|Units Mar/02|2613|DOT Mar/02|7839
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Apr/02|3621|USD Sales Apr/02|3207|LC Sales Apr/02|109994|Units Apr/02|2558|DOT Apr/02|7674
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales May/02|3977|USD Sales May/02|3648|LC Sales May/02|121714|Units May/02|2824|DOT May/02|8472
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jun/02|2573|USD Sales Jun/02|2459|LC Sales Jun/02|77925|Units Jun/02|1808|DOT Jun/02|5424
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jul/02|3114|USD Sales Jul/02|3089|LC Sales Jul/02|92794|Units Jul/02|2158|DOT Jul/02|6474
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Aug/02|2917|USD Sales Aug/02|2851|LC Sales Aug/02|89876|Units Aug/02|2038|DOT Aug/02|6114
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Sep/02|3086|USD Sales Sep/02|3026|LC Sales Sep/02|93183|Units Sep/02|2094|DOT Sep/02|6282
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Oct/02|3324|USD Sales Oct/02|3260|LC Sales Oct/02|101746|Units Oct/02|2256|DOT Oct/02|6768
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Nov/02|2873|USD Sales Nov/02|2877|LC Sales Nov/02|88261|Units Nov/02|1957|DOT Nov/02|5871
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Dec/02|3357|USD Sales Dec/02|3412|LC Sales Dec/02|104437|Units Dec/02|2326|DOT Dec/02|6978
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jan/03|3544|USD Sales Jan/03|3764|LC Sales Jan/03|111487|Units Jan/03|2472|DOT Jan/03|7416
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Feb/03|2569|USD Sales Feb/03|2768|LC Sales Feb/03|81225|Units Feb/03|1805|DOT Feb/03|5415
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Mar/03|2535|USD Sales Mar/03|2739|LC Sales Mar/03|80416|Units Mar/03|1791|DOT Mar/03|5373
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Apr/03|2656|USD Sales Apr/03|2880|LC Sales Apr/03|83963|Units Apr/03|1870|DOT Apr/03|5610
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales May/03|2655|USD Sales May/03|3071|LC Sales May/03|83290|Units May/03|1855|DOT May/03|5565
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jun/03|1930|USD Sales Jun/03|2251|LC Sales Jun/03|60613|Units Jun/03|1341|DOT Jun/03|4023
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jul/03|2717|USD Sales Jul/03|3090|LC Sales Jul/03|86532|Units Jul/03|1906|DOT Jul/03|5718
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Aug/03|2015|USD Sales Aug/03|2244|LC Sales Aug/03|64994|Units Aug/03|1416|DOT Aug/03|4248
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Sep/03|2673|USD Sales Sep/03|2994|LC Sales Sep/03|86516|Units Sep/03|1889|DOT Sep/03|5667
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Oct/03|2310|USD Sales Oct/03|2703|LC Sales Oct/03|73853|Units Oct/03|1609|DOT Oct/03|4827
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Nov/03|2150|USD Sales Nov/03|2516|LC Sales Nov/03|68712|Units Nov/03|1497|DOT Nov/03|4491
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Dec/03|2325|USD Sales Dec/03|2854|LC Sales Dec/03|75072|Units Dec/03|1632|DOT Dec/03|4896
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jan/04|2870|USD Sales Jan/04|3621|LC Sales Jan/04|93932|Units Jan/04|2042|DOT Jan/04|6126
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Feb/04|2210|USD Sales Feb/04|2794|LC Sales Feb/04|72588|Units Feb/04|1578|DOT Feb/04|4734
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Mar/04|2882|USD Sales Mar/04|3537|LC Sales Mar/04|95036|Units Mar/04|2066|DOT Mar/04|6198
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Apr/04|2681|USD Sales Apr/04|3214|LC Sales Apr/04|87170|Units Apr/04|1895|DOT Apr/04|5685
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales May/04|2584|USD Sales May/04|3102|LC Sales May/04|82662|Units May/04|1797|DOT May/04|5391
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jun/04|2907|USD Sales Jun/04|3528|LC Sales Jun/04|91908|Units Jun/04|1998|DOT Jun/04|5994
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jul/04|2187|USD Sales Jul/04|2683|LC Sales Jul/04|69000|Units Jul/04|1500|DOT Jul/04|4500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Aug/04|2480|USD Sales Aug/04|3020|LC Sales Aug/04|78430|Units Aug/04|1705|DOT Aug/04|5115
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Sep/04|2385|USD Sales Sep/04|2913|LC Sales Sep/04|75348|Units Sep/04|1638|DOT Sep/04|4914
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Oct/04|2587|USD Sales Oct/04|3232|LC Sales Oct/04|81466|Units Oct/04|1771|DOT Oct/04|5313
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Nov/04|2943|USD Sales Nov/04|3823|LC Sales Nov/04|92092|Units Nov/04|2002|DOT Nov/04|6006
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Dec/04|2878|USD Sales Dec/04|3856|LC Sales Dec/04|88228|Units Dec/04|1918|DOT Dec/04|5754
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jan/05|3606|USD Sales Jan/05|4735|LC Sales Jan/05|109296|Units Jan/05|2376|DOT Jan/05|7128
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Feb/05|2789|USD Sales Feb/05|3631|LC Sales Feb/05|83582|Units Feb/05|1817|DOT Feb/05|5451
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Mar/05|2744|USD Sales Mar/05|3624|LC Sales Mar/05|81696|Units Mar/05|1776|DOT Mar/05|5328
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Apr/05|2503|USD Sales Apr/05|3239|LC Sales Apr/05|75394|Units Apr/05|1639|DOT Apr/05|4917
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales May/05|3068|USD Sales May/05|3893|LC Sales May/05|92796|Units May/05|2053|DOT May/05|6159
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jun/05|2628|USD Sales Jun/05|3197|LC Sales Jun/05|78936|Units Jun/05|1716|DOT Jun/05|5148
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jul/05|2142|USD Sales Jul/05|2579|LC Sales Jul/05|64627|Units Jul/05|1408|DOT Jul/05|4224
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Aug/05|2738|USD Sales Aug/05|3366|LC Sales Aug/05|81006|Units Aug/05|1761|DOT Aug/05|5283
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Sep/05|2918|USD Sales Sep/05|3576|LC Sales Sep/05|85518|Units Sep/05|1808|DOT Sep/05|5424
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Oct/05|2570|USD Sales Oct/05|3090|LC Sales Oct/05|76284|Units Oct/05|1630|DOT Oct/05|4890
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Nov/05|3254|USD Sales Nov/05|3835|LC Sales Nov/05|95238|Units Nov/05|2035|DOT Nov/05|6105
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Dec/05|2760|USD Sales Dec/05|3273|LC Sales Dec/05|79910|Units Dec/05|1693|DOT Dec/05|5079
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jan/06|3108|USD Sales Jan/06|3762|LC Sales Jan/06|89255|Units Jan/06|1887|DOT Jan/06|5661
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Feb/06|2795|USD Sales Feb/06|3340|LC Sales Feb/06|79464|Units Feb/06|1680|DOT Feb/06|5040
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Mar/06|3117|USD Sales Mar/06|3747|LC Sales Mar/06|89255|Units Mar/06|1887|DOT Mar/06|5661
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Apr/06|2860|USD Sales Apr/06|3508|LC Sales Apr/06|81545|Units Apr/06|1724|DOT Apr/06|5172
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales May/06|3321|USD Sales May/06|4239|LC Sales May/06|93891|Units May/06|1985|DOT May/06|5955
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jun/06|3179|USD Sales Jun/06|4025|LC Sales Jun/06|90201|Units Jun/06|1907|DOT Jun/06|5721
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Jul/06|2347|USD Sales Jul/06|2978|LC Sales Jul/06|66759|Units Jul/06|1445|DOT Jul/06|4335
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Aug/06|3087|USD Sales Aug/06|3954|LC Sales Aug/06|87032|Units Aug/06|1840|DOT Aug/06|5520
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Sep/06|2410|USD Sales Sep/06|3069|LC Sales Sep/06|68396|Units Sep/06|1446|DOT Sep/06|4338
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|TEVA*|TEVA|IVAX CR|ANACID|0000|SUSP 30 5 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1990|1990/01|3.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|63|47.3|66.1|EURO Sales Oct/06|3061|USD Sales Oct/06|3861|LC Sales Oct/06|86559|Units Oct/06|1830|DOT Oct/06|5490
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Apr/02|45|USD Sales Apr/02|40|LC Sales Apr/02|1372|Units Apr/02|36|DOT Apr/02|108
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales May/02|4|USD Sales May/02|3|LC Sales May/02|114|Units May/02|3|DOT May/02|9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jun/02|9|USD Sales Jun/02|8|LC Sales Jun/02|267|Units Jun/02|7|DOT Jun/02|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jul/02|4|USD Sales Jul/02|4|LC Sales Jul/02|114|Units Jul/02|3|DOT Jul/02|9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Sep/02|3|USD Sales Sep/02|2|LC Sales Sep/02|76|Units Sep/02|2|DOT Sep/02|6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Oct/02|16|USD Sales Oct/02|16|LC Sales Oct/02|494|Units Oct/02|13|DOT Oct/02|39
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Nov/02|10|USD Sales Nov/02|10|LC Sales Nov/02|304|Units Nov/02|8|DOT Nov/02|24
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Dec/02|24|USD Sales Dec/02|25|LC Sales Dec/02|760|Units Dec/02|20|DOT Dec/02|60
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jan/03|22|USD Sales Jan/03|23|LC Sales Jan/03|684|Units Jan/03|18|DOT Jan/03|54
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Feb/03|14|USD Sales Feb/03|16|LC Sales Feb/03|456|Units Feb/03|12|DOT Feb/03|36
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Mar/03|8|USD Sales Mar/03|9|LC Sales Mar/03|266|Units Mar/03|7|DOT Mar/03|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Apr/03|8|USD Sales Apr/03|9|LC Sales Apr/03|266|Units Apr/03|7|DOT Apr/03|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales May/03|1|USD Sales May/03|1|LC Sales May/03|38|Units May/03|1|DOT May/03|3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jun/03|4|USD Sales Jun/03|4|LC Sales Jun/03|113|Units Jun/03|3|DOT Jun/03|9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jul/03|5|USD Sales Jul/03|6|LC Sales Jul/03|171|Units Jul/03|5|DOT Jul/03|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Aug/03|6|USD Sales Aug/03|7|LC Sales Aug/03|205|Units Aug/03|6|DOT Aug/03|18
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Sep/03|7|USD Sales Sep/03|8|LC Sales Sep/03|239|Units Sep/03|7|DOT Sep/03|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Oct/03|14|USD Sales Oct/03|16|LC Sales Oct/03|443|Units Oct/03|13|DOT Oct/03|39
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Nov/03|3|USD Sales Nov/03|4|LC Sales Nov/03|102|Units Nov/03|3|DOT Nov/03|9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Dec/03|3|USD Sales Dec/03|4|LC Sales Dec/03|102|Units Dec/03|3|DOT Dec/03|9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jan/04|4|USD Sales Jan/04|5|LC Sales Jan/04|136|Units Jan/04|4|DOT Jan/04|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Feb/04|9|USD Sales Feb/04|12|LC Sales Feb/04|307|Units Feb/04|9|DOT Feb/04|27
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Mar/04|1|USD Sales Mar/04|1|LC Sales Mar/04|34|Units Mar/04|1|DOT Mar/04|3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Apr/04|9|USD Sales Apr/04|11|LC Sales Apr/04|307|Units Apr/04|9|DOT Apr/04|27
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales May/04|3|USD Sales May/04|4|LC Sales May/04|102|Units May/04|3|DOT May/04|9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jun/04|4|USD Sales Jun/04|5|LC Sales Jun/04|136|Units Jun/04|4|DOT Jun/04|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jul/04|4|USD Sales Jul/04|5|LC Sales Jul/04|131|Units Jul/04|4|DOT Jul/04|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Aug/04|2|USD Sales Aug/04|3|LC Sales Aug/04|65|Units Aug/04|2|DOT Aug/04|6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Sep/04|2|USD Sales Sep/04|3|LC Sales Sep/04|65|Units Sep/04|2|DOT Sep/04|6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Oct/04|5|USD Sales Oct/04|6|LC Sales Oct/04|163|Units Oct/04|5|DOT Oct/04|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Nov/04|2|USD Sales Nov/04|3|LC Sales Nov/04|65|Units Nov/04|2|DOT Nov/04|6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Dec/04|4|USD Sales Dec/04|6|LC Sales Dec/04|129|Units Dec/04|4|DOT Dec/04|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jan/05|2|USD Sales Jan/05|3|LC Sales Jan/05|59|Units Jan/05|2|DOT Jan/05|6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Feb/05|3|USD Sales Feb/05|4|LC Sales Feb/05|83|Units Feb/05|3|DOT Feb/05|9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Mar/05|3|USD Sales Mar/05|4|LC Sales Mar/05|89|Units Mar/05|3|DOT Mar/05|9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Apr/05|2|USD Sales Apr/05|2|LC Sales Apr/05|57|Units Apr/05|2|DOT Apr/05|6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales May/05|4|USD Sales May/05|5|LC Sales May/05|116|Units May/05|4|DOT May/05|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Aug/05|7|USD Sales Aug/05|9|LC Sales Aug/05|215|Units Aug/05|10|DOT Aug/05|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Sep/05|33|USD Sales Sep/05|40|LC Sales Sep/05|968|Units Sep/05|45|DOT Sep/05|135
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Oct/05|33|USD Sales Oct/05|39|LC Sales Oct/05|968|Units Oct/05|45|DOT Oct/05|135
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Nov/05|18|USD Sales Nov/05|22|LC Sales Nov/05|538|Units Nov/05|25|DOT Nov/05|75
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Dec/05|46|USD Sales Dec/05|55|LC Sales Dec/05|1333|Units Dec/05|62|DOT Dec/05|186
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jan/06|15|USD Sales Jan/06|18|LC Sales Jan/06|422|Units Jan/06|17|DOT Jan/06|51
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Feb/06|2|USD Sales Feb/06|3|LC Sales Feb/06|64|Units Feb/06|2|DOT Feb/06|6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|VALEANT PHARMA*|VALEANT PHARMA|ICN ALKALOIDA|TISADYNE|0500MG|TABS 500 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|2002|2002/04|3.00|10.00 DF|MONO|ALUMINIUM AND MAGNESIUM|64|38|51.4|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jul/02|19|USD Sales Jul/02|19|LC Sales Jul/02|568|Units Jul/02|13|DOT Jul/02|52
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Aug/02|1|USD Sales Aug/02|1|LC Sales Aug/02|44|Units Aug/02|1|DOT Aug/02|4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Sep/02|6|USD Sales Sep/02|6|LC Sales Sep/02|175|Units Sep/02|4|DOT Sep/02|16
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Oct/02|34|USD Sales Oct/02|34|LC Sales Oct/02|1049|Units Oct/02|24|DOT Oct/02|96
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jan/03|3|USD Sales Jan/03|3|LC Sales Jan/03|87|Units Jan/03|2|DOT Jan/03|8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Feb/03|4|USD Sales Feb/03|4|LC Sales Feb/03|131|Units Feb/03|3|DOT Feb/03|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jun/03|1|USD Sales Jun/03|2|LC Sales Jun/03|44|Units Jun/03|1|DOT Jun/03|4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 20 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/03|4.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|65|44.3|60|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jul/02|7|USD Sales Jul/02|7|LC Sales Jul/02|207|Units Jul/02|4|DOT Jul/02|24
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Oct/02|25|USD Sales Oct/02|25|LC Sales Oct/02|776|Units Oct/02|15|DOT Oct/02|90
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Nov/02|8|USD Sales Nov/02|8|LC Sales Nov/02|259|Units Nov/02|5|DOT Nov/02|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Dec/02|3|USD Sales Dec/02|3|LC Sales Dec/02|103|Units Dec/02|2|DOT Dec/02|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jan/03|3|USD Sales Jan/03|3|LC Sales Jan/03|103|Units Jan/03|2|DOT Jan/03|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Feb/03|11|USD Sales Feb/03|12|LC Sales Feb/03|362|Units Feb/03|7|DOT Feb/03|42
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Mar/03|3|USD Sales Mar/03|4|LC Sales Mar/03|103|Units Mar/03|2|DOT Mar/03|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Apr/03|3|USD Sales Apr/03|4|LC Sales Apr/03|103|Units Apr/03|2|DOT Apr/03|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales May/03|2|USD Sales May/03|2|LC Sales May/03|52|Units May/03|1|DOT May/03|6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jun/03|2|USD Sales Jun/03|2|LC Sales Jun/03|52|Units Jun/03|1|DOT Jun/03|6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIDANON|0000|SUSP SACH 30 10 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|2002|2002/01|6.00|50.00 ML|COMBI|ALUMINIUM;MAGNESIUM|66|52.5|71|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales May/06|537|USD Sales May/06|686|LC Sales May/06|15187|Units May/06|767|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jun/06|650|USD Sales Jun/06|824|LC Sales Jun/06|18454|Units Jun/06|932|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Jul/06|93|USD Sales Jul/06|118|LC Sales Jul/06|2653|Units Jul/06|134|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Aug/06|323|USD Sales Aug/06|414|LC Sales Aug/06|9108|Units Aug/06|460|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Sep/06|330|USD Sales Sep/06|420|LC Sales Sep/06|9365|Units Sep/06|473|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|67|19.8|27.7|EURO Sales Oct/06|247|USD Sales Oct/06|312|LC Sales Oct/06|6989|Units Oct/06|353|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales May/06|635|USD Sales May/06|810|LC Sales May/06|17952|Units May/06|544|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jun/06|583|USD Sales Jun/06|738|LC Sales Jun/06|16533|Units Jun/06|501|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Jul/06|99|USD Sales Jul/06|125|LC Sales Jul/06|2805|Units Jul/06|85|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Aug/06|385|USD Sales Aug/06|493|LC Sales Aug/06|10857|Units Aug/06|329|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Sep/06|336|USD Sales Sep/06|428|LC Sales Sep/06|9537|Units Sep/06|289|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|ACIX|0000|TABS CHEW 40|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|2006|2006/04|0.00|0.00|COMBI|ALUMINIUM;MAGNESIUM|68|33|46.1|EURO Sales Oct/06|155|USD Sales Oct/06|196|LC Sales Oct/06|4389|Units Oct/06|133|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Nov/01|729|USD Sales Nov/01|647|LC Sales Nov/01|24219|Units Nov/01|897|DOT Nov/01|4485
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Dec/01|826|USD Sales Dec/01|738|LC Sales Dec/01|26781|Units Dec/01|981|DOT Dec/01|4905
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jan/02|1074|USD Sales Jan/02|949|LC Sales Jan/02|34469|Units Jan/02|1258|DOT Jan/02|6290
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Feb/02|986|USD Sales Feb/02|858|LC Sales Feb/02|31313|Units Feb/02|1147|DOT Feb/02|5735
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Mar/02|901|USD Sales Mar/02|788|LC Sales Mar/02|28249|Units Mar/02|1031|DOT Mar/02|5155
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Apr/02|976|USD Sales Apr/02|864|LC Sales Apr/02|29647|Units Apr/02|1082|DOT Apr/02|5410
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales May/02|993|USD Sales May/02|911|LC Sales May/02|30387|Units May/02|1109|DOT May/02|5545
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jun/02|821|USD Sales Jun/02|784|LC Sales Jun/02|24851|Units Jun/02|917|DOT Jun/02|4585
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jul/02|931|USD Sales Jul/02|923|LC Sales Jul/02|27729|Units Jul/02|1027|DOT Jul/02|5135
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Aug/02|724|USD Sales Aug/02|708|LC Sales Aug/02|22313|Units Aug/02|842|DOT Aug/02|4210
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Sep/02|947|USD Sales Sep/02|929|LC Sales Sep/02|28595|Units Sep/02|1075|DOT Sep/02|5375
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Oct/02|953|USD Sales Oct/02|935|LC Sales Oct/02|29180|Units Oct/02|1097|DOT Oct/02|5485
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Nov/02|647|USD Sales Nov/02|648|LC Sales Nov/02|19870|Units Nov/02|747|DOT Nov/02|3735
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Dec/02|333|USD Sales Dec/02|339|LC Sales Dec/02|10368|Units Dec/02|384|DOT Dec/02|1920
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jan/03|1543|USD Sales Jan/03|1639|LC Sales Jan/03|48546|Units Jan/03|1798|DOT Jan/03|8990
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Feb/03|815|USD Sales Feb/03|878|LC Sales Feb/03|25758|Units Feb/03|954|DOT Feb/03|4770
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Mar/03|706|USD Sales Mar/03|762|LC Sales Mar/03|22383|Units Mar/03|829|DOT Mar/03|4145
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Apr/03|771|USD Sales Apr/03|836|LC Sales Apr/03|24381|Units Apr/03|903|DOT Apr/03|4515
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales May/03|659|USD Sales May/03|763|LC Sales May/03|20682|Units May/03|766|DOT May/03|3830
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jun/03|665|USD Sales Jun/03|775|LC Sales Jun/03|20871|Units Jun/03|773|DOT Jun/03|3865
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jul/03|700|USD Sales Jul/03|796|LC Sales Jul/03|22276|Units Jul/03|822|DOT Jul/03|4110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Aug/03|598|USD Sales Aug/03|666|LC Sales Aug/03|19295|Units Aug/03|712|DOT Aug/03|3560
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Sep/03|678|USD Sales Sep/03|760|LC Sales Sep/03|21951|Units Sep/03|810|DOT Sep/03|4050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Oct/03|754|USD Sales Oct/03|882|LC Sales Oct/03|24092|Units Oct/03|889|DOT Oct/03|4445
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Nov/03|605|USD Sales Nov/03|708|LC Sales Nov/03|19349|Units Nov/03|714|DOT Nov/03|3570
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Dec/03|802|USD Sales Dec/03|985|LC Sales Dec/03|25908|Units Dec/03|956|DOT Dec/03|4780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jan/04|713|USD Sales Jan/04|899|LC Sales Jan/04|23333|Units Jan/04|861|DOT Jan/04|4305
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Feb/04|662|USD Sales Feb/04|838|LC Sales Feb/04|21761|Units Feb/04|803|DOT Feb/04|4015
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Mar/04|779|USD Sales Mar/04|956|LC Sales Mar/04|25691|Units Mar/04|948|DOT Mar/04|4740
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Apr/04|734|USD Sales Apr/04|879|LC Sales Apr/04|23848|Units Apr/04|880|DOT Apr/04|4400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales May/04|772|USD Sales May/04|926|LC Sales May/04|24688|Units May/04|911|DOT May/04|4555
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jun/04|789|USD Sales Jun/04|957|LC Sales Jun/04|24932|Units Jun/04|920|DOT Jun/04|4600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jul/04|542|USD Sales Jul/04|665|LC Sales Jul/04|17100|Units Jul/04|631|DOT Jul/04|3155
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Aug/04|711|USD Sales Aug/04|866|LC Sales Aug/04|22493|Units Aug/04|830|DOT Aug/04|4150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Sep/04|708|USD Sales Sep/04|864|LC Sales Sep/04|22358|Units Sep/04|825|DOT Sep/04|4125
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Oct/04|639|USD Sales Oct/04|799|LC Sales Oct/04|20135|Units Oct/04|743|DOT Oct/04|3715
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Nov/04|694|USD Sales Nov/04|901|LC Sales Nov/04|21707|Units Nov/04|801|DOT Nov/04|4005
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Dec/04|782|USD Sales Dec/04|1047|LC Sales Dec/04|23956|Units Dec/04|884|DOT Dec/04|4420
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jan/05|806|USD Sales Jan/05|1058|LC Sales Jan/05|24417|Units Jan/05|901|DOT Jan/05|4505
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Feb/05|736|USD Sales Feb/05|958|LC Sales Feb/05|22059|Units Feb/05|814|DOT Feb/05|4070
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Mar/05|574|USD Sales Mar/05|759|LC Sales Mar/05|17100|Units Mar/05|631|DOT Mar/05|3155
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Apr/05|590|USD Sales Apr/05|764|LC Sales Apr/05|17778|Units Apr/05|656|DOT Apr/05|3280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales May/05|658|USD Sales May/05|834|LC Sales May/05|19891|Units May/05|734|DOT May/05|3670
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jun/05|610|USD Sales Jun/05|742|LC Sales Jun/05|18320|Units Jun/05|676|DOT Jun/05|3380
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jul/05|23|USD Sales Jul/05|28|LC Sales Jul/05|699|Units Jul/05|26|DOT Jul/05|130
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A1 PLAIN ANTACIDS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTROGEL|0500MG|TABS 500 MG 50|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|NON-RX BOUND|1969|1969/12|5.00|10.00 DF|MONO|MAGNESIUM|69|27|36.6|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Nov/01|69|USD Sales Nov/01|62|LC Sales Nov/01|2309|Units Nov/01|39|DOT Nov/01|160.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Dec/01|88|USD Sales Dec/01|79|LC Sales Dec/01|2861|Units Dec/01|48|DOT Dec/01|197.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jan/02|100|USD Sales Jan/02|89|LC Sales Jan/02|3218|Units Jan/02|54|DOT Jan/02|222.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Feb/02|109|USD Sales Feb/02|95|LC Sales Feb/02|3457|Units Feb/02|58|DOT Feb/02|238.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Mar/02|65|USD Sales Mar/02|57|LC Sales Mar/02|2026|Units Mar/02|34|DOT Mar/02|140
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Apr/02|100|USD Sales Apr/02|89|LC Sales Apr/02|3040|Units Apr/02|51|DOT Apr/02|210.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales May/02|115|USD Sales May/02|105|LC Sales May/02|3516|Units May/02|59|DOT May/02|243
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jun/02|128|USD Sales Jun/02|122|LC Sales Jun/02|3874|Units Jun/02|65|DOT Jun/02|267.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jul/02|108|USD Sales Jul/02|107|LC Sales Jul/02|3218|Units Jul/02|54|DOT Jul/02|222.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Aug/02|95|USD Sales Aug/02|93|LC Sales Aug/02|2920|Units Aug/02|49|DOT Aug/02|201.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Sep/02|94|USD Sales Sep/02|93|LC Sales Sep/02|2851|Units Sep/02|48|DOT Sep/02|197.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Oct/02|114|USD Sales Oct/02|112|LC Sales Oct/02|3481|Units Oct/02|59|DOT Oct/02|243
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Nov/02|73|USD Sales Nov/02|73|LC Sales Nov/02|2242|Units Nov/02|38|DOT Nov/02|156.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Dec/02|84|USD Sales Dec/02|86|LC Sales Dec/02|2622|Units Dec/02|44|DOT Dec/02|181.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jan/03|108|USD Sales Jan/03|115|LC Sales Jan/03|3397|Units Jan/03|57|DOT Jan/03|234.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Feb/03|111|USD Sales Feb/03|120|LC Sales Feb/03|3516|Units Feb/03|59|DOT Feb/03|243
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Mar/03|92|USD Sales Mar/03|99|LC Sales Mar/03|2916|Units Mar/03|49|DOT Mar/03|201.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Apr/03|119|USD Sales Apr/03|129|LC Sales Apr/03|3755|Units Apr/03|63|DOT Apr/03|259.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales May/03|55|USD Sales May/03|64|LC Sales May/03|1728|Units May/03|29|DOT May/03|119.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jun/03|118|USD Sales Jun/03|137|LC Sales Jun/03|3695|Units Jun/03|62|DOT Jun/03|255.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jul/03|75|USD Sales Jul/03|85|LC Sales Jul/03|2384|Units Jul/03|40|DOT Jul/03|164.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Aug/03|94|USD Sales Aug/03|104|LC Sales Aug/03|3024|Units Aug/03|51|DOT Aug/03|210.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Sep/03|125|USD Sales Sep/03|141|LC Sales Sep/03|4060|Units Sep/03|68|DOT Sep/03|280.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Oct/03|71|USD Sales Oct/03|83|LC Sales Oct/03|2265|Units Oct/03|38|DOT Oct/03|156.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Nov/03|121|USD Sales Nov/03|141|LC Sales Nov/03|3855|Units Nov/03|65|DOT Nov/03|267.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Dec/03|99|USD Sales Dec/03|122|LC Sales Dec/03|3202|Units Dec/03|54|DOT Dec/03|222.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jan/04|109|USD Sales Jan/04|138|LC Sales Jan/04|3582|Units Jan/04|60|DOT Jan/04|247.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Feb/04|126|USD Sales Feb/04|159|LC Sales Feb/04|4126|Units Feb/04|69|DOT Feb/04|284.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Mar/04|124|USD Sales Mar/04|152|LC Sales Mar/04|4073|Units Mar/04|68|DOT Mar/04|280.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Apr/04|155|USD Sales Apr/04|185|LC Sales Apr/04|5023|Units Apr/04|84|DOT Apr/04|346
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales May/04|147|USD Sales May/04|176|LC Sales May/04|4701|Units May/04|79|DOT May/04|325.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jun/04|148|USD Sales Jun/04|180|LC Sales Jun/04|4680|Units Jun/04|80|DOT Jun/04|329.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jul/04|86|USD Sales Jul/04|105|LC Sales Jul/04|2705|Units Jul/04|46|DOT Jul/04|189.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Aug/04|130|USD Sales Aug/04|158|LC Sales Aug/04|4102|Units Aug/04|70|DOT Aug/04|288.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Sep/04|128|USD Sales Sep/04|156|LC Sales Sep/04|4030|Units Sep/04|69|DOT Sep/04|284.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Oct/04|189|USD Sales Oct/04|235|LC Sales Oct/04|5936|Units Oct/04|102|DOT Oct/04|420.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Nov/04|574|USD Sales Nov/04|745|LC Sales Nov/04|17949|Units Nov/04|310|DOT Nov/04|1277.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Dec/04|171|USD Sales Dec/04|230|LC Sales Dec/04|5251|Units Dec/04|91|DOT Dec/04|374.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jan/05|129|USD Sales Jan/05|169|LC Sales Jan/05|3896|Units Jan/05|68|DOT Jan/05|280.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Feb/05|199|USD Sales Feb/05|258|LC Sales Feb/05|5949|Units Feb/05|104|DOT Feb/05|428.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Mar/05|198|USD Sales Mar/05|262|LC Sales Mar/05|5902|Units Mar/05|103|DOT Mar/05|424.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Apr/05|139|USD Sales Apr/05|180|LC Sales Apr/05|4190|Units Apr/05|73|DOT Apr/05|300.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales May/05|197|USD Sales May/05|250|LC Sales May/05|5949|Units May/05|104|DOT May/05|428.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jun/05|244|USD Sales Jun/05|297|LC Sales Jun/05|7340|Units Jun/05|129|DOT Jun/05|531.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jul/05|179|USD Sales Jul/05|215|LC Sales Jul/05|5396|Units Jul/05|95|DOT Jul/05|391.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Aug/05|258|USD Sales Aug/05|317|LC Sales Aug/05|7638|Units Aug/05|134|DOT Aug/05|552
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Sep/05|195|USD Sales Sep/05|240|LC Sales Sep/05|5730|Units Sep/05|100|DOT Sep/05|412
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Oct/05|137|USD Sales Oct/05|164|LC Sales Oct/05|4054|Units Oct/05|71|DOT Oct/05|292.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Nov/05|131|USD Sales Nov/05|154|LC Sales Nov/05|3826|Units Nov/05|67|DOT Nov/05|276
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Dec/05|4|USD Sales Dec/05|5|LC Sales Dec/05|114|Units Dec/05|2|DOT Dec/05|8.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Sep/06|94|USD Sales Sep/06|120|LC Sales Sep/06|2675|Units Sep/06|43|DOT Sep/06|177.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0000|SUSP 1 50 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1998|1998/03|4.12|0.50 G|MONO|SIMETICONE|70|62.6|87.4|EURO Sales Oct/06|38|USD Sales Oct/06|47|LC Sales Oct/06|1064|Units Oct/06|17|DOT Oct/06|70
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Nov/01|93|USD Sales Nov/01|83|LC Sales Nov/01|3089|Units Nov/01|67|DOT Nov/01|112.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Dec/01|72|USD Sales Dec/01|64|LC Sales Dec/01|2341|Units Dec/01|51|DOT Dec/01|85.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jan/02|101|USD Sales Jan/02|89|LC Sales Jan/02|3227|Units Jan/02|70|DOT Jan/02|117.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Feb/02|137|USD Sales Feb/02|119|LC Sales Feb/02|4343|Units Feb/02|93|DOT Feb/02|156.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Mar/02|84|USD Sales Mar/02|74|LC Sales Mar/02|2646|Units Mar/02|60|DOT Mar/02|100.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Apr/02|64|USD Sales Apr/02|57|LC Sales Apr/02|1958|Units Apr/02|51|DOT Apr/02|85.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales May/02|116|USD Sales May/02|106|LC Sales May/02|3553|Units May/02|93|DOT May/02|156.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jun/02|85|USD Sales Jun/02|81|LC Sales Jun/02|2564|Units Jun/02|68|DOT Jun/02|114.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jul/02|142|USD Sales Jul/02|141|LC Sales Jul/02|4226|Units Jul/02|113|DOT Jul/02|189.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Aug/02|121|USD Sales Aug/02|118|LC Sales Aug/02|3721|Units Aug/02|106|DOT Aug/02|178
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Sep/02|158|USD Sales Sep/02|155|LC Sales Sep/02|4776|Units Sep/02|143|DOT Sep/02|240.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Oct/02|121|USD Sales Oct/02|118|LC Sales Oct/02|3696|Units Oct/02|111|DOT Oct/02|186.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Nov/02|125|USD Sales Nov/02|125|LC Sales Nov/02|3832|Units Nov/02|119|DOT Nov/02|199.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Dec/02|146|USD Sales Dec/02|148|LC Sales Dec/02|4530|Units Dec/02|152|DOT Dec/02|255.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jan/03|150|USD Sales Jan/03|160|LC Sales Jan/03|4728|Units Jan/03|153|DOT Jan/03|257
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Feb/03|144|USD Sales Feb/03|155|LC Sales Feb/03|4560|Units Feb/03|152|DOT Feb/03|255.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Mar/03|134|USD Sales Mar/03|145|LC Sales Mar/03|4244|Units Mar/03|141|DOT Mar/03|236.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Apr/03|115|USD Sales Apr/03|124|LC Sales Apr/03|3627|Units Apr/03|117|DOT Apr/03|196.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales May/03|163|USD Sales May/03|189|LC Sales May/03|5119|Units May/03|143|DOT May/03|240.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jun/03|131|USD Sales Jun/03|153|LC Sales Jun/03|4114|Units Jun/03|110|DOT Jun/03|184.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jul/03|64|USD Sales Jul/03|73|LC Sales Jul/03|2035|Units Jul/03|48|DOT Jul/03|80.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Aug/03|148|USD Sales Aug/03|165|LC Sales Aug/03|4788|Units Aug/03|127|DOT Aug/03|213.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Sep/03|104|USD Sales Sep/03|117|LC Sales Sep/03|3376|Units Sep/03|92|DOT Sep/03|154.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Oct/03|169|USD Sales Oct/03|198|LC Sales Oct/03|5400|Units Oct/03|144|DOT Oct/03|241.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Nov/03|105|USD Sales Nov/03|123|LC Sales Nov/03|3346|Units Nov/03|89|DOT Nov/03|149.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Dec/03|75|USD Sales Dec/03|91|LC Sales Dec/03|2406|Units Dec/03|64|DOT Dec/03|107.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jan/04|121|USD Sales Jan/04|153|LC Sales Jan/04|3974|Units Jan/04|108|DOT Jan/04|181.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Feb/04|132|USD Sales Feb/04|167|LC Sales Feb/04|4329|Units Feb/04|117|DOT Feb/04|196.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Mar/04|156|USD Sales Mar/04|192|LC Sales Mar/04|5157|Units Mar/04|139|DOT Mar/04|233.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Apr/04|87|USD Sales Apr/04|104|LC Sales Apr/04|2820|Units Apr/04|76|DOT Apr/04|127.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales May/04|67|USD Sales May/04|81|LC Sales May/04|2148|Units May/04|59|DOT May/04|99.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jun/04|178|USD Sales Jun/04|216|LC Sales Jun/04|5621|Units Jun/04|157|DOT Jun/04|263.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jul/04|88|USD Sales Jul/04|108|LC Sales Jul/04|2772|Units Jul/04|77|DOT Jul/04|129.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Aug/04|126|USD Sales Aug/04|153|LC Sales Aug/04|3974|Units Aug/04|111|DOT Aug/04|186.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Sep/04|140|USD Sales Sep/04|171|LC Sales Sep/04|4428|Units Sep/04|123|DOT Sep/04|206.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Oct/04|124|USD Sales Oct/04|155|LC Sales Oct/04|3902|Units Oct/04|109|DOT Oct/04|183.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Nov/04|114|USD Sales Nov/04|148|LC Sales Nov/04|3554|Units Nov/04|99|DOT Nov/04|166.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Dec/04|108|USD Sales Dec/04|145|LC Sales Dec/04|3320|Units Dec/04|93|DOT Dec/04|156.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jan/05|152|USD Sales Jan/05|200|LC Sales Jan/05|4607|Units Jan/05|132|DOT Jan/05|221.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Feb/05|208|USD Sales Feb/05|271|LC Sales Feb/05|6228|Units Feb/05|180|DOT Feb/05|302.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Mar/05|245|USD Sales Mar/05|324|LC Sales Mar/05|7292|Units Mar/05|202|DOT Mar/05|339.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Apr/05|223|USD Sales Apr/05|289|LC Sales Apr/05|6728|Units Apr/05|189|DOT Apr/05|317.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales May/05|278|USD Sales May/05|353|LC Sales May/05|8411|Units May/05|233|DOT May/05|391.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jun/05|213|USD Sales Jun/05|260|LC Sales Jun/05|6408|Units Jun/05|178|DOT Jun/05|299
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jul/05|141|USD Sales Jul/05|170|LC Sales Jul/05|4260|Units Jul/05|118|DOT Jul/05|198.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Aug/05|110|USD Sales Aug/05|135|LC Sales Aug/05|3249|Units Aug/05|90|DOT Aug/05|151.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Sep/05|278|USD Sales Sep/05|341|LC Sales Sep/05|8154|Units Sep/05|224|DOT Sep/05|376.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Oct/05|128|USD Sales Oct/05|154|LC Sales Oct/05|3812|Units Oct/05|105|DOT Oct/05|176.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Nov/05|113|USD Sales Nov/05|133|LC Sales Nov/05|3312|Units Nov/05|91|DOT Nov/05|152.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Dec/05|1|USD Sales Dec/05|1|LC Sales Dec/05|36|Units Dec/05|1|DOT Dec/05|1.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Sep/06|126|USD Sales Sep/06|160|LC Sales Sep/06|3564|Units Sep/06|90|DOT Sep/06|151.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|BAYER*|BAYER|ASCHE|LEFAX|0042MG|TABS CHEW 42 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1998|1998/03|1.68|0.50 G|MONO|SIMETICONE|71|39.7|55.4|EURO Sales Oct/06|73|USD Sales Oct/06|92|LC Sales Oct/06|2064|Units Oct/06|52|DOT Oct/06|87.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales May/02|8|USD Sales May/02|7|LC Sales May/02|239|Units May/02|4|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jul/02|6|USD Sales Jul/02|6|LC Sales Jul/02|179|Units Jul/02|3|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Aug/02|6|USD Sales Aug/02|6|LC Sales Aug/02|197|Units Aug/02|3|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Nov/02|4|USD Sales Nov/02|4|LC Sales Nov/02|129|Units Nov/02|2|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Dec/02|4|USD Sales Dec/02|4|LC Sales Dec/02|120|Units Dec/02|2|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jan/03|2|USD Sales Jan/03|2|LC Sales Jan/03|68|Units Jan/03|1|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Feb/03|4|USD Sales Feb/03|5|LC Sales Feb/03|135|Units Feb/03|2|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Mar/03|2|USD Sales Mar/03|2|LC Sales Mar/03|60|Units Mar/03|1|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Apr/03|13|USD Sales Apr/03|14|LC Sales Apr/03|419|Units Apr/03|7|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales May/03|6|USD Sales May/03|7|LC Sales May/03|179|Units May/03|3|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Aug/03|7|USD Sales Aug/03|8|LC Sales Aug/03|239|Units Aug/03|4|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jan/04|38|USD Sales Jan/04|48|LC Sales Jan/04|1256|Units Jan/04|21|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Feb/04|9|USD Sales Feb/04|12|LC Sales Feb/04|299|Units Feb/04|5|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Mar/04|4|USD Sales Mar/04|4|LC Sales Mar/04|120|Units Mar/04|2|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Apr/04|28|USD Sales Apr/04|33|LC Sales Apr/04|897|Units Apr/04|15|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales May/04|26|USD Sales May/04|31|LC Sales May/04|837|Units May/04|14|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jun/04|40|USD Sales Jun/04|48|LC Sales Jun/04|1256|Units Jun/04|21|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jul/04|23|USD Sales Jul/04|28|LC Sales Jul/04|718|Units Jul/04|12|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Aug/04|4|USD Sales Aug/04|5|LC Sales Aug/04|120|Units Aug/04|2|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Sep/04|4|USD Sales Sep/04|5|LC Sales Sep/04|120|Units Sep/04|2|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Oct/04|15|USD Sales Oct/04|19|LC Sales Oct/04|478|Units Oct/04|8|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Nov/04|17|USD Sales Nov/04|22|LC Sales Nov/04|539|Units Nov/04|9|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Dec/04|10|USD Sales Dec/04|13|LC Sales Dec/04|300|Units Dec/04|5|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jan/05|4|USD Sales Jan/05|5|LC Sales Jan/05|120|Units Jan/05|2|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Feb/05|2|USD Sales Feb/05|3|LC Sales Feb/05|61|Units Feb/05|1|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Mar/05|6|USD Sales Mar/05|8|LC Sales Mar/05|183|Units Mar/05|3|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales May/05|4|USD Sales May/05|5|LC Sales May/05|121|Units May/05|2|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jun/05|2|USD Sales Jun/05|2|LC Sales Jun/05|60|Units Jun/05|1|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jul/05|6|USD Sales Jul/05|7|LC Sales Jul/05|182|Units Jul/05|3|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Aug/05|4|USD Sales Aug/05|5|LC Sales Aug/05|120|Units Aug/05|2|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Sep/05|10|USD Sales Sep/05|13|LC Sales Sep/05|301|Units Sep/05|5|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Oct/05|6|USD Sales Oct/05|8|LC Sales Oct/05|189|Units Oct/05|3|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Dec/05|7|USD Sales Dec/05|8|LC Sales Dec/05|196|Units Dec/05|3|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jan/06|5|USD Sales Jan/06|5|LC Sales Jan/06|130|Units Jan/06|2|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Feb/06|2|USD Sales Feb/06|3|LC Sales Feb/06|65|Units Feb/06|1|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales May/06|5|USD Sales May/06|6|LC Sales May/06|130|Units May/06|2|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Jul/06|5|USD Sales Jul/06|6|LC Sales Jul/06|130|Units Jul/06|2|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Sep/06|2|USD Sales Sep/06|3|LC Sales Sep/06|65|Units Sep/06|1|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|C.S.C PRAHA|C.S.C PRAHA|C.S.C PRAHA|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1997|1997/09|0.00|0.00|MONO|ANTIFLATULENTS|72|65.1|90.9|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Feb/05|38|USD Sales Feb/05|50|LC Sales Feb/05|1148|Units Feb/05|20|DOT Feb/05|160
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 100|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1984|1984/01|8.00|0.50 G|MONO|SIMETICONE|73|58.7|79.5|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Nov/01|2324|USD Sales Nov/01|2065|LC Sales Nov/01|77256|Units Nov/01|1332|DOT Nov/01|5328
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Dec/01|1965|USD Sales Dec/01|1754|LC Sales Dec/01|63684|Units Dec/01|1098|DOT Dec/01|4392
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jan/02|2885|USD Sales Jan/02|2548|LC Sales Jan/02|92568|Units Jan/02|1596|DOT Jan/02|6384
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Feb/02|2585|USD Sales Feb/02|2248|LC Sales Feb/02|82070|Units Feb/02|1415|DOT Feb/02|5660
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Mar/02|2433|USD Sales Mar/02|2130|LC Sales Mar/02|76328|Units Mar/02|1316|DOT Mar/02|5264
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Apr/02|2700|USD Sales Apr/02|2391|LC Sales Apr/02|82012|Units Apr/02|1414|DOT Apr/02|5656
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales May/02|2566|USD Sales May/02|2354|LC Sales May/02|78532|Units May/02|1354|DOT May/02|5416
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jun/02|2493|USD Sales Jun/02|2382|LC Sales Jun/02|75498|Units Jun/02|1313|DOT Jun/02|5252
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jul/02|3976|USD Sales Jul/02|3944|LC Sales Jul/02|118461|Units Jul/02|2071|DOT Jul/02|8284
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Aug/02|3119|USD Sales Aug/02|3048|LC Sales Aug/02|96099|Units Aug/02|1683|DOT Aug/02|6732
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Sep/02|3300|USD Sales Sep/02|3235|LC Sales Sep/02|99640|Units Sep/02|1745|DOT Sep/02|6980
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Oct/02|4125|USD Sales Oct/02|4045|LC Sales Oct/02|126248|Units Oct/02|2211|DOT Oct/02|8844
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Nov/02|3592|USD Sales Nov/02|3596|LC Sales Nov/02|110339|Units Nov/02|1929|DOT Nov/02|7716
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Dec/02|3523|USD Sales Dec/02|3580|LC Sales Dec/02|109595|Units Dec/02|1916|DOT Dec/02|7664
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jan/03|4387|USD Sales Jan/03|4660|LC Sales Jan/03|138024|Units Jan/03|2413|DOT Jan/03|9652
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Feb/03|3200|USD Sales Feb/03|3449|LC Sales Feb/03|101187|Units Feb/03|1769|DOT Feb/03|7076
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Mar/03|2839|USD Sales Mar/03|3067|LC Sales Mar/03|90047|Units Mar/03|1577|DOT Mar/03|6308
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Apr/03|4355|USD Sales Apr/03|4723|LC Sales Apr/03|137680|Units Apr/03|2407|DOT Apr/03|9628
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales May/03|3400|USD Sales May/03|3933|LC Sales May/03|106678|Units May/03|1865|DOT May/03|7460
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jun/03|2835|USD Sales Jun/03|3306|LC Sales Jun/03|89034|Units Jun/03|1562|DOT Jun/03|6248
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jul/03|3399|USD Sales Jul/03|3865|LC Sales Jul/03|108224|Units Jul/03|1902|DOT Jul/03|7608
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Aug/03|3088|USD Sales Aug/03|3439|LC Sales Aug/03|99632|Units Aug/03|1751|DOT Aug/03|7004
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Sep/03|3572|USD Sales Sep/03|4001|LC Sales Sep/03|115621|Units Sep/03|2032|DOT Sep/03|8128
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Oct/03|3402|USD Sales Oct/03|3980|LC Sales Oct/03|108751|Units Oct/03|1918|DOT Oct/03|7672
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Nov/03|3580|USD Sales Nov/03|4189|LC Sales Nov/03|114426|Units Nov/03|2011|DOT Nov/03|8044
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Dec/03|3227|USD Sales Dec/03|3960|LC Sales Dec/03|104184|Units Dec/03|1831|DOT Dec/03|7324
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jan/04|3512|USD Sales Jan/04|4430|LC Sales Jan/04|114938|Units Jan/04|2020|DOT Jan/04|8080
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Feb/04|3241|USD Sales Feb/04|4098|LC Sales Feb/04|106460|Units Feb/04|1871|DOT Feb/04|7484
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Mar/04|4023|USD Sales Mar/04|4936|LC Sales Mar/04|132634|Units Mar/04|2331|DOT Mar/04|9324
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Apr/04|3523|USD Sales Apr/04|4223|LC Sales Apr/04|114540|Units Apr/04|2013|DOT Apr/04|8052
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales May/04|3498|USD Sales May/04|4199|LC Sales May/04|111922|Units May/04|1967|DOT May/04|7868
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jun/04|3530|USD Sales Jun/04|4284|LC Sales Jun/04|111581|Units Jun/04|1961|DOT Jun/04|7844
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jul/04|2850|USD Sales Jul/04|3496|LC Sales Jul/04|89904|Units Jul/04|1569|DOT Jul/04|6276
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Aug/04|3528|USD Sales Aug/04|4297|LC Sales Aug/04|111586|Units Aug/04|1944|DOT Aug/04|7776
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Sep/04|8807|USD Sales Sep/04|10757|LC Sales Sep/04|278275|Units Sep/04|4848|DOT Sep/04|19392
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Oct/04|9421|USD Sales Oct/04|11767|LC Sales Oct/04|296643|Units Oct/04|5168|DOT Oct/04|20672
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Nov/04|8649|USD Sales Nov/04|11234|LC Sales Nov/04|270628|Units Nov/04|4723|DOT Nov/04|18892
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Dec/04|7659|USD Sales Dec/04|10261|LC Sales Dec/04|234758|Units Dec/04|4097|DOT Dec/04|16388
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jan/05|7771|USD Sales Jan/05|10203|LC Sales Jan/05|235512|Units Jan/05|4103|DOT Jan/05|16412
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Feb/05|7531|USD Sales Feb/05|9804|LC Sales Feb/05|225697|Units Feb/05|3932|DOT Feb/05|15728
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Mar/05|9062|USD Sales Mar/05|11969|LC Sales Mar/05|269780|Units Mar/05|4700|DOT Mar/05|18800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Apr/05|8421|USD Sales Apr/05|10897|LC Sales Apr/05|253651|Units Apr/05|4419|DOT Apr/05|17676
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales May/05|7892|USD Sales May/05|10013|LC Sales May/05|238669|Units May/05|4158|DOT May/05|16632
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jun/05|7655|USD Sales Jun/05|9312|LC Sales Jun/05|229887|Units Jun/05|4005|DOT Jun/05|16020
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jul/05|5973|USD Sales Jul/05|7192|LC Sales Jul/05|180236|Units Jul/05|3140|DOT Jul/05|12560
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Aug/05|6798|USD Sales Aug/05|8358|LC Sales Aug/05|201130|Units Aug/05|3504|DOT Aug/05|14016
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Sep/05|6938|USD Sales Sep/05|8503|LC Sales Sep/05|203368|Units Sep/05|3543|DOT Sep/05|14172
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Oct/05|7309|USD Sales Oct/05|8788|LC Sales Oct/05|216915|Units Oct/05|3779|DOT Oct/05|15116
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Nov/05|8357|USD Sales Nov/05|9849|LC Sales Nov/05|244581|Units Nov/05|4261|DOT Nov/05|17044
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Dec/05|8903|USD Sales Dec/05|10559|LC Sales Dec/05|257796|Units Dec/05|4620|DOT Dec/05|18480
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jan/06|9607|USD Sales Jan/06|11629|LC Sales Jan/06|275900|Units Jan/06|4815|DOT Jan/06|19260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Feb/06|9419|USD Sales Feb/06|11253|LC Sales Feb/06|267763|Units Feb/06|4673|DOT Feb/06|18692
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Mar/06|17011|USD Sales Mar/06|20454|LC Sales Mar/06|487165|Units Mar/06|8502|DOT Mar/06|34008
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Apr/06|11977|USD Sales Apr/06|14687|LC Sales Apr/06|341451|Units Apr/06|5959|DOT Apr/06|23836
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales May/06|11047|USD Sales May/06|14102|LC Sales May/06|312342|Units May/06|5451|DOT May/06|21804
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jun/06|11260|USD Sales Jun/06|14261|LC Sales Jun/06|319546|Units Jun/06|5696|DOT Jun/06|22784
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Jul/06|5583|USD Sales Jul/06|7084|LC Sales Jul/06|158821|Units Jul/06|2826|DOT Jul/06|11304
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Aug/06|8506|USD Sales Aug/06|10897|LC Sales Aug/06|239828|Units Aug/06|4275|DOT Aug/06|17100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Sep/06|10993|USD Sales Sep/06|14000|LC Sales Sep/06|312026|Units Sep/06|5436|DOT Sep/06|21744
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|CAPS 40 MG 50|A ORAL SOLID ORDINARY|AC ORAL S ORD CAPSULES|ACA ORAL S ORD CAPSULES|NON-RX BOUND|1992|1992/01|4.00|0.50 G|MONO|SIMETICONE|74|57.4|80.2|EURO Sales Oct/06|11124|USD Sales Oct/06|14035|LC Sales Oct/06|314609|Units Oct/06|5481|DOT Oct/06|21924
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MENARINI*|MENARINI|BERLIN-CH/MENARINI|ESPUMISAN|0040MG|SYRUP 40 MG 1 100 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGM ORAL L ORD SYRUPS|NON-RX BOUND|1994|1994/10|1.60|0.50 G|MONO|SIMETICONE|75|36.2|49|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Nov/01|6|USD Sales Nov/01|5|LC Sales Nov/01|185|Units Nov/01|4|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Dec/01|3|USD Sales Dec/01|3|LC Sales Dec/01|93|Units Dec/01|2|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jan/02|11|USD Sales Jan/02|10|LC Sales Jan/02|367|Units Jan/02|8|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Feb/02|6|USD Sales Feb/02|5|LC Sales Feb/02|182|Units Feb/02|4|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Mar/02|1|USD Sales Mar/02|1|LC Sales Mar/02|44|Units Mar/02|1|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Apr/02|1|USD Sales Apr/02|1|LC Sales Apr/02|39|Units Apr/02|1|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales May/02|7|USD Sales May/02|7|LC Sales May/02|227|Units May/02|5|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jun/02|4|USD Sales Jun/02|4|LC Sales Jun/02|136|Units Jun/02|3|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jul/02|8|USD Sales Jul/02|8|LC Sales Jul/02|228|Units Jul/02|5|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Aug/02|6|USD Sales Aug/02|6|LC Sales Aug/02|182|Units Aug/02|4|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Sep/02|5|USD Sales Sep/02|4|LC Sales Sep/02|136|Units Sep/02|3|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Oct/02|3|USD Sales Oct/02|3|LC Sales Oct/02|91|Units Oct/02|2|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Nov/02|7|USD Sales Nov/02|7|LC Sales Nov/02|227|Units Nov/02|5|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Dec/02|13|USD Sales Dec/02|13|LC Sales Dec/02|409|Units Dec/02|9|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jan/03|17|USD Sales Jan/03|18|LC Sales Jan/03|545|Units Jan/03|12|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Feb/03|22|USD Sales Feb/03|23|LC Sales Feb/03|681|Units Feb/03|15|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Mar/03|42|USD Sales Mar/03|45|LC Sales Mar/03|1317|Units Mar/03|29|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Apr/03|19|USD Sales Apr/03|20|LC Sales Apr/03|590|Units Apr/03|13|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales May/03|46|USD Sales May/03|54|LC Sales May/03|1453|Units May/03|32|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jun/03|35|USD Sales Jun/03|40|LC Sales Jun/03|1090|Units Jun/03|24|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jul/03|16|USD Sales Jul/03|18|LC Sales Jul/03|499|Units Jul/03|11|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Aug/03|17|USD Sales Aug/03|19|LC Sales Aug/03|545|Units Aug/03|12|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Sep/03|7|USD Sales Sep/03|8|LC Sales Sep/03|227|Units Sep/03|5|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Oct/03|12|USD Sales Oct/03|14|LC Sales Oct/03|390|Units Oct/03|13|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Nov/03|9|USD Sales Nov/03|11|LC Sales Nov/03|300|Units Nov/03|10|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Dec/03|2|USD Sales Dec/03|2|LC Sales Dec/03|60|Units Dec/03|2|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jan/04|1|USD Sales Jan/04|1|LC Sales Jan/04|30|Units Jan/04|1|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Mar/04|11|USD Sales Mar/04|14|LC Sales Mar/04|363|Units Mar/04|8|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Apr/04|8|USD Sales Apr/04|10|LC Sales Apr/04|272|Units Apr/04|6|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales May/04|10|USD Sales May/04|12|LC Sales May/04|318|Units May/04|7|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jun/04|10|USD Sales Jun/04|12|LC Sales Jun/04|318|Units Jun/04|7|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jul/04|7|USD Sales Jul/04|9|LC Sales Jul/04|227|Units Jul/04|5|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Aug/04|40|USD Sales Aug/04|49|LC Sales Aug/04|1271|Units Aug/04|28|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Sep/04|22|USD Sales Sep/04|26|LC Sales Sep/04|681|Units Sep/04|15|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Oct/04|16|USD Sales Oct/04|20|LC Sales Oct/04|499|Units Oct/04|11|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Nov/04|15|USD Sales Nov/04|19|LC Sales Nov/04|454|Units Nov/04|10|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Dec/04|21|USD Sales Dec/04|28|LC Sales Dec/04|636|Units Dec/04|14|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jan/05|7|USD Sales Jan/05|10|LC Sales Jan/05|227|Units Jan/05|5|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Feb/05|32|USD Sales Feb/05|41|LC Sales Feb/05|953|Units Feb/05|21|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Mar/05|9|USD Sales Mar/05|12|LC Sales Mar/05|272|Units Mar/05|6|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Apr/05|17|USD Sales Apr/05|21|LC Sales Apr/05|499|Units Apr/05|11|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales May/05|11|USD Sales May/05|13|LC Sales May/05|318|Units May/05|7|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jun/05|12|USD Sales Jun/05|15|LC Sales Jun/05|363|Units Jun/05|8|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jul/05|5|USD Sales Jul/05|5|LC Sales Jul/05|136|Units Jul/05|3|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Nov/05|19|USD Sales Nov/05|22|LC Sales Nov/05|545|Units Nov/05|12|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|MVM MEDICAMENTA|MVM MEDICAMENTA|MVM MEDICAMENTA|AQUA CARMINATIVA|0000|SOLUT. 1 1 L|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|RX BOUND|1990|1990/01|0.00|0.00|MONO|ANTIFLATULENTS|76|45.4|61.4|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Nov/01|378|USD Sales Nov/01|336|LC Sales Nov/01|12563|Units Nov/01|297|DOT Nov/01|950.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Dec/01|279|USD Sales Dec/01|249|LC Sales Dec/01|9052|Units Dec/01|212|DOT Dec/01|678.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jan/02|391|USD Sales Jan/02|345|LC Sales Jan/02|12538|Units Jan/02|295|DOT Jan/02|944
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Feb/02|317|USD Sales Feb/02|276|LC Sales Feb/02|10070|Units Feb/02|245|DOT Feb/02|784
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Mar/02|348|USD Sales Mar/02|305|LC Sales Mar/02|10918|Units Mar/02|265|DOT Mar/02|848
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Apr/02|357|USD Sales Apr/02|316|LC Sales Apr/02|10850|Units Apr/02|264|DOT Apr/02|844.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales May/02|441|USD Sales May/02|405|LC Sales May/02|13512|Units May/02|332|DOT May/02|1062.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jun/02|339|USD Sales Jun/02|324|LC Sales Jun/02|10277|Units Jun/02|255|DOT Jun/02|816
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jul/02|720|USD Sales Jul/02|714|LC Sales Jul/02|21440|Units Jul/02|532|DOT Jul/02|1702.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Aug/02|612|USD Sales Aug/02|598|LC Sales Aug/02|18860|Units Aug/02|468|DOT Aug/02|1497.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Sep/02|795|USD Sales Sep/02|779|LC Sales Sep/02|24000|Units Sep/02|600|DOT Sep/02|1920
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Oct/02|793|USD Sales Oct/02|778|LC Sales Oct/02|24281|Units Oct/02|604|DOT Oct/02|1932.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Nov/02|730|USD Sales Nov/02|731|LC Sales Nov/02|22432|Units Nov/02|558|DOT Nov/02|1785.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Dec/02|777|USD Sales Dec/02|790|LC Sales Dec/02|24179|Units Dec/02|597|DOT Dec/02|1910.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jan/03|1397|USD Sales Jan/03|1484|LC Sales Jan/03|43956|Units Jan/03|1080|DOT Jan/03|3456
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Feb/03|805|USD Sales Feb/03|867|LC Sales Feb/03|25438|Units Feb/03|625|DOT Feb/03|2000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Mar/03|857|USD Sales Mar/03|926|LC Sales Mar/03|27188|Units Mar/03|668|DOT Mar/03|2137.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Apr/03|883|USD Sales Apr/03|958|LC Sales Apr/03|27920|Units Apr/03|686|DOT Apr/03|2195.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales May/03|712|USD Sales May/03|824|LC Sales May/03|22344|Units May/03|549|DOT May/03|1756.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jun/03|772|USD Sales Jun/03|901|LC Sales Jun/03|24257|Units Jun/03|596|DOT Jun/03|1907.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jul/03|798|USD Sales Jul/03|907|LC Sales Jul/03|25397|Units Jul/03|624|DOT Jul/03|1996.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Aug/03|661|USD Sales Aug/03|736|LC Sales Aug/03|21327|Units Aug/03|524|DOT Aug/03|1676.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Sep/03|831|USD Sales Sep/03|931|LC Sales Sep/03|26903|Units Sep/03|661|DOT Sep/03|2115.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Oct/03|859|USD Sales Oct/03|1005|LC Sales Oct/03|27473|Units Oct/03|675|DOT Oct/03|2160
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Nov/03|739|USD Sales Nov/03|864|LC Sales Nov/03|23606|Units Nov/03|580|DOT Nov/03|1856
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Dec/03|996|USD Sales Dec/03|1222|LC Sales Dec/03|32150|Units Dec/03|788|DOT Dec/03|2521.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jan/04|981|USD Sales Jan/04|1238|LC Sales Jan/04|32110|Units Jan/04|787|DOT Jan/04|2518.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Feb/04|888|USD Sales Feb/04|1123|LC Sales Feb/04|29172|Units Feb/04|715|DOT Feb/04|2288
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Mar/04|1077|USD Sales Mar/04|1321|LC Sales Mar/04|35496|Units Mar/04|870|DOT Mar/04|2784
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Apr/04|851|USD Sales Apr/04|1021|LC Sales Apr/04|27676|Units Apr/04|680|DOT Apr/04|2176
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales May/04|940|USD Sales May/04|1128|LC Sales May/04|30077|Units May/04|739|DOT May/04|2364.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jun/04|1084|USD Sales Jun/04|1316|LC Sales Jun/04|34269|Units Jun/04|842|DOT Jun/04|2694.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jul/04|857|USD Sales Jul/04|1051|LC Sales Jul/04|27025|Units Jul/04|664|DOT Jul/04|2124.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Aug/04|842|USD Sales Aug/04|1025|LC Sales Aug/04|26618|Units Aug/04|654|DOT Aug/04|2092.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Sep/04|1051|USD Sales Sep/04|1284|LC Sales Sep/04|33211|Units Sep/04|816|DOT Sep/04|2611.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Oct/04|966|USD Sales Oct/04|1206|LC Sales Oct/04|30403|Units Oct/04|747|DOT Oct/04|2390.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Nov/04|1068|USD Sales Nov/04|1387|LC Sales Nov/04|33415|Units Nov/04|821|DOT Nov/04|2627.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Dec/04|801|USD Sales Dec/04|1074|LC Sales Dec/04|24562|Units Dec/04|602|DOT Dec/04|1926.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jan/05|774|USD Sales Jan/05|1016|LC Sales Jan/05|23443|Units Jan/05|576|DOT Jan/05|1843.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Feb/05|7|USD Sales Feb/05|9|LC Sales Feb/05|204|Units Feb/05|5|DOT Feb/05|16
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|0080MG|TABS CHEW 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAG ORAL S ORD CHEWABLE TABLETS|NON-RX BOUND|1992|1992/01|3.20|0.50 G|MONO|DIMETHICONE|77|41.7|56.4|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Nov/01|3435|USD Sales Nov/01|3051|LC Sales Nov/01|114167|Units Nov/01|1965|DOT Nov/01|8174.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Dec/01|3577|USD Sales Dec/01|3193|LC Sales Dec/01|115934|Units Dec/01|1992|DOT Dec/01|8286.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jan/02|4329|USD Sales Jan/02|3823|LC Sales Jan/02|138908|Units Jan/02|2420|DOT Jan/02|10067.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Feb/02|4501|USD Sales Feb/02|3915|LC Sales Feb/02|142933|Units Feb/02|2512|DOT Feb/02|10449.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Mar/02|3701|USD Sales Mar/02|3241|LC Sales Mar/02|116116|Units Mar/02|2030|DOT Mar/02|8444.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Apr/02|4057|USD Sales Apr/02|3594|LC Sales Apr/02|123252|Units Apr/02|2151|DOT Apr/02|8948.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales May/02|3964|USD Sales May/02|3636|LC Sales May/02|121316|Units May/02|2151|DOT May/02|8948.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jun/02|3802|USD Sales Jun/02|3633|LC Sales Jun/02|115136|Units Jun/02|2056|DOT Jun/02|8552.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jul/02|4225|USD Sales Jul/02|4191|LC Sales Jul/02|125888|Units Jul/02|2244|DOT Jul/02|9335
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Aug/02|3591|USD Sales Aug/02|3510|LC Sales Aug/02|110651|Units Aug/02|1983|DOT Aug/02|8249.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Sep/02|3979|USD Sales Sep/02|3901|LC Sales Sep/02|120137|Units Sep/02|2153|DOT Sep/02|8956.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Oct/02|4667|USD Sales Oct/02|4576|LC Sales Oct/02|142831|Units Oct/02|2546|DOT Oct/02|10591.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Nov/02|4147|USD Sales Nov/02|4152|LC Sales Nov/02|127403|Units Nov/02|2271|DOT Nov/02|9447.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Dec/02|3758|USD Sales Dec/02|3819|LC Sales Dec/02|116887|Units Dec/02|2091|DOT Dec/02|8698.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jan/03|5786|USD Sales Jan/03|6146|LC Sales Jan/03|182028|Units Jan/03|3268|DOT Jan/03|13594.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Feb/03|4262|USD Sales Feb/03|4593|LC Sales Feb/03|134757|Units Feb/03|2415|DOT Feb/03|10046.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Mar/03|3975|USD Sales Mar/03|4295|LC Sales Mar/03|126108|Units Mar/03|2260|DOT Mar/03|9401.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Apr/03|4663|USD Sales Apr/03|5058|LC Sales Apr/03|147431|Units Apr/03|2628|DOT Apr/03|10932.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales May/03|4198|USD Sales May/03|4857|LC Sales May/03|131723|Units May/03|2348|DOT May/03|9767.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jun/03|3950|USD Sales Jun/03|4607|LC Sales Jun/03|124042|Units Jun/03|2219|DOT Jun/03|9231
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jul/03|4630|USD Sales Jul/03|5265|LC Sales Jul/03|147424|Units Jul/03|2642|DOT Jul/03|10990.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Aug/03|3643|USD Sales Aug/03|4057|LC Sales Aug/03|117530|Units Aug/03|2095|DOT Aug/03|8715.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Sep/03|4646|USD Sales Sep/03|5204|LC Sales Sep/03|150371|Units Sep/03|2690|DOT Sep/03|11190.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Oct/03|4660|USD Sales Oct/03|5452|LC Sales Oct/03|148974|Units Oct/03|2665|DOT Oct/03|11086.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Nov/03|4437|USD Sales Nov/03|5192|LC Sales Nov/03|141821|Units Nov/03|2528|DOT Nov/03|10516.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Dec/03|4588|USD Sales Dec/03|5632|LC Sales Dec/03|148160|Units Dec/03|2641|DOT Dec/03|10986.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jan/04|5037|USD Sales Jan/04|6353|LC Sales Jan/04|164822|Units Jan/04|2938|DOT Jan/04|12222
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Feb/04|4186|USD Sales Feb/04|5293|LC Sales Feb/04|137501|Units Feb/04|2451|DOT Feb/04|10196.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Mar/04|5045|USD Sales Mar/04|6190|LC Sales Mar/04|166337|Units Mar/04|2965|DOT Mar/04|12334.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Apr/04|4195|USD Sales Apr/04|5029|LC Sales Apr/04|136379|Units Apr/04|2431|DOT Apr/04|10112.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales May/04|4917|USD Sales May/04|5902|LC Sales May/04|157304|Units May/04|2804|DOT May/04|11664.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jun/04|4939|USD Sales Jun/04|5994|LC Sales Jun/04|156126|Units Jun/04|2783|DOT Jun/04|11577.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jul/04|4126|USD Sales Jul/04|5061|LC Sales Jul/04|130152|Units Jul/04|2320|DOT Jul/04|9651.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Aug/04|4344|USD Sales Aug/04|5290|LC Sales Aug/04|137389|Units Aug/04|2449|DOT Aug/04|10187.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Sep/04|5168|USD Sales Sep/04|6313|LC Sales Sep/04|163307|Units Sep/04|2911|DOT Sep/04|12109.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Oct/04|4331|USD Sales Oct/04|5410|LC Sales Oct/04|136379|Units Oct/04|2431|DOT Oct/04|10112.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Nov/04|5875|USD Sales Nov/04|7632|LC Sales Nov/04|183840|Units Nov/04|3277|DOT Nov/04|13632.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Dec/04|4746|USD Sales Dec/04|6358|LC Sales Dec/04|145467|Units Dec/04|2593|DOT Dec/04|10786.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jan/05|4896|USD Sales Jan/05|6429|LC Sales Jan/05|148385|Units Jan/05|2645|DOT Jan/05|11003.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Feb/05|5535|USD Sales Feb/05|7206|LC Sales Feb/05|165888|Units Feb/05|2957|DOT Feb/05|12301.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Mar/05|5783|USD Sales Mar/05|7638|LC Sales Mar/05|172171|Units Mar/05|3069|DOT Mar/05|12767
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Apr/05|5362|USD Sales Apr/05|6939|LC Sales Apr/05|161512|Units Apr/05|2879|DOT Apr/05|11976.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales May/05|5647|USD Sales May/05|7164|LC Sales May/05|170768|Units May/05|3044|DOT May/05|12663
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jun/05|5823|USD Sales Jun/05|7083|LC Sales Jun/05|174877|Units Jun/05|3134|DOT Jun/05|13037.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jul/05|4912|USD Sales Jul/05|5914|LC Sales Jul/05|148218|Units Jul/05|2661|DOT Jul/05|11069.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Aug/05|5934|USD Sales Aug/05|7296|LC Sales Aug/05|175566|Units Aug/05|3152|DOT Aug/05|13112.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Sep/05|5897|USD Sales Sep/05|7226|LC Sales Sep/05|172837|Units Sep/05|3103|DOT Sep/05|12908.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Oct/05|5531|USD Sales Oct/05|6650|LC Sales Oct/05|164148|Units Oct/05|2947|DOT Oct/05|12259.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Nov/05|5605|USD Sales Nov/05|6606|LC Sales Nov/05|164037|Units Nov/05|2945|DOT Nov/05|12251.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Dec/05|5517|USD Sales Dec/05|6543|LC Sales Dec/05|159742|Units Dec/05|2915|DOT Dec/05|12126.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jan/06|5761|USD Sales Jan/06|6973|LC Sales Jan/06|165429|Units Jan/06|2970|DOT Jan/06|12355.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Feb/06|5837|USD Sales Feb/06|6974|LC Sales Feb/06|165930|Units Feb/06|2979|DOT Feb/06|12392.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Mar/06|6502|USD Sales Mar/06|7818|LC Sales Mar/06|186205|Units Mar/06|3343|DOT Mar/06|13906.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Apr/06|4892|USD Sales Apr/06|5999|LC Sales Apr/06|139473|Units Apr/06|2504|DOT Apr/06|10416.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales May/06|6686|USD Sales May/06|8535|LC Sales May/06|189046|Units May/06|3394|DOT May/06|14119
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jun/06|5539|USD Sales Jun/06|7015|LC Sales Jun/06|157180|Units Jun/06|2900|DOT Jun/06|12064
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Jul/06|4336|USD Sales Jul/06|5503|LC Sales Jul/06|123363|Units Jul/06|2293|DOT Jul/06|9538.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Aug/06|6154|USD Sales Aug/06|7883|LC Sales Aug/06|173505|Units Aug/06|3225|DOT Aug/06|13416
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Sep/06|5605|USD Sales Sep/06|7138|LC Sales Sep/06|159087|Units Sep/06|2957|DOT Sep/06|12301.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PFIZER*|PFIZER|PFIZER|SAB SIMPLEX|2.08G|SUSP 2.08 G 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGK ORAL L ORD SUSPENSIONS|NON-RX BOUND|1989|1989/10|4.16|0.50 G|MONO|SIMETICONE|78|53.8|75.1|EURO Sales Oct/06|6251|USD Sales Oct/06|7887|LC Sales Oct/06|176787|Units Oct/06|3286|DOT Oct/06|13669.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Dec/01|2|USD Sales Dec/01|2|LC Sales Dec/01|67|Units Dec/01|1|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Feb/02|2|USD Sales Feb/02|2|LC Sales Feb/02|69|Units Feb/02|1|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Mar/02|13|USD Sales Mar/02|12|LC Sales Mar/02|418|Units Mar/02|6|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Apr/02|7|USD Sales Apr/02|6|LC Sales Apr/02|209|Units Apr/02|3|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales May/02|2|USD Sales May/02|2|LC Sales May/02|70|Units May/02|1|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jun/02|5|USD Sales Jun/02|4|LC Sales Jun/02|140|Units Jun/02|2|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jul/02|16|USD Sales Jul/02|16|LC Sales Jul/02|489|Units Jul/02|7|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Aug/02|7|USD Sales Aug/02|7|LC Sales Aug/02|210|Units Aug/02|3|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Sep/02|12|USD Sales Sep/02|11|LC Sales Sep/02|350|Units Sep/02|5|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Oct/02|2|USD Sales Oct/02|2|LC Sales Oct/02|70|Units Oct/02|1|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Nov/02|11|USD Sales Nov/02|11|LC Sales Nov/02|350|Units Nov/02|5|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Dec/02|11|USD Sales Dec/02|11|LC Sales Dec/02|350|Units Dec/02|5|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jan/03|29|USD Sales Jan/03|31|LC Sales Jan/03|909|Units Jan/03|13|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Feb/03|24|USD Sales Feb/03|26|LC Sales Feb/03|769|Units Feb/03|11|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Mar/03|18|USD Sales Mar/03|19|LC Sales Mar/03|559|Units Mar/03|8|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Apr/03|9|USD Sales Apr/03|10|LC Sales Apr/03|280|Units Apr/03|4|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales May/03|42|USD Sales May/03|49|LC Sales May/03|1328|Units May/03|19|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jun/03|2|USD Sales Jun/03|3|LC Sales Jun/03|70|Units Jun/03|1|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Aug/03|7|USD Sales Aug/03|7|LC Sales Aug/03|210|Units Aug/03|3|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Sep/03|2|USD Sales Sep/03|2|LC Sales Sep/03|70|Units Sep/03|1|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Oct/03|4|USD Sales Oct/03|5|LC Sales Oct/03|140|Units Oct/03|2|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Nov/03|2|USD Sales Nov/03|3|LC Sales Nov/03|70|Units Nov/03|1|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Dec/03|2|USD Sales Dec/03|3|LC Sales Dec/03|70|Units Dec/03|1|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jan/04|6|USD Sales Jan/04|8|LC Sales Jan/04|210|Units Jan/04|3|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Mar/04|4|USD Sales Mar/04|5|LC Sales Mar/04|140|Units Mar/04|2|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|PROFARMA PRODUCT|PROFARMA PRODUCT|PROFARMA PRODUCT|AQUA CARMINATIVA|0000|SOLUT. 1 1000 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGA ORAL L ORD LIQUIDS|NON-RX BOUND|1998|1998/02|0.00|0.00|MONO|ESSENTIAL OILS|79|71.6|96.9|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Nov/01|1132|USD Sales Nov/01|1006|LC Sales Nov/01|37631|Units Nov/01|1555|DOT Nov/01|4976
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Dec/01|1013|USD Sales Dec/01|904|LC Sales Dec/01|32835|Units Dec/01|1324|DOT Dec/01|4236.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jan/02|1373|USD Sales Jan/02|1212|LC Sales Jan/02|44045|Units Jan/02|1776|DOT Jan/02|5683.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Feb/02|1089|USD Sales Feb/02|947|LC Sales Feb/02|34571|Units Feb/02|1394|DOT Feb/02|4460.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Mar/02|1249|USD Sales Mar/02|1094|LC Sales Mar/02|39194|Units Mar/02|1537|DOT Mar/02|4918.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Apr/02|1149|USD Sales Apr/02|1018|LC Sales Apr/02|34918|Units Apr/02|1364|DOT Apr/02|4364.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales May/02|1176|USD Sales May/02|1079|LC Sales May/02|35992|Units May/02|1417|DOT May/02|4534.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jun/02|51|USD Sales Jun/02|49|LC Sales Jun/02|1556|Units Jun/02|63|DOT Jun/02|201.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Mar/03|2|USD Sales Mar/03|2|LC Sales Mar/03|51|Units Mar/03|2|DOT Mar/03|6.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A2 PLAIN ANTIFLATULENTS|SOLVAY*|SOLVAY|SOLVAY PHARMA|CEOLAT|0080MG|TABS 80 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1987|1987/01|3.20|0.50 G|MONO|DIMETHICONE|80|24.4|33|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Nov/01|374|USD Sales Nov/01|332|LC Sales Nov/01|12421|Units Nov/01|254|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Dec/01|317|USD Sales Dec/01|283|LC Sales Dec/01|10269|Units Dec/01|210|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jan/02|394|USD Sales Jan/02|348|LC Sales Jan/02|12644|Units Jan/02|257|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Feb/02|317|USD Sales Feb/02|275|LC Sales Feb/02|10057|Units Feb/02|222|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Mar/02|391|USD Sales Mar/02|342|LC Sales Mar/02|12266|Units Mar/02|269|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Apr/02|281|USD Sales Apr/02|249|LC Sales Apr/02|8532|Units Apr/02|180|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales May/02|291|USD Sales May/02|267|LC Sales May/02|8921|Units May/02|189|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jun/02|293|USD Sales Jun/02|280|LC Sales Jun/02|8870|Units Jun/02|198|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jul/02|360|USD Sales Jul/02|357|LC Sales Jul/02|10716|Units Jul/02|243|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Aug/02|337|USD Sales Aug/02|329|LC Sales Aug/02|10370|Units Aug/02|244|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Sep/02|233|USD Sales Sep/02|229|LC Sales Sep/02|7047|Units Sep/02|167|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Oct/02|326|USD Sales Oct/02|319|LC Sales Oct/02|9964|Units Oct/02|235|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Nov/02|306|USD Sales Nov/02|306|LC Sales Nov/02|9402|Units Nov/02|226|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Dec/02|257|USD Sales Dec/02|262|LC Sales Dec/02|8006|Units Dec/02|192|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jan/03|367|USD Sales Jan/03|389|LC Sales Jan/03|11536|Units Jan/03|280|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Feb/03|206|USD Sales Feb/03|222|LC Sales Feb/03|6528|Units Feb/03|160|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Mar/03|234|USD Sales Mar/03|253|LC Sales Mar/03|7419|Units Mar/03|185|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Apr/03|318|USD Sales Apr/03|345|LC Sales Apr/03|10058|Units Apr/03|254|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales May/03|240|USD Sales May/03|278|LC Sales May/03|7545|Units May/03|191|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jun/03|317|USD Sales Jun/03|369|LC Sales Jun/03|9944|Units Jun/03|261|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jul/03|331|USD Sales Jul/03|376|LC Sales Jul/03|10534|Units Jul/03|228|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Aug/03|204|USD Sales Aug/03|227|LC Sales Aug/03|6588|Units Aug/03|135|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Sep/03|297|USD Sales Sep/03|332|LC Sales Sep/03|9604|Units Sep/03|196|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Oct/03|230|USD Sales Oct/03|269|LC Sales Oct/03|7346|Units Oct/03|149|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Nov/03|212|USD Sales Nov/03|248|LC Sales Nov/03|6762|Units Nov/03|138|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Dec/03|284|USD Sales Dec/03|349|LC Sales Dec/03|9170|Units Dec/03|186|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jan/04|220|USD Sales Jan/04|278|LC Sales Jan/04|7200|Units Jan/04|150|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Feb/04|279|USD Sales Feb/04|353|LC Sales Feb/04|9170|Units Feb/04|186|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Mar/04|241|USD Sales Mar/04|295|LC Sales Mar/04|7937|Units Mar/04|161|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Apr/04|281|USD Sales Apr/04|337|LC Sales Apr/04|9139|Units Apr/04|185|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales May/04|216|USD Sales May/04|259|LC Sales May/04|6916|Units May/04|140|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jun/04|181|USD Sales Jun/04|220|LC Sales Jun/04|5730|Units Jun/04|116|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jul/04|200|USD Sales Jul/04|246|LC Sales Jul/04|6323|Units Jul/04|128|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Aug/04|222|USD Sales Aug/04|270|LC Sales Aug/04|7015|Units Aug/04|142|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Sep/04|192|USD Sales Sep/04|235|LC Sales Sep/04|6076|Units Sep/04|123|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Oct/04|30|USD Sales Oct/04|37|LC Sales Oct/04|935|Units Oct/04|19|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Dec/04|3|USD Sales Dec/04|4|LC Sales Dec/04|99|Units Dec/04|2|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A6 ANTACIDS + OTHER DRUGS|ZENTIVA*|ZENTIVA|ZENTIVA|GASTERIN|0000|JEL. 20 16 G|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGN ORAL L ORD UNIT DOSE LIQUIDS|NON-RX BOUND|1984|1984/01|0.00|0.00|COMBI|ALUMINIUM;PECTIN|81|50.5|68.4|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Mar/02|1|USD Sales Mar/02|1|LC Sales Mar/02|44|Units Mar/02|1|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02A ANTACIDS ANTIFLATULENTS|A02A7 ANTIFLATULENTS + OTHERS|DENTINOX|DENTINOX|DENTINOX|CARMINATIVUM BABY|0000|SOLUT. 1 30 ML|D ORAL LIQUID ORDINARY|DG ORAL L ORD LIQUIDS|DGB ORAL L ORD DROPS|NON-RX BOUND|1999|1999/03|0.00|0.00|COMBI|CORIANDRUM SATIVUM;FOENICULUM VULGARE;MATRICARIA CHAMOMILLA;SORBITOL|82|43.7|59.2|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO CIMETIDINE|0400MG|FILM C.TABS 400 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX STATUS UNKNOWN|1993|1993/01|50.00|0.80 G|MONO|CIMETIDINE|83|153.3|207.5|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Nov/01|2878|USD Sales Nov/01|2557|LC Sales Nov/01|95673|Units Nov/01|658|DOT Nov/01|32900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Dec/01|2439|USD Sales Dec/01|2178|LC Sales Dec/01|79061|Units Dec/01|543|DOT Dec/01|27150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jan/02|3517|USD Sales Jan/02|3105|LC Sales Jan/02|112830|Units Jan/02|776|DOT Jan/02|38800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Feb/02|3400|USD Sales Feb/02|2957|LC Sales Feb/02|107961|Units Feb/02|742|DOT Feb/02|37100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Mar/02|3103|USD Sales Mar/02|2717|LC Sales Mar/02|97328|Units Mar/02|668|DOT Mar/02|33400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Apr/02|3307|USD Sales Apr/02|2929|LC Sales Apr/02|100456|Units Apr/02|689|DOT Apr/02|34450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales May/02|3461|USD Sales May/02|3175|LC Sales May/02|105923|Units May/02|726|DOT May/02|36300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jun/02|3323|USD Sales Jun/02|3176|LC Sales Jun/02|100630|Units Jun/02|694|DOT Jun/02|34700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jul/02|3803|USD Sales Jul/02|3772|LC Sales Jul/02|113312|Units Jul/02|782|DOT Jul/02|39100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Aug/02|3663|USD Sales Aug/02|3580|LC Sales Aug/02|112866|Units Aug/02|780|DOT Aug/02|39000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Sep/02|4100|USD Sales Sep/02|4019|LC Sales Sep/02|123778|Units Sep/02|856|DOT Sep/02|42800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Oct/02|4397|USD Sales Oct/02|4312|LC Sales Oct/02|134571|Units Oct/02|930|DOT Oct/02|46500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Nov/02|4145|USD Sales Nov/02|4150|LC Sales Nov/02|127336|Units Nov/02|880|DOT Nov/02|44000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Dec/02|2931|USD Sales Dec/02|2979|LC Sales Dec/02|91185|Units Dec/02|649|DOT Dec/02|32450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jan/03|3834|USD Sales Jan/03|4072|LC Sales Jan/03|120600|Units Jan/03|867|DOT Jan/03|43350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Feb/03|3219|USD Sales Feb/03|3469|LC Sales Feb/03|101789|Units Feb/03|736|DOT Feb/03|36800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Mar/03|3080|USD Sales Mar/03|3328|LC Sales Mar/03|97710|Units Mar/03|706|DOT Mar/03|35300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Apr/03|4186|USD Sales Apr/03|4540|LC Sales Apr/03|132353|Units Apr/03|957|DOT Apr/03|47850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales May/03|3156|USD Sales May/03|3651|LC Sales May/03|99023|Units May/03|716|DOT May/03|35800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jun/03|3149|USD Sales Jun/03|3672|LC Sales Jun/03|98885|Units Jun/03|715|DOT Jun/03|35750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jul/03|3366|USD Sales Jul/03|3828|LC Sales Jul/03|107183|Units Jul/03|775|DOT Jul/03|38750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Aug/03|2816|USD Sales Aug/03|3137|LC Sales Aug/03|90863|Units Aug/03|657|DOT Aug/03|32850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Sep/03|3585|USD Sales Sep/03|4016|LC Sales Sep/03|116034|Units Sep/03|839|DOT Sep/03|41950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Oct/03|3230|USD Sales Oct/03|3779|LC Sales Oct/03|103257|Units Oct/03|766|DOT Oct/03|38300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Nov/03|3807|USD Sales Nov/03|4454|LC Sales Nov/03|121663|Units Nov/03|890|DOT Nov/03|44500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Dec/03|2990|USD Sales Dec/03|3669|LC Sales Dec/03|96533|Units Dec/03|698|DOT Dec/03|34900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jan/04|3647|USD Sales Jan/04|4601|LC Sales Jan/04|119353|Units Jan/04|863|DOT Jan/04|43150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Feb/04|3406|USD Sales Feb/04|4307|LC Sales Feb/04|111885|Units Feb/04|809|DOT Feb/04|40450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Mar/04|3666|USD Sales Mar/04|4498|LC Sales Mar/04|120874|Units Mar/04|874|DOT Mar/04|43700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Apr/04|5067|USD Sales Apr/04|6074|LC Sales Apr/04|164715|Units Apr/04|1191|DOT Apr/04|59550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales May/04|3301|USD Sales May/04|3963|LC Sales May/04|105616|Units May/04|767|DOT May/04|38350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jun/04|3637|USD Sales Jun/04|4414|LC Sales Jun/04|114974|Units Jun/04|838|DOT Jun/04|41900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jul/04|3273|USD Sales Jul/04|4014|LC Sales Jul/04|103236|Units Jul/04|753|DOT Jul/04|37650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Aug/04|3464|USD Sales Aug/04|4218|LC Sales Aug/04|109543|Units Aug/04|799|DOT Aug/04|39950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Sep/04|4096|USD Sales Sep/04|5003|LC Sales Sep/04|129422|Units Sep/04|944|DOT Sep/04|47200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Oct/04|3949|USD Sales Oct/04|4933|LC Sales Oct/04|124350|Units Oct/04|907|DOT Oct/04|45350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Nov/04|4535|USD Sales Nov/04|5891|LC Sales Nov/04|141899|Units Nov/04|1035|DOT Nov/04|51750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Dec/04|3174|USD Sales Dec/04|4253|LC Sales Dec/04|97300|Units Dec/04|771|DOT Dec/04|38550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jan/05|3409|USD Sales Jan/05|4476|LC Sales Jan/05|103313|Units Jan/05|842|DOT Jan/05|42100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Feb/05|3795|USD Sales Feb/05|4941|LC Sales Feb/05|113743|Units Feb/05|927|DOT Feb/05|46350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Mar/05|3112|USD Sales Mar/05|4110|LC Sales Mar/05|92639|Units Mar/05|755|DOT Mar/05|37750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Apr/05|3080|USD Sales Apr/05|3985|LC Sales Apr/05|92761|Units Apr/05|756|DOT Apr/05|37800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales May/05|3441|USD Sales May/05|4365|LC Sales May/05|104050|Units May/05|848|DOT May/05|42400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jun/05|2992|USD Sales Jun/05|3640|LC Sales Jun/05|89864|Units Jun/05|752|DOT Jun/05|37600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jul/05|2703|USD Sales Jul/05|3255|LC Sales Jul/05|81567|Units Jul/05|682|DOT Jul/05|34100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Aug/05|3198|USD Sales Aug/05|3931|LC Sales Aug/05|94604|Units Aug/05|791|DOT Aug/05|39550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Sep/05|3104|USD Sales Sep/05|3804|LC Sales Sep/05|90983|Units Sep/05|762|DOT Sep/05|38100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Oct/05|3088|USD Sales Oct/05|3713|LC Sales Oct/05|91655|Units Oct/05|735|DOT Oct/05|36750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Nov/05|3856|USD Sales Nov/05|4545|LC Sales Nov/05|112865|Units Nov/05|932|DOT Nov/05|46600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Dec/05|2489|USD Sales Dec/05|2952|LC Sales Dec/05|72072|Units Dec/05|624|DOT Dec/05|31200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jan/06|3282|USD Sales Jan/06|3973|LC Sales Jan/06|94251|Units Jan/06|821|DOT Jan/06|41050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Feb/06|2757|USD Sales Feb/06|3294|LC Sales Feb/06|78378|Units Feb/06|693|DOT Feb/06|34650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Mar/06|3408|USD Sales Mar/06|4098|LC Sales Mar/06|97605|Units Mar/06|863|DOT Mar/06|43150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Apr/06|3100|USD Sales Apr/06|3801|LC Sales Apr/06|88368|Units Apr/06|789|DOT Apr/06|39450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales May/06|3206|USD Sales May/06|4092|LC Sales May/06|90639|Units May/06|810|DOT May/06|40500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jun/06|3322|USD Sales Jun/06|4207|LC Sales Jun/06|94276|Units Jun/06|841|DOT Jun/06|42050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Jul/06|2722|USD Sales Jul/06|3455|LC Sales Jul/06|77450|Units Jul/06|694|DOT Jul/06|34700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Aug/06|3180|USD Sales Aug/06|4074|LC Sales Aug/06|89654|Units Aug/06|792|DOT Aug/06|39600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Sep/06|2642|USD Sales Sep/06|3364|LC Sales Sep/06|74985|Units Sep/06|663|DOT Sep/06|33150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|50.00|40.00 MG|MONO|FAMOTIDINE|84|112.4|157|EURO Sales Oct/06|2782|USD Sales Oct/06|3510|LC Sales Oct/06|78680|Units Oct/06|700|DOT Oct/06|35000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Nov/01|2743|USD Sales Nov/01|2437|LC Sales Nov/01|91179|Units Nov/01|330|DOT Nov/01|33000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Dec/01|2710|USD Sales Dec/01|2419|LC Sales Dec/01|87832|Units Dec/01|318|DOT Dec/01|31800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jan/02|3290|USD Sales Jan/02|2905|LC Sales Jan/02|105547|Units Jan/02|382|DOT Jan/02|38200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Feb/02|3173|USD Sales Feb/02|2760|LC Sales Feb/02|100755|Units Feb/02|364|DOT Feb/02|36400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Mar/02|3861|USD Sales Mar/02|3380|LC Sales Mar/02|121107|Units Mar/02|438|DOT Mar/02|43800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Apr/02|3447|USD Sales Apr/02|3053|LC Sales Apr/02|104706|Units Apr/02|378|DOT Apr/02|37800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales May/02|3337|USD Sales May/02|3061|LC Sales May/02|102139|Units May/02|369|DOT May/02|36900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jun/02|3059|USD Sales Jun/02|2923|LC Sales Jun/02|92628|Units Jun/02|335|DOT Jun/02|33500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jul/02|2490|USD Sales Jul/02|2470|LC Sales Jul/02|74182|Units Jul/02|268|DOT Jul/02|26800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Aug/02|848|USD Sales Aug/02|829|LC Sales Aug/02|26125|Units Aug/02|95|DOT Aug/02|9500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Sep/02|4803|USD Sales Sep/02|4709|LC Sales Sep/02|145028|Units Sep/02|523|DOT Sep/02|52300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Oct/02|2069|USD Sales Oct/02|2029|LC Sales Oct/02|63336|Units Oct/02|232|DOT Oct/02|23200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Nov/02|4353|USD Sales Nov/02|4359|LC Sales Nov/02|133742|Units Nov/02|489|DOT Nov/02|48900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Dec/02|2616|USD Sales Dec/02|2659|LC Sales Dec/02|81391|Units Dec/02|295|DOT Dec/02|29500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jan/03|3627|USD Sales Jan/03|3852|LC Sales Jan/03|114091|Units Jan/03|421|DOT Jan/03|42100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Feb/03|2318|USD Sales Feb/03|2498|LC Sales Feb/03|73304|Units Feb/03|272|DOT Feb/03|27200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Mar/03|3032|USD Sales Mar/03|3276|LC Sales Mar/03|96176|Units Mar/03|357|DOT Mar/03|35700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Apr/03|2931|USD Sales Apr/03|3179|LC Sales Apr/03|92674|Units Apr/03|344|DOT Apr/03|34400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales May/03|3314|USD Sales May/03|3834|LC Sales May/03|103988|Units May/03|386|DOT May/03|38600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jun/03|3021|USD Sales Jun/03|3523|LC Sales Jun/03|94864|Units Jun/03|352|DOT Jun/03|35200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jul/03|2877|USD Sales Jul/03|3271|LC Sales Jul/03|91596|Units Jul/03|340|DOT Jul/03|34000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Aug/03|2429|USD Sales Aug/03|2705|LC Sales Aug/03|78366|Units Aug/03|291|DOT Aug/03|29100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Sep/03|2920|USD Sales Sep/03|3271|LC Sales Sep/03|94524|Units Sep/03|351|DOT Sep/03|35100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Oct/03|3319|USD Sales Oct/03|3883|LC Sales Oct/03|106104|Units Oct/03|394|DOT Oct/03|39400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Nov/03|2841|USD Sales Nov/03|3325|LC Sales Nov/03|90808|Units Nov/03|341|DOT Nov/03|34100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Dec/03|3136|USD Sales Dec/03|3849|LC Sales Dec/03|101257|Units Dec/03|376|DOT Dec/03|37600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jan/04|2806|USD Sales Jan/04|3540|LC Sales Jan/04|91831|Units Jan/04|341|DOT Jan/04|34100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Feb/04|2205|USD Sales Feb/04|2789|LC Sales Feb/04|72442|Units Feb/04|269|DOT Feb/04|26900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Mar/04|3169|USD Sales Mar/04|3888|LC Sales Mar/04|104488|Units Mar/04|388|DOT Mar/04|38800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Apr/04|3986|USD Sales Apr/04|4778|LC Sales Apr/04|129581|Units Apr/04|481|DOT Apr/04|48100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales May/04|2624|USD Sales May/04|3150|LC Sales May/04|83964|Units May/04|314|DOT May/04|31400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jun/04|2518|USD Sales Jun/04|3056|LC Sales Jun/04|79596|Units Jun/04|298|DOT Jun/04|29800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jul/04|2031|USD Sales Jul/04|2492|LC Sales Jul/04|64080|Units Jul/04|240|DOT Jul/04|24000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Aug/04|2955|USD Sales Aug/04|3598|LC Sales Aug/04|93450|Units Aug/04|350|DOT Aug/04|35000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Sep/04|2400|USD Sales Sep/04|2931|LC Sales Sep/04|75828|Units Sep/04|284|DOT Sep/04|28400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Oct/04|2909|USD Sales Oct/04|3633|LC Sales Oct/04|91581|Units Oct/04|343|DOT Oct/04|34300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Nov/04|4045|USD Sales Nov/04|5254|LC Sales Nov/04|126558|Units Nov/04|474|DOT Nov/04|47400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Dec/04|2254|USD Sales Dec/04|3019|LC Sales Dec/04|69080|Units Dec/04|275|DOT Dec/04|27500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jan/05|2900|USD Sales Jan/05|3808|LC Sales Jan/05|87893|Units Jan/05|357|DOT Jan/05|35700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Feb/05|3110|USD Sales Feb/05|4049|LC Sales Feb/05|93214|Units Feb/05|380|DOT Feb/05|38000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Mar/05|3563|USD Sales Mar/05|4706|LC Sales Mar/05|106074|Units Mar/05|426|DOT Mar/05|42600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Apr/05|2604|USD Sales Apr/05|3370|LC Sales Apr/05|78440|Units Apr/05|324|DOT Apr/05|32400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales May/05|2917|USD Sales May/05|3700|LC Sales May/05|88206|Units May/05|366|DOT May/05|36600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jun/05|2124|USD Sales Jun/05|2583|LC Sales Jun/05|63778|Units Jun/05|260|DOT Jun/05|26000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jul/05|2073|USD Sales Jul/05|2496|LC Sales Jul/05|62552|Units Jul/05|255|DOT Jul/05|25500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Aug/05|2802|USD Sales Aug/05|3445|LC Sales Aug/05|82911|Units Aug/05|338|DOT Aug/05|33800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Sep/05|2904|USD Sales Sep/05|3559|LC Sales Sep/05|85119|Units Sep/05|347|DOT Sep/05|34700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Oct/05|2356|USD Sales Oct/05|2832|LC Sales Oct/05|69911|Units Oct/05|285|DOT Oct/05|28500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Nov/05|2715|USD Sales Nov/05|3200|LC Sales Nov/05|79477|Units Nov/05|324|DOT Nov/05|32400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Dec/05|1340|USD Sales Dec/05|1590|LC Sales Dec/05|38811|Units Dec/05|166|DOT Dec/05|16600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jan/06|2156|USD Sales Jan/06|2610|LC Sales Jan/06|61924|Units Jan/06|271|DOT Jan/06|27100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Feb/06|2231|USD Sales Feb/06|2665|LC Sales Feb/06|63418|Units Feb/06|273|DOT Feb/06|27300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Mar/06|2461|USD Sales Mar/06|2959|LC Sales Mar/06|70470|Units Mar/06|308|DOT Mar/06|30800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Apr/06|1958|USD Sales Apr/06|2401|LC Sales Apr/06|55827|Units Apr/06|244|DOT Apr/06|24400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales May/06|2429|USD Sales May/06|3101|LC Sales May/06|68684|Units May/06|308|DOT May/06|30800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jun/06|2330|USD Sales Jun/06|2951|LC Sales Jun/06|66123|Units Jun/06|289|DOT Jun/06|28900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Jul/06|2309|USD Sales Jul/06|2930|LC Sales Jul/06|65694|Units Jul/06|287|DOT Jul/06|28700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Aug/06|2346|USD Sales Aug/06|3006|LC Sales Aug/06|66152|Units Aug/06|289|DOT Aug/06|28900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Sep/06|2355|USD Sales Sep/06|2999|LC Sales Sep/06|66839|Units Sep/06|292|DOT Sep/06|29200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO FAMOTIDINE|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/01|100.00|40.00 MG|MONO|FAMOTIDINE|85|228.9|318.8|EURO Sales Oct/06|2031|USD Sales Oct/06|2563|LC Sales Oct/06|57454|Units Oct/06|251|DOT Oct/06|25100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Nov/01|2298|USD Sales Nov/01|2042|LC Sales Nov/01|76397|Units Nov/01|519|DOT Nov/01|25950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Dec/01|2433|USD Sales Dec/01|2172|LC Sales Dec/01|78859|Units Dec/01|535|DOT Dec/01|26750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jan/02|2472|USD Sales Jan/02|2183|LC Sales Jan/02|79301|Units Jan/02|538|DOT Jan/02|26900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Feb/02|2233|USD Sales Feb/02|1942|LC Sales Feb/02|70899|Units Feb/02|481|DOT Feb/02|24050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Mar/02|2072|USD Sales Mar/02|1814|LC Sales Mar/02|65003|Units Mar/02|441|DOT Mar/02|22050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Apr/02|1873|USD Sales Apr/02|1659|LC Sales Apr/02|56903|Units Apr/02|385|DOT Apr/02|19250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales May/02|2216|USD Sales May/02|2033|LC Sales May/02|67830|Units May/02|451|DOT May/02|22550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jun/02|2064|USD Sales Jun/02|1972|LC Sales Jun/02|62499|Units Jun/02|415|DOT Jun/02|20750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jul/02|3108|USD Sales Jul/02|3083|LC Sales Jul/02|92596|Units Jul/02|612|DOT Jul/02|30600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Aug/02|2473|USD Sales Aug/02|2417|LC Sales Aug/02|76202|Units Aug/02|501|DOT Aug/02|25050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Sep/02|2589|USD Sales Sep/02|2539|LC Sales Sep/02|78181|Units Sep/02|513|DOT Sep/02|25650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Oct/02|2078|USD Sales Oct/02|2038|LC Sales Oct/02|63593|Units Oct/02|417|DOT Oct/02|20850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Nov/02|2346|USD Sales Nov/02|2349|LC Sales Nov/02|72085|Units Nov/02|473|DOT Nov/02|23650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Dec/02|2287|USD Sales Dec/02|2324|LC Sales Dec/02|71146|Units Dec/02|483|DOT Dec/02|24150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jan/03|2535|USD Sales Jan/03|2692|LC Sales Jan/03|79734|Units Jan/03|545|DOT Jan/03|27250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Feb/03|1864|USD Sales Feb/03|2008|LC Sales Feb/03|58928|Units Feb/03|405|DOT Feb/03|20250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Mar/03|1821|USD Sales Mar/03|1968|LC Sales Mar/03|57764|Units Mar/03|397|DOT Mar/03|19850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Apr/03|1486|USD Sales Apr/03|1612|LC Sales Apr/03|46997|Units Apr/03|323|DOT Apr/03|16150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales May/03|1883|USD Sales May/03|2178|LC Sales May/03|59073|Units May/03|406|DOT May/03|20300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jun/03|1353|USD Sales Jun/03|1578|LC Sales Jun/03|42486|Units Jun/03|292|DOT Jun/03|14600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jul/03|1614|USD Sales Jul/03|1836|LC Sales Jul/03|51397|Units Jul/03|353|DOT Jul/03|17650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Aug/03|1582|USD Sales Aug/03|1762|LC Sales Aug/03|51030|Units Aug/03|350|DOT Aug/03|17500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Sep/03|1972|USD Sales Sep/03|2209|LC Sales Sep/03|63831|Units Sep/03|439|DOT Sep/03|21950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Oct/03|1671|USD Sales Oct/03|1955|LC Sales Oct/03|53435|Units Oct/03|367|DOT Oct/03|18350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Nov/03|1777|USD Sales Nov/03|2079|LC Sales Nov/03|56784|Units Nov/03|390|DOT Nov/03|19500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Dec/03|1912|USD Sales Dec/03|2347|LC Sales Dec/03|61734|Units Dec/03|424|DOT Dec/03|21200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jan/04|1918|USD Sales Jan/04|2419|LC Sales Jan/04|62754|Units Jan/04|431|DOT Jan/04|21550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Feb/04|1370|USD Sales Feb/04|1732|LC Sales Feb/04|44990|Units Feb/04|309|DOT Feb/04|15450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Mar/04|1791|USD Sales Mar/04|2197|LC Sales Mar/04|59049|Units Mar/04|405|DOT Mar/04|20250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Apr/04|1674|USD Sales Apr/04|2007|LC Sales Apr/04|54417|Units Apr/04|374|DOT Apr/04|18700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales May/04|1949|USD Sales May/04|2340|LC Sales May/04|62366|Units May/04|431|DOT May/04|21550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jun/04|2310|USD Sales Jun/04|2803|LC Sales Jun/04|73016|Units Jun/04|506|DOT Jun/04|25300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jul/04|1902|USD Sales Jul/04|2333|LC Sales Jul/04|59987|Units Jul/04|416|DOT Jul/04|20800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Aug/04|1737|USD Sales Aug/04|2116|LC Sales Aug/04|54940|Units Aug/04|381|DOT Aug/04|19050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Sep/04|2250|USD Sales Sep/04|2748|LC Sales Sep/04|71091|Units Sep/04|493|DOT Sep/04|24650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Oct/04|1937|USD Sales Oct/04|2420|LC Sales Oct/04|60997|Units Oct/04|423|DOT Oct/04|21150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Nov/04|2221|USD Sales Nov/04|2885|LC Sales Nov/04|69504|Units Nov/04|482|DOT Nov/04|24100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Dec/04|1596|USD Sales Dec/04|2138|LC Sales Dec/04|48924|Units Dec/04|360|DOT Dec/04|18000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jan/05|2293|USD Sales Jan/05|3011|LC Sales Jan/05|69494|Units Jan/05|519|DOT Jan/05|25950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Feb/05|1595|USD Sales Feb/05|2076|LC Sales Feb/05|47793|Units Feb/05|358|DOT Feb/05|17900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Mar/05|1910|USD Sales Mar/05|2523|LC Sales Mar/05|56871|Units Mar/05|426|DOT Mar/05|21300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Apr/05|2092|USD Sales Apr/05|2707|LC Sales Apr/05|63012|Units Apr/05|472|DOT Apr/05|23600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales May/05|1713|USD Sales May/05|2173|LC Sales May/05|51798|Units May/05|388|DOT May/05|19400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jun/05|2151|USD Sales Jun/05|2617|LC Sales Jun/05|64614|Units Jun/05|484|DOT Jun/05|24200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jul/05|2110|USD Sales Jul/05|2541|LC Sales Jul/05|63680|Units Jul/05|477|DOT Jul/05|23850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Aug/05|2026|USD Sales Aug/05|2491|LC Sales Aug/05|59942|Units Aug/05|449|DOT Aug/05|22450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Sep/05|1817|USD Sales Sep/05|2227|LC Sales Sep/05|53267|Units Sep/05|399|DOT Sep/05|19950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Oct/05|1489|USD Sales Oct/05|1790|LC Sales Oct/05|44189|Units Oct/05|331|DOT Oct/05|16550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Nov/05|1966|USD Sales Nov/05|2317|LC Sales Nov/05|57539|Units Nov/05|431|DOT Nov/05|21550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Dec/05|1289|USD Sales Dec/05|1529|LC Sales Dec/05|37335|Units Dec/05|291|DOT Dec/05|14550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jan/06|1950|USD Sales Jan/06|2360|LC Sales Jan/06|55988|Units Jan/06|444|DOT Jan/06|22200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Feb/06|1477|USD Sales Feb/06|1765|LC Sales Feb/06|41990|Units Feb/06|337|DOT Feb/06|16850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Mar/06|1731|USD Sales Mar/06|2081|LC Sales Mar/06|49569|Units Mar/06|403|DOT Mar/06|20150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Apr/06|1597|USD Sales Apr/06|1958|LC Sales Apr/06|45522|Units Apr/06|371|DOT Apr/06|18550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales May/06|2161|USD Sales May/06|2759|LC Sales May/06|61105|Units May/06|498|DOT May/06|24900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jun/06|1730|USD Sales Jun/06|2190|LC Sales Jun/06|49080|Units Jun/06|400|DOT Jun/06|20000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Jul/06|1491|USD Sales Jul/06|1892|LC Sales Jul/06|42423|Units Jul/06|355|DOT Jul/06|17750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Aug/06|1744|USD Sales Aug/06|2234|LC Sales Aug/06|49163|Units Aug/06|401|DOT Aug/06|20050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Sep/06|1507|USD Sales Sep/06|1920|LC Sales Sep/06|42787|Units Sep/06|349|DOT Sep/06|17450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|50.00|0.30 G|MONO|RANITIDINE|86|122.6|171.2|EURO Sales Oct/06|1205|USD Sales Oct/06|1520|LC Sales Oct/06|34083|Units Oct/06|278|DOT Oct/06|13900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/10|250.00|0.30 G|MONO|RANITIDINE|87|776.4|1050.8|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1995|1995/09|30.00|0.30 G|MONO|RANITIDINE|88|88.7|120.1|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|APOTEX|APOTEX|APOTEX|APO RANITIDINE|0300MG|FILM C.TABS 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1994|1994/10|100.00|0.30 G|MONO|RANITIDINE|89|310.7|420.5|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|C.TAB 200 MG 35|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1993|1993/10|8.75|0.80 G|MONO|CIMETIDINE|90|57.6|78|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|BELUPO|BELUPO|BELUPO|BELOMET|0200MG|VIAL 200 MG 10 2 ML|F PARENTERAL ORDINARY|FP PARENT ORD VIALS|FPD PARENT ORD IM VIALS|RX STATUS UNKNOWN|1981|1981/01|2.50|0.80 G|MONO|CIMETIDINE|91|153.5|207.8|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|CIMETIDIN|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1987|1987/01|25.00|0.80 G|MONO|CIMETIDINE|92|67.4|91.2|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Nov/01|118|USD Sales Nov/01|105|LC Sales Nov/01|3937|Units Nov/01|56|DOT Nov/01|1400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Dec/01|31|USD Sales Dec/01|27|LC Sales Dec/01|993|Units Dec/01|14|DOT Dec/01|350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jan/02|117|USD Sales Jan/02|103|LC Sales Jan/02|3758|Units Jan/02|53|DOT Jan/02|1325
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Feb/02|82|USD Sales Feb/02|71|LC Sales Feb/02|2603|Units Feb/02|36|DOT Feb/02|900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Mar/02|80|USD Sales Mar/02|70|LC Sales Mar/02|2506|Units Mar/02|34|DOT Mar/02|850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Apr/02|123|USD Sales Apr/02|109|LC Sales Apr/02|3749|Units Apr/02|51|DOT Apr/02|1275
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales May/02|53|USD Sales May/02|49|LC Sales May/02|1619|Units May/02|22|DOT May/02|550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jun/02|80|USD Sales Jun/02|77|LC Sales Jun/02|2432|Units Jun/02|33|DOT Jun/02|825
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jul/02|79|USD Sales Jul/02|79|LC Sales Jul/02|2363|Units Jul/02|35|DOT Jul/02|875
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Aug/02|70|USD Sales Aug/02|68|LC Sales Aug/02|2159|Units Aug/02|34|DOT Aug/02|850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Sep/02|45|USD Sales Sep/02|44|LC Sales Sep/02|1355|Units Sep/02|22|DOT Sep/02|550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Oct/02|29|USD Sales Oct/02|28|LC Sales Oct/02|876|Units Oct/02|15|DOT Oct/02|375
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Nov/02|62|USD Sales Nov/02|62|LC Sales Nov/02|1914|Units Nov/02|32|DOT Nov/02|800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Dec/02|43|USD Sales Dec/02|44|LC Sales Dec/02|1340|Units Dec/02|22|DOT Dec/02|550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jan/03|91|USD Sales Jan/03|97|LC Sales Jan/03|2862|Units Jan/03|47|DOT Jan/03|1175
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Feb/03|69|USD Sales Feb/03|75|LC Sales Feb/03|2192|Units Feb/03|36|DOT Feb/03|900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Mar/03|38|USD Sales Mar/03|41|LC Sales Mar/03|1202|Units Mar/03|20|DOT Mar/03|500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Apr/03|52|USD Sales Apr/03|56|LC Sales Apr/03|1646|Units Apr/03|28|DOT Apr/03|700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales May/03|68|USD Sales May/03|78|LC Sales May/03|2124|Units May/03|36|DOT May/03|900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jun/03|48|USD Sales Jun/03|56|LC Sales Jun/03|1500|Units Jun/03|26|DOT Jun/03|650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jul/03|17|USD Sales Jul/03|20|LC Sales Jul/03|552|Units Jul/03|10|DOT Jul/03|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Aug/03|2|USD Sales Aug/03|2|LC Sales Aug/03|54|Units Aug/03|1|DOT Aug/03|25
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2|0200MG|FILM C.TABS 200 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/09|25.00|0.80 G|MONO|CIMETIDINE|93|42.6|57.7|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA HEALTHCARE|ZYDUS CADILA|CADILA HEALTHCARE|LOCK 2E|0200MG|AMP. 200 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/10|1.25|0.80 G|MONO|CIMETIDINE|94|29.4|39.8|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0150MG|C.TAB 150 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|50.00|0.30 G|MONO|RANITIDINE|95|159.6|216|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|CADILA LABS|CADILA|CADILA LABS|ACILOC|0300MG|C.TAB 300 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX STATUS UNKNOWN|1996|1996/08|100.00|0.30 G|MONO|RANITIDINE|96|322.3|436.2|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Nov/01|27854|USD Sales Nov/01|24743|LC Sales Nov/01|925812|Units Nov/01|6407|DOT Nov/01|16017.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Dec/01|26234|USD Sales Dec/01|23424|LC Sales Dec/01|850393|Units Dec/01|5881|DOT Dec/01|14702.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jan/02|30610|USD Sales Jan/02|27031|LC Sales Jan/02|982132|Units Jan/02|6778|DOT Jan/02|16945
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Feb/02|26416|USD Sales Feb/02|22975|LC Sales Feb/02|838826|Units Feb/02|5789|DOT Feb/02|14472.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Mar/02|31129|USD Sales Mar/02|27256|LC Sales Mar/02|976531|Units Mar/02|6744|DOT Mar/02|16860
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Apr/02|32857|USD Sales Apr/02|29105|LC Sales Apr/02|998141|Units Apr/02|6898|DOT Apr/02|17245
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales May/02|32578|USD Sales May/02|29885|LC Sales May/02|997082|Units May/02|6905|DOT May/02|17262.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jun/02|28943|USD Sales Jun/02|27660|LC Sales Jun/02|876508|Units Jun/02|6070|DOT Jun/02|15175
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jul/02|33419|USD Sales Jul/02|33147|LC Sales Jul/02|995699|Units Jul/02|6848|DOT Jul/02|17120
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Aug/02|32134|USD Sales Aug/02|31406|LC Sales Aug/02|990120|Units Aug/02|6777|DOT Aug/02|16942.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Sep/02|30973|USD Sales Sep/02|30366|LC Sales Sep/02|935150|Units Sep/02|6392|DOT Sep/02|15980
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Oct/02|38001|USD Sales Oct/02|37267|LC Sales Oct/02|1.16312e+006|Units Oct/02|7907|DOT Oct/02|19767.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Nov/02|30194|USD Sales Nov/02|30233|LC Sales Nov/02|927613|Units Nov/02|6306|DOT Nov/02|15765
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Dec/02|31714|USD Sales Dec/02|32229|LC Sales Dec/02|986534|Units Dec/02|6702|DOT Dec/02|16755
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jan/03|30461|USD Sales Jan/03|32353|LC Sales Jan/03|958272|Units Jan/03|6510|DOT Jan/03|16275
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Feb/03|31993|USD Sales Feb/03|34474|LC Sales Feb/03|1.01156e+006|Units Feb/03|6872|DOT Feb/03|17180
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Mar/03|30876|USD Sales Mar/03|33362|LC Sales Mar/03|979469|Units Mar/03|6654|DOT Mar/03|16635
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Apr/03|31631|USD Sales Apr/03|34308|LC Sales Apr/03|1.00008e+006|Units Apr/03|6794|DOT Apr/03|16985
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales May/03|33942|USD Sales May/03|39269|LC Sales May/03|1.06499e+006|Units May/03|7235|DOT May/03|18087.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jun/03|31707|USD Sales Jun/03|36978|LC Sales Jun/03|995707|Units Jun/03|6792|DOT Jun/03|16980
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jul/03|31587|USD Sales Jul/03|35921|LC Sales Jul/03|1.0058e+006|Units Jul/03|6819|DOT Jul/03|17047.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Aug/03|26257|USD Sales Aug/03|29242|LC Sales Aug/03|847076|Units Aug/03|5739|DOT Aug/03|14347.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Sep/03|32360|USD Sales Sep/03|36247|LC Sales Sep/03|1.04737e+006|Units Sep/03|7096|DOT Sep/03|17740
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Oct/03|33492|USD Sales Oct/03|39182|LC Sales Oct/03|1.07069e+006|Units Oct/03|7254|DOT Oct/03|18135
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Nov/03|29553|USD Sales Nov/03|34583|LC Sales Nov/03|944542|Units Nov/03|6395|DOT Nov/03|15987.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Dec/03|30670|USD Sales Dec/03|37644|LC Sales Dec/03|990329|Units Dec/03|6705|DOT Dec/03|16762.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jan/04|31197|USD Sales Jan/04|39352|LC Sales Jan/04|1.0209e+006|Units Jan/04|6912|DOT Jan/04|17280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Feb/04|28924|USD Sales Feb/04|36575|LC Sales Feb/04|950154|Units Feb/04|6433|DOT Feb/04|16082.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Mar/04|31603|USD Sales Mar/04|38777|LC Sales Mar/04|1.04199e+006|Units Mar/04|7132|DOT Mar/04|17830
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Apr/04|33450|USD Sales Apr/04|40097|LC Sales Apr/04|1.08742e+006|Units Apr/04|7443|DOT Apr/04|18607.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales May/04|34802|USD Sales May/04|41778|LC Sales May/04|1.11349e+006|Units May/04|7611|DOT May/04|19027.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jun/04|34307|USD Sales Jun/04|41634|LC Sales Jun/04|1.08453e+006|Units Jun/04|7408|DOT Jun/04|18520
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jul/04|34435|USD Sales Jul/04|42240|LC Sales Jul/04|1.08627e+006|Units Jul/04|7237|DOT Jul/04|18092.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Aug/04|35304|USD Sales Aug/04|42997|LC Sales Aug/04|1.11659e+006|Units Aug/04|7439|DOT Aug/04|18597.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Sep/04|36002|USD Sales Sep/04|43975|LC Sales Sep/04|1.13763e+006|Units Sep/04|7564|DOT Sep/04|18910
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Oct/04|35092|USD Sales Oct/04|43829|LC Sales Oct/04|1.10492e+006|Units Oct/04|7298|DOT Oct/04|18245
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Nov/04|40015|USD Sales Nov/04|51977|LC Sales Nov/04|1.25209e+006|Units Nov/04|8281|DOT Nov/04|20702.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Dec/04|40201|USD Sales Dec/04|53861|LC Sales Dec/04|1.23225e+006|Units Dec/04|8166|DOT Dec/04|20415
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jan/05|37878|USD Sales Jan/05|49731|LC Sales Jan/05|1.1479e+006|Units Jan/05|7602|DOT Jan/05|19005
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Feb/05|36036|USD Sales Feb/05|46910|LC Sales Feb/05|1.07995e+006|Units Feb/05|7119|DOT Feb/05|17797.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Mar/05|41204|USD Sales Mar/05|54423|LC Sales Mar/05|1.22669e+006|Units Mar/05|8113|DOT Mar/05|20282.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Apr/05|37021|USD Sales Apr/05|47905|LC Sales Apr/05|1.1151e+006|Units Apr/05|7375|DOT Apr/05|18437.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales May/05|36849|USD Sales May/05|46751|LC Sales May/05|1.11439e+006|Units May/05|7346|DOT May/05|18365
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jun/05|37275|USD Sales Jun/05|45343|LC Sales Jun/05|1.11944e+006|Units Jun/05|7574|DOT Jun/05|18935
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jul/05|30121|USD Sales Jul/05|36267|LC Sales Jul/05|908901|Units Jul/05|6183|DOT Jul/05|15457.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Aug/05|35980|USD Sales Aug/05|44236|LC Sales Aug/05|1.06448e+006|Units Aug/05|7306|DOT Aug/05|18265
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Sep/05|35919|USD Sales Sep/05|44020|LC Sales Sep/05|1.05284e+006|Units Sep/05|7236|DOT Sep/05|18090
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Oct/05|34578|USD Sales Oct/05|41574|LC Sales Oct/05|1.02618e+006|Units Oct/05|7019|DOT Oct/05|17547.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Nov/05|36134|USD Sales Nov/05|42588|LC Sales Nov/05|1.05758e+006|Units Nov/05|7219|DOT Nov/05|18047.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Dec/05|35200|USD Sales Dec/05|41748|LC Sales Dec/05|1.0193e+006|Units Dec/05|6934|DOT Dec/05|17335
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jan/06|33958|USD Sales Jan/06|41105|LC Sales Jan/06|975198|Units Jan/06|6634|DOT Jan/06|16585
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Feb/06|31650|USD Sales Feb/06|37816|LC Sales Feb/06|899787|Units Feb/06|6121|DOT Feb/06|15302.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Mar/06|35443|USD Sales Mar/06|42617|LC Sales Mar/06|1.01504e+006|Units Mar/06|6905|DOT Mar/06|17262.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Apr/06|31660|USD Sales Apr/06|38825|LC Sales Apr/06|902606|Units Apr/06|6136|DOT Apr/06|15340
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales May/06|35100|USD Sales May/06|44805|LC Sales May/06|992397|Units May/06|6751|DOT May/06|16877.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jun/06|36937|USD Sales Jun/06|46778|LC Sales Jun/06|1.04819e+006|Units Jun/06|7269|DOT Jun/06|18172.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Jul/06|28097|USD Sales Jul/06|35654|LC Sales Jul/06|799318|Units Jul/06|5629|DOT Jul/06|14072.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Aug/06|37078|USD Sales Aug/06|47497|LC Sales Aug/06|1.04536e+006|Units Aug/06|7300|DOT Aug/06|18250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Sep/06|30622|USD Sales Sep/06|38998|LC Sales Sep/06|869182|Units Sep/06|6121|DOT Sep/06|15302.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|AMP DRY 20 MG 5|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMB PARENT ORD DRY AMPOULES|RX BOUND|1996|1996/09|2.50|40.00 MG|MONO|FAMOTIDINE|97|142|198.3|EURO Sales Oct/06|34779|USD Sales Oct/06|43881|LC Sales Oct/06|983634|Units Oct/06|6927|DOT Oct/06|17317.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Nov/01|3830|USD Sales Nov/01|3402|LC Sales Nov/01|127310|Units Nov/01|3256|DOT Nov/01|45584
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Dec/01|3565|USD Sales Dec/01|3184|LC Sales Dec/01|115577|Units Dec/01|2926|DOT Dec/01|40964
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jan/02|4494|USD Sales Jan/02|3969|LC Sales Jan/02|144204|Units Jan/02|3660|DOT Jan/02|51240
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Feb/02|4083|USD Sales Feb/02|3551|LC Sales Feb/02|129639|Units Feb/02|3282|DOT Feb/02|45948
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Mar/02|4183|USD Sales Mar/02|3662|LC Sales Mar/02|131219|Units Mar/02|3322|DOT Mar/02|46508
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Apr/02|4520|USD Sales Apr/02|4004|LC Sales Apr/02|137319|Units Apr/02|3512|DOT Apr/02|49168
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales May/02|4610|USD Sales May/02|4229|LC Sales May/02|141091|Units May/02|3581|DOT May/02|50134
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jun/02|4325|USD Sales Jun/02|4133|LC Sales Jun/02|130966|Units Jun/02|3324|DOT Jun/02|46536
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jul/02|4541|USD Sales Jul/02|4504|LC Sales Jul/02|135300|Units Jul/02|3434|DOT Jul/02|48076
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Aug/02|4250|USD Sales Aug/02|4154|LC Sales Aug/02|130966|Units Aug/02|3324|DOT Aug/02|46536
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Sep/02|4366|USD Sales Sep/02|4280|LC Sales Sep/02|131806|Units Sep/02|3371|DOT Sep/02|47194
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Oct/02|4844|USD Sales Oct/02|4750|LC Sales Oct/02|148254|Units Oct/02|3782|DOT Oct/02|52948
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Nov/02|4622|USD Sales Nov/02|4628|LC Sales Nov/02|141998|Units Nov/02|3604|DOT Nov/02|50456
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Dec/02|4187|USD Sales Dec/02|4255|LC Sales Dec/02|130232|Units Dec/02|3297|DOT Dec/02|46158
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jan/03|5087|USD Sales Jan/03|5403|LC Sales Jan/03|160024|Units Jan/03|4041|DOT Jan/03|56574
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Feb/03|3968|USD Sales Feb/03|4276|LC Sales Feb/03|125453|Units Feb/03|3168|DOT Feb/03|44352
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Mar/03|3957|USD Sales Mar/03|4276|LC Sales Mar/03|125532|Units Mar/03|3170|DOT Mar/03|44380
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Apr/03|4391|USD Sales Apr/03|4763|LC Sales Apr/03|138843|Units Apr/03|3515|DOT Apr/03|49210
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales May/03|4147|USD Sales May/03|4798|LC Sales May/03|130126|Units May/03|3286|DOT May/03|46004
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jun/03|4057|USD Sales Jun/03|4731|LC Sales Jun/03|127393|Units Jun/03|3217|DOT Jun/03|45038
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jul/03|4016|USD Sales Jul/03|4567|LC Sales Jul/03|127868|Units Jul/03|3229|DOT Jul/03|45206
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Aug/03|3585|USD Sales Aug/03|3992|LC Sales Aug/03|115646|Units Aug/03|2913|DOT Aug/03|40782
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Sep/03|4231|USD Sales Sep/03|4739|LC Sales Sep/03|136947|Units Sep/03|3467|DOT Sep/03|48538
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Oct/03|3865|USD Sales Oct/03|4522|LC Sales Oct/03|123556|Units Oct/03|3128|DOT Oct/03|43792
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Nov/03|3514|USD Sales Nov/03|4112|LC Sales Nov/03|112311|Units Nov/03|2829|DOT Nov/03|39606
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Dec/03|3944|USD Sales Dec/03|4841|LC Sales Dec/03|127358|Units Dec/03|3208|DOT Dec/03|44912
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jan/04|3621|USD Sales Jan/04|4568|LC Sales Jan/04|118495|Units Jan/04|3054|DOT Jan/04|42756
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Feb/04|3699|USD Sales Feb/04|4678|LC Sales Feb/04|121522|Units Feb/04|3061|DOT Feb/04|42854
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Mar/04|3736|USD Sales Mar/04|4584|LC Sales Mar/04|123189|Units Mar/04|3103|DOT Mar/04|43442
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Apr/04|3506|USD Sales Apr/04|4202|LC Sales Apr/04|113969|Units Apr/04|2878|DOT Apr/04|40292
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales May/04|3586|USD Sales May/04|4304|LC Sales May/04|114721|Units May/04|2897|DOT May/04|40558
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jun/04|3831|USD Sales Jun/04|4649|LC Sales Jun/04|121097|Units Jun/04|3058|DOT Jun/04|42812
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jul/04|2993|USD Sales Jul/04|3671|LC Sales Jul/04|94406|Units Jul/04|2384|DOT Jul/04|33376
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Aug/04|3129|USD Sales Aug/04|3811|LC Sales Aug/04|98960|Units Aug/04|2499|DOT Aug/04|34986
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Sep/04|3534|USD Sales Sep/04|4317|LC Sales Sep/04|111672|Units Sep/04|2820|DOT Sep/04|39480
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Oct/04|3101|USD Sales Oct/04|3873|LC Sales Oct/04|97629|Units Oct/04|2453|DOT Oct/04|34342
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Nov/04|3750|USD Sales Nov/04|4871|LC Sales Nov/04|117330|Units Nov/04|2948|DOT Nov/04|41272
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Dec/04|3620|USD Sales Dec/04|4850|LC Sales Dec/04|110962|Units Dec/04|2788|DOT Dec/04|39032
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jan/05|4180|USD Sales Jan/05|5488|LC Sales Jan/05|126683|Units Jan/05|3183|DOT Jan/05|44562
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Feb/05|3334|USD Sales Feb/05|4340|LC Sales Feb/05|99911|Units Feb/05|2523|DOT Feb/05|35322
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Mar/05|3570|USD Sales Mar/05|4715|LC Sales Mar/05|106286|Units Mar/05|2684|DOT Mar/05|37576
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Apr/05|3789|USD Sales Apr/05|4903|LC Sales Apr/05|114127|Units Apr/05|2882|DOT Apr/05|40348
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales May/05|3136|USD Sales May/05|3979|LC Sales May/05|94842|Units May/05|2395|DOT May/05|33530
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jun/05|3642|USD Sales Jun/05|4430|LC Sales Jun/05|109376|Units Jun/05|2769|DOT Jun/05|38766
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jul/05|2873|USD Sales Jul/05|3460|LC Sales Jul/05|86703|Units Jul/05|2195|DOT Jul/05|30730
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Aug/05|3271|USD Sales Aug/05|4022|LC Sales Aug/05|96775|Units Aug/05|2450|DOT Aug/05|34300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Sep/05|3172|USD Sales Sep/05|3888|LC Sales Sep/05|92983|Units Sep/05|2354|DOT Sep/05|32956
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Oct/05|3144|USD Sales Oct/05|3780|LC Sales Oct/05|93299|Units Oct/05|2362|DOT Oct/05|33068
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Nov/05|3429|USD Sales Nov/05|4042|LC Sales Nov/05|100370|Units Nov/05|2541|DOT Nov/05|35574
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Dec/05|3102|USD Sales Dec/05|3679|LC Sales Dec/05|89823|Units Dec/05|2274|DOT Dec/05|31836
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jan/06|3360|USD Sales Jan/06|4067|LC Sales Jan/06|96499|Units Jan/06|2443|DOT Jan/06|34202
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Feb/06|2884|USD Sales Feb/06|3446|LC Sales Feb/06|82002|Units Feb/06|2076|DOT Feb/06|29064
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Mar/06|3582|USD Sales Mar/06|4307|LC Sales Mar/06|102582|Units Mar/06|2597|DOT Mar/06|36358
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Apr/06|3321|USD Sales Apr/06|4073|LC Sales Apr/06|94684|Units Apr/06|2391|DOT Apr/06|33474
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales May/06|3482|USD Sales May/06|4445|LC Sales May/06|98446|Units May/06|2486|DOT May/06|34804
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jun/06|3061|USD Sales Jun/06|3877|LC Sales Jun/06|86864|Units Jun/06|2268|DOT Jun/06|31752
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Jul/06|2487|USD Sales Jul/06|3156|LC Sales Jul/06|70762|Units Jul/06|1872|DOT Jul/06|26208
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Aug/06|2942|USD Sales Aug/06|3769|LC Sales Aug/06|82956|Units Aug/06|2230|DOT Aug/06|31220
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Sep/06|3014|USD Sales Sep/06|3838|LC Sales Sep/06|85538|Units Sep/06|2251|DOT Sep/06|31514
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|C.TAB 20 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|98|38|53.1|EURO Sales Oct/06|2859|USD Sales Oct/06|3607|LC Sales Oct/06|80864|Units Oct/06|2128|DOT Oct/06|29792
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Sep/03|13|USD Sales Sep/03|15|LC Sales Sep/03|429|Units Sep/03|5|DOT Sep/03|140
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Oct/03|98|USD Sales Oct/03|114|LC Sales Oct/03|3128|Units Oct/03|39|DOT Oct/03|1092
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Nov/03|65|USD Sales Nov/03|76|LC Sales Nov/03|2085|Units Nov/03|26|DOT Nov/03|728
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Dec/03|32|USD Sales Dec/03|40|LC Sales Dec/03|1043|Units Dec/03|13|DOT Dec/03|364
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jan/04|5|USD Sales Jan/04|6|LC Sales Jan/04|160|Units Jan/04|2|DOT Jan/04|56
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Feb/04|71|USD Sales Feb/04|90|LC Sales Feb/04|2326|Units Feb/04|29|DOT Feb/04|812
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Mar/04|122|USD Sales Mar/04|149|LC Sales Mar/04|4010|Units Mar/04|50|DOT Mar/04|1400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Apr/04|62|USD Sales Apr/04|74|LC Sales Apr/04|2005|Units Apr/04|25|DOT Apr/04|700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales May/04|178|USD Sales May/04|214|LC Sales May/04|5701|Units May/04|71|DOT May/04|1988
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jun/04|203|USD Sales Jun/04|247|LC Sales Jun/04|6424|Units Jun/04|80|DOT Jun/04|2240
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jul/04|190|USD Sales Jul/04|233|LC Sales Jul/04|5993|Units Jul/04|73|DOT Jul/04|2044
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Aug/04|86|USD Sales Aug/04|104|LC Sales Aug/04|2713|Units Aug/04|33|DOT Aug/04|924
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Sep/04|172|USD Sales Sep/04|210|LC Sales Sep/04|5432|Units Sep/04|66|DOT Sep/04|1848
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Oct/04|152|USD Sales Oct/04|189|LC Sales Oct/04|4773|Units Oct/04|58|DOT Oct/04|1624
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Nov/04|205|USD Sales Nov/04|266|LC Sales Nov/04|6419|Units Nov/04|78|DOT Nov/04|2184
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Dec/04|109|USD Sales Dec/04|146|LC Sales Dec/04|3347|Units Dec/04|42|DOT Dec/04|1176
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jan/05|247|USD Sales Jan/05|325|LC Sales Jan/05|7497|Units Jan/05|98|DOT Jan/05|2744
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Feb/05|238|USD Sales Feb/05|310|LC Sales Feb/05|7135|Units Feb/05|94|DOT Feb/05|2632
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Mar/05|194|USD Sales Mar/05|256|LC Sales Mar/05|5768|Units Mar/05|76|DOT Mar/05|2128
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Apr/05|204|USD Sales Apr/05|264|LC Sales Apr/05|6148|Units Apr/05|81|DOT Apr/05|2268
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales May/05|444|USD Sales May/05|564|LC Sales May/05|13434|Units May/05|177|DOT May/05|4956
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jun/05|420|USD Sales Jun/05|510|LC Sales Jun/05|12599|Units Jun/05|166|DOT Jun/05|4648
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jul/05|377|USD Sales Jul/05|454|LC Sales Jul/05|11385|Units Jul/05|150|DOT Jul/05|4200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Aug/05|418|USD Sales Aug/05|514|LC Sales Aug/05|12372|Units Aug/05|163|DOT Aug/05|4564
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Sep/05|495|USD Sales Sep/05|606|LC Sales Sep/05|14497|Units Sep/05|191|DOT Sep/05|5348
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Oct/05|315|USD Sales Oct/05|378|LC Sales Oct/05|9336|Units Oct/05|123|DOT Oct/05|3444
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Nov/05|443|USD Sales Nov/05|523|LC Sales Nov/05|12979|Units Nov/05|171|DOT Nov/05|4788
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Dec/05|212|USD Sales Dec/05|252|LC Sales Dec/05|6148|Units Dec/05|81|DOT Dec/05|2268
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jan/06|574|USD Sales Jan/06|694|LC Sales Jan/06|16470|Units Jan/06|217|DOT Jan/06|6076
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Feb/06|462|USD Sales Feb/06|552|LC Sales Feb/06|13131|Units Feb/06|173|DOT Feb/06|4844
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Mar/06|596|USD Sales Mar/06|717|LC Sales Mar/06|17083|Units Mar/06|221|DOT Mar/06|6188
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Apr/06|602|USD Sales Apr/06|739|LC Sales Apr/06|17172|Units Apr/06|221|DOT Apr/06|6188
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales May/06|437|USD Sales May/06|558|LC Sales May/06|12354|Units May/06|159|DOT May/06|4452
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jun/06|643|USD Sales Jun/06|814|LC Sales Jun/06|18243|Units Jun/06|236|DOT Jun/06|6608
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Jul/06|422|USD Sales Jul/06|536|LC Sales Jul/06|12012|Units Jul/06|156|DOT Jul/06|4368
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Aug/06|483|USD Sales Aug/06|619|LC Sales Aug/06|13629|Units Aug/06|177|DOT Aug/06|4956
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Sep/06|751|USD Sales Sep/06|957|LC Sales Sep/06|21329|Units Sep/06|277|DOT Sep/06|7756
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0020MG|FILM C.TABS 20 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|28.00|40.00 MG|MONO|FAMOTIDINE|99|77|107.5|EURO Sales Oct/06|574|USD Sales Oct/06|725|LC Sales Oct/06|16247|Units Oct/06|211|DOT Oct/06|5908
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Nov/01|1079|USD Sales Nov/01|959|LC Sales Nov/01|35866|Units Nov/01|922|DOT Nov/01|12908
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Dec/01|1184|USD Sales Dec/01|1057|LC Sales Dec/01|38376|Units Dec/01|984|DOT Dec/01|13776
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jan/02|1485|USD Sales Jan/02|1312|LC Sales Jan/02|47658|Units Jan/02|1222|DOT Jan/02|17108
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Feb/02|1083|USD Sales Feb/02|942|LC Sales Feb/02|34398|Units Feb/02|882|DOT Feb/02|12348
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Mar/02|1227|USD Sales Mar/02|1074|LC Sales Mar/02|38493|Units Mar/02|987|DOT Mar/02|13818
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Apr/02|1349|USD Sales Apr/02|1195|LC Sales Apr/02|40989|Units Apr/02|1051|DOT Apr/02|14714
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales May/02|1329|USD Sales May/02|1219|LC Sales May/02|40677|Units May/02|1043|DOT May/02|14602
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jun/02|1332|USD Sales Jun/02|1273|LC Sales Jun/02|40326|Units Jun/02|1034|DOT Jun/02|14476
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jul/02|1363|USD Sales Jul/02|1352|LC Sales Jul/02|40624|Units Jul/02|1047|DOT Jul/02|14658
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Aug/02|1087|USD Sales Aug/02|1062|LC Sales Aug/02|33484|Units Aug/02|863|DOT Aug/02|12082
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Sep/02|1261|USD Sales Sep/02|1237|LC Sales Sep/02|38081|Units Sep/02|984|DOT Sep/02|13776
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Oct/02|1637|USD Sales Oct/02|1605|LC Sales Oct/02|50091|Units Oct/02|1291|DOT Oct/02|18074
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Nov/02|1264|USD Sales Nov/02|1266|LC Sales Nov/02|38839|Units Nov/02|1001|DOT Nov/02|14014
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Dec/02|997|USD Sales Dec/02|1013|LC Sales Dec/02|31005|Units Dec/02|795|DOT Dec/02|11130
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jan/03|1426|USD Sales Jan/03|1514|LC Sales Jan/03|44850|Units Jan/03|1150|DOT Jan/03|16100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Feb/03|952|USD Sales Feb/03|1026|LC Sales Feb/03|30108|Units Feb/03|772|DOT Feb/03|10808
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Mar/03|932|USD Sales Mar/03|1007|LC Sales Mar/03|29562|Units Mar/03|758|DOT Mar/03|10612
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Apr/03|1084|USD Sales Apr/03|1176|LC Sales Apr/03|34281|Units Apr/03|879|DOT Apr/03|12306
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales May/03|957|USD Sales May/03|1107|LC Sales May/03|30030|Units May/03|770|DOT May/03|10780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jun/03|1085|USD Sales Jun/03|1266|LC Sales Jun/03|34086|Units Jun/03|874|DOT Jun/03|12236
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jul/03|1062|USD Sales Jul/03|1208|LC Sales Jul/03|33822|Units Jul/03|865|DOT Jul/03|12110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Aug/03|813|USD Sales Aug/03|906|LC Sales Aug/03|26236|Units Aug/03|671|DOT Aug/03|9394
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Sep/03|1111|USD Sales Sep/03|1245|LC Sales Sep/03|35972|Units Sep/03|920|DOT Sep/03|12880
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Oct/03|1062|USD Sales Oct/03|1242|LC Sales Oct/03|33939|Units Oct/03|868|DOT Oct/03|12152
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Nov/03|896|USD Sales Nov/03|1048|LC Sales Nov/03|28621|Units Nov/03|732|DOT Nov/03|10248
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Dec/03|1016|USD Sales Dec/03|1247|LC Sales Dec/03|32805|Units Dec/03|839|DOT Dec/03|11746
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jan/04|1170|USD Sales Jan/04|1476|LC Sales Jan/04|38279|Units Jan/04|979|DOT Jan/04|13706
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Feb/04|995|USD Sales Feb/04|1258|LC Sales Feb/04|32688|Units Feb/04|836|DOT Feb/04|11704
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Mar/04|594|USD Sales Mar/04|729|LC Sales Mar/04|19589|Units Mar/04|501|DOT Mar/04|7014
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Apr/04|1|USD Sales Apr/04|1|LC Sales Apr/04|39|Units Apr/04|1|DOT Apr/04|14
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Apr/05|1|USD Sales Apr/05|2|LC Sales Apr/05|39|Units Apr/05|1|DOT Apr/05|14
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Oct/05|1|USD Sales Oct/05|2|LC Sales Oct/05|39|Units Oct/05|1|DOT Oct/05|14
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1996|1996/09|14.00|40.00 MG|MONO|FAMOTIDINE|100|40.1|54.3|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Nov/01|447|USD Sales Nov/01|397|LC Sales Nov/01|14861|Units Nov/01|193|DOT Nov/01|5404
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Dec/01|335|USD Sales Dec/01|299|LC Sales Dec/01|10871|Units Dec/01|141|DOT Dec/01|3948
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jan/02|459|USD Sales Jan/02|405|LC Sales Jan/02|14726|Units Jan/02|191|DOT Jan/02|5348
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Feb/02|449|USD Sales Feb/02|391|LC Sales Feb/02|14264|Units Feb/02|185|DOT Feb/02|5180
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Mar/02|479|USD Sales Mar/02|420|LC Sales Mar/02|15035|Units Mar/02|195|DOT Mar/02|5460
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Apr/02|660|USD Sales Apr/02|585|LC Sales Apr/02|20046|Units Apr/02|260|DOT Apr/02|7280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales May/02|526|USD Sales May/02|483|LC Sales May/02|16114|Units May/02|209|DOT May/02|5852
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jun/02|598|USD Sales Jun/02|572|LC Sales Jun/02|18119|Units Jun/02|235|DOT Jun/02|6580
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jul/02|422|USD Sales Jul/02|418|LC Sales Jul/02|12567|Units Jul/02|163|DOT Jul/02|4564
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Aug/02|465|USD Sales Aug/02|455|LC Sales Aug/02|14341|Units Aug/02|186|DOT Aug/02|5208
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Sep/02|439|USD Sales Sep/02|431|LC Sales Sep/02|13261|Units Sep/02|172|DOT Sep/02|4816
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Oct/02|511|USD Sales Oct/02|501|LC Sales Oct/02|15651|Units Oct/02|203|DOT Oct/02|5684
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Nov/02|567|USD Sales Nov/02|567|LC Sales Nov/02|17411|Units Nov/02|227|DOT Nov/02|6356
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Dec/02|382|USD Sales Dec/02|388|LC Sales Dec/02|11873|Units Dec/02|154|DOT Dec/02|4312
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jan/03|556|USD Sales Jan/03|591|LC Sales Jan/03|17502|Units Jan/03|227|DOT Jan/03|6356
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Feb/03|495|USD Sales Feb/03|533|LC Sales Feb/03|15651|Units Feb/03|203|DOT Feb/03|5684
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Mar/03|518|USD Sales Mar/03|559|LC Sales Mar/03|16422|Units Mar/03|213|DOT Mar/03|5964
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Apr/03|558|USD Sales Apr/03|605|LC Sales Apr/03|17641|Units Apr/03|230|DOT Apr/03|6440
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales May/03|604|USD Sales May/03|699|LC Sales May/03|18967|Units May/03|246|DOT May/03|6888
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jun/03|570|USD Sales Jun/03|664|LC Sales Jun/03|17887|Units Jun/03|232|DOT Jun/03|6496
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jul/03|659|USD Sales Jul/03|749|LC Sales Jul/03|20971|Units Jul/03|272|DOT Jul/03|7616
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Aug/03|425|USD Sales Aug/03|474|LC Sales Aug/03|13724|Units Aug/03|178|DOT Aug/03|4984
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Sep/03|638|USD Sales Sep/03|714|LC Sales Sep/03|20635|Units Sep/03|316|DOT Sep/03|8848
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Oct/03|498|USD Sales Oct/03|582|LC Sales Oct/03|15914|Units Oct/03|292|DOT Oct/03|8176
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Nov/03|304|USD Sales Nov/03|355|LC Sales Nov/03|9702|Units Nov/03|165|DOT Nov/03|4620
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Dec/03|141|USD Sales Dec/03|174|LC Sales Dec/03|4568|Units Dec/03|75|DOT Dec/03|2100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jan/04|796|USD Sales Jan/04|1005|LC Sales Jan/04|26060|Units Jan/04|338|DOT Jan/04|9464
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Feb/04|894|USD Sales Feb/04|1131|LC Sales Feb/04|29375|Units Feb/04|381|DOT Feb/04|10668
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Mar/04|1581|USD Sales Mar/04|1940|LC Sales Mar/04|52120|Units Mar/04|676|DOT Mar/04|18928
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Apr/04|1954|USD Sales Apr/04|2343|LC Sales Apr/04|63530|Units Apr/04|824|DOT Apr/04|23072
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales May/04|1995|USD Sales May/04|2395|LC Sales May/04|63839|Units May/04|828|DOT May/04|23184
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jun/04|1612|USD Sales Jun/04|1956|LC Sales Jun/04|50963|Units Jun/04|661|DOT Jun/04|18508
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jul/04|1620|USD Sales Jul/04|1988|LC Sales Jul/04|51117|Units Jul/04|663|DOT Jul/04|18564
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Aug/04|1672|USD Sales Aug/04|2037|LC Sales Aug/04|52891|Units Aug/04|686|DOT Aug/04|19208
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Sep/04|1806|USD Sales Sep/04|2205|LC Sales Sep/04|57054|Units Sep/04|740|DOT Sep/04|20720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Oct/04|1809|USD Sales Oct/04|2259|LC Sales Oct/04|56950|Units Oct/04|732|DOT Oct/04|20496
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Nov/04|1944|USD Sales Nov/04|2526|LC Sales Nov/04|60838|Units Nov/04|784|DOT Nov/04|21952
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Dec/04|1813|USD Sales Dec/04|2429|LC Sales Dec/04|55562|Units Dec/04|716|DOT Dec/04|20048
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jan/05|2230|USD Sales Jan/05|2928|LC Sales Jan/05|67580|Units Jan/05|872|DOT Jan/05|24416
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Feb/05|1518|USD Sales Feb/05|1976|LC Sales Feb/05|45489|Units Feb/05|590|DOT Feb/05|16520
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Mar/05|1840|USD Sales Mar/05|2431|LC Sales Mar/05|54793|Units Mar/05|707|DOT Mar/05|19796
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Apr/05|1712|USD Sales Apr/05|2216|LC Sales Apr/05|51580|Units Apr/05|669|DOT Apr/05|18732
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales May/05|1731|USD Sales May/05|2196|LC Sales May/05|52351|Units May/05|679|DOT May/05|19012
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jun/05|1687|USD Sales Jun/05|2052|LC Sales Jun/05|50655|Units Jun/05|657|DOT Jun/05|18396
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jul/05|1528|USD Sales Jul/05|1840|LC Sales Jul/05|46106|Units Jul/05|598|DOT Jul/05|16744
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Aug/05|1806|USD Sales Aug/05|2220|LC Sales Aug/05|53430|Units Aug/05|693|DOT Aug/05|19404
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Sep/05|1570|USD Sales Sep/05|1925|LC Sales Sep/05|46029|Units Sep/05|597|DOT Sep/05|16716
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Oct/05|1868|USD Sales Oct/05|2246|LC Sales Oct/05|55435|Units Oct/05|719|DOT Oct/05|20132
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Nov/05|1536|USD Sales Nov/05|1810|LC Sales Nov/05|44949|Units Nov/05|583|DOT Nov/05|16324
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Dec/05|1134|USD Sales Dec/05|1345|LC Sales Dec/05|32845|Units Dec/05|426|DOT Dec/05|11928
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jan/06|1528|USD Sales Jan/06|1849|LC Sales Jan/06|43870|Units Jan/06|569|DOT Jan/06|15932
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Feb/06|1573|USD Sales Feb/06|1879|LC Sales Feb/06|44718|Units Feb/06|580|DOT Feb/06|16240
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Mar/06|1513|USD Sales Mar/06|1820|LC Sales Mar/06|43344|Units Mar/06|560|DOT Mar/06|15680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Apr/06|1530|USD Sales Apr/06|1876|LC Sales Apr/06|43624|Units Apr/06|560|DOT Apr/06|15680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales May/06|1188|USD Sales May/06|1516|LC Sales May/06|33575|Units May/06|431|DOT May/06|12068
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jun/06|1318|USD Sales Jun/06|1669|LC Sales Jun/06|37402|Units Jun/06|487|DOT Jun/06|13636
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Jul/06|1277|USD Sales Jul/06|1620|LC Sales Jul/06|36316|Units Jul/06|481|DOT Jul/06|13468
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Aug/06|1065|USD Sales Aug/06|1364|LC Sales Aug/06|30029|Units Aug/06|402|DOT Aug/06|11256
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Sep/06|1285|USD Sales Sep/06|1636|LC Sales Sep/06|36467|Units Sep/06|483|DOT Sep/06|13524
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|C.TAB 40 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|2001|2001/02|28.00|40.00 MG|MONO|FAMOTIDINE|101|75.5|105.4|EURO Sales Oct/06|1177|USD Sales Oct/06|1485|LC Sales Oct/06|33296|Units Oct/06|441|DOT Oct/06|12348
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Sep/03|20|USD Sales Sep/03|22|LC Sales Sep/03|633|Units Sep/03|4|DOT Sep/03|224
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Oct/03|69|USD Sales Oct/03|81|LC Sales Oct/03|2216|Units Oct/03|14|DOT Oct/03|784
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Nov/03|25|USD Sales Nov/03|29|LC Sales Nov/03|791|Units Nov/03|5|DOT Nov/03|280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Dec/03|5|USD Sales Dec/03|6|LC Sales Dec/03|158|Units Dec/03|1|DOT Dec/03|56
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jan/04|73|USD Sales Jan/04|91|LC Sales Jan/04|2373|Units Jan/04|15|DOT Jan/04|840
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Feb/04|67|USD Sales Feb/04|85|LC Sales Feb/04|2215|Units Feb/04|14|DOT Feb/04|784
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Mar/04|38|USD Sales Mar/04|47|LC Sales Mar/04|1266|Units Mar/04|8|DOT Mar/04|448
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Apr/04|54|USD Sales Apr/04|64|LC Sales Apr/04|1741|Units Apr/04|11|DOT Apr/04|616
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales May/04|40|USD Sales May/04|48|LC Sales May/04|1266|Units May/04|8|DOT May/04|448
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jun/04|50|USD Sales Jun/04|61|LC Sales Jun/04|1583|Units Jun/04|10|DOT Jun/04|560
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jul/04|175|USD Sales Jul/04|215|LC Sales Jul/04|5532|Units Jul/04|34|DOT Jul/04|1904
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Aug/04|112|USD Sales Aug/04|137|LC Sales Aug/04|3549|Units Aug/04|22|DOT Aug/04|1232
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Sep/04|124|USD Sales Sep/04|151|LC Sales Sep/04|3919|Units Sep/04|24|DOT Sep/04|1344
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Oct/04|150|USD Sales Oct/04|188|LC Sales Oct/04|4736|Units Oct/04|29|DOT Oct/04|1624
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Nov/04|73|USD Sales Nov/04|95|LC Sales Nov/04|2285|Units Nov/04|14|DOT Nov/04|784
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Dec/04|122|USD Sales Dec/04|164|LC Sales Dec/04|3754|Units Dec/04|23|DOT Dec/04|1288
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jan/05|25|USD Sales Jan/05|33|LC Sales Jan/05|772|Units Jan/05|5|DOT Jan/05|280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Feb/05|71|USD Sales Feb/05|92|LC Sales Feb/05|2125|Units Feb/05|14|DOT Feb/05|784
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Mar/05|158|USD Sales Mar/05|209|LC Sales Mar/05|4706|Units Mar/05|31|DOT Mar/05|1736
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Apr/05|212|USD Sales Apr/05|274|LC Sales Apr/05|6376|Units Apr/05|42|DOT Apr/05|2352
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales May/05|120|USD Sales May/05|153|LC Sales May/05|3643|Units May/05|24|DOT May/05|1344
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jun/05|142|USD Sales Jun/05|172|LC Sales Jun/05|4250|Units Jun/05|28|DOT Jun/05|1568
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jul/05|150|USD Sales Jul/05|181|LC Sales Jul/05|4536|Units Jul/05|30|DOT Jul/05|1680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Aug/05|281|USD Sales Aug/05|345|LC Sales Aug/05|8300|Units Aug/05|55|DOT Aug/05|3080
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Sep/05|197|USD Sales Sep/05|241|LC Sales Sep/05|5768|Units Sep/05|38|DOT Sep/05|2128
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Oct/05|289|USD Sales Oct/05|348|LC Sales Oct/05|8590|Units Oct/05|57|DOT Oct/05|3192
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Nov/05|263|USD Sales Nov/05|310|LC Sales Nov/05|7706|Units Nov/05|51|DOT Nov/05|2856
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Dec/05|218|USD Sales Dec/05|258|LC Sales Dec/05|6308|Units Dec/05|42|DOT Dec/05|2352
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jan/06|238|USD Sales Jan/06|288|LC Sales Jan/06|6831|Units Jan/06|45|DOT Jan/06|2520
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Feb/06|338|USD Sales Feb/06|404|LC Sales Feb/06|9606|Units Feb/06|64|DOT Feb/06|3584
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Mar/06|153|USD Sales Mar/06|184|LC Sales Mar/06|4394|Units Mar/06|29|DOT Mar/06|1624
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Apr/06|418|USD Sales Apr/06|512|LC Sales Apr/06|11911|Units Apr/06|78|DOT Apr/06|4368
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales May/06|264|USD Sales May/06|337|LC Sales May/06|7454|Units May/06|48|DOT May/06|2688
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jun/06|452|USD Sales Jun/06|572|LC Sales Jun/06|12827|Units Jun/06|84|DOT Jun/06|4704
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Jul/06|140|USD Sales Jul/06|177|LC Sales Jul/06|3970|Units Jul/06|26|DOT Jul/06|1456
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Aug/06|450|USD Sales Aug/06|576|LC Sales Aug/06|12684|Units Aug/06|84|DOT Aug/06|4704
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Sep/06|129|USD Sales Sep/06|164|LC Sales Sep/06|3665|Units Sep/06|24|DOT Sep/06|1344
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL|0040MG|FILM C.TABS 40 MG 56|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2003|2003/08|56.00|40.00 MG|MONO|FAMOTIDINE|102|152.7|213.2|EURO Sales Oct/06|265|USD Sales Oct/06|334|LC Sales Oct/06|7482|Units Oct/06|49|DOT Oct/06|2744
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Oct/05|16|USD Sales Oct/05|19|LC Sales Oct/05|473|Units Oct/05|10|DOT Oct/05|35
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Nov/05|26|USD Sales Nov/05|30|LC Sales Nov/05|757|Units Nov/05|16|DOT Nov/05|56
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Dec/05|15|USD Sales Dec/05|17|LC Sales Dec/05|426|Units Dec/05|9|DOT Dec/05|31.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jan/06|35|USD Sales Jan/06|42|LC Sales Jan/06|993|Units Jan/06|21|DOT Jan/06|73.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Feb/06|15|USD Sales Feb/06|18|LC Sales Feb/06|425|Units Feb/06|9|DOT Feb/06|31.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Mar/06|23|USD Sales Mar/06|28|LC Sales Mar/06|671|Units Mar/06|14|DOT Mar/06|49
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Apr/06|13|USD Sales Apr/06|17|LC Sales Apr/06|384|Units Apr/06|8|DOT Apr/06|28
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales May/06|5|USD Sales May/06|7|LC Sales May/06|144|Units May/06|3|DOT May/06|10.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jun/06|19|USD Sales Jun/06|24|LC Sales Jun/06|528|Units Jun/06|11|DOT Jun/06|38.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Jul/06|10|USD Sales Jul/06|13|LC Sales Jul/06|289|Units Jul/06|6|DOT Jul/06|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Aug/06|27|USD Sales Aug/06|34|LC Sales Aug/06|752|Units Aug/06|16|DOT Aug/06|56
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Sep/06|22|USD Sales Sep/06|28|LC Sales Sep/06|628|Units Sep/06|13|DOT Sep/06|45.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GEDEON RICHTER*|GEDEON RICHTER|GEDEON RICHTER|QUAMATEL MINI|0010MG|FILM C.TABS 10 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/09|3.50|40.00 MG|MONO|FAMOTIDINE|103|48.3|67.5|EURO Sales Oct/06|38|USD Sales Oct/06|47|LC Sales Oct/06|1063|Units Oct/06|22|DOT Oct/06|77
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Mar/02|8|USD Sales Mar/02|7|LC Sales Mar/02|238|Units Mar/02|1|DOT Mar/02|7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 14|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|7.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|104|241|326.2|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Mar/02|8|USD Sales Mar/02|7|LC Sales Mar/02|257|Units Mar/02|1|DOT Mar/02|14
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ERADIPAK|0400MG|FILM C.TABS 400 MG 28|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/06|14.00|0.80 G|MONO|RANITIDINE BISMUTH CITRATE|105|260.3|352.3|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1992|1992/04|0.83|0.30 G|MONO|RANITIDINE|106|98.3|133.1|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Nov/01|48|USD Sales Nov/01|42|LC Sales Nov/01|1588|Units Nov/01|22|DOT Nov/01|55
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Dec/01|98|USD Sales Dec/01|88|LC Sales Dec/01|3186|Units Dec/01|44|DOT Dec/01|110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jan/02|50|USD Sales Jan/02|44|LC Sales Jan/02|1593|Units Jan/02|22|DOT Jan/02|55
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Feb/02|30|USD Sales Feb/02|26|LC Sales Feb/02|941|Units Feb/02|13|DOT Feb/02|32.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Mar/02|55|USD Sales Mar/02|49|LC Sales Mar/02|1738|Units Mar/02|24|DOT Mar/02|60
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Apr/02|81|USD Sales Apr/02|72|LC Sales Apr/02|2462|Units Apr/02|34|DOT Apr/02|85
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales May/02|57|USD Sales May/02|52|LC Sales May/02|1738|Units May/02|24|DOT May/02|60
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jun/02|29|USD Sales Jun/02|27|LC Sales Jun/02|869|Units Jun/02|12|DOT Jun/02|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jul/02|39|USD Sales Jul/02|39|LC Sales Jul/02|1158|Units Jul/02|16|DOT Jul/02|40
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Aug/02|16|USD Sales Aug/02|16|LC Sales Aug/02|507|Units Aug/02|7|DOT Aug/02|17.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Sep/02|221|USD Sales Sep/02|216|LC Sales Sep/02|6661|Units Sep/02|92|DOT Sep/02|230
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Oct/02|130|USD Sales Oct/02|128|LC Sales Oct/02|3982|Units Oct/02|55|DOT Oct/02|137.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Nov/02|17|USD Sales Nov/02|17|LC Sales Nov/02|507|Units Nov/02|7|DOT Nov/02|17.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Dec/02|28|USD Sales Dec/02|28|LC Sales Dec/02|869|Units Dec/02|12|DOT Dec/02|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jan/03|35|USD Sales Jan/03|37|LC Sales Jan/03|1086|Units Jan/03|15|DOT Jan/03|37.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Feb/03|44|USD Sales Feb/03|47|LC Sales Feb/03|1376|Units Feb/03|19|DOT Feb/03|47.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Mar/03|18|USD Sales Mar/03|20|LC Sales Mar/03|579|Units Mar/03|8|DOT Mar/03|20
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Apr/03|32|USD Sales Apr/03|35|LC Sales Apr/03|1014|Units Apr/03|14|DOT Apr/03|35
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales May/03|16|USD Sales May/03|19|LC Sales May/03|507|Units May/03|7|DOT May/03|17.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jun/03|28|USD Sales Jun/03|32|LC Sales Jun/03|869|Units Jun/03|12|DOT Jun/03|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jul/03|75|USD Sales Jul/03|85|LC Sales Jul/03|2389|Units Jul/03|33|DOT Jul/03|82.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Aug/03|47|USD Sales Aug/03|52|LC Sales Aug/03|1520|Units Aug/03|21|DOT Aug/03|52.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Sep/03|51|USD Sales Sep/03|58|LC Sales Sep/03|1665|Units Sep/03|23|DOT Sep/03|57.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Oct/03|54|USD Sales Oct/03|64|LC Sales Oct/03|1738|Units Oct/03|24|DOT Oct/03|60
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Nov/03|36|USD Sales Nov/03|42|LC Sales Nov/03|1158|Units Nov/03|16|DOT Nov/03|40
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Dec/03|11|USD Sales Dec/03|14|LC Sales Dec/03|362|Units Dec/03|5|DOT Dec/03|12.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jan/04|24|USD Sales Jan/04|31|LC Sales Jan/04|796|Units Jan/04|11|DOT Jan/04|27.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Feb/04|9|USD Sales Feb/04|11|LC Sales Feb/04|290|Units Feb/04|4|DOT Feb/04|10
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Mar/04|20|USD Sales Mar/04|24|LC Sales Mar/04|651|Units Mar/04|9|DOT Mar/04|22.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Apr/04|11|USD Sales Apr/04|13|LC Sales Apr/04|362|Units Apr/04|5|DOT Apr/04|12.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales May/04|14|USD Sales May/04|16|LC Sales May/04|434|Units May/04|6|DOT May/04|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jun/04|82|USD Sales Jun/04|100|LC Sales Jun/04|2606|Units Jun/04|36|DOT Jun/04|90
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jul/04|21|USD Sales Jul/04|25|LC Sales Jul/04|652|Units Jul/04|9|DOT Jul/04|22.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Aug/04|25|USD Sales Aug/04|31|LC Sales Aug/04|796|Units Aug/04|11|DOT Aug/04|27.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Sep/04|25|USD Sales Sep/04|31|LC Sales Sep/04|796|Units Sep/04|11|DOT Sep/04|27.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Oct/04|32|USD Sales Oct/04|40|LC Sales Oct/04|1014|Units Oct/04|14|DOT Oct/04|35
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Nov/04|2|USD Sales Nov/04|3|LC Sales Nov/04|72|Units Nov/04|1|DOT Nov/04|2.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Dec/04|31|USD Sales Dec/04|41|LC Sales Dec/04|941|Units Dec/04|13|DOT Dec/04|32.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jan/05|19|USD Sales Jan/05|25|LC Sales Jan/05|579|Units Jan/05|8|DOT Jan/05|20
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Feb/05|29|USD Sales Feb/05|38|LC Sales Feb/05|869|Units Feb/05|12|DOT Feb/05|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Mar/05|19|USD Sales Mar/05|26|LC Sales Mar/05|579|Units Mar/05|8|DOT Mar/05|20
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Apr/05|10|USD Sales Apr/05|12|LC Sales Apr/05|290|Units Apr/05|4|DOT Apr/05|10
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales May/05|14|USD Sales May/05|18|LC Sales May/05|434|Units May/05|6|DOT May/05|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jun/05|14|USD Sales Jun/05|18|LC Sales Jun/05|434|Units Jun/05|6|DOT Jun/05|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jul/05|14|USD Sales Jul/05|17|LC Sales Jul/05|434|Units Jul/05|6|DOT Jul/05|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Aug/05|27|USD Sales Aug/05|33|LC Sales Aug/05|796|Units Aug/05|11|DOT Aug/05|27.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Sep/05|27|USD Sales Sep/05|33|LC Sales Sep/05|796|Units Sep/05|11|DOT Sep/05|27.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Oct/05|7|USD Sales Oct/05|9|LC Sales Oct/05|217|Units Oct/05|3|DOT Oct/05|7.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Nov/05|7|USD Sales Nov/05|9|LC Sales Nov/05|217|Units Nov/05|3|DOT Nov/05|7.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Dec/05|15|USD Sales Dec/05|18|LC Sales Dec/05|434|Units Dec/05|6|DOT Dec/05|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jan/06|8|USD Sales Jan/06|9|LC Sales Jan/06|217|Units Jan/06|3|DOT Jan/06|7.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|2.50|0.30 G|MONO|RANITIDINE|107|72.4|98|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Nov/01|49|USD Sales Nov/01|43|LC Sales Nov/01|1627|Units Nov/01|36|DOT Nov/01|45
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Dec/01|60|USD Sales Dec/01|54|LC Sales Dec/01|1961|Units Dec/01|43|DOT Dec/01|53.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jan/02|31|USD Sales Jan/02|28|LC Sales Jan/02|1003|Units Jan/02|22|DOT Jan/02|27.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Feb/02|19|USD Sales Feb/02|16|LC Sales Feb/02|593|Units Feb/02|13|DOT Feb/02|16.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Mar/02|20|USD Sales Mar/02|18|LC Sales Mar/02|638|Units Mar/02|14|DOT Mar/02|17.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Apr/02|47|USD Sales Apr/02|41|LC Sales Apr/02|1414|Units Apr/02|31|DOT Apr/02|38.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales May/02|63|USD Sales May/02|57|LC Sales May/02|1915|Units May/02|42|DOT May/02|52.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jun/02|29|USD Sales Jun/02|27|LC Sales Jun/02|866|Units Jun/02|19|DOT Jun/02|23.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jul/02|38|USD Sales Jul/02|38|LC Sales Jul/02|1140|Units Jul/02|25|DOT Jul/02|31.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Aug/02|27|USD Sales Aug/02|26|LC Sales Aug/02|821|Units Aug/02|18|DOT Aug/02|22.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Sep/02|5|USD Sales Sep/02|4|LC Sales Sep/02|137|Units Sep/02|3|DOT Sep/02|3.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Oct/02|13|USD Sales Oct/02|13|LC Sales Oct/02|410|Units Oct/02|9|DOT Oct/02|11.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Nov/02|13|USD Sales Nov/02|13|LC Sales Nov/02|390|Units Nov/02|13|DOT Nov/02|16.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Dec/02|28|USD Sales Dec/02|28|LC Sales Dec/02|860|Units Dec/02|40|DOT Dec/02|50
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jan/03|27|USD Sales Jan/03|28|LC Sales Jan/03|839|Units Jan/03|39|DOT Jan/03|48.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Feb/03|49|USD Sales Feb/03|53|LC Sales Feb/03|1548|Units Feb/03|72|DOT Feb/03|90
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Mar/03|32|USD Sales Mar/03|34|LC Sales Mar/03|1011|Units Mar/03|47|DOT Mar/03|58.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Apr/03|8|USD Sales Apr/03|9|LC Sales Apr/03|258|Units Apr/03|12|DOT Apr/03|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales May/03|13|USD Sales May/03|15|LC Sales May/03|409|Units May/03|19|DOT May/03|23.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jun/03|6|USD Sales Jun/03|7|LC Sales Jun/03|194|Units Jun/03|9|DOT Jun/03|11.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Aug/03|1|USD Sales Aug/03|1|LC Sales Aug/03|43|Units Aug/03|2|DOT Aug/03|2.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0075MG|FILM C.TABS 75 MG 5|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2000|2000/01|1.25|0.30 G|MONO|RANITIDINE|108|21.3|28.8|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|GLAXOSMITHKLINE*|GLAXOSMITHKLINE|GLAXOSMITHKLINE|ZANTAC|0300MG|TABS 300 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1997|1997/07|10.00|0.30 G|MONO|RANITIDINE|109|211.4|286.1|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Nov/01|13|USD Sales Nov/01|11|LC Sales Nov/01|417|Units Nov/01|11|DOT Nov/01|33
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Dec/01|4|USD Sales Dec/01|3|LC Sales Dec/01|125|Units Dec/01|4|DOT Dec/01|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jan/02|6|USD Sales Jan/02|5|LC Sales Jan/02|187|Units Jan/02|6|DOT Jan/02|18
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Feb/02|7|USD Sales Feb/02|6|LC Sales Feb/02|218|Units Feb/02|7|DOT Feb/02|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Mar/02|3|USD Sales Mar/02|3|LC Sales Mar/02|94|Units Mar/02|3|DOT Mar/02|9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Apr/02|43|USD Sales Apr/02|38|LC Sales Apr/02|1310|Units Apr/02|42|DOT Apr/02|126
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales May/02|18|USD Sales May/02|17|LC Sales May/02|553|Units May/02|18|DOT May/02|54
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jun/02|5|USD Sales Jun/02|5|LC Sales Jun/02|154|Units Jun/02|5|DOT Jun/02|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jul/02|35|USD Sales Jul/02|35|LC Sales Jul/02|1040|Units Jul/02|36|DOT Jul/02|108
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Aug/02|12|USD Sales Aug/02|12|LC Sales Aug/02|368|Units Aug/02|13|DOT Aug/02|39
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Sep/02|32|USD Sales Sep/02|32|LC Sales Sep/02|979|Units Sep/02|34|DOT Sep/02|102
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Oct/02|15|USD Sales Oct/02|15|LC Sales Oct/02|456|Units Oct/02|16|DOT Oct/02|48
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Nov/02|6|USD Sales Nov/02|6|LC Sales Nov/02|199|Units Nov/02|7|DOT Nov/02|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Dec/02|10|USD Sales Dec/02|10|LC Sales Dec/02|304|Units Dec/02|10|DOT Dec/02|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jan/03|6|USD Sales Jan/03|6|LC Sales Jan/03|187|Units Jan/03|6|DOT Jan/03|18
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Mar/03|2|USD Sales Mar/03|2|LC Sales Mar/03|62|Units Mar/03|2|DOT Mar/03|6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Apr/03|15|USD Sales Apr/03|16|LC Sales Apr/03|468|Units Apr/03|15|DOT Apr/03|45
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales May/03|11|USD Sales May/03|13|LC Sales May/03|343|Units May/03|11|DOT May/03|33
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jun/03|9|USD Sales Jun/03|10|LC Sales Jun/03|281|Units Jun/03|9|DOT Jun/03|27
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jul/03|4|USD Sales Jul/03|4|LC Sales Jul/03|125|Units Jul/03|4|DOT Jul/03|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Aug/03|7|USD Sales Aug/03|8|LC Sales Aug/03|218|Units Aug/03|7|DOT Aug/03|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Sep/03|25|USD Sales Sep/03|28|LC Sales Sep/03|809|Units Sep/03|26|DOT Sep/03|78
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Oct/03|10|USD Sales Oct/03|11|LC Sales Oct/03|312|Units Oct/03|10|DOT Oct/03|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Nov/03|13|USD Sales Nov/03|15|LC Sales Nov/03|402|Units Nov/03|13|DOT Nov/03|39
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Dec/03|15|USD Sales Dec/03|19|LC Sales Dec/03|499|Units Dec/03|16|DOT Dec/03|48
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jan/04|7|USD Sales Jan/04|8|LC Sales Jan/04|216|Units Jan/04|7|DOT Jan/04|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Feb/04|8|USD Sales Feb/04|10|LC Sales Feb/04|249|Units Feb/04|8|DOT Feb/04|24
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Mar/04|10|USD Sales Mar/04|13|LC Sales Mar/04|343|Units Mar/04|11|DOT Mar/04|33
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Apr/04|8|USD Sales Apr/04|9|LC Sales Apr/04|250|Units Apr/04|8|DOT Apr/04|24
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales May/04|20|USD Sales May/04|23|LC Sales May/04|624|Units May/04|20|DOT May/04|60
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jun/04|9|USD Sales Jun/04|11|LC Sales Jun/04|281|Units Jun/04|9|DOT Jun/04|27
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jul/04|8|USD Sales Jul/04|10|LC Sales Jul/04|250|Units Jul/04|8|DOT Jul/04|24
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Aug/04|9|USD Sales Aug/04|11|LC Sales Aug/04|281|Units Aug/04|9|DOT Aug/04|27
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Sep/04|3|USD Sales Sep/04|4|LC Sales Sep/04|94|Units Sep/04|3|DOT Sep/04|9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Oct/04|7|USD Sales Oct/04|9|LC Sales Oct/04|218|Units Oct/04|7|DOT Oct/04|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Nov/04|15|USD Sales Nov/04|19|LC Sales Nov/04|468|Units Nov/04|15|DOT Nov/04|45
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Dec/04|17|USD Sales Dec/04|23|LC Sales Dec/04|530|Units Dec/04|17|DOT Dec/04|51
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jan/05|14|USD Sales Jan/05|19|LC Sales Jan/05|437|Units Jan/05|14|DOT Jan/05|42
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Feb/05|9|USD Sales Feb/05|12|LC Sales Feb/05|281|Units Feb/05|9|DOT Feb/05|27
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Mar/05|4|USD Sales Mar/05|6|LC Sales Mar/05|125|Units Mar/05|4|DOT Mar/05|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Apr/05|17|USD Sales Apr/05|21|LC Sales Apr/05|499|Units Apr/05|16|DOT Apr/05|48
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales May/05|4|USD Sales May/05|5|LC Sales May/05|125|Units May/05|4|DOT May/05|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jun/05|11|USD Sales Jun/05|14|LC Sales Jun/05|343|Units Jun/05|11|DOT Jun/05|33
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jul/05|13|USD Sales Jul/05|16|LC Sales Jul/05|406|Units Jul/05|13|DOT Jul/05|39
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Aug/05|26|USD Sales Aug/05|32|LC Sales Aug/05|780|Units Aug/05|25|DOT Aug/05|75
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Sep/05|40|USD Sales Sep/05|50|LC Sales Sep/05|1186|Units Sep/05|38|DOT Sep/05|114
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Oct/05|15|USD Sales Oct/05|18|LC Sales Oct/05|437|Units Oct/05|14|DOT Oct/05|42
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Nov/05|23|USD Sales Nov/05|28|LC Sales Nov/05|686|Units Nov/05|22|DOT Nov/05|66
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Dec/05|27|USD Sales Dec/05|32|LC Sales Dec/05|780|Units Dec/05|25|DOT Dec/05|75
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jan/06|4|USD Sales Jan/06|5|LC Sales Jan/06|125|Units Jan/06|4|DOT Jan/06|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Feb/06|1|USD Sales Feb/06|1|LC Sales Feb/06|31|Units Feb/06|1|DOT Feb/06|3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 12|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/04|3.00|0.30 G|MONO|RANITIDINE|110|31.2|42.2|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Nov/01|14|USD Sales Nov/01|13|LC Sales Nov/01|472|Units Nov/01|13|DOT Nov/01|19.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Dec/01|28|USD Sales Dec/01|25|LC Sales Dec/01|908|Units Dec/01|25|DOT Dec/01|37.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jan/02|1|USD Sales Jan/02|1|LC Sales Jan/02|31|Units Jan/02|2|DOT Jan/02|3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Feb/02|5|USD Sales Feb/02|5|LC Sales Feb/02|172|Units Feb/02|11|DOT Feb/02|16.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Mar/02|4|USD Sales Mar/02|4|LC Sales Mar/02|126|Units Mar/02|8|DOT Mar/02|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Apr/02|17|USD Sales Apr/02|15|LC Sales Apr/02|515|Units Apr/02|33|DOT Apr/02|49.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales May/02|13|USD Sales May/02|12|LC Sales May/02|403|Units May/02|26|DOT May/02|39
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jun/02|8|USD Sales Jun/02|8|LC Sales Jun/02|246|Units Jun/02|16|DOT Jun/02|24
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jul/02|12|USD Sales Jul/02|12|LC Sales Jul/02|348|Units Jul/02|24|DOT Jul/02|36
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Aug/02|8|USD Sales Aug/02|8|LC Sales Aug/02|255|Units Aug/02|17|DOT Aug/02|25.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Sep/02|15|USD Sales Sep/02|15|LC Sales Sep/02|459|Units Sep/02|30|DOT Sep/02|45
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Oct/02|6|USD Sales Oct/02|6|LC Sales Oct/02|187|Units Oct/02|12|DOT Oct/02|18
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Nov/02|6|USD Sales Nov/02|6|LC Sales Nov/02|187|Units Nov/02|12|DOT Nov/02|18
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Dec/02|3|USD Sales Dec/02|3|LC Sales Dec/02|78|Units Dec/02|5|DOT Dec/02|7.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jan/03|1|USD Sales Jan/03|1|LC Sales Jan/03|32|Units Jan/03|2|DOT Jan/03|3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Mar/03|9|USD Sales Mar/03|10|LC Sales Mar/03|296|Units Mar/03|19|DOT Mar/03|28.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Apr/03|10|USD Sales Apr/03|11|LC Sales Apr/03|312|Units Apr/03|20|DOT Apr/03|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales May/03|6|USD Sales May/03|7|LC Sales May/03|203|Units May/03|13|DOT May/03|19.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jun/03|5|USD Sales Jun/03|6|LC Sales Jun/03|172|Units Jun/03|11|DOT Jun/03|16.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jul/03|8|USD Sales Jul/03|9|LC Sales Jul/03|265|Units Jul/03|17|DOT Jul/03|25.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Aug/03|6|USD Sales Aug/03|6|LC Sales Aug/03|187|Units Aug/03|12|DOT Aug/03|18
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Sep/03|11|USD Sales Sep/03|12|LC Sales Sep/03|361|Units Sep/03|23|DOT Sep/03|34.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Oct/03|5|USD Sales Oct/03|6|LC Sales Oct/03|156|Units Oct/03|10|DOT Oct/03|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Nov/03|3|USD Sales Nov/03|4|LC Sales Nov/03|110|Units Nov/03|7|DOT Nov/03|10.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Dec/03|11|USD Sales Dec/03|14|LC Sales Dec/03|361|Units Dec/03|23|DOT Dec/03|34.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jan/04|4|USD Sales Jan/04|5|LC Sales Jan/04|141|Units Jan/04|9|DOT Jan/04|13.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Feb/04|7|USD Sales Feb/04|8|LC Sales Feb/04|220|Units Feb/04|14|DOT Feb/04|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Mar/04|5|USD Sales Mar/04|6|LC Sales Mar/04|173|Units Mar/04|11|DOT Mar/04|16.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Apr/04|8|USD Sales Apr/04|10|LC Sales Apr/04|265|Units Apr/04|17|DOT Apr/04|25.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales May/04|12|USD Sales May/04|15|LC Sales May/04|390|Units May/04|25|DOT May/04|37.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jun/04|3|USD Sales Jun/04|4|LC Sales Jun/04|109|Units Jun/04|7|DOT Jun/04|10.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jul/04|6|USD Sales Jul/04|8|LC Sales Jul/04|203|Units Jul/04|13|DOT Jul/04|19.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Aug/04|8|USD Sales Aug/04|10|LC Sales Aug/04|250|Units Aug/04|16|DOT Aug/04|24
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Sep/04|3|USD Sales Sep/04|4|LC Sales Sep/04|109|Units Sep/04|7|DOT Sep/04|10.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Oct/04|7|USD Sales Oct/04|9|LC Sales Oct/04|218|Units Oct/04|14|DOT Oct/04|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Nov/04|5|USD Sales Nov/04|6|LC Sales Nov/04|156|Units Nov/04|10|DOT Nov/04|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Dec/04|16|USD Sales Dec/04|21|LC Sales Dec/04|484|Units Dec/04|31|DOT Dec/04|46.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jan/05|11|USD Sales Jan/05|14|LC Sales Jan/05|328|Units Jan/05|21|DOT Jan/05|31.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Feb/05|2|USD Sales Feb/05|2|LC Sales Feb/05|47|Units Feb/05|3|DOT Feb/05|4.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Mar/05|5|USD Sales Mar/05|7|LC Sales Mar/05|156|Units Mar/05|10|DOT Mar/05|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Apr/05|2|USD Sales Apr/05|3|LC Sales Apr/05|62|Units Apr/05|4|DOT Apr/05|6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales May/05|7|USD Sales May/05|9|LC Sales May/05|218|Units May/05|14|DOT May/05|21
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jun/05|8|USD Sales Jun/05|9|LC Sales Jun/05|234|Units Jun/05|15|DOT Jun/05|22.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jul/05|8|USD Sales Jul/05|10|LC Sales Jul/05|250|Units Jul/05|16|DOT Jul/05|24
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Aug/05|15|USD Sales Aug/05|19|LC Sales Aug/05|452|Units Aug/05|29|DOT Aug/05|43.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Sep/05|27|USD Sales Sep/05|33|LC Sales Sep/05|796|Units Sep/05|51|DOT Sep/05|76.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Oct/05|14|USD Sales Oct/05|17|LC Sales Oct/05|421|Units Oct/05|27|DOT Oct/05|40.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Nov/05|10|USD Sales Nov/05|11|LC Sales Nov/05|281|Units Nov/05|18|DOT Nov/05|27
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Dec/05|8|USD Sales Dec/05|10|LC Sales Dec/05|234|Units Dec/05|15|DOT Dec/05|22.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jan/06|17|USD Sales Jan/06|21|LC Sales Jan/06|499|Units Jan/06|32|DOT Jan/06|48
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Feb/06|16|USD Sales Feb/06|20|LC Sales Feb/06|468|Units Feb/06|30|DOT Feb/06|45
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Mar/06|4|USD Sales Mar/06|5|LC Sales Mar/06|125|Units Mar/06|8|DOT Mar/06|12
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0075MG|FILM C.TABS 75 MG 6|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/07|1.50|0.30 G|MONO|RANITIDINE|111|15.6|21.8|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Nov/01|782|USD Sales Nov/01|695|LC Sales Nov/01|26003|Units Nov/01|956|DOT Nov/01|9560
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Dec/01|523|USD Sales Dec/01|467|LC Sales Dec/01|16953|Units Dec/01|621|DOT Dec/01|6210
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jan/02|773|USD Sales Jan/02|682|LC Sales Jan/02|24788|Units Jan/02|908|DOT Jan/02|9080
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Feb/02|621|USD Sales Feb/02|540|LC Sales Feb/02|19728|Units Feb/02|720|DOT Feb/02|7200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Mar/02|430|USD Sales Mar/02|376|LC Sales Mar/02|13481|Units Mar/02|492|DOT Mar/02|4920
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Apr/02|792|USD Sales Apr/02|701|LC Sales Apr/02|24057|Units Apr/02|878|DOT Apr/02|8780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales May/02|756|USD Sales May/02|694|LC Sales May/02|23144|Units May/02|880|DOT May/02|8800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jun/02|782|USD Sales Jun/02|747|LC Sales Jun/02|23681|Units Jun/02|936|DOT Jun/02|9360
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jul/02|1046|USD Sales Jul/02|1038|LC Sales Jul/02|31170|Units Jul/02|1232|DOT Jul/02|12320
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Aug/02|918|USD Sales Aug/02|898|LC Sales Aug/02|28299|Units Aug/02|1076|DOT Aug/02|10760
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Sep/02|1111|USD Sales Sep/02|1089|LC Sales Sep/02|33552|Units Sep/02|1229|DOT Sep/02|12290
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Oct/02|1310|USD Sales Oct/02|1284|LC Sales Oct/02|40086|Units Oct/02|1463|DOT Oct/02|14630
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Nov/02|1173|USD Sales Nov/02|1175|LC Sales Nov/02|36036|Units Nov/02|1320|DOT Nov/02|13200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Dec/02|1155|USD Sales Dec/02|1174|LC Sales Dec/02|35921|Units Dec/02|1311|DOT Dec/02|13110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jan/03|1416|USD Sales Jan/03|1504|LC Sales Jan/03|44552|Units Jan/03|1626|DOT Jan/03|16260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Feb/03|1120|USD Sales Feb/03|1206|LC Sales Feb/03|35401|Units Feb/03|1292|DOT Feb/03|12920
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Mar/03|1174|USD Sales Mar/03|1268|LC Sales Mar/03|37237|Units Mar/03|1359|DOT Mar/03|13590
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Apr/03|1435|USD Sales Apr/03|1557|LC Sales Apr/03|45374|Units Apr/03|1656|DOT Apr/03|16560
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales May/03|1391|USD Sales May/03|1609|LC Sales May/03|43648|Units May/03|1593|DOT May/03|15930
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jun/03|1396|USD Sales Jun/03|1628|LC Sales Jun/03|43848|Units Jun/03|1618|DOT Jun/03|16180
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jul/03|827|USD Sales Jul/03|940|LC Sales Jul/03|26320|Units Jul/03|1120|DOT Jul/03|11200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Aug/03|799|USD Sales Aug/03|890|LC Sales Aug/03|25780|Units Aug/03|1097|DOT Aug/03|10970
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Sep/03|1086|USD Sales Sep/03|1217|LC Sales Sep/03|35156|Units Sep/03|1496|DOT Sep/03|14960
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Oct/03|861|USD Sales Oct/03|1008|LC Sales Oct/03|27541|Units Oct/03|1167|DOT Oct/03|11670
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Nov/03|885|USD Sales Nov/03|1035|LC Sales Nov/03|28271|Units Nov/03|1203|DOT Nov/03|12030
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Dec/03|981|USD Sales Dec/03|1204|LC Sales Dec/03|31671|Units Dec/03|1342|DOT Dec/03|13420
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jan/04|957|USD Sales Jan/04|1207|LC Sales Jan/04|31317|Units Jan/04|1327|DOT Jan/04|13270
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Feb/04|745|USD Sales Feb/04|942|LC Sales Feb/04|24473|Units Feb/04|1037|DOT Feb/04|10370
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Mar/04|882|USD Sales Mar/04|1082|LC Sales Mar/04|29075|Units Mar/04|1232|DOT Mar/04|12320
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Apr/04|922|USD Sales Apr/04|1106|LC Sales Apr/04|29986|Units Apr/04|1276|DOT Apr/04|12760
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales May/04|922|USD Sales May/04|1107|LC Sales May/04|29493|Units May/04|1255|DOT May/04|12550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jun/04|868|USD Sales Jun/04|1053|LC Sales Jun/04|27425|Units Jun/04|1167|DOT Jun/04|11670
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jul/04|770|USD Sales Jul/04|945|LC Sales Jul/04|24304|Units Jul/04|1085|DOT Jul/04|10850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Aug/04|723|USD Sales Aug/04|881|LC Sales Aug/04|22870|Units Aug/04|1021|DOT Aug/04|10210
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Sep/04|958|USD Sales Sep/04|1170|LC Sales Sep/04|30262|Units Sep/04|1351|DOT Sep/04|13510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Oct/04|699|USD Sales Oct/04|873|LC Sales Oct/04|21997|Units Oct/04|982|DOT Oct/04|9820
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Nov/04|835|USD Sales Nov/04|1085|LC Sales Nov/04|26141|Units Nov/04|1167|DOT Nov/04|11670
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Dec/04|903|USD Sales Dec/04|1210|LC Sales Dec/04|27686|Units Dec/04|1236|DOT Dec/04|12360
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jan/05|770|USD Sales Jan/05|1011|LC Sales Jan/05|23341|Units Jan/05|1042|DOT Jan/05|10420
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Feb/05|738|USD Sales Feb/05|960|LC Sales Feb/05|22109|Units Feb/05|987|DOT Feb/05|9870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Mar/05|850|USD Sales Mar/05|1123|LC Sales Mar/05|25312|Units Mar/05|1130|DOT Mar/05|11300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Apr/05|1001|USD Sales Apr/05|1295|LC Sales Apr/05|30150|Units Apr/05|1346|DOT Apr/05|13460
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales May/05|818|USD Sales May/05|1037|LC Sales May/05|24730|Units May/05|1104|DOT May/05|11040
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jun/05|737|USD Sales Jun/05|896|LC Sales Jun/05|22131|Units Jun/05|988|DOT Jun/05|9880
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jul/05|486|USD Sales Jul/05|585|LC Sales Jul/05|14650|Units Jul/05|654|DOT Jul/05|6540
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Aug/05|103|USD Sales Aug/05|127|LC Sales Aug/05|3046|Units Aug/05|136|DOT Aug/05|1360
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Sep/05|5|USD Sales Sep/05|7|LC Sales Sep/05|157|Units Sep/05|7|DOT Sep/05|70
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/02|10.00|0.30 G|MONO|RANITIDINE|112|23|31.1|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jan/02|4|USD Sales Jan/02|4|LC Sales Jan/02|129|Units Jan/02|5|DOT Jan/02|50
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Feb/02|11|USD Sales Feb/02|10|LC Sales Feb/02|361|Units Feb/02|14|DOT Feb/02|140
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Mar/02|5|USD Sales Mar/02|4|LC Sales Mar/02|155|Units Mar/02|6|DOT Mar/02|60
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Apr/02|5|USD Sales Apr/02|5|LC Sales Apr/02|155|Units Apr/02|6|DOT Apr/02|60
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales May/02|8|USD Sales May/02|8|LC Sales May/02|259|Units May/02|10|DOT May/02|100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jun/02|6|USD Sales Jun/02|6|LC Sales Jun/02|181|Units Jun/02|7|DOT Jun/02|70
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jul/02|6|USD Sales Jul/02|6|LC Sales Jul/02|178|Units Jul/02|7|DOT Jul/02|70
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Aug/02|2|USD Sales Aug/02|2|LC Sales Aug/02|76|Units Aug/02|3|DOT Aug/02|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Sep/02|4|USD Sales Sep/02|4|LC Sales Sep/02|127|Units Sep/02|5|DOT Sep/02|50
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Oct/02|4|USD Sales Oct/02|4|LC Sales Oct/02|130|Units Oct/02|5|DOT Oct/02|50
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Nov/02|1|USD Sales Nov/02|1|LC Sales Nov/02|26|Units Nov/02|1|DOT Nov/02|10
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Dec/02|3|USD Sales Dec/02|3|LC Sales Dec/02|104|Units Dec/02|4|DOT Dec/02|40
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jan/03|2|USD Sales Jan/03|2|LC Sales Jan/03|52|Units Jan/03|2|DOT Jan/03|20
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Feb/03|16|USD Sales Feb/03|17|LC Sales Feb/03|492|Units Feb/03|19|DOT Feb/03|190
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Mar/03|11|USD Sales Mar/03|11|LC Sales Mar/03|337|Units Mar/03|13|DOT Mar/03|130
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Apr/03|3|USD Sales Apr/03|4|LC Sales Apr/03|104|Units Apr/03|4|DOT Apr/03|40
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales May/03|2|USD Sales May/03|3|LC Sales May/03|78|Units May/03|3|DOT May/03|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jun/03|1|USD Sales Jun/03|1|LC Sales Jun/03|26|Units Jun/03|1|DOT Jun/03|10
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Aug/03|2|USD Sales Aug/03|2|LC Sales Aug/03|67|Units Aug/03|3|DOT Aug/03|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|INTERCHEMIA*|INTERCHEMIA|RANBAXY INTERCHEM|HISTAC|0300MG|FILM C.TABS 300 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|10.00|0.30 G|MONO|RANITIDINE|113|22.6|30.6|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Nov/01|543|USD Sales Nov/01|482|LC Sales Nov/01|18041|Units Nov/01|633|DOT Nov/01|6330
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Dec/01|667|USD Sales Dec/01|595|LC Sales Dec/01|21617|Units Dec/01|748|DOT Dec/01|7480
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jan/02|891|USD Sales Jan/02|787|LC Sales Jan/02|28597|Units Jan/02|976|DOT Jan/02|9760
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Feb/02|693|USD Sales Feb/02|603|LC Sales Feb/02|22004|Units Feb/02|751|DOT Feb/02|7510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Mar/02|852|USD Sales Mar/02|746|LC Sales Mar/02|26725|Units Mar/02|909|DOT Mar/02|9090
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Apr/02|856|USD Sales Apr/02|759|LC Sales Apr/02|26019|Units Apr/02|885|DOT Apr/02|8850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales May/02|907|USD Sales May/02|832|LC Sales May/02|27754|Units May/02|944|DOT May/02|9440
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jun/02|694|USD Sales Jun/02|663|LC Sales Jun/02|21004|Units Jun/02|712|DOT Jun/02|7120
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jul/02|762|USD Sales Jul/02|756|LC Sales Jul/02|22697|Units Jul/02|772|DOT Jul/02|7720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Aug/02|783|USD Sales Aug/02|765|LC Sales Aug/02|24131|Units Aug/02|818|DOT Aug/02|8180
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Sep/02|1031|USD Sales Sep/02|1011|LC Sales Sep/02|31135|Units Sep/02|1059|DOT Sep/02|10590
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Oct/02|675|USD Sales Oct/02|662|LC Sales Oct/02|20657|Units Oct/02|705|DOT Oct/02|7050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Nov/02|488|USD Sales Nov/02|488|LC Sales Nov/02|14986|Units Nov/02|508|DOT Nov/02|5080
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Dec/02|720|USD Sales Dec/02|731|LC Sales Dec/02|22391|Units Dec/02|759|DOT Dec/02|7590
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jan/03|526|USD Sales Jan/03|559|LC Sales Jan/03|16550|Units Jan/03|561|DOT Jan/03|5610
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Feb/03|421|USD Sales Feb/03|453|LC Sales Feb/03|13305|Units Feb/03|451|DOT Feb/03|4510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Mar/03|485|USD Sales Mar/03|524|LC Sales Mar/03|15370|Units Mar/03|521|DOT Mar/03|5210
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Apr/03|594|USD Sales Apr/03|645|LC Sales Apr/03|18792|Units Apr/03|637|DOT Apr/03|6370
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales May/03|497|USD Sales May/03|575|LC Sales May/03|15606|Units May/03|529|DOT May/03|5290
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jun/03|401|USD Sales Jun/03|468|LC Sales Jun/03|12595|Units Jun/03|458|DOT Jun/03|4580
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jul/03|489|USD Sales Jul/03|556|LC Sales Jul/03|15575|Units Jul/03|579|DOT Jul/03|5790
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Aug/03|396|USD Sales Aug/03|441|LC Sales Aug/03|12778|Units Aug/03|475|DOT Aug/03|4750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Sep/03|464|USD Sales Sep/03|519|LC Sales Sep/03|15010|Units Sep/03|558|DOT Sep/03|5580
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Oct/03|533|USD Sales Oct/03|623|LC Sales Oct/03|17028|Units Oct/03|633|DOT Oct/03|6330
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Nov/03|476|USD Sales Nov/03|557|LC Sales Nov/03|15225|Units Nov/03|566|DOT Nov/03|5660
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Dec/03|464|USD Sales Dec/03|570|LC Sales Dec/03|14983|Units Dec/03|557|DOT Dec/03|5570
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jan/04|478|USD Sales Jan/04|603|LC Sales Jan/04|15633|Units Jan/04|579|DOT Jan/04|5790
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Feb/04|522|USD Sales Feb/04|660|LC Sales Feb/04|17135|Units Feb/04|637|DOT Feb/04|6370
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Mar/04|471|USD Sales Mar/04|577|LC Sales Mar/04|15517|Units Mar/04|579|DOT Mar/04|5790
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Apr/04|388|USD Sales Apr/04|465|LC Sales Apr/04|12623|Units Apr/04|471|DOT Apr/04|4710
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales May/04|390|USD Sales May/04|468|LC Sales May/04|12462|Units May/04|465|DOT May/04|4650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jun/04|482|USD Sales Jun/04|585|LC Sales Jun/04|15248|Units Jun/04|591|DOT Jun/04|5910
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jul/04|353|USD Sales Jul/04|433|LC Sales Jul/04|11146|Units Jul/04|432|DOT Jul/04|4320
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Aug/04|392|USD Sales Aug/04|477|LC Sales Aug/04|12390|Units Aug/04|484|DOT Aug/04|4840
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Sep/04|433|USD Sales Sep/04|528|LC Sales Sep/04|13670|Units Sep/04|534|DOT Sep/04|5340
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Oct/04|346|USD Sales Oct/04|433|LC Sales Oct/04|10906|Units Oct/04|426|DOT Oct/04|4260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Nov/04|422|USD Sales Nov/04|548|LC Sales Nov/04|13210|Units Nov/04|514|DOT Nov/04|5140
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Dec/04|274|USD Sales Dec/04|367|LC Sales Dec/04|8398|Units Dec/04|340|DOT Dec/04|3400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jan/05|428|USD Sales Jan/05|563|LC Sales Jan/05|12985|Units Jan/05|530|DOT Jan/05|5300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Feb/05|284|USD Sales Feb/05|370|LC Sales Feb/05|8526|Units Feb/05|348|DOT Feb/05|3480
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Mar/05|406|USD Sales Mar/05|536|LC Sales Mar/05|12079|Units Mar/05|493|DOT Mar/05|4930
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Apr/05|364|USD Sales Apr/05|472|LC Sales Apr/05|10976|Units Apr/05|448|DOT Apr/05|4480
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales May/05|361|USD Sales May/05|458|LC Sales May/05|10927|Units May/05|446|DOT May/05|4460
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jun/05|337|USD Sales Jun/05|410|LC Sales Jun/05|10119|Units Jun/05|413|DOT Jun/05|4130
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jul/05|326|USD Sales Jul/05|393|LC Sales Jul/05|9849|Units Jul/05|402|DOT Jul/05|4020
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Aug/05|308|USD Sales Aug/05|379|LC Sales Aug/05|9114|Units Aug/05|372|DOT Aug/05|3720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Sep/05|318|USD Sales Sep/05|390|LC Sales Sep/05|9335|Units Sep/05|381|DOT Sep/05|3810
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Oct/05|405|USD Sales Oct/05|486|LC Sales Oct/05|12005|Units Oct/05|490|DOT Oct/05|4900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Nov/05|294|USD Sales Nov/05|346|LC Sales Nov/05|8600|Units Nov/05|351|DOT Nov/05|3510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Dec/05|258|USD Sales Dec/05|306|LC Sales Dec/05|7475|Units Dec/05|325|DOT Dec/05|3250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jan/06|341|USD Sales Jan/06|413|LC Sales Jan/06|9789|Units Jan/06|437|DOT Jan/06|4370
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Feb/06|305|USD Sales Feb/06|364|LC Sales Feb/06|8669|Units Feb/06|387|DOT Feb/06|3870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Mar/06|650|USD Sales Mar/06|782|LC Sales Mar/06|18614|Units Mar/06|831|DOT Mar/06|8310
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Apr/06|534|USD Sales Apr/06|654|LC Sales Apr/06|15210|Units Apr/06|679|DOT Apr/06|6790
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales May/06|397|USD Sales May/06|507|LC Sales May/06|11222|Units May/06|501|DOT May/06|5010
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jun/06|325|USD Sales Jun/06|412|LC Sales Jun/06|9229|Units Jun/06|412|DOT Jun/06|4120
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Jul/06|305|USD Sales Jul/06|387|LC Sales Jul/06|8669|Units Jul/06|387|DOT Jul/06|3870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Aug/06|354|USD Sales Aug/06|454|LC Sales Aug/06|9990|Units Aug/06|446|DOT Aug/06|4460
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Sep/06|343|USD Sales Sep/06|437|LC Sales Sep/06|9746|Units Sep/06|445|DOT Sep/06|4450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0020MG|TABS 20 MG 20|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/04|10.00|40.00 MG|MONO|FAMOTIDINE|114|22.4|31.3|EURO Sales Oct/06|347|USD Sales Oct/06|438|LC Sales Oct/06|9811|Units Oct/06|438|DOT Oct/06|4380
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Nov/01|134|USD Sales Nov/01|119|LC Sales Nov/01|4460|Units Nov/01|161|DOT Nov/01|1610
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Dec/01|139|USD Sales Dec/01|125|LC Sales Dec/01|4520|Units Dec/01|162|DOT Dec/01|1620
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jan/02|292|USD Sales Jan/02|258|LC Sales Jan/02|9374|Units Jan/02|336|DOT Jan/02|3360
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Feb/02|157|USD Sales Feb/02|137|LC Sales Feb/02|4994|Units Feb/02|179|DOT Feb/02|1790
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Mar/02|198|USD Sales Mar/02|174|LC Sales Mar/02|6222|Units Mar/02|223|DOT Mar/02|2230
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Apr/02|200|USD Sales Apr/02|177|LC Sales Apr/02|6076|Units Apr/02|217|DOT Apr/02|2170
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales May/02|216|USD Sales May/02|198|LC Sales May/02|6608|Units May/02|236|DOT May/02|2360
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jun/02|138|USD Sales Jun/02|132|LC Sales Jun/02|4172|Units Jun/02|149|DOT Jun/02|1490
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jul/02|178|USD Sales Jul/02|176|LC Sales Jul/02|5292|Units Jul/02|189|DOT Jul/02|1890
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Aug/02|196|USD Sales Aug/02|192|LC Sales Aug/02|6048|Units Aug/02|216|DOT Aug/02|2160
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Sep/02|130|USD Sales Sep/02|127|LC Sales Sep/02|3920|Units Sep/02|140|DOT Sep/02|1400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Oct/02|223|USD Sales Oct/02|219|LC Sales Oct/02|6832|Units Oct/02|244|DOT Oct/02|2440
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Nov/02|161|USD Sales Nov/02|162|LC Sales Nov/02|4956|Units Nov/02|177|DOT Nov/02|1770
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Dec/02|171|USD Sales Dec/02|174|LC Sales Dec/02|5320|Units Dec/02|190|DOT Dec/02|1900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jan/03|119|USD Sales Jan/03|127|LC Sales Jan/03|3752|Units Jan/03|134|DOT Jan/03|1340
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Feb/03|70|USD Sales Feb/03|75|LC Sales Feb/03|2212|Units Feb/03|79|DOT Feb/03|790
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Mar/03|102|USD Sales Mar/03|110|LC Sales Mar/03|3220|Units Mar/03|115|DOT Mar/03|1150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Apr/03|109|USD Sales Apr/03|118|LC Sales Apr/03|3444|Units Apr/03|123|DOT Apr/03|1230
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales May/03|117|USD Sales May/03|135|LC Sales May/03|3668|Units May/03|131|DOT May/03|1310
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jun/03|68|USD Sales Jun/03|80|LC Sales Jun/03|2149|Units Jun/03|79|DOT Jun/03|790
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jul/03|96|USD Sales Jul/03|110|LC Sales Jul/03|3067|Units Jul/03|114|DOT Jul/03|1140
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Aug/03|78|USD Sales Aug/03|86|LC Sales Aug/03|2502|Units Aug/03|93|DOT Aug/03|930
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Sep/03|72|USD Sales Sep/03|81|LC Sales Sep/03|2340|Units Sep/03|87|DOT Sep/03|870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Oct/03|162|USD Sales Oct/03|190|LC Sales Oct/03|5192|Units Oct/03|193|DOT Oct/03|1930
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Nov/03|82|USD Sales Nov/03|96|LC Sales Nov/03|2609|Units Nov/03|97|DOT Nov/03|970
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Dec/03|98|USD Sales Dec/03|121|LC Sales Dec/03|3174|Units Dec/03|118|DOT Dec/03|1180
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jan/04|105|USD Sales Jan/04|133|LC Sales Jan/04|3443|Units Jan/04|128|DOT Jan/04|1280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Feb/04|36|USD Sales Feb/04|46|LC Sales Feb/04|1184|Units Feb/04|44|DOT Feb/04|440
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Mar/04|92|USD Sales Mar/04|113|LC Sales Mar/04|3040|Units Mar/04|113|DOT Mar/04|1130
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Apr/04|79|USD Sales Apr/04|94|LC Sales Apr/04|2558|Units Apr/04|93|DOT Apr/04|930
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales May/04|106|USD Sales May/04|127|LC Sales May/04|3389|Units May/04|126|DOT May/04|1260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jun/04|73|USD Sales Jun/04|88|LC Sales Jun/04|2296|Units Jun/04|89|DOT Jun/04|890
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jul/04|63|USD Sales Jul/04|78|LC Sales Jul/04|1997|Units Jul/04|78|DOT Jul/04|780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Aug/04|56|USD Sales Aug/04|68|LC Sales Aug/04|1761|Units Aug/04|68|DOT Aug/04|680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Sep/04|92|USD Sales Sep/04|113|LC Sales Sep/04|2918|Units Sep/04|114|DOT Sep/04|1140
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Oct/04|66|USD Sales Oct/04|83|LC Sales Oct/04|2080|Units Oct/04|80|DOT Oct/04|800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Nov/04|51|USD Sales Nov/04|66|LC Sales Nov/04|1593|Units Nov/04|62|DOT Nov/04|620
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Dec/04|70|USD Sales Dec/04|94|LC Sales Dec/04|2149|Units Dec/04|87|DOT Dec/04|870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jan/05|63|USD Sales Jan/05|83|LC Sales Jan/05|1911|Units Jan/05|78|DOT Jan/05|780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Feb/05|49|USD Sales Feb/05|64|LC Sales Feb/05|1470|Units Feb/05|60|DOT Feb/05|600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Mar/05|76|USD Sales Mar/05|100|LC Sales Mar/05|2254|Units Mar/05|92|DOT Mar/05|920
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Apr/05|61|USD Sales Apr/05|79|LC Sales Apr/05|1845|Units Apr/05|75|DOT Apr/05|750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales May/05|38|USD Sales May/05|48|LC Sales May/05|1152|Units May/05|47|DOT May/05|470
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jun/05|40|USD Sales Jun/05|49|LC Sales Jun/05|1205|Units Jun/05|49|DOT Jun/05|490
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jul/05|22|USD Sales Jul/05|26|LC Sales Jul/05|664|Units Jul/05|27|DOT Jul/05|270
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Aug/05|54|USD Sales Aug/05|66|LC Sales Aug/05|1599|Units Aug/05|65|DOT Aug/05|650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Sep/05|48|USD Sales Sep/05|59|LC Sales Sep/05|1421|Units Sep/05|58|DOT Sep/05|580
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Oct/05|49|USD Sales Oct/05|59|LC Sales Oct/05|1451|Units Oct/05|59|DOT Oct/05|590
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Nov/05|55|USD Sales Nov/05|65|LC Sales Nov/05|1617|Units Nov/05|66|DOT Nov/05|660
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Dec/05|44|USD Sales Dec/05|52|LC Sales Dec/05|1260|Units Dec/05|55|DOT Dec/05|550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jan/06|68|USD Sales Jan/06|82|LC Sales Jan/06|1949|Units Jan/06|87|DOT Jan/06|870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Feb/06|57|USD Sales Feb/06|68|LC Sales Feb/06|1613|Units Feb/06|72|DOT Feb/06|720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Mar/06|54|USD Sales Mar/06|65|LC Sales Mar/06|1546|Units Mar/06|69|DOT Mar/06|690
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Apr/06|53|USD Sales Apr/06|65|LC Sales Apr/06|1501|Units Apr/06|67|DOT Apr/06|670
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales May/06|63|USD Sales May/06|81|LC Sales May/06|1792|Units May/06|80|DOT May/06|800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jun/06|49|USD Sales Jun/06|62|LC Sales Jun/06|1389|Units Jun/06|62|DOT Jun/06|620
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Jul/06|43|USD Sales Jul/06|55|LC Sales Jul/06|1232|Units Jul/06|55|DOT Jul/06|550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Aug/06|64|USD Sales Aug/06|81|LC Sales Aug/06|1792|Units Aug/06|80|DOT Aug/06|800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Sep/06|41|USD Sales Sep/06|53|LC Sales Sep/06|1177|Units Sep/06|54|DOT Sep/06|540
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULFAMID|0040MG|TABS 40 MG 10|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1992|1992/10|10.00|40.00 MG|MONO|FAMOTIDINE|115|22.4|31.3|EURO Sales Oct/06|42|USD Sales Oct/06|53|LC Sales Oct/06|1187|Units Oct/06|53|DOT Oct/06|530
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|KRKA*|KRKA|KRKA|ULRAN|0150MG|FILM C.TABS 150 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/07|10.00|0.30 G|MONO|RANITIDINE|116|29.9|40.5|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Nov/01|32|USD Sales Nov/01|29|LC Sales Nov/01|1073|Units Nov/01|39|DOT Nov/01|390
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Dec/01|22|USD Sales Dec/01|19|LC Sales Dec/01|700|Units Dec/01|25|DOT Dec/01|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jan/02|22|USD Sales Jan/02|19|LC Sales Jan/02|700|Units Jan/02|25|DOT Jan/02|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Feb/02|24|USD Sales Feb/02|21|LC Sales Feb/02|756|Units Feb/02|27|DOT Feb/02|270
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Mar/02|29|USD Sales Mar/02|26|LC Sales Mar/02|924|Units Mar/02|33|DOT Mar/02|330
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Apr/02|23|USD Sales Apr/02|20|LC Sales Apr/02|698|Units Apr/02|25|DOT Apr/02|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales May/02|26|USD Sales May/02|23|LC Sales May/02|784|Units May/02|28|DOT May/02|280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jun/02|17|USD Sales Jun/02|16|LC Sales Jun/02|519|Units Jun/02|19|DOT Jun/02|190
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jul/02|21|USD Sales Jul/02|21|LC Sales Jul/02|619|Units Jul/02|23|DOT Jul/02|230
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Aug/02|17|USD Sales Aug/02|17|LC Sales Aug/02|534|Units Aug/02|20|DOT Aug/02|200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Sep/02|30|USD Sales Sep/02|29|LC Sales Sep/02|908|Units Sep/02|34|DOT Sep/02|340
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Oct/02|20|USD Sales Oct/02|20|LC Sales Oct/02|614|Units Oct/02|23|DOT Oct/02|230
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Nov/02|15|USD Sales Nov/02|15|LC Sales Nov/02|454|Units Nov/02|17|DOT Nov/02|170
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jan/03|33|USD Sales Jan/03|35|LC Sales Jan/03|1041|Units Jan/03|39|DOT Jan/03|390
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Feb/03|8|USD Sales Feb/03|9|LC Sales Feb/03|267|Units Feb/03|10|DOT Feb/03|100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Mar/03|10|USD Sales Mar/03|11|LC Sales Mar/03|320|Units Mar/03|12|DOT Mar/03|120
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales May/03|1|USD Sales May/03|1|LC Sales May/03|27|Units May/03|1|DOT May/03|10
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jun/03|73|USD Sales Jun/03|85|LC Sales Jun/03|2285|Units Jun/03|116|DOT Jun/03|1160
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jul/03|17|USD Sales Jul/03|20|LC Sales Jul/03|551|Units Jul/03|26|DOT Jul/03|260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|117|18.3|24.7|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Nov/01|63|USD Sales Nov/01|56|LC Sales Nov/01|2085|Units Nov/01|25|DOT Nov/01|750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Dec/01|103|USD Sales Dec/01|92|LC Sales Dec/01|3328|Units Dec/01|40|DOT Dec/01|1200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jan/02|73|USD Sales Jan/02|65|LC Sales Jan/02|2346|Units Jan/02|28|DOT Jan/02|840
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Feb/02|110|USD Sales Feb/02|96|LC Sales Feb/02|3494|Units Feb/02|42|DOT Feb/02|1260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Mar/02|96|USD Sales Mar/02|84|LC Sales Mar/02|3006|Units Mar/02|36|DOT Mar/02|1080
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Apr/02|88|USD Sales Apr/02|78|LC Sales Apr/02|2678|Units Apr/02|32|DOT Apr/02|960
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales May/02|120|USD Sales May/02|110|LC Sales May/02|3678|Units May/02|44|DOT May/02|1320
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jun/02|104|USD Sales Jun/02|99|LC Sales Jun/02|3150|Units Jun/02|38|DOT Jun/02|1140
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jul/02|124|USD Sales Jul/02|123|LC Sales Jul/02|3694|Units Jul/02|46|DOT Jul/02|1380
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Aug/02|164|USD Sales Aug/02|160|LC Sales Aug/02|5046|Units Aug/02|63|DOT Aug/02|1890
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Sep/02|64|USD Sales Sep/02|63|LC Sales Sep/02|1925|Units Sep/02|24|DOT Sep/02|720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Oct/02|186|USD Sales Oct/02|182|LC Sales Oct/02|5694|Units Oct/02|71|DOT Oct/02|2130
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Nov/02|188|USD Sales Nov/02|188|LC Sales Nov/02|5774|Units Nov/02|72|DOT Nov/02|2160
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Dec/02|147|USD Sales Dec/02|149|LC Sales Dec/02|4571|Units Dec/02|57|DOT Dec/02|1710
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jan/03|140|USD Sales Jan/03|149|LC Sales Jan/03|4411|Units Jan/03|55|DOT Jan/03|1650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Feb/03|183|USD Sales Feb/03|197|LC Sales Feb/03|5774|Units Feb/03|72|DOT Feb/03|2160
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Mar/03|71|USD Sales Mar/03|77|LC Sales Mar/03|2246|Units Mar/03|28|DOT Mar/03|840
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Apr/03|61|USD Sales Apr/03|66|LC Sales Apr/03|1925|Units Apr/03|24|DOT Apr/03|720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales May/03|120|USD Sales May/03|139|LC Sales May/03|3769|Units May/03|47|DOT May/03|1410
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jun/03|61|USD Sales Jun/03|71|LC Sales Jun/03|1908|Units Jun/03|26|DOT Jun/03|780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jul/03|4|USD Sales Jul/03|5|LC Sales Jul/03|143|Units Jul/03|2|DOT Jul/03|60
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/07|30.00|40.00 MG|MONO|FAMOTIDINE|118|72|97.5|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Nov/01|175|USD Sales Nov/01|155|LC Sales Nov/01|5809|Units Nov/01|5|DOT Nov/01|2500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Dec/01|471|USD Sales Dec/01|421|LC Sales Dec/01|15282|Units Dec/01|13|DOT Dec/01|6500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jan/02|476|USD Sales Jan/02|420|LC Sales Jan/02|15259|Units Jan/02|13|DOT Jan/02|6500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Feb/02|335|USD Sales Feb/02|291|LC Sales Feb/02|10622|Units Feb/02|9|DOT Feb/02|4500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Mar/02|268|USD Sales Mar/02|235|LC Sales Mar/02|8406|Units Mar/02|7|DOT Mar/02|3500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Apr/02|442|USD Sales Apr/02|392|LC Sales Apr/02|13442|Units Apr/02|11|DOT Apr/02|5500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales May/02|240|USD Sales May/02|220|LC Sales May/02|7332|Units May/02|6|DOT May/02|3000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jun/02|114|USD Sales Jun/02|109|LC Sales Jun/02|3443|Units Jun/02|3|DOT Jun/02|1500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jul/02|259|USD Sales Jul/02|256|LC Sales Jul/02|7704|Units Jul/02|7|DOT Jul/02|3500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Aug/02|326|USD Sales Aug/02|318|LC Sales Aug/02|10041|Units Aug/02|9|DOT Aug/02|4500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Sep/02|232|USD Sales Sep/02|228|LC Sales Sep/02|7012|Units Sep/02|6|DOT Sep/02|3000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Oct/02|458|USD Sales Oct/02|449|LC Sales Oct/02|14024|Units Oct/02|12|DOT Oct/02|6000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Nov/02|380|USD Sales Nov/02|381|LC Sales Nov/02|11687|Units Nov/02|10|DOT Nov/02|5000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Dec/02|564|USD Sales Dec/02|573|LC Sales Dec/02|17531|Units Dec/02|15|DOT Dec/02|7500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jan/03|186|USD Sales Jan/03|197|LC Sales Jan/03|5844|Units Jan/03|5|DOT Jan/03|2500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Feb/03|480|USD Sales Feb/03|517|LC Sales Feb/03|15168|Units Feb/03|13|DOT Feb/03|6500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Mar/03|37|USD Sales Mar/03|40|LC Sales Mar/03|1169|Units Mar/03|1|DOT Mar/03|500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Apr/03|36|USD Sales Apr/03|39|LC Sales Apr/03|1143|Units Apr/03|1|DOT Apr/03|500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jun/03|37|USD Sales Jun/03|43|LC Sales Jun/03|1169|Units Jun/03|1|DOT Jun/03|500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jul/03|37|USD Sales Jul/03|42|LC Sales Jul/03|1169|Units Jul/03|1|DOT Jul/03|500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|MEDOCHEMIE|MEDO CHEM|MEDOCHEMIE|ULCERAN|0040MG|FILM C.TABS 40 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/01|500.00|40.00 MG|MONO|FAMOTIDINE|119|1186.1|1605.2|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Nov/01|2354|USD Sales Nov/01|2091|LC Sales Nov/01|78232|Units Nov/01|1116|DOT Nov/01|2790
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Dec/01|2086|USD Sales Dec/01|1862|LC Sales Dec/01|67610|Units Dec/01|959|DOT Dec/01|2397.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jan/02|1591|USD Sales Jan/02|1405|LC Sales Jan/02|51042|Units Jan/02|724|DOT Jan/02|1810
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Feb/02|1986|USD Sales Feb/02|1727|LC Sales Feb/02|63059|Units Feb/02|897|DOT Feb/02|2242.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Mar/02|1836|USD Sales Mar/02|1608|LC Sales Mar/02|57599|Units Mar/02|817|DOT Mar/02|2042.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Apr/02|2230|USD Sales Apr/02|1976|LC Sales Apr/02|67751|Units Apr/02|961|DOT Apr/02|2402.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales May/02|2217|USD Sales May/02|2034|LC Sales May/02|67866|Units May/02|964|DOT May/02|2410
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jun/02|2570|USD Sales Jun/02|2456|LC Sales Jun/02|77832|Units Jun/02|1104|DOT Jun/02|2760
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jul/02|1916|USD Sales Jul/02|1901|LC Sales Jul/02|57094|Units Jul/02|811|DOT Jul/02|2027.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Aug/02|1922|USD Sales Aug/02|1878|LC Sales Aug/02|59220|Units Aug/02|840|DOT Aug/02|2100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Sep/02|1364|USD Sales Sep/02|1337|LC Sales Sep/02|41172|Units Sep/02|584|DOT Sep/02|1460
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Oct/02|2870|USD Sales Oct/02|2815|LC Sales Oct/02|87843|Units Oct/02|1246|DOT Oct/02|3115
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Nov/02|1638|USD Sales Nov/02|1640|LC Sales Nov/02|50332|Units Nov/02|718|DOT Nov/02|1795
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Dec/02|1979|USD Sales Dec/02|2011|LC Sales Dec/02|61547|Units Dec/02|873|DOT Dec/02|2182.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jan/03|2994|USD Sales Jan/03|3180|LC Sales Jan/03|94188|Units Jan/03|1336|DOT Jan/03|3340
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Feb/03|1750|USD Sales Feb/03|1886|LC Sales Feb/03|55343|Units Feb/03|785|DOT Feb/03|1962.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Mar/03|1620|USD Sales Mar/03|1751|LC Sales Mar/03|51395|Units Mar/03|729|DOT Mar/03|1822.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Apr/03|2303|USD Sales Apr/03|2498|LC Sales Apr/03|72827|Units Apr/03|1033|DOT Apr/03|2582.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales May/03|2004|USD Sales May/03|2319|LC Sales May/03|62886|Units May/03|892|DOT May/03|2230
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jun/03|2024|USD Sales Jun/03|2361|LC Sales Jun/03|63571|Units Jun/03|903|DOT Jun/03|2257.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jul/03|1952|USD Sales Jul/03|2220|LC Sales Jul/03|62163|Units Jul/03|883|DOT Jul/03|2207.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Aug/03|1759|USD Sales Aug/03|1959|LC Sales Aug/03|56742|Units Aug/03|806|DOT Aug/03|2015
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Sep/03|1982|USD Sales Sep/03|2219|LC Sales Sep/03|64134|Units Sep/03|911|DOT Sep/03|2277.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Oct/03|2336|USD Sales Oct/03|2733|LC Sales Oct/03|74694|Units Oct/03|1061|DOT Oct/03|2652.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Nov/03|1460|USD Sales Nov/03|1709|LC Sales Nov/03|46675|Units Nov/03|663|DOT Nov/03|1657.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Dec/03|2414|USD Sales Dec/03|2962|LC Sales Dec/03|77933|Units Dec/03|1107|DOT Dec/03|2767.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jan/04|1622|USD Sales Jan/04|2046|LC Sales Jan/04|53077|Units Jan/04|755|DOT Jan/04|1887.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Feb/04|1547|USD Sales Feb/04|1957|LC Sales Feb/04|50829|Units Feb/04|722|DOT Feb/04|1805
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Mar/04|1800|USD Sales Mar/04|2208|LC Sales Mar/04|59333|Units Mar/04|844|DOT Mar/04|2110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Apr/04|2232|USD Sales Apr/04|2675|LC Sales Apr/04|72545|Units Apr/04|1029|DOT Apr/04|2572.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales May/04|2001|USD Sales May/04|2402|LC Sales May/04|64014|Units May/04|908|DOT May/04|2270
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jun/04|1880|USD Sales Jun/04|2282|LC Sales Jun/04|59432|Units Jun/04|843|DOT Jun/04|2107.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jul/04|2011|USD Sales Jul/04|2467|LC Sales Jul/04|63450|Units Jul/04|900|DOT Jul/04|2250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Aug/04|1823|USD Sales Aug/04|2221|LC Sales Aug/04|57669|Units Aug/04|818|DOT Aug/04|2045
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Sep/04|2004|USD Sales Sep/04|2447|LC Sales Sep/04|63309|Units Sep/04|898|DOT Sep/04|2245
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Oct/04|2532|USD Sales Oct/04|3163|LC Sales Oct/04|79736|Units Oct/04|1131|DOT Oct/04|2827.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Nov/04|2495|USD Sales Nov/04|3241|LC Sales Nov/04|78074|Units Nov/04|1109|DOT Nov/04|2772.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Dec/04|2565|USD Sales Dec/04|3437|LC Sales Dec/04|78637|Units Dec/04|1117|DOT Dec/04|2792.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jan/05|2864|USD Sales Jan/05|3760|LC Sales Jan/05|86786|Units Jan/05|1231|DOT Jan/05|3077.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Feb/05|2141|USD Sales Feb/05|2787|LC Sales Feb/05|64155|Units Feb/05|910|DOT Feb/05|2275
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Mar/05|2662|USD Sales Mar/05|3516|LC Sales Mar/05|79242|Units Mar/05|1124|DOT Mar/05|2810
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Apr/05|2619|USD Sales Apr/05|3389|LC Sales Apr/05|78890|Units Apr/05|1119|DOT Apr/05|2797.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales May/05|2571|USD Sales May/05|3262|LC Sales May/05|77762|Units May/05|1103|DOT May/05|2757.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jun/05|2711|USD Sales Jun/05|3298|LC Sales Jun/05|81428|Units Jun/05|1155|DOT Jun/05|2887.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jul/05|1944|USD Sales Jul/05|2340|LC Sales Jul/05|58656|Units Jul/05|832|DOT Jul/05|2080
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Aug/05|2238|USD Sales Aug/05|2751|LC Sales Aug/05|66200|Units Aug/05|939|DOT Aug/05|2347.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Sep/05|2405|USD Sales Sep/05|2948|LC Sales Sep/05|70500|Units Sep/05|1000|DOT Sep/05|2500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Oct/05|2129|USD Sales Oct/05|2559|LC Sales Oct/05|63168|Units Oct/05|896|DOT Oct/05|2240
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Nov/05|2539|USD Sales Nov/05|2992|LC Sales Nov/05|74307|Units Nov/05|1054|DOT Nov/05|2635
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Dec/05|2393|USD Sales Dec/05|2838|LC Sales Dec/05|69302|Units Dec/05|983|DOT Dec/05|2457.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jan/06|2561|USD Sales Jan/06|3099|LC Sales Jan/06|73532|Units Jan/06|1043|DOT Jan/06|2607.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Feb/06|2334|USD Sales Feb/06|2788|LC Sales Feb/06|66341|Units Feb/06|941|DOT Feb/06|2352.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Mar/06|2811|USD Sales Mar/06|3380|LC Sales Mar/06|80511|Units Mar/06|1142|DOT Mar/06|2855
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Apr/06|2040|USD Sales Apr/06|2502|LC Sales Apr/06|58163|Units Apr/06|825|DOT Apr/06|2062.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales May/06|2439|USD Sales May/06|3113|LC Sales May/06|68949|Units May/06|978|DOT May/06|2445
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jun/06|2415|USD Sales Jun/06|3058|LC Sales Jun/06|68526|Units Jun/06|972|DOT Jun/06|2430
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Jul/06|2339|USD Sales Jul/06|2969|LC Sales Jul/06|66552|Units Jul/06|944|DOT Jul/06|2360
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Aug/06|2448|USD Sales Aug/06|3136|LC Sales Aug/06|69020|Units Aug/06|979|DOT Aug/06|2447.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Sep/06|2521|USD Sales Sep/06|3211|LC Sales Sep/06|71558|Units Sep/06|1015|DOT Sep/06|2537.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|AMP. 200 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/07|2.50|0.80 G|MONO|CIMETIDINE|120|70.5|98.5|EURO Sales Oct/06|2438|USD Sales Oct/06|3076|LC Sales Oct/06|68949|Units Oct/06|978|DOT Oct/06|2445
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Nov/01|283|USD Sales Nov/01|251|LC Sales Nov/01|9406|Units Nov/01|122|DOT Nov/01|3050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Dec/01|167|USD Sales Dec/01|149|LC Sales Dec/01|5411|Units Dec/01|70|DOT Dec/01|1750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jan/02|224|USD Sales Jan/02|198|LC Sales Jan/02|7189|Units Jan/02|93|DOT Jan/02|2325
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Feb/02|226|USD Sales Feb/02|197|LC Sales Feb/02|7189|Units Feb/02|93|DOT Feb/02|2325
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Mar/02|274|USD Sales Mar/02|239|LC Sales Mar/02|8580|Units Mar/02|111|DOT Mar/02|2775
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Apr/02|303|USD Sales Apr/02|268|LC Sales Apr/02|9199|Units Apr/02|119|DOT Apr/02|2975
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales May/02|333|USD Sales May/02|306|LC Sales May/02|10204|Units May/02|132|DOT May/02|3300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jun/02|248|USD Sales Jun/02|237|LC Sales Jun/02|7498|Units Jun/02|97|DOT Jun/02|2425
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jul/02|223|USD Sales Jul/02|221|LC Sales Jul/02|6648|Units Jul/02|86|DOT Jul/02|2150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Aug/02|181|USD Sales Aug/02|177|LC Sales Aug/02|5566|Units Aug/02|72|DOT Aug/02|1800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Sep/02|317|USD Sales Sep/02|311|LC Sales Sep/02|9585|Units Sep/02|124|DOT Sep/02|3100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Oct/02|283|USD Sales Oct/02|277|LC Sales Oct/02|8658|Units Oct/02|112|DOT Oct/02|2800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Nov/02|289|USD Sales Nov/02|290|LC Sales Nov/02|8890|Units Nov/02|115|DOT Nov/02|2875
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Dec/02|256|USD Sales Dec/02|260|LC Sales Dec/02|7962|Units Dec/02|103|DOT Dec/02|2575
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jan/03|265|USD Sales Jan/03|282|LC Sales Jan/03|8348|Units Jan/03|108|DOT Jan/03|2700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Feb/03|222|USD Sales Feb/03|240|LC Sales Feb/03|7034|Units Feb/03|91|DOT Feb/03|2275
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Mar/03|278|USD Sales Mar/03|300|LC Sales Mar/03|8812|Units Mar/03|114|DOT Mar/03|2850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Apr/03|311|USD Sales Apr/03|337|LC Sales Apr/03|9817|Units Apr/03|127|DOT Apr/03|3175
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales May/03|244|USD Sales May/03|282|LC Sales May/03|7653|Units May/03|99|DOT May/03|2475
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jun/03|234|USD Sales Jun/03|273|LC Sales Jun/03|7344|Units Jun/03|95|DOT Jun/03|2375
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jul/03|192|USD Sales Jul/03|218|LC Sales Jul/03|6107|Units Jul/03|79|DOT Jul/03|1975
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Aug/03|239|USD Sales Aug/03|267|LC Sales Aug/03|7720|Units Aug/03|100|DOT Aug/03|2500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Sep/03|234|USD Sales Sep/03|262|LC Sales Sep/03|7566|Units Sep/03|98|DOT Sep/03|2450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Oct/03|215|USD Sales Oct/03|252|LC Sales Oct/03|6880|Units Oct/03|89|DOT Oct/03|2225
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Nov/03|223|USD Sales Nov/03|261|LC Sales Nov/03|7115|Units Nov/03|93|DOT Nov/03|2325
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Dec/03|313|USD Sales Dec/03|384|LC Sales Dec/03|10113|Units Dec/03|131|DOT Dec/03|3275
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jan/04|311|USD Sales Jan/04|393|LC Sales Jan/04|10190|Units Jan/04|132|DOT Jan/04|3300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Feb/04|247|USD Sales Feb/04|312|LC Sales Feb/04|8106|Units Feb/04|105|DOT Feb/04|2625
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Mar/04|248|USD Sales Mar/04|305|LC Sales Mar/04|8183|Units Mar/04|106|DOT Mar/04|2650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Apr/04|140|USD Sales Apr/04|168|LC Sales Apr/04|4561|Units Apr/04|59|DOT Apr/04|1475
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales May/04|331|USD Sales May/04|397|LC Sales May/04|10590|Units May/04|137|DOT May/04|3425
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jun/04|301|USD Sales Jun/04|365|LC Sales Jun/04|9508|Units Jun/04|123|DOT Jun/04|3075
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jul/04|314|USD Sales Jul/04|385|LC Sales Jul/04|9894|Units Jul/04|128|DOT Jul/04|3200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Aug/04|134|USD Sales Aug/04|164|LC Sales Aug/04|4246|Units Aug/04|55|DOT Aug/04|1375
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Sep/04|269|USD Sales Sep/04|329|LC Sales Sep/04|8503|Units Sep/04|110|DOT Sep/04|2750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Oct/04|272|USD Sales Oct/04|340|LC Sales Oct/04|8580|Units Oct/04|111|DOT Oct/04|2775
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Nov/04|247|USD Sales Nov/04|320|LC Sales Nov/04|7720|Units Nov/04|100|DOT Nov/04|2500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Dec/04|237|USD Sales Dec/04|317|LC Sales Dec/04|7257|Units Dec/04|94|DOT Dec/04|2350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jan/05|293|USD Sales Jan/05|385|LC Sales Jan/05|8890|Units Jan/05|115|DOT Jan/05|2875
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Feb/05|188|USD Sales Feb/05|245|LC Sales Feb/05|5643|Units Feb/05|73|DOT Feb/05|1825
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Mar/05|280|USD Sales Mar/05|370|LC Sales Mar/05|8348|Units Mar/05|108|DOT Mar/05|2700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Apr/05|180|USD Sales Apr/05|232|LC Sales Apr/05|5411|Units Apr/05|70|DOT Apr/05|1750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales May/05|222|USD Sales May/05|282|LC Sales May/05|6725|Units May/05|87|DOT May/05|2175
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jun/05|165|USD Sales Jun/05|200|LC Sales Jun/05|4941|Units Jun/05|64|DOT Jun/05|1600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jul/05|159|USD Sales Jul/05|191|LC Sales Jul/05|4786|Units Jul/05|62|DOT Jul/05|1550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Aug/05|269|USD Sales Aug/05|331|LC Sales Aug/05|7962|Units Aug/05|103|DOT Aug/05|2575
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Sep/05|137|USD Sales Sep/05|168|LC Sales Sep/05|4020|Units Sep/05|52|DOT Sep/05|1300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Oct/05|195|USD Sales Oct/05|235|LC Sales Oct/05|5798|Units Oct/05|75|DOT Oct/05|1875
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Nov/05|225|USD Sales Nov/05|265|LC Sales Nov/05|6571|Units Nov/05|85|DOT Nov/05|2125
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Dec/05|198|USD Sales Dec/05|234|LC Sales Dec/05|5720|Units Dec/05|74|DOT Dec/05|1850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jan/06|212|USD Sales Jan/06|257|LC Sales Jan/06|6099|Units Jan/06|79|DOT Jan/06|1975
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Feb/06|144|USD Sales Feb/06|172|LC Sales Feb/06|4092|Units Feb/06|53|DOT Feb/06|1325
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Mar/06|280|USD Sales Mar/06|337|LC Sales Mar/06|8029|Units Mar/06|104|DOT Mar/06|2600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Apr/06|225|USD Sales Apr/06|276|LC Sales Apr/06|6408|Units Apr/06|83|DOT Apr/06|2075
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales May/06|276|USD Sales May/06|352|LC Sales May/06|7797|Units May/06|101|DOT May/06|2525
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jun/06|261|USD Sales Jun/06|331|LC Sales Jun/06|7411|Units Jun/06|96|DOT Jun/06|2400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Jul/06|160|USD Sales Jul/06|203|LC Sales Jul/06|4555|Units Jul/06|59|DOT Jul/06|1475
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Aug/06|174|USD Sales Aug/06|223|LC Sales Aug/06|4914|Units Aug/06|65|DOT Aug/06|1625
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Sep/06|291|USD Sales Sep/06|371|LC Sales Sep/06|8260|Units Sep/06|107|DOT Sep/06|2675
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|PRIMAMET|0200MG|TABS 200 MG 100|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1991|1991/10|25.00|0.80 G|MONO|CIMETIDINE|121|77.2|107.8|EURO Sales Oct/06|276|USD Sales Oct/06|348|LC Sales Oct/06|7797|Units Oct/06|101|DOT Oct/06|2525
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Nov/01|4313|USD Sales Nov/01|3832|LC Sales Nov/01|143370|Units Nov/01|1770|DOT Nov/01|1469.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Dec/01|4211|USD Sales Dec/01|3760|LC Sales Dec/01|136503|Units Dec/01|1679|DOT Dec/01|1393.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jan/02|5101|USD Sales Jan/02|4504|LC Sales Jan/02|163657|Units Jan/02|2013|DOT Jan/02|1670.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Feb/02|4918|USD Sales Feb/02|4278|LC Sales Feb/02|156177|Units Feb/02|1921|DOT Feb/02|1594.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Mar/02|4598|USD Sales Mar/02|4026|LC Sales Mar/02|144226|Units Mar/02|1774|DOT Mar/02|1472.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Apr/02|5824|USD Sales Apr/02|5159|LC Sales Apr/02|176909|Units Apr/02|2176|DOT Apr/02|1806
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales May/02|4590|USD Sales May/02|4211|LC Sales May/02|140486|Units May/02|1728|DOT May/02|1434.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jun/02|5454|USD Sales Jun/02|5212|LC Sales Jun/02|165161|Units Jun/02|2034|DOT Jun/02|1688.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jul/02|5747|USD Sales Jul/02|5700|LC Sales Jul/02|171227|Units Jul/02|2135|DOT Jul/02|1772
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Aug/02|5234|USD Sales Aug/02|5116|LC Sales Aug/02|161282|Units Aug/02|2011|DOT Aug/02|1669.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Sep/02|3594|USD Sales Sep/02|3524|LC Sales Sep/02|108511|Units Sep/02|1353|DOT Sep/02|1122.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Oct/02|4407|USD Sales Oct/02|4322|LC Sales Oct/02|134896|Units Oct/02|1682|DOT Oct/02|1396
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Nov/02|3482|USD Sales Nov/02|3487|LC Sales Nov/02|106987|Units Nov/02|1334|DOT Nov/02|1107.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Dec/02|4128|USD Sales Dec/02|4195|LC Sales Dec/02|128400|Units Dec/02|1601|DOT Dec/02|1328.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jan/03|3763|USD Sales Jan/03|3997|LC Sales Jan/03|118375|Units Jan/03|1476|DOT Jan/03|1225
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Feb/03|3645|USD Sales Feb/03|3928|LC Sales Feb/03|115247|Units Feb/03|1437|DOT Feb/03|1192.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Mar/03|3274|USD Sales Mar/03|3538|LC Sales Mar/03|103859|Units Mar/03|1295|DOT Mar/03|1074.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Apr/03|4553|USD Sales Apr/03|4939|LC Sales Apr/03|143959|Units Apr/03|1795|DOT Apr/03|1489.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales May/03|5099|USD Sales May/03|5900|LC Sales May/03|159999|Units May/03|1995|DOT May/03|1655.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jun/03|5343|USD Sales Jun/03|6231|LC Sales Jun/03|167778|Units Jun/03|2092|DOT Jun/03|1736.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jul/03|5326|USD Sales Jul/03|6057|LC Sales Jul/03|169594|Units Jul/03|2112|DOT Jul/03|1752.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Aug/03|4547|USD Sales Aug/03|5064|LC Sales Aug/03|146686|Units Aug/03|1829|DOT Aug/03|1518
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Sep/03|5895|USD Sales Sep/03|6603|LC Sales Sep/03|190793|Units Sep/03|2376|DOT Sep/03|1972
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Oct/03|5466|USD Sales Oct/03|6394|LC Sales Oct/03|174733|Units Oct/03|2176|DOT Oct/03|1806
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Nov/03|4760|USD Sales Nov/03|5570|LC Sales Nov/03|152139|Units Nov/03|1897|DOT Nov/03|1574.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Dec/03|4138|USD Sales Dec/03|5079|LC Sales Dec/03|133613|Units Dec/03|1666|DOT Dec/03|1382.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jan/04|3402|USD Sales Jan/04|4291|LC Sales Jan/04|111318|Units Jan/04|1388|DOT Jan/04|1152
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Feb/04|3180|USD Sales Feb/04|4021|LC Sales Feb/04|104470|Units Feb/04|1301|DOT Feb/04|1079.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Mar/04|3821|USD Sales Mar/04|4689|LC Sales Mar/04|125994|Units Mar/04|1571|DOT Mar/04|1303.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Apr/04|3448|USD Sales Apr/04|4133|LC Sales Apr/04|112078|Units Apr/04|1394|DOT Apr/04|1157
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales May/04|3636|USD Sales May/04|4365|LC Sales May/04|116339|Units May/04|1447|DOT May/04|1201
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jun/04|5426|USD Sales Jun/04|6586|LC Sales Jun/04|171545|Units Jun/04|2147|DOT Jun/04|1782
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jul/04|4473|USD Sales Jul/04|5487|LC Sales Jul/04|141117|Units Jul/04|1753|DOT Jul/04|1454.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Aug/04|3732|USD Sales Aug/04|4545|LC Sales Aug/04|118039|Units Aug/04|1436|DOT Aug/04|1191.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Sep/04|3610|USD Sales Sep/04|4410|LC Sales Sep/04|114087|Units Sep/04|1393|DOT Sep/04|1156.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Oct/04|3697|USD Sales Oct/04|4618|LC Sales Oct/04|116417|Units Oct/04|1406|DOT Oct/04|1166.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Nov/04|4231|USD Sales Nov/04|5496|LC Sales Nov/04|132397|Units Nov/04|1599|DOT Nov/04|1327.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Dec/04|3220|USD Sales Dec/04|4314|LC Sales Dec/04|98698|Units Dec/04|1192|DOT Dec/04|989.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jan/05|5143|USD Sales Jan/05|6752|LC Sales Jan/05|155852|Units Jan/05|1880|DOT Jan/05|1560.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Feb/05|3007|USD Sales Feb/05|3914|LC Sales Feb/05|90112|Units Feb/05|1087|DOT Feb/05|902.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Mar/05|3534|USD Sales Mar/05|4667|LC Sales Mar/05|105200|Units Mar/05|1269|DOT Mar/05|1053.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Apr/05|2805|USD Sales Apr/05|3629|LC Sales Apr/05|84475|Units Apr/05|1019|DOT Apr/05|845.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales May/05|3224|USD Sales May/05|4090|LC Sales May/05|97490|Units May/05|1176|DOT May/05|976
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jun/05|3757|USD Sales Jun/05|4571|LC Sales Jun/05|112840|Units Jun/05|1400|DOT Jun/05|1162
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jul/05|2100|USD Sales Jul/05|2528|LC Sales Jul/05|63359|Units Jul/05|791|DOT Jul/05|656.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Aug/05|3723|USD Sales Aug/05|4577|LC Sales Aug/05|110138|Units Aug/05|1375|DOT Aug/05|1141.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Sep/05|2607|USD Sales Sep/05|3195|LC Sales Sep/05|76415|Units Sep/05|954|DOT Sep/05|791.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Oct/05|3217|USD Sales Oct/05|3868|LC Sales Oct/05|95479|Units Oct/05|1192|DOT Oct/05|989.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Nov/05|2466|USD Sales Nov/05|2906|LC Sales Nov/05|72170|Units Nov/05|901|DOT Nov/05|747.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Dec/05|3234|USD Sales Dec/05|3835|LC Sales Dec/05|93637|Units Dec/05|1169|DOT Dec/05|970.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jan/06|2784|USD Sales Jan/06|3369|LC Sales Jan/06|79940|Units Jan/06|998|DOT Jan/06|828.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Feb/06|2694|USD Sales Feb/06|3218|LC Sales Feb/06|76576|Units Feb/06|956|DOT Feb/06|793.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Mar/06|3281|USD Sales Mar/06|3945|LC Sales Mar/06|93957|Units Mar/06|1173|DOT Mar/06|973.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Apr/06|2866|USD Sales Apr/06|3514|LC Sales Apr/06|81702|Units Apr/06|1020|DOT Apr/06|846.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales May/06|3504|USD Sales May/06|4473|LC Sales May/06|99084|Units May/06|1237|DOT May/06|1026.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jun/06|2975|USD Sales Jun/06|3768|LC Sales Jun/06|84426|Units Jun/06|1081|DOT Jun/06|897.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Jul/06|2386|USD Sales Jul/06|3028|LC Sales Jul/06|67890|Units Jul/06|876|DOT Jul/06|727
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Aug/06|3161|USD Sales Aug/06|4050|LC Sales Aug/06|89125|Units Aug/06|1150|DOT Aug/06|954.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Sep/06|2859|USD Sales Sep/06|3641|LC Sales Sep/06|81143|Units Sep/06|1047|DOT Sep/06|869
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0050MG|AMP. 50 MG 5 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|1991|1991/01|0.83|0.30 G|MONO|RANITIDINE|122|77.5|108.2|EURO Sales Oct/06|3023|USD Sales Oct/06|3813|LC Sales Oct/06|85483|Units Oct/06|1103|DOT Oct/06|915.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Nov/01|2229|USD Sales Nov/01|1980|LC Sales Nov/01|74088|Units Nov/01|1680|DOT Nov/01|25200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Dec/01|2126|USD Sales Dec/01|1898|LC Sales Dec/01|68908|Units Dec/01|1559|DOT Dec/01|23385
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jan/02|2707|USD Sales Jan/02|2390|LC Sales Jan/02|86853|Units Jan/02|1965|DOT Jan/02|29475
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Feb/02|1826|USD Sales Feb/02|1588|LC Sales Feb/02|57990|Units Feb/02|1312|DOT Feb/02|19680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Mar/02|2377|USD Sales Mar/02|2081|LC Sales Mar/02|74565|Units Mar/02|1687|DOT Mar/02|25305
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Apr/02|2328|USD Sales Apr/02|2062|LC Sales Apr/02|70720|Units Apr/02|1600|DOT Apr/02|24000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales May/02|2178|USD Sales May/02|1998|LC Sales May/02|66654|Units May/02|1508|DOT May/02|22620
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jun/02|2097|USD Sales Jun/02|2004|LC Sales Jun/02|63515|Units Jun/02|1437|DOT Jun/02|21555
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jul/02|2326|USD Sales Jul/02|2307|LC Sales Jul/02|69306|Units Jul/02|1568|DOT Jul/02|23520
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Aug/02|1726|USD Sales Aug/02|1687|LC Sales Aug/02|53185|Units Aug/02|1206|DOT Aug/02|18090
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Sep/02|2200|USD Sales Sep/02|2157|LC Sales Sep/02|66433|Units Sep/02|1503|DOT Sep/02|22545
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Oct/02|2117|USD Sales Oct/02|2076|LC Sales Oct/02|64797|Units Oct/02|1466|DOT Oct/02|21990
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Nov/02|1896|USD Sales Nov/02|1899|LC Sales Nov/02|58256|Units Nov/02|1318|DOT Nov/02|19770
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Dec/02|1879|USD Sales Dec/02|1910|LC Sales Dec/02|58465|Units Dec/02|1366|DOT Dec/02|20490
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jan/03|2028|USD Sales Jan/03|2154|LC Sales Jan/03|63814|Units Jan/03|1534|DOT Jan/03|23010
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Feb/03|1821|USD Sales Feb/03|1962|LC Sales Feb/03|57561|Units Feb/03|1387|DOT Feb/03|20805
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Mar/03|1852|USD Sales Mar/03|2001|LC Sales Mar/03|58739|Units Mar/03|1412|DOT Mar/03|21180
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Apr/03|1645|USD Sales Apr/03|1784|LC Sales Apr/03|51998|Units Apr/03|1256|DOT Apr/03|18840
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales May/03|2271|USD Sales May/03|2627|LC Sales May/03|71256|Units May/03|1717|DOT May/03|25755
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jun/03|1911|USD Sales Jun/03|2229|LC Sales Jun/03|60009|Units Jun/03|1446|DOT Jun/03|21690
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jul/03|2314|USD Sales Jul/03|2631|LC Sales Jul/03|73674|Units Jul/03|1771|DOT Jul/03|26565
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Aug/03|1849|USD Sales Aug/03|2059|LC Sales Aug/03|59654|Units Aug/03|1434|DOT Aug/03|21510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Sep/03|1772|USD Sales Sep/03|1985|LC Sales Sep/03|57366|Units Sep/03|1379|DOT Sep/03|20685
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Oct/03|2082|USD Sales Oct/03|2436|LC Sales Oct/03|66560|Units Oct/03|1600|DOT Oct/03|24000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Nov/03|1843|USD Sales Nov/03|2157|LC Sales Nov/03|58906|Units Nov/03|1416|DOT Nov/03|21240
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Dec/03|1829|USD Sales Dec/03|2245|LC Sales Dec/03|59072|Units Dec/03|1420|DOT Dec/03|21300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jan/04|2072|USD Sales Jan/04|2614|LC Sales Jan/04|67808|Units Jan/04|1630|DOT Jan/04|24450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Feb/04|1764|USD Sales Feb/04|2231|LC Sales Feb/04|57949|Units Feb/04|1393|DOT Feb/04|20895
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Mar/04|2275|USD Sales Mar/04|2791|LC Sales Mar/04|75005|Units Mar/04|1803|DOT Mar/04|27045
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Apr/04|2035|USD Sales Apr/04|2439|LC Sales Apr/04|66151|Units Apr/04|1594|DOT Apr/04|23910
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales May/04|1950|USD Sales May/04|2340|LC Sales May/04|62375|Units May/04|1503|DOT May/04|22545
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jun/04|1889|USD Sales Jun/04|2293|LC Sales Jun/04|59719|Units Jun/04|1439|DOT Jun/04|21585
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jul/04|1710|USD Sales Jul/04|2098|LC Sales Jul/04|53950|Units Jul/04|1300|DOT Jul/04|19500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Aug/04|1720|USD Sales Aug/04|2095|LC Sales Aug/04|54407|Units Aug/04|1311|DOT Aug/04|19665
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Sep/04|2248|USD Sales Sep/04|2746|LC Sales Sep/04|71048|Units Sep/04|1712|DOT Sep/04|25680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Oct/04|1692|USD Sales Oct/04|2114|LC Sales Oct/04|53286|Units Oct/04|1284|DOT Oct/04|19260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Nov/04|1673|USD Sales Nov/04|2172|LC Sales Nov/04|52333|Units Nov/04|1258|DOT Nov/04|18870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Dec/04|1638|USD Sales Dec/04|2194|LC Sales Dec/04|50200|Units Dec/04|1255|DOT Dec/04|18825
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jan/05|1562|USD Sales Jan/05|2050|LC Sales Jan/05|47325|Units Jan/05|1286|DOT Jan/05|19290
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Feb/05|1492|USD Sales Feb/05|1942|LC Sales Feb/05|44712|Units Feb/05|1215|DOT Feb/05|18225
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Mar/05|3190|USD Sales Mar/05|4214|LC Sales Mar/05|94981|Units Mar/05|2581|DOT Mar/05|38715
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Apr/05|6144|USD Sales Apr/05|7951|LC Sales Apr/05|185067|Units Apr/05|5029|DOT Apr/05|75435
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales May/05|921|USD Sales May/05|1169|LC Sales May/05|27858|Units May/05|757|DOT May/05|11355
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jun/05|1|USD Sales Jun/05|1|LC Sales Jun/05|37|Units Jun/05|1|DOT Jun/05|15
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jul/05|2|USD Sales Jul/05|3|LC Sales Jul/05|74|Units Jul/05|2|DOT Jul/05|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Sep/05|1410|USD Sales Sep/05|1728|LC Sales Sep/05|41326|Units Sep/05|1123|DOT Sep/05|16845
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Oct/05|816|USD Sales Oct/05|981|LC Sales Oct/05|24214|Units Oct/05|658|DOT Oct/05|9870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Nov/05|1012|USD Sales Nov/05|1193|LC Sales Nov/05|29624|Units Nov/05|805|DOT Nov/05|12075
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Dec/05|863|USD Sales Dec/05|1023|LC Sales Dec/05|24986|Units Dec/05|696|DOT Dec/05|10440
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jan/06|986|USD Sales Jan/06|1193|LC Sales Jan/06|28308|Units Jan/06|845|DOT Jan/06|12675
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Feb/06|755|USD Sales Feb/06|902|LC Sales Feb/06|21474|Units Feb/06|641|DOT Feb/06|9615
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Mar/06|887|USD Sales Mar/06|1066|LC Sales Mar/06|25393|Units Mar/06|758|DOT Mar/06|11370
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Apr/06|951|USD Sales Apr/06|1166|LC Sales Apr/06|27102|Units Apr/06|809|DOT Apr/06|12135
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales May/06|818|USD Sales May/06|1044|LC Sales May/06|23115|Units May/06|690|DOT May/06|10350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jun/06|1210|USD Sales Jun/06|1532|LC Sales Jun/06|34338|Units Jun/06|1025|DOT Jun/06|15375
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Jul/06|777|USD Sales Jul/06|986|LC Sales Jul/06|22109|Units Jul/06|658|DOT Jul/06|9870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Aug/06|977|USD Sales Aug/06|1252|LC Sales Aug/06|27552|Units Aug/06|820|DOT Aug/06|12300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Sep/06|934|USD Sales Sep/06|1189|LC Sales Sep/06|26510|Units Sep/06|789|DOT Sep/06|11835
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0150MG|TABS 150 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1988|1988/01|15.00|0.30 G|MONO|RANITIDINE|123|33.6|46.9|EURO Sales Oct/06|1261|USD Sales Oct/06|1590|LC Sales Oct/06|35650|Units Oct/06|1061|DOT Oct/06|15915
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Nov/01|147|USD Sales Nov/01|130|LC Sales Nov/01|4872|Units Nov/01|58|DOT Nov/01|1740
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Dec/01|232|USD Sales Dec/01|207|LC Sales Dec/01|7524|Units Dec/01|90|DOT Dec/01|2700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jan/02|178|USD Sales Jan/02|157|LC Sales Jan/02|5705|Units Jan/02|68|DOT Jan/02|2040
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Feb/02|183|USD Sales Feb/02|159|LC Sales Feb/02|5796|Units Feb/02|69|DOT Feb/02|2070
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Mar/02|133|USD Sales Mar/02|117|LC Sales Mar/02|4175|Units Mar/02|50|DOT Mar/02|1500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Apr/02|187|USD Sales Apr/02|166|LC Sales Apr/02|5692|Units Apr/02|68|DOT Apr/02|2040
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales May/02|69|USD Sales May/02|63|LC Sales May/02|2100|Units May/02|25|DOT May/02|750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jun/02|165|USD Sales Jun/02|158|LC Sales Jun/02|5010|Units Jun/02|60|DOT Jun/02|1800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jul/02|155|USD Sales Jul/02|154|LC Sales Jul/02|4620|Units Jul/02|55|DOT Jul/02|1650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Aug/02|134|USD Sales Aug/02|131|LC Sales Aug/02|4116|Units Aug/02|49|DOT Aug/02|1470
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Sep/02|189|USD Sales Sep/02|185|LC Sales Sep/02|5712|Units Sep/02|68|DOT Sep/02|2040
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Oct/02|121|USD Sales Oct/02|118|LC Sales Oct/02|3696|Units Oct/02|44|DOT Oct/02|1320
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Nov/02|211|USD Sales Nov/02|211|LC Sales Nov/02|6468|Units Nov/02|77|DOT Nov/02|2310
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Dec/02|182|USD Sales Dec/02|185|LC Sales Dec/02|5672|Units Dec/02|69|DOT Dec/02|2070
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jan/03|147|USD Sales Jan/03|156|LC Sales Jan/03|4628|Units Jan/03|57|DOT Jan/03|1710
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Feb/03|87|USD Sales Feb/03|94|LC Sales Feb/03|2747|Units Feb/03|34|DOT Feb/03|1020
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Mar/03|153|USD Sales Mar/03|165|LC Sales Mar/03|4848|Units Mar/03|60|DOT Mar/03|1800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Apr/03|120|USD Sales Apr/03|130|LC Sales Apr/03|3798|Units Apr/03|47|DOT Apr/03|1410
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales May/03|70|USD Sales May/03|80|LC Sales May/03|2182|Units May/03|27|DOT May/03|810
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jun/03|224|USD Sales Jun/03|261|LC Sales Jun/03|7030|Units Jun/03|87|DOT Jun/03|2610
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jul/03|71|USD Sales Jul/03|81|LC Sales Jul/03|2262|Units Jul/03|28|DOT Jul/03|840
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Aug/03|70|USD Sales Aug/03|78|LC Sales Aug/03|2262|Units Aug/03|28|DOT Aug/03|840
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Sep/03|150|USD Sales Sep/03|168|LC Sales Sep/03|4848|Units Sep/03|60|DOT Sep/03|1800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Oct/03|30|USD Sales Oct/03|35|LC Sales Oct/03|970|Units Oct/03|12|DOT Oct/03|360
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Nov/03|33|USD Sales Nov/03|38|LC Sales Nov/03|1050|Units Nov/03|13|DOT Nov/03|390
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Dec/03|98|USD Sales Dec/03|120|LC Sales Dec/03|3155|Units Dec/03|39|DOT Dec/03|1170
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jan/04|77|USD Sales Jan/04|97|LC Sales Jan/04|2508|Units Jan/04|31|DOT Jan/04|930
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Feb/04|79|USD Sales Feb/04|100|LC Sales Feb/04|2589|Units Feb/04|32|DOT Feb/04|960
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Mar/04|20|USD Sales Mar/04|24|LC Sales Mar/04|647|Units Mar/04|8|DOT Mar/04|240
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Apr/04|137|USD Sales Apr/04|164|LC Sales Apr/04|4444|Units Apr/04|55|DOT Apr/04|1650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales May/04|53|USD Sales May/04|64|LC Sales May/04|1697|Units May/04|21|DOT May/04|630
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jun/04|100|USD Sales Jun/04|121|LC Sales Jun/04|3151|Units Jun/04|39|DOT Jun/04|1170
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jul/04|100|USD Sales Jul/04|123|LC Sales Jul/04|3151|Units Jul/04|39|DOT Jul/04|1170
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Aug/04|100|USD Sales Aug/04|121|LC Sales Aug/04|3151|Units Aug/04|39|DOT Aug/04|1170
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Sep/04|156|USD Sales Sep/04|191|LC Sales Sep/04|4929|Units Sep/04|61|DOT Sep/04|1830
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Oct/04|31|USD Sales Oct/04|38|LC Sales Oct/04|970|Units Oct/04|12|DOT Oct/04|360
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Nov/04|98|USD Sales Nov/04|127|LC Sales Nov/04|3070|Units Nov/04|38|DOT Nov/04|1140
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Dec/04|113|USD Sales Dec/04|152|LC Sales Dec/04|3474|Units Dec/04|43|DOT Dec/04|1290
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jan/05|53|USD Sales Jan/05|70|LC Sales Jan/05|1616|Units Jan/05|20|DOT Jan/05|600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Feb/05|54|USD Sales Feb/05|70|LC Sales Feb/05|1616|Units Feb/05|20|DOT Feb/05|600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Mar/05|100|USD Sales Mar/05|133|LC Sales Mar/05|2990|Units Mar/05|37|DOT Mar/05|1110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Apr/05|72|USD Sales Apr/05|94|LC Sales Apr/05|2182|Units Apr/05|27|DOT Apr/05|810
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales May/05|99|USD Sales May/05|125|LC Sales May/05|2990|Units May/05|37|DOT May/05|1110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jun/05|105|USD Sales Jun/05|128|LC Sales Jun/05|3151|Units Jun/05|39|DOT Jun/05|1170
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jul/05|107|USD Sales Jul/05|129|LC Sales Jul/05|3232|Units Jul/05|40|DOT Jul/05|1200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Aug/05|68|USD Sales Aug/05|84|LC Sales Aug/05|2020|Units Aug/05|25|DOT Aug/05|750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Sep/05|58|USD Sales Sep/05|71|LC Sales Sep/05|1697|Units Sep/05|21|DOT Sep/05|630
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Oct/05|133|USD Sales Oct/05|160|LC Sales Oct/05|3959|Units Oct/05|49|DOT Oct/05|1470
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Nov/05|160|USD Sales Nov/05|189|LC Sales Nov/05|4686|Units Nov/05|58|DOT Nov/05|1740
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Dec/05|179|USD Sales Dec/05|212|LC Sales Dec/05|5171|Units Dec/05|64|DOT Dec/05|1920
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jan/06|59|USD Sales Jan/06|72|LC Sales Jan/06|1697|Units Jan/06|21|DOT Jan/06|630
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Feb/06|54|USD Sales Feb/06|65|LC Sales Feb/06|1535|Units Feb/06|19|DOT Feb/06|570
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Mar/06|76|USD Sales Mar/06|92|LC Sales Mar/06|2182|Units Mar/06|27|DOT Mar/06|810
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Apr/06|85|USD Sales Apr/06|104|LC Sales Apr/06|2424|Units Apr/06|30|DOT Apr/06|900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales May/06|69|USD Sales May/06|88|LC Sales May/06|1939|Units May/06|24|DOT May/06|720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jun/06|122|USD Sales Jun/06|155|LC Sales Jun/06|3474|Units Jun/06|43|DOT Jun/06|1290
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Jul/06|67|USD Sales Jul/06|85|LC Sales Jul/06|1910|Units Jul/06|24|DOT Jul/06|720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Aug/06|66|USD Sales Aug/06|84|LC Sales Aug/06|1858|Units Aug/06|23|DOT Aug/06|690
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Sep/06|142|USD Sales Sep/06|181|LC Sales Sep/06|4040|Units Sep/06|50|DOT Sep/06|1500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|NOVARTIS*|NOVARTIS|SANDOZ|RANITAL|0300MG|TABS 300 MG 30|A ORAL SOLID ORDINARY|AA ORAL S ORD TABLETS|AAA ORAL S ORD TABLETS|RX BOUND|1996|1996/01|30.00|0.30 G|MONO|RANITIDINE|124|80.8|112.8|EURO Sales Oct/06|57|USD Sales Oct/06|72|LC Sales Oct/06|1616|Units Oct/06|20|DOT Oct/06|600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Nov/05|35|USD Sales Nov/05|41|LC Sales Nov/05|1020|Units Nov/05|34|DOT Nov/05|85
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Dec/05|33|USD Sales Dec/05|39|LC Sales Dec/05|960|Units Dec/05|32|DOT Dec/05|80
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jan/06|46|USD Sales Jan/06|56|LC Sales Jan/06|1320|Units Jan/06|44|DOT Jan/06|110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Feb/06|27|USD Sales Feb/06|33|LC Sales Feb/06|780|Units Feb/06|26|DOT Feb/06|65
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Mar/06|102|USD Sales Mar/06|122|LC Sales Mar/06|2910|Units Mar/06|97|DOT Mar/06|242.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Apr/06|113|USD Sales Apr/06|138|LC Sales Apr/06|3210|Units Apr/06|107|DOT Apr/06|267.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales May/06|222|USD Sales May/06|283|LC Sales May/06|6270|Units May/06|209|DOT May/06|522.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jun/06|228|USD Sales Jun/06|289|LC Sales Jun/06|6480|Units Jun/06|216|DOT Jun/06|540
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Jul/06|35|USD Sales Jul/06|44|LC Sales Jul/06|990|Units Jul/06|33|DOT Jul/06|82.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Aug/06|22|USD Sales Aug/06|29|LC Sales Aug/06|630|Units Aug/06|21|DOT Aug/06|52.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Sep/06|53|USD Sales Sep/06|67|LC Sales Sep/06|1500|Units Sep/06|50|DOT Sep/06|125
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0010MG|FILM C.TABS 10 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2005|2005/11|2.50|40.00 MG|MONO|FAMOTIDINE|125|30|41.9|EURO Sales Oct/06|93|USD Sales Oct/06|118|LC Sales Oct/06|2640|Units Oct/06|88|DOT Oct/06|220
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Feb/04|29|USD Sales Feb/04|36|LC Sales Feb/04|945|Units Feb/04|7|DOT Feb/04|350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Mar/04|246|USD Sales Mar/04|301|LC Sales Mar/04|8100|Units Mar/04|60|DOT Mar/04|3000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Apr/04|382|USD Sales Apr/04|458|LC Sales Apr/04|12420|Units Apr/04|92|DOT Apr/04|4600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales May/04|333|USD Sales May/04|400|LC Sales May/04|10665|Units May/04|79|DOT May/04|3950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jun/04|295|USD Sales Jun/04|358|LC Sales Jun/04|9315|Units Jun/04|69|DOT Jun/04|3450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jul/04|248|USD Sales Jul/04|304|LC Sales Jul/04|7830|Units Jul/04|58|DOT Jul/04|2900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Aug/04|491|USD Sales Aug/04|598|LC Sales Aug/04|15525|Units Aug/04|115|DOT Aug/04|5750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Sep/04|315|USD Sales Sep/04|385|LC Sales Sep/04|9953|Units Sep/04|75|DOT Sep/04|3750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Oct/04|402|USD Sales Oct/04|503|LC Sales Oct/04|12671|Units Oct/04|94|DOT Oct/04|4700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Nov/04|298|USD Sales Nov/04|387|LC Sales Nov/04|9315|Units Nov/04|69|DOT Nov/04|3450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Dec/04|394|USD Sales Dec/04|528|LC Sales Dec/04|12076|Units Dec/04|91|DOT Dec/04|4550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jan/05|470|USD Sales Jan/05|617|LC Sales Jan/05|14235|Units Jan/05|112|DOT Jan/05|5600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Feb/05|252|USD Sales Feb/05|328|LC Sales Feb/05|7560|Units Feb/05|60|DOT Feb/05|3000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Mar/05|190|USD Sales Mar/05|252|LC Sales Mar/05|5670|Units Mar/05|45|DOT Mar/05|2250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Apr/05|310|USD Sales Apr/05|401|LC Sales Apr/05|9324|Units Apr/05|74|DOT Apr/05|3700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales May/05|342|USD Sales May/05|433|LC Sales May/05|10332|Units May/05|82|DOT May/05|4100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jun/05|428|USD Sales Jun/05|521|LC Sales Jun/05|12852|Units Jun/05|102|DOT Jun/05|5100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jul/05|301|USD Sales Jul/05|362|LC Sales Jul/05|9072|Units Jul/05|72|DOT Jul/05|3600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Aug/05|324|USD Sales Aug/05|398|LC Sales Aug/05|9576|Units Aug/05|76|DOT Aug/05|3800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Sep/05|451|USD Sales Sep/05|553|LC Sales Sep/05|13230|Units Sep/05|105|DOT Sep/05|5250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Oct/05|739|USD Sales Oct/05|888|LC Sales Oct/05|21924|Units Oct/05|174|DOT Oct/05|8700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Nov/05|314|USD Sales Nov/05|370|LC Sales Nov/05|9198|Units Nov/05|73|DOT Nov/05|3650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Dec/05|353|USD Sales Dec/05|419|LC Sales Dec/05|10226|Units Dec/05|89|DOT Dec/05|4450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jan/06|297|USD Sales Jan/06|359|LC Sales Jan/06|8520|Units Jan/06|76|DOT Jan/06|3800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Feb/06|460|USD Sales Feb/06|550|LC Sales Feb/06|13081|Units Feb/06|117|DOT Feb/06|5850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Mar/06|1483|USD Sales Mar/06|1784|LC Sales Mar/06|42484|Units Mar/06|380|DOT Mar/06|19000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Apr/06|502|USD Sales Apr/06|616|LC Sales Apr/06|14310|Units Apr/06|128|DOT Apr/06|6400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales May/06|1079|USD Sales May/06|1378|LC Sales May/06|30521|Units May/06|273|DOT May/06|13650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jun/06|150|USD Sales Jun/06|190|LC Sales Jun/06|4248|Units Jun/06|38|DOT Jun/06|1900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Jul/06|341|USD Sales Jul/06|432|LC Sales Jul/06|9692|Units Jul/06|86|DOT Jul/06|4300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Aug/06|648|USD Sales Aug/06|830|LC Sales Aug/06|18270|Units Aug/06|164|DOT Aug/06|8200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Sep/06|851|USD Sales Sep/06|1084|LC Sales Sep/06|24152|Units Sep/06|217|DOT Sep/06|10850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|50.00|40.00 MG|MONO|FAMOTIDINE|126|111.3|155.4|EURO Sales Oct/06|500|USD Sales Oct/06|631|LC Sales Oct/06|14135|Units Oct/06|127|DOT Oct/06|6350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Nov/01|2049|USD Sales Nov/01|1820|LC Sales Nov/01|68094|Units Nov/01|2332|DOT Nov/01|23320
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Dec/01|1989|USD Sales Dec/01|1776|LC Sales Dec/01|64460|Units Dec/01|2200|DOT Dec/01|22000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jan/02|2285|USD Sales Jan/02|2018|LC Sales Jan/02|73324|Units Jan/02|2494|DOT Jan/02|24940
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Feb/02|1983|USD Sales Feb/02|1725|LC Sales Feb/02|62975|Units Feb/02|2142|DOT Feb/02|21420
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Mar/02|1964|USD Sales Mar/02|1720|LC Sales Mar/02|61622|Units Mar/02|2096|DOT Mar/02|20960
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Apr/02|2187|USD Sales Apr/02|1937|LC Sales Apr/02|66444|Units Apr/02|2260|DOT Apr/02|22600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales May/02|2186|USD Sales May/02|2006|LC Sales May/02|66914|Units May/02|2276|DOT May/02|22760
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jun/02|1993|USD Sales Jun/02|1905|LC Sales Jun/02|60358|Units Jun/02|2053|DOT Jun/02|20530
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jul/02|2112|USD Sales Jul/02|2095|LC Sales Jul/02|62936|Units Jul/02|2148|DOT Jul/02|21480
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Aug/02|1769|USD Sales Aug/02|1729|LC Sales Aug/02|54508|Units Aug/02|1854|DOT Aug/02|18540
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Sep/02|1869|USD Sales Sep/02|1832|LC Sales Sep/02|56419|Units Sep/02|1919|DOT Sep/02|19190
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Oct/02|2118|USD Sales Oct/02|2077|LC Sales Oct/02|64827|Units Oct/02|2205|DOT Oct/02|22050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Nov/02|2220|USD Sales Nov/02|2223|LC Sales Nov/02|68208|Units Nov/02|2320|DOT Nov/02|23200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Dec/02|1998|USD Sales Dec/02|2030|LC Sales Dec/02|62147|Units Dec/02|2196|DOT Dec/02|21960
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jan/03|2242|USD Sales Jan/03|2381|LC Sales Jan/03|70518|Units Jan/03|2555|DOT Jan/03|25550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Feb/03|1832|USD Sales Feb/03|1974|LC Sales Feb/03|57915|Units Feb/03|2106|DOT Feb/03|21060
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Mar/03|1884|USD Sales Mar/03|2035|LC Sales Mar/03|59754|Units Mar/03|2165|DOT Mar/03|21650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Apr/03|1990|USD Sales Apr/03|2159|LC Sales Apr/03|62928|Units Apr/03|2280|DOT Apr/03|22800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales May/03|1795|USD Sales May/03|2077|LC Sales May/03|56332|Units May/03|2041|DOT May/03|20410
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jun/03|1866|USD Sales Jun/03|2176|LC Sales Jun/03|58595|Units Jun/03|2123|DOT Jun/03|21230
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jul/03|1931|USD Sales Jul/03|2196|LC Sales Jul/03|61493|Units Jul/03|2228|DOT Jul/03|22280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Aug/03|1424|USD Sales Aug/03|1586|LC Sales Aug/03|45954|Units Aug/03|1659|DOT Aug/03|16590
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Sep/03|1809|USD Sales Sep/03|2027|LC Sales Sep/03|58558|Units Sep/03|2114|DOT Sep/03|21140
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Oct/03|1742|USD Sales Oct/03|2039|LC Sales Oct/03|55705|Units Oct/03|2011|DOT Oct/03|20110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Nov/03|1764|USD Sales Nov/03|2064|LC Sales Nov/03|56370|Units Nov/03|2035|DOT Nov/03|20350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Dec/03|1767|USD Sales Dec/03|2169|LC Sales Dec/03|57062|Units Dec/03|2060|DOT Dec/03|20600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jan/04|1824|USD Sales Jan/04|2301|LC Sales Jan/04|59694|Units Jan/04|2155|DOT Jan/04|21550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Feb/04|1704|USD Sales Feb/04|2155|LC Sales Feb/04|55982|Units Feb/04|2021|DOT Feb/04|20210
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Mar/04|1785|USD Sales Mar/04|2191|LC Sales Mar/04|58863|Units Mar/04|2125|DOT Mar/04|21250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Apr/04|1933|USD Sales Apr/04|2317|LC Sales Apr/04|62845|Units Apr/04|2277|DOT Apr/04|22770
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales May/04|1603|USD Sales May/04|1924|LC Sales May/04|51281|Units May/04|1858|DOT May/04|18580
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jun/04|2000|USD Sales Jun/04|2427|LC Sales Jun/04|63232|Units Jun/04|2291|DOT Jun/04|22910
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jul/04|1321|USD Sales Jul/04|1621|LC Sales Jul/04|41676|Units Jul/04|1510|DOT Jul/04|15100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Aug/04|1867|USD Sales Aug/04|2273|LC Sales Aug/04|59036|Units Aug/04|2139|DOT Aug/04|21390
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Sep/04|1646|USD Sales Sep/04|2011|LC Sales Sep/04|52026|Units Sep/04|1885|DOT Sep/04|18850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Oct/04|1661|USD Sales Oct/04|2075|LC Sales Oct/04|52302|Units Oct/04|1895|DOT Oct/04|18950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Nov/04|1696|USD Sales Nov/04|2203|LC Sales Nov/04|53075|Units Nov/04|1923|DOT Nov/04|19230
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Dec/04|1614|USD Sales Dec/04|2162|LC Sales Dec/04|49459|Units Dec/04|1792|DOT Dec/04|17920
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jan/05|1619|USD Sales Jan/05|2126|LC Sales Jan/05|49073|Units Jan/05|1778|DOT Jan/05|17780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Feb/05|1415|USD Sales Feb/05|1841|LC Sales Feb/05|42394|Units Feb/05|1536|DOT Feb/05|15360
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Mar/05|1403|USD Sales Mar/05|1853|LC Sales Mar/05|41759|Units Mar/05|1513|DOT Mar/05|15130
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Apr/05|1259|USD Sales Apr/05|1629|LC Sales Apr/05|37922|Units Apr/05|1374|DOT Apr/05|13740
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales May/05|1565|USD Sales May/05|1986|LC Sales May/05|47334|Units May/05|1715|DOT May/05|17150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jun/05|1481|USD Sales Jun/05|1801|LC Sales Jun/05|44464|Units Jun/05|1611|DOT Jun/05|16110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jul/05|1232|USD Sales Jul/05|1483|LC Sales Jul/05|37177|Units Jul/05|1347|DOT Jul/05|13470
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Aug/05|1441|USD Sales Aug/05|1772|LC Sales Aug/05|42642|Units Aug/05|1545|DOT Aug/05|15450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Sep/05|1639|USD Sales Sep/05|2009|LC Sales Sep/05|48052|Units Sep/05|1741|DOT Sep/05|17410
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Oct/05|1903|USD Sales Oct/05|2288|LC Sales Oct/05|56470|Units Oct/05|2046|DOT Oct/05|20460
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Nov/05|1304|USD Sales Nov/05|1537|LC Sales Nov/05|38171|Units Nov/05|1383|DOT Nov/05|13830
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Dec/05|1245|USD Sales Dec/05|1477|LC Sales Dec/05|36062|Units Dec/05|1366|DOT Dec/05|13660
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jan/06|1437|USD Sales Jan/06|1739|LC Sales Jan/06|41259|Units Jan/06|1593|DOT Jan/06|15930
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Feb/06|1080|USD Sales Feb/06|1291|LC Sales Feb/06|30717|Units Feb/06|1186|DOT Feb/06|11860
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Mar/06|31|USD Sales Mar/06|37|LC Sales Mar/06|881|Units Mar/06|34|DOT Mar/06|340
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Apr/06|1665|USD Sales Apr/06|2042|LC Sales Apr/06|47475|Units Apr/06|1833|DOT Apr/06|18330
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales May/06|1184|USD Sales May/06|1511|LC Sales May/06|33463|Units May/06|1292|DOT May/06|12920
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jun/06|1158|USD Sales Jun/06|1467|LC Sales Jun/06|32867|Units Jun/06|1269|DOT Jun/06|12690
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Jul/06|876|USD Sales Jul/06|1111|LC Sales Jul/06|24909|Units Jul/06|973|DOT Jul/06|9730
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Aug/06|1104|USD Sales Aug/06|1414|LC Sales Aug/06|31115|Units Aug/06|1206|DOT Aug/06|12060
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Sep/06|1190|USD Sales Sep/06|1515|LC Sales Sep/06|33772|Units Sep/06|1309|DOT Sep/06|13090
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|127|25.8|36|EURO Sales Oct/06|1125|USD Sales Oct/06|1419|LC Sales Oct/06|31811|Units Oct/06|1233|DOT Oct/06|12330
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Nov/01|536|USD Sales Nov/01|476|LC Sales Nov/01|17825|Units Nov/01|255|DOT Nov/01|6375
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Dec/01|688|USD Sales Dec/01|614|LC Sales Dec/01|22292|Units Dec/01|318|DOT Dec/01|7950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jan/02|714|USD Sales Jan/02|631|LC Sales Jan/02|22923|Units Jan/02|327|DOT Jan/02|8175
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Feb/02|702|USD Sales Feb/02|611|LC Sales Feb/02|22292|Units Feb/02|318|DOT Feb/02|7950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Mar/02|717|USD Sales Mar/02|628|LC Sales Mar/02|22502|Units Mar/02|321|DOT Mar/02|8025
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Apr/02|782|USD Sales Apr/02|693|LC Sales Apr/02|23764|Units Apr/02|339|DOT Apr/02|8475
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales May/02|750|USD Sales May/02|688|LC Sales May/02|22960|Units May/02|328|DOT May/02|8200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jun/02|751|USD Sales Jun/02|718|LC Sales Jun/02|22750|Units Jun/02|325|DOT Jun/02|8125
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jul/02|707|USD Sales Jul/02|701|LC Sales Jul/02|21070|Units Jul/02|301|DOT Jul/02|7525
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Aug/02|879|USD Sales Aug/02|859|LC Sales Aug/02|27090|Units Aug/02|387|DOT Aug/02|9675
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Sep/02|865|USD Sales Sep/02|848|LC Sales Sep/02|26110|Units Sep/02|373|DOT Sep/02|9325
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Oct/02|1041|USD Sales Oct/02|1020|LC Sales Oct/02|31850|Units Oct/02|455|DOT Oct/02|11375
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Nov/02|882|USD Sales Nov/02|883|LC Sales Nov/02|27090|Units Nov/02|387|DOT Nov/02|9675
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Dec/02|1074|USD Sales Dec/02|1091|LC Sales Dec/02|33408|Units Dec/02|480|DOT Dec/02|12000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jan/03|1183|USD Sales Jan/03|1257|LC Sales Jan/03|37230|Units Jan/03|538|DOT Jan/03|13450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Feb/03|920|USD Sales Feb/03|991|LC Sales Feb/03|29091|Units Feb/03|421|DOT Feb/03|10525
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Mar/03|978|USD Sales Mar/03|1057|LC Sales Mar/03|31026|Units Mar/03|449|DOT Mar/03|11225
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Apr/03|1034|USD Sales Apr/03|1121|LC Sales Apr/03|32684|Units Apr/03|473|DOT Apr/03|11825
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales May/03|1088|USD Sales May/03|1259|LC Sales May/03|34135|Units May/03|494|DOT May/03|12350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jun/03|1072|USD Sales Jun/03|1250|LC Sales Jun/03|33652|Units Jun/03|487|DOT Jun/03|12175
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jul/03|1146|USD Sales Jul/03|1303|LC Sales Jul/03|36485|Units Jul/03|528|DOT Jul/03|13200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Aug/03|737|USD Sales Aug/03|821|LC Sales Aug/03|23770|Units Aug/03|344|DOT Aug/03|8600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Sep/03|1206|USD Sales Sep/03|1351|LC Sales Sep/03|39042|Units Sep/03|565|DOT Sep/03|14125
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Oct/03|932|USD Sales Oct/03|1090|LC Sales Oct/03|29782|Units Oct/03|431|DOT Oct/03|10775
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Nov/03|934|USD Sales Nov/03|1093|LC Sales Nov/03|29851|Units Nov/03|432|DOT Nov/03|10800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Dec/03|1143|USD Sales Dec/03|1403|LC Sales Dec/03|36899|Units Dec/03|534|DOT Dec/03|13350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jan/04|1159|USD Sales Jan/04|1462|LC Sales Jan/04|37936|Units Jan/04|549|DOT Jan/04|13725
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Feb/04|1281|USD Sales Feb/04|1620|LC Sales Feb/04|42082|Units Feb/04|609|DOT Feb/04|15225
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Mar/04|1377|USD Sales Mar/04|1689|LC Sales Mar/04|45399|Units Mar/04|657|DOT Mar/04|16425
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Apr/04|1314|USD Sales Apr/04|1575|LC Sales Apr/04|42704|Units Apr/04|618|DOT Apr/04|15450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales May/04|1266|USD Sales May/04|1519|LC Sales May/04|40493|Units May/04|586|DOT May/04|14650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jun/04|1309|USD Sales Jun/04|1589|LC Sales Jun/04|41391|Units Jun/04|599|DOT Jun/04|14975
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jul/04|1082|USD Sales Jul/04|1327|LC Sales Jul/04|34135|Units Jul/04|494|DOT Jul/04|12350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Aug/04|1532|USD Sales Aug/04|1865|LC Sales Aug/04|48439|Units Aug/04|701|DOT Aug/04|17525
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Sep/04|1068|USD Sales Sep/04|1304|LC Sales Sep/04|33734|Units Sep/04|505|DOT Sep/04|12625
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Oct/04|1367|USD Sales Oct/04|1707|LC Sales Oct/04|43029|Units Oct/04|630|DOT Oct/04|15750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Nov/04|1275|USD Sales Nov/04|1656|LC Sales Nov/04|39882|Units Nov/04|578|DOT Nov/04|14450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Dec/04|1141|USD Sales Dec/04|1528|LC Sales Dec/04|34959|Units Dec/04|521|DOT Dec/04|13025
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jan/05|1527|USD Sales Jan/05|2004|LC Sales Jan/05|46262|Units Jan/05|702|DOT Jan/05|17550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Feb/05|1258|USD Sales Feb/05|1638|LC Sales Feb/05|37703|Units Feb/05|573|DOT Feb/05|14325
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Mar/05|1238|USD Sales Mar/05|1635|LC Sales Mar/05|36858|Units Mar/05|561|DOT Mar/05|14025
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Apr/05|1407|USD Sales Apr/05|1821|LC Sales Apr/05|42377|Units Apr/05|645|DOT Apr/05|16125
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales May/05|1264|USD Sales May/05|1604|LC Sales May/05|38237|Units May/05|582|DOT May/05|14550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jun/05|1236|USD Sales Jun/05|1504|LC Sales Jun/05|37121|Units Jun/05|565|DOT Jun/05|14125
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jul/05|1252|USD Sales Jul/05|1507|LC Sales Jul/05|37778|Units Jul/05|575|DOT Jul/05|14375
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Aug/05|1188|USD Sales Aug/05|1461|LC Sales Aug/05|35150|Units Aug/05|535|DOT Aug/05|13375
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Sep/05|49|USD Sales Sep/05|60|LC Sales Sep/05|1445|Units Sep/05|22|DOT Sep/05|550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Oct/05|983|USD Sales Oct/05|1182|LC Sales Oct/05|29171|Units Oct/05|444|DOT Oct/05|11100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Nov/05|1221|USD Sales Nov/05|1439|LC Sales Nov/05|35741|Units Nov/05|544|DOT Nov/05|13600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Dec/05|974|USD Sales Dec/05|1156|LC Sales Dec/05|28215|Units Dec/05|450|DOT Dec/05|11250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jan/06|1502|USD Sales Jan/06|1818|LC Sales Jan/06|43120|Units Jan/06|700|DOT Jan/06|17500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Feb/06|1133|USD Sales Feb/06|1354|LC Sales Feb/06|32217|Units Feb/06|523|DOT Feb/06|13075
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Mar/06|282|USD Sales Mar/06|339|LC Sales Mar/06|8070|Units Mar/06|131|DOT Mar/06|3275
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Apr/06|1065|USD Sales Apr/06|1306|LC Sales Apr/06|30369|Units Apr/06|493|DOT Apr/06|12325
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales May/06|1177|USD Sales May/06|1502|LC Sales May/06|33264|Units May/06|540|DOT May/06|13500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jun/06|1724|USD Sales Jun/06|2183|LC Sales Jun/06|48910|Units Jun/06|794|DOT Jun/06|19850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Jul/06|1345|USD Sales Jul/06|1706|LC Sales Jul/06|38249|Units Jul/06|645|DOT Jul/06|16125
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Aug/06|1383|USD Sales Aug/06|1772|LC Sales Aug/06|38995|Units Aug/06|651|DOT Aug/06|16275
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Sep/06|1249|USD Sales Sep/06|1591|LC Sales Sep/06|35461|Units Sep/06|599|DOT Sep/06|14975
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|25.00|40.00 MG|MONO|FAMOTIDINE|128|59.2|82.7|EURO Sales Oct/06|1308|USD Sales Oct/06|1651|LC Sales Oct/06|37000|Units Oct/06|625|DOT Oct/06|15625
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Mar/04|0|USD Sales Mar/04|0|LC Sales Mar/04|0|Units Mar/04|0|DOT Mar/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Apr/04|0|USD Sales Apr/04|0|LC Sales Apr/04|0|Units Apr/04|0|DOT Apr/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jun/04|0|USD Sales Jun/04|0|LC Sales Jun/04|0|Units Jun/04|0|DOT Jun/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Sep/04|0|USD Sales Sep/04|0|LC Sales Sep/04|0|Units Sep/04|0|DOT Sep/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Oct/04|0|USD Sales Oct/04|0|LC Sales Oct/04|0|Units Oct/04|0|DOT Oct/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0020MG|FILM C.TABS 20 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1999|1999/11|250.00|40.00 MG|MONO|FAMOTIDINE|129|729.2|986.9|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Nov/01|932|USD Sales Nov/01|828|LC Sales Nov/01|30965|Units Nov/01|1126|DOT Nov/01|11260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Dec/01|767|USD Sales Dec/01|685|LC Sales Dec/01|24864|Units Dec/01|888|DOT Dec/01|8880
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jan/02|1012|USD Sales Jan/02|894|LC Sales Jan/02|32480|Units Jan/02|1160|DOT Jan/02|11600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Feb/02|792|USD Sales Feb/02|689|LC Sales Feb/02|25144|Units Feb/02|898|DOT Feb/02|8980
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Mar/02|791|USD Sales Mar/02|692|LC Sales Mar/02|24808|Units Mar/02|886|DOT Mar/02|8860
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Apr/02|892|USD Sales Apr/02|790|LC Sales Apr/02|27104|Units Apr/02|968|DOT Apr/02|9680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales May/02|833|USD Sales May/02|764|LC Sales May/02|25480|Units May/02|910|DOT May/02|9100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jun/02|707|USD Sales Jun/02|676|LC Sales Jun/02|21420|Units Jun/02|765|DOT Jun/02|7650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jul/02|938|USD Sales Jul/02|930|LC Sales Jul/02|27944|Units Jul/02|998|DOT Jul/02|9980
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Aug/02|789|USD Sales Aug/02|771|LC Sales Aug/02|24304|Units Aug/02|868|DOT Aug/02|8680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Sep/02|810|USD Sales Sep/02|794|LC Sales Sep/02|24444|Units Sep/02|873|DOT Sep/02|8730
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Oct/02|843|USD Sales Oct/02|826|LC Sales Oct/02|25788|Units Oct/02|921|DOT Oct/02|9210
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Nov/02|859|USD Sales Nov/02|860|LC Sales Nov/02|26376|Units Nov/02|942|DOT Nov/02|9420
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Dec/02|682|USD Sales Dec/02|693|LC Sales Dec/02|21208|Units Dec/02|774|DOT Dec/02|7740
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jan/03|626|USD Sales Jan/03|665|LC Sales Jan/03|19691|Units Jan/03|732|DOT Jan/03|7320
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Feb/03|658|USD Sales Feb/03|709|LC Sales Feb/03|20794|Units Feb/03|773|DOT Feb/03|7730
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Mar/03|493|USD Sales Mar/03|532|LC Sales Mar/03|15629|Units Mar/03|581|DOT Mar/03|5810
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Apr/03|678|USD Sales Apr/03|735|LC Sales Apr/03|21439|Units Apr/03|797|DOT Apr/03|7970
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales May/03|696|USD Sales May/03|805|LC Sales May/03|21843|Units May/03|812|DOT May/03|8120
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jun/03|744|USD Sales Jun/03|867|LC Sales Jun/03|23349|Units Jun/03|868|DOT Jun/03|8680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jul/03|714|USD Sales Jul/03|812|LC Sales Jul/03|22731|Units Jul/03|845|DOT Jul/03|8450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Aug/03|704|USD Sales Aug/03|784|LC Sales Aug/03|22704|Units Aug/03|844|DOT Aug/03|8440
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Sep/03|652|USD Sales Sep/03|731|LC Sales Sep/03|21117|Units Sep/03|785|DOT Sep/03|7850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Oct/03|587|USD Sales Oct/03|687|LC Sales Oct/03|18776|Units Oct/03|698|DOT Oct/03|6980
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Nov/03|504|USD Sales Nov/03|590|LC Sales Nov/03|16113|Units Nov/03|599|DOT Nov/03|5990
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Dec/03|644|USD Sales Dec/03|790|LC Sales Dec/03|20794|Units Dec/03|773|DOT Dec/03|7730
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jan/04|520|USD Sales Jan/04|656|LC Sales Jan/04|17028|Units Jan/04|633|DOT Jan/04|6330
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Feb/04|555|USD Sales Feb/04|702|LC Sales Feb/04|18238|Units Feb/04|678|DOT Feb/04|6780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Mar/04|579|USD Sales Mar/04|711|LC Sales Mar/04|19099|Units Mar/04|710|DOT Mar/04|7100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Apr/04|534|USD Sales Apr/04|640|LC Sales Apr/04|17351|Units Apr/04|645|DOT Apr/04|6450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales May/04|531|USD Sales May/04|637|LC Sales May/04|16974|Units May/04|631|DOT May/04|6310
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jun/04|602|USD Sales Jun/04|731|LC Sales Jun/04|19045|Units Jun/04|708|DOT Jun/04|7080
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jul/04|379|USD Sales Jul/04|464|LC Sales Jul/04|11944|Units Jul/04|444|DOT Jul/04|4440
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Aug/04|554|USD Sales Aug/04|674|LC Sales Aug/04|17512|Units Aug/04|651|DOT Aug/04|6510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Sep/04|421|USD Sales Sep/04|514|LC Sales Sep/04|13289|Units Sep/04|494|DOT Sep/04|4940
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Oct/04|423|USD Sales Oct/04|528|LC Sales Oct/04|13316|Units Oct/04|495|DOT Oct/04|4950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Nov/04|191|USD Sales Nov/04|248|LC Sales Nov/04|5972|Units Nov/04|222|DOT Nov/04|2220
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Dec/04|484|USD Sales Dec/04|648|LC Sales Dec/04|14822|Units Dec/04|551|DOT Dec/04|5510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jan/05|401|USD Sales Jan/05|527|LC Sales Jan/05|12159|Units Jan/05|452|DOT Jan/05|4520
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Feb/05|421|USD Sales Feb/05|548|LC Sales Feb/05|12616|Units Feb/05|469|DOT Feb/05|4690
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Mar/05|588|USD Sales Mar/05|777|LC Sales Mar/05|17512|Units Mar/05|651|DOT Mar/05|6510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Apr/05|458|USD Sales Apr/05|593|LC Sales Apr/05|13800|Units Apr/05|513|DOT Apr/05|5130
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales May/05|331|USD Sales May/05|420|LC Sales May/05|10007|Units May/05|372|DOT May/05|3720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jun/05|255|USD Sales Jun/05|311|LC Sales Jun/05|7667|Units Jun/05|285|DOT Jun/05|2850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jul/05|270|USD Sales Jul/05|325|LC Sales Jul/05|8151|Units Jul/05|303|DOT Jul/05|3030
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Aug/05|245|USD Sales Aug/05|301|LC Sales Aug/05|7236|Units Aug/05|269|DOT Aug/05|2690
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Sep/05|329|USD Sales Sep/05|404|LC Sales Sep/05|9657|Units Sep/05|359|DOT Sep/05|3590
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Oct/05|264|USD Sales Oct/05|317|LC Sales Oct/05|7828|Units Oct/05|291|DOT Oct/05|2910
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Nov/05|317|USD Sales Nov/05|374|LC Sales Nov/05|9281|Units Nov/05|345|DOT Nov/05|3450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Dec/05|268|USD Sales Dec/05|318|LC Sales Dec/05|7752|Units Dec/05|304|DOT Dec/05|3040
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jan/06|303|USD Sales Jan/06|366|LC Sales Jan/06|8694|Units Jan/06|345|DOT Jan/06|3450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Feb/06|204|USD Sales Feb/06|244|LC Sales Feb/06|5796|Units Feb/06|230|DOT Feb/06|2300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Mar/06|347|USD Sales Mar/06|417|LC Sales Mar/06|9929|Units Mar/06|394|DOT Mar/06|3940
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Apr/06|215|USD Sales Apr/06|263|LC Sales Apr/06|6124|Units Apr/06|243|DOT Apr/06|2430
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales May/06|301|USD Sales May/06|385|LC Sales May/06|8518|Units May/06|338|DOT May/06|3380
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jun/06|227|USD Sales Jun/06|288|LC Sales Jun/06|6451|Units Jun/06|256|DOT Jun/06|2560
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Jul/06|230|USD Sales Jul/06|292|LC Sales Jul/06|6552|Units Jul/06|260|DOT Jul/06|2600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Aug/06|192|USD Sales Aug/06|246|LC Sales Aug/06|5418|Units Aug/06|215|DOT Aug/06|2150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Sep/06|203|USD Sales Sep/06|258|LC Sales Sep/06|5756|Units Sep/06|234|DOT Sep/06|2340
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1996|1996/01|10.00|40.00 MG|MONO|FAMOTIDINE|130|25.2|35.2|EURO Sales Oct/06|263|USD Sales Oct/06|332|LC Sales Oct/06|7434|Units Oct/06|295|DOT Oct/06|2950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Dec/02|0|USD Sales Dec/02|0|LC Sales Dec/02|0|Units Dec/02|0|DOT Dec/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Feb/03|0|USD Sales Feb/03|0|LC Sales Feb/03|0|Units Feb/03|0|DOT Feb/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jul/03|0|USD Sales Jul/03|0|LC Sales Jul/03|0|Units Jul/03|0|DOT Jul/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Sep/03|0|USD Sales Sep/03|0|LC Sales Sep/03|0|Units Sep/03|0|DOT Sep/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Feb/04|43|USD Sales Feb/04|54|LC Sales Feb/04|1398|Units Feb/04|6|DOT Feb/04|600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Mar/04|325|USD Sales Mar/04|399|LC Sales Mar/04|10718|Units Mar/04|46|DOT Mar/04|4600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Apr/04|710|USD Sales Apr/04|851|LC Sales Apr/04|23067|Units Apr/04|99|DOT Apr/04|9900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales May/04|524|USD Sales May/04|629|LC Sales May/04|16776|Units May/04|72|DOT May/04|7200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jun/04|685|USD Sales Jun/04|832|LC Sales Jun/04|21669|Units Jun/04|93|DOT Jun/04|9300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jul/04|414|USD Sales Jul/04|507|LC Sales Jul/04|13048|Units Jul/04|56|DOT Jul/04|5600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Aug/04|1053|USD Sales Aug/04|1283|LC Sales Aug/04|33319|Units Aug/04|143|DOT Aug/04|14300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Sep/04|288|USD Sales Sep/04|351|LC Sales Sep/04|9087|Units Sep/04|39|DOT Sep/04|3900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Oct/04|518|USD Sales Oct/04|647|LC Sales Oct/04|16310|Units Oct/04|70|DOT Oct/04|7000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Nov/04|715|USD Sales Nov/04|929|LC Sales Nov/04|22368|Units Nov/04|96|DOT Nov/04|9600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Dec/04|684|USD Sales Dec/04|917|LC Sales Dec/04|20970|Units Dec/04|90|DOT Dec/04|9000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jan/05|1153|USD Sales Jan/05|1514|LC Sales Jan/05|34950|Units Jan/05|150|DOT Jan/05|15000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Feb/05|583|USD Sales Feb/05|759|LC Sales Feb/05|17475|Units Feb/05|75|DOT Feb/05|7500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Mar/05|524|USD Sales Mar/05|693|LC Sales Mar/05|15611|Units Mar/05|67|DOT Mar/05|6700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Apr/05|31|USD Sales Apr/05|40|LC Sales Apr/05|932|Units Apr/05|4|DOT Apr/05|400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jun/05|16|USD Sales Jun/05|19|LC Sales Jun/05|466|Units Jun/05|2|DOT Jun/05|200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Sep/05|151|USD Sales Sep/05|185|LC Sales Sep/05|4427|Units Sep/05|19|DOT Sep/05|1900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Oct/05|667|USD Sales Oct/05|802|LC Sales Oct/05|19805|Units Oct/05|85|DOT Oct/05|8500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Nov/05|613|USD Sales Nov/05|722|LC Sales Nov/05|17941|Units Nov/05|77|DOT Nov/05|7700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Dec/05|557|USD Sales Dec/05|661|LC Sales Dec/05|16131|Units Dec/05|71|DOT Dec/05|7100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jan/06|546|USD Sales Jan/06|661|LC Sales Jan/06|15680|Units Jan/06|70|DOT Jan/06|7000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Feb/06|338|USD Sales Feb/06|404|LC Sales Feb/06|9615|Units Feb/06|43|DOT Feb/06|4300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Mar/06|562|USD Sales Mar/06|676|LC Sales Mar/06|16099|Units Mar/06|72|DOT Mar/06|7200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Apr/06|831|USD Sales Apr/06|1020|LC Sales Apr/06|23702|Units Apr/06|106|DOT Apr/06|10600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales May/06|704|USD Sales May/06|898|LC Sales May/06|19900|Units May/06|89|DOT May/06|8900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jun/06|733|USD Sales Jun/06|928|LC Sales Jun/06|20795|Units Jun/06|93|DOT Jun/06|9300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Jul/06|565|USD Sales Jul/06|717|LC Sales Jul/06|16078|Units Jul/06|72|DOT Jul/06|7200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Aug/06|713|USD Sales Aug/06|913|LC Sales Aug/06|20088|Units Aug/06|90|DOT Aug/06|9000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Sep/06|1077|USD Sales Sep/06|1372|LC Sales Sep/06|30578|Units Sep/06|137|DOT Sep/06|13700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 100|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2004|2004/01|100.00|70.00 MG|MONO|FAMOTIDINE|131|223.2|310.9|EURO Sales Oct/06|363|USD Sales Oct/06|458|LC Sales Oct/06|10267|Units Oct/06|46|DOT Oct/06|4600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Nov/01|477|USD Sales Nov/01|424|LC Sales Nov/01|15848|Units Nov/01|283|DOT Nov/01|5660
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Dec/01|329|USD Sales Dec/01|294|LC Sales Dec/01|10659|Units Dec/01|190|DOT Dec/01|3800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jan/02|325|USD Sales Jan/02|287|LC Sales Jan/02|10435|Units Jan/02|186|DOT Jan/02|3720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Feb/02|610|USD Sales Feb/02|530|LC Sales Feb/02|19355|Units Feb/02|345|DOT Feb/02|6900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Mar/02|653|USD Sales Mar/02|572|LC Sales Mar/02|20477|Units Mar/02|365|DOT Mar/02|7300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Apr/02|626|USD Sales Apr/02|555|LC Sales Apr/02|19018|Units Apr/02|339|DOT Apr/02|6780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales May/02|374|USD Sales May/02|343|LC Sales May/02|11444|Units May/02|204|DOT May/02|4080
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jun/02|632|USD Sales Jun/02|604|LC Sales Jun/02|19130|Units Jun/02|341|DOT Jun/02|6820
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jul/02|535|USD Sales Jul/02|530|LC Sales Jul/02|15932|Units Jul/02|284|DOT Jul/02|5680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Aug/02|564|USD Sales Aug/02|552|LC Sales Aug/02|17391|Units Aug/02|310|DOT Aug/02|6200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Sep/02|528|USD Sales Sep/02|517|LC Sales Sep/02|15932|Units Sep/02|284|DOT Sep/02|5680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Oct/02|568|USD Sales Oct/02|557|LC Sales Oct/02|17391|Units Oct/02|310|DOT Oct/02|6200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Nov/02|365|USD Sales Nov/02|366|LC Sales Nov/02|11220|Units Nov/02|200|DOT Nov/02|4000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Dec/02|477|USD Sales Dec/02|484|LC Sales Dec/02|14823|Units Dec/02|270|DOT Dec/02|5400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jan/03|497|USD Sales Jan/03|528|LC Sales Jan/03|15635|Units Jan/03|289|DOT Jan/03|5780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Feb/03|470|USD Sales Feb/03|506|LC Sales Feb/03|14849|Units Feb/03|276|DOT Feb/03|5520
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Mar/03|477|USD Sales Mar/03|515|LC Sales Mar/03|15118|Units Mar/03|281|DOT Mar/03|5620
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Apr/03|545|USD Sales Apr/03|591|LC Sales Apr/03|17216|Units Apr/03|320|DOT Apr/03|6400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales May/03|324|USD Sales May/03|375|LC Sales May/03|10168|Units May/03|189|DOT May/03|3780
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jun/03|567|USD Sales Jun/03|661|LC Sales Jun/03|17808|Units Jun/03|331|DOT Jun/03|6620
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jul/03|645|USD Sales Jul/03|734|LC Sales Jul/03|20552|Units Jul/03|382|DOT Jul/03|7640
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Aug/03|477|USD Sales Aug/03|531|LC Sales Aug/03|15387|Units Aug/03|286|DOT Aug/03|5720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Sep/03|598|USD Sales Sep/03|670|LC Sales Sep/03|19368|Units Sep/03|360|DOT Sep/03|7200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Oct/03|636|USD Sales Oct/03|744|LC Sales Oct/03|20336|Units Oct/03|378|DOT Oct/03|7560
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Nov/03|524|USD Sales Nov/03|613|LC Sales Nov/03|16732|Units Nov/03|311|DOT Nov/03|6220
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Dec/03|512|USD Sales Dec/03|629|LC Sales Dec/03|16547|Units Dec/03|307|DOT Dec/03|6140
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jan/04|430|USD Sales Jan/04|542|LC Sales Jan/04|14068|Units Jan/04|261|DOT Jan/04|5220
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Feb/04|560|USD Sales Feb/04|708|LC Sales Feb/04|18380|Units Feb/04|341|DOT Feb/04|6820
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Mar/04|497|USD Sales Mar/04|610|LC Sales Mar/04|16386|Units Mar/04|304|DOT Mar/04|6080
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Apr/04|468|USD Sales Apr/04|561|LC Sales Apr/04|15225|Units Apr/04|283|DOT Apr/04|5660
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales May/04|604|USD Sales May/04|725|LC Sales May/04|19314|Units May/04|359|DOT May/04|7180
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jun/04|601|USD Sales Jun/04|729|LC Sales Jun/04|18991|Units Jun/04|353|DOT Jun/04|7060
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jul/04|534|USD Sales Jul/04|655|LC Sales Jul/04|16839|Units Jul/04|313|DOT Jul/04|6260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Aug/04|595|USD Sales Aug/04|725|LC Sales Aug/04|18830|Units Aug/04|350|DOT Aug/04|7000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Sep/04|478|USD Sales Sep/04|584|LC Sales Sep/04|15105|Units Sep/04|285|DOT Sep/04|5700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Oct/04|472|USD Sales Oct/04|589|LC Sales Oct/04|14849|Units Oct/04|276|DOT Oct/04|5520
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Nov/04|1009|USD Sales Nov/04|1311|LC Sales Nov/04|31581|Units Nov/04|587|DOT Nov/04|11740
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Dec/04|701|USD Sales Dec/04|939|LC Sales Dec/04|21493|Units Dec/04|404|DOT Dec/04|8080
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jan/05|593|USD Sales Jan/05|779|LC Sales Jan/05|17971|Units Jan/05|341|DOT Jan/05|6820
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Feb/05|538|USD Sales Feb/05|700|LC Sales Feb/05|16126|Units Feb/05|306|DOT Feb/05|6120
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Mar/05|269|USD Sales Mar/05|355|LC Sales Mar/05|8010|Units Mar/05|152|DOT Mar/05|3040
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Apr/05|411|USD Sales Apr/05|532|LC Sales Apr/05|12385|Units Apr/05|235|DOT Apr/05|4700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales May/05|458|USD Sales May/05|581|LC Sales May/05|13860|Units May/05|263|DOT May/05|5260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jun/05|342|USD Sales Jun/05|416|LC Sales Jun/05|10277|Units Jun/05|195|DOT Jun/05|3900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jul/05|344|USD Sales Jul/05|414|LC Sales Jul/05|10382|Units Jul/05|197|DOT Jul/05|3940
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Aug/05|360|USD Sales Aug/05|442|LC Sales Aug/05|10645|Units Aug/05|202|DOT Aug/05|4040
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Sep/05|635|USD Sales Sep/05|778|LC Sales Sep/05|18603|Units Sep/05|353|DOT Sep/05|7060
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Oct/05|495|USD Sales Oct/05|596|LC Sales Oct/05|14703|Units Oct/05|279|DOT Oct/05|5580
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Nov/05|407|USD Sales Nov/05|480|LC Sales Nov/05|11910|Units Nov/05|226|DOT Nov/05|4520
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Dec/05|311|USD Sales Dec/05|369|LC Sales Dec/05|9014|Units Dec/05|181|DOT Dec/05|3620
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jan/06|502|USD Sales Jan/06|607|LC Sales Jan/06|14406|Units Jan/06|294|DOT Jan/06|5880
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Feb/06|290|USD Sales Feb/06|346|LC Sales Feb/06|8232|Units Feb/06|168|DOT Feb/06|3360
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Mar/06|352|USD Sales Mar/06|424|LC Sales Mar/06|10094|Units Mar/06|206|DOT Mar/06|4120
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Apr/06|454|USD Sales Apr/06|556|LC Sales Apr/06|12936|Units Apr/06|264|DOT Apr/06|5280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales May/06|458|USD Sales May/06|584|LC Sales May/06|12936|Units May/06|264|DOT May/06|5280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jun/06|361|USD Sales Jun/06|457|LC Sales Jun/06|10241|Units Jun/06|209|DOT Jun/06|4180
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Jul/06|248|USD Sales Jul/06|315|LC Sales Jul/06|7066|Units Jul/06|146|DOT Jul/06|2920
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Aug/06|526|USD Sales Aug/06|674|LC Sales Aug/06|14835|Units Aug/06|304|DOT Aug/06|6080
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Sep/06|428|USD Sales Sep/06|545|LC Sales Sep/06|12151|Units Sep/06|249|DOT Sep/06|4980
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 20|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|1998|1998/05|20.00|40.00 MG|MONO|FAMOTIDINE|132|48.8|68.2|EURO Sales Oct/06|381|USD Sales Oct/06|481|LC Sales Oct/06|10785|Units Oct/06|221|DOT Oct/06|4420
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Nov/01|734|USD Sales Nov/01|652|LC Sales Nov/01|24401|Units Nov/01|201|DOT Nov/01|10050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Dec/01|747|USD Sales Dec/01|667|LC Sales Dec/01|24218|Units Dec/01|199|DOT Dec/01|9950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jan/02|1070|USD Sales Jan/02|945|LC Sales Jan/02|34319|Units Jan/02|282|DOT Jan/02|14100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Feb/02|816|USD Sales Feb/02|710|LC Sales Feb/02|25922|Units Feb/02|213|DOT Feb/02|10650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Mar/02|1125|USD Sales Mar/02|985|LC Sales Mar/02|35293|Units Mar/02|290|DOT Mar/02|14500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Apr/02|1002|USD Sales Apr/02|887|LC Sales Apr/02|30425|Units Apr/02|250|DOT Apr/02|12500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales May/02|1551|USD Sales May/02|1423|LC Sales May/02|47463|Units May/02|390|DOT May/02|19500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jun/02|1467|USD Sales Jun/02|1402|LC Sales Jun/02|44421|Units Jun/02|365|DOT Jun/02|18250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jul/02|1532|USD Sales Jul/02|1519|LC Sales Jul/02|45638|Units Jul/02|375|DOT Jul/02|18750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Aug/02|2362|USD Sales Aug/02|2308|LC Sales Aug/02|72777|Units Aug/02|598|DOT Aug/02|29900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Sep/02|1399|USD Sales Sep/02|1371|LC Sales Sep/02|42230|Units Sep/02|347|DOT Sep/02|17350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Oct/02|1917|USD Sales Oct/02|1879|LC Sales Oct/02|58659|Units Oct/02|482|DOT Oct/02|24100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Nov/02|1383|USD Sales Nov/02|1384|LC Sales Nov/02|42473|Units Nov/02|349|DOT Nov/02|17450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Dec/02|1307|USD Sales Dec/02|1328|LC Sales Dec/02|40648|Units Dec/02|334|DOT Dec/02|16700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jan/03|1447|USD Sales Jan/03|1537|LC Sales Jan/03|45516|Units Jan/03|374|DOT Jan/03|18700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Feb/03|1243|USD Sales Feb/03|1340|LC Sales Feb/03|39309|Units Feb/03|323|DOT Feb/03|16150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Mar/03|1366|USD Sales Mar/03|1476|LC Sales Mar/03|43325|Units Mar/03|356|DOT Mar/03|17800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Apr/03|1894|USD Sales Apr/03|2054|LC Sales Apr/03|59876|Units Apr/03|492|DOT Apr/03|24600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales May/03|1703|USD Sales May/03|1970|LC Sales May/03|53426|Units May/03|439|DOT May/03|21950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jun/03|1682|USD Sales Jun/03|1962|LC Sales Jun/03|52818|Units Jun/03|434|DOT Jun/03|21700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jul/03|1878|USD Sales Jul/03|2136|LC Sales Jul/03|59804|Units Jul/03|491|DOT Jul/03|24550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Aug/03|1378|USD Sales Aug/03|1535|LC Sales Aug/03|44457|Units Aug/03|365|DOT Aug/03|18250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Sep/03|1720|USD Sales Sep/03|1926|LC Sales Sep/03|55663|Units Sep/03|457|DOT Sep/03|22850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Oct/03|1939|USD Sales Oct/03|2269|LC Sales Oct/03|61996|Units Oct/03|509|DOT Oct/03|25450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Nov/03|1692|USD Sales Nov/03|1980|LC Sales Nov/03|54079|Units Nov/03|444|DOT Nov/03|22200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Dec/03|1762|USD Sales Dec/03|2162|LC Sales Dec/03|56881|Units Dec/03|467|DOT Dec/03|23350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jan/04|1623|USD Sales Jan/04|2047|LC Sales Jan/04|53105|Units Jan/04|436|DOT Jan/04|21800
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Feb/04|1628|USD Sales Feb/04|2058|LC Sales Feb/04|53470|Units Feb/04|439|DOT Feb/04|21950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Mar/04|2346|USD Sales Mar/04|2878|LC Sales Mar/04|77343|Units Mar/04|635|DOT Mar/04|31750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Apr/04|1924|USD Sales Apr/04|2307|LC Sales Apr/04|62554|Units Apr/04|514|DOT Apr/04|25700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales May/04|1795|USD Sales May/04|2155|LC Sales May/04|57442|Units May/04|472|DOT May/04|23600
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jun/04|1856|USD Sales Jun/04|2252|LC Sales Jun/04|58659|Units Jun/04|482|DOT Jun/04|24100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jul/04|1439|USD Sales Jul/04|1765|LC Sales Jul/04|45394|Units Jul/04|373|DOT Jul/04|18650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Aug/04|1610|USD Sales Aug/04|1960|LC Sales Aug/04|50912|Units Aug/04|418|DOT Aug/04|20900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Sep/04|1569|USD Sales Sep/04|1916|LC Sales Sep/04|49573|Units Sep/04|407|DOT Sep/04|20350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Oct/04|1489|USD Sales Oct/04|1860|LC Sales Oct/04|46893|Units Oct/04|385|DOT Oct/04|19250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Nov/04|1192|USD Sales Nov/04|1548|LC Sales Nov/04|37301|Units Nov/04|306|DOT Nov/04|15300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Dec/04|1411|USD Sales Dec/04|1890|LC Sales Dec/04|43239|Units Dec/04|355|DOT Dec/04|17750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jan/05|1801|USD Sales Jan/05|2364|LC Sales Jan/05|54566|Units Jan/05|448|DOT Jan/05|22400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Feb/05|1459|USD Sales Feb/05|1899|LC Sales Feb/05|43726|Units Feb/05|359|DOT Feb/05|17950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Mar/05|1317|USD Sales Mar/05|1740|LC Sales Mar/05|39220|Units Mar/05|322|DOT Mar/05|16100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Apr/05|1977|USD Sales Apr/05|2559|LC Sales Apr/05|59560|Units Apr/05|489|DOT Apr/05|24450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales May/05|2030|USD Sales May/05|2575|LC Sales May/05|61387|Units May/05|504|DOT May/05|25200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jun/05|1979|USD Sales Jun/05|2408|LC Sales Jun/05|59438|Units Jun/05|488|DOT Jun/05|24400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jul/05|1837|USD Sales Jul/05|2211|LC Sales Jul/05|55419|Units Jul/05|455|DOT Jul/05|22750
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Aug/05|2001|USD Sales Aug/05|2460|LC Sales Aug/05|59195|Units Aug/05|486|DOT Aug/05|24300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Sep/05|2493|USD Sales Sep/05|3056|LC Sales Sep/05|73080|Units Sep/05|600|DOT Sep/05|30000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Oct/05|1822|USD Sales Oct/05|2191|LC Sales Oct/05|54079|Units Oct/05|444|DOT Oct/05|22200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Nov/05|1448|USD Sales Nov/05|1707|LC Sales Nov/05|42386|Units Nov/05|348|DOT Nov/05|17400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Dec/05|1295|USD Sales Dec/05|1536|LC Sales Dec/05|37501|Units Dec/05|317|DOT Dec/05|15850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jan/06|1657|USD Sales Jan/06|2006|LC Sales Jan/06|47588|Units Jan/06|405|DOT Jan/06|20250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Feb/06|1442|USD Sales Feb/06|1723|LC Sales Feb/06|41008|Units Feb/06|349|DOT Feb/06|17450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Mar/06|1305|USD Sales Mar/06|1569|LC Sales Mar/06|37365|Units Mar/06|318|DOT Mar/06|15900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Apr/06|1335|USD Sales Apr/06|1638|LC Sales Apr/06|38070|Units Apr/06|324|DOT Apr/06|16200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales May/06|1509|USD Sales May/06|1926|LC Sales May/06|42653|Units May/06|363|DOT May/06|18150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jun/06|1549|USD Sales Jun/06|1961|LC Sales Jun/06|43945|Units Jun/06|374|DOT Jun/06|18700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Jul/06|1131|USD Sales Jul/06|1435|LC Sales Jul/06|32177|Units Jul/06|284|DOT Jul/06|14200
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Aug/06|1456|USD Sales Aug/06|1866|LC Sales Aug/06|41063|Units Aug/06|365|DOT Aug/06|18250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Sep/06|1714|USD Sales Sep/06|2182|LC Sales Sep/06|48638|Units Sep/06|437|DOT Sep/06|21850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|FAMOSAN|0040MG|FILM C.TABS 40 MG 50|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/08|50.00|40.00 MG|MONO|FAMOTIDINE|133|111.3|155.4|EURO Sales Oct/06|1484|USD Sales Oct/06|1872|LC Sales Oct/06|41960|Units Oct/06|377|DOT Oct/06|18850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Aug/02|344|USD Sales Aug/02|336|LC Sales Aug/02|10586|Units Aug/02|79|DOT Aug/02|131.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Sep/02|1833|USD Sales Sep/02|1797|LC Sales Sep/02|55342|Units Sep/02|413|DOT Sep/02|689.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Oct/02|2115|USD Sales Oct/02|2074|LC Sales Oct/02|64722|Units Oct/02|483|DOT Oct/02|806.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Nov/02|2264|USD Sales Nov/02|2267|LC Sales Nov/02|69546|Units Nov/02|519|DOT Nov/02|866.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Dec/02|2477|USD Sales Dec/02|2517|LC Sales Dec/02|77050|Units Dec/02|575|DOT Dec/02|960.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jan/03|2922|USD Sales Jan/03|3104|LC Sales Jan/03|91924|Units Jan/03|686|DOT Jan/03|1145.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Feb/03|3547|USD Sales Feb/03|3822|LC Sales Feb/03|112158|Units Feb/03|837|DOT Feb/03|1397.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Mar/03|2822|USD Sales Mar/03|3049|LC Sales Mar/03|89512|Units Mar/03|668|DOT Mar/03|1115.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Apr/03|2174|USD Sales Apr/03|2358|LC Sales Apr/03|68742|Units Apr/03|513|DOT Apr/03|856.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales May/03|13|USD Sales May/03|15|LC Sales May/03|402|Units May/03|3|DOT May/03|5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jun/03|9|USD Sales Jun/03|10|LC Sales Jun/03|268|Units Jun/03|2|DOT Jun/03|3.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jul/03|2618|USD Sales Jul/03|2977|LC Sales Jul/03|83348|Units Jul/03|622|DOT Jul/03|1038.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Aug/03|2376|USD Sales Aug/03|2646|LC Sales Aug/03|76648|Units Aug/03|572|DOT Aug/03|955.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Sep/03|3739|USD Sales Sep/03|4188|LC Sales Sep/03|121002|Units Sep/03|903|DOT Sep/03|1508
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Oct/03|3274|USD Sales Oct/03|3830|LC Sales Oct/03|104654|Units Oct/03|781|DOT Oct/03|1304.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Nov/03|2776|USD Sales Nov/03|3248|LC Sales Nov/03|88708|Units Nov/03|662|DOT Nov/03|1105.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Dec/03|4096|USD Sales Dec/03|5027|LC Sales Dec/03|132258|Units Dec/03|987|DOT Dec/03|1648.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jan/04|3042|USD Sales Jan/04|3838|LC Sales Jan/04|99562|Units Jan/04|743|DOT Jan/04|1240.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Feb/04|3349|USD Sales Feb/04|4235|LC Sales Feb/04|110014|Units Feb/04|821|DOT Feb/04|1371
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Mar/04|3637|USD Sales Mar/04|4463|LC Sales Mar/04|119930|Units Mar/04|895|DOT Mar/04|1494.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Apr/04|3990|USD Sales Apr/04|4783|LC Sales Apr/04|129712|Units Apr/04|968|DOT Apr/04|1616.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales May/04|3757|USD Sales May/04|4510|LC Sales May/04|120198|Units May/04|897|DOT May/04|1497.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jun/04|1157|USD Sales Jun/04|1404|LC Sales Jun/04|36582|Units Jun/04|273|DOT Jun/04|455.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jul/04|3891|USD Sales Jul/04|4773|LC Sales Jul/04|122744|Units Jul/04|916|DOT Jul/04|1529.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Aug/04|3004|USD Sales Aug/04|3658|LC Sales Aug/04|95006|Units Aug/04|709|DOT Aug/04|1184
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Sep/04|3079|USD Sales Sep/04|3761|LC Sales Sep/04|97284|Units Sep/04|726|DOT Sep/04|1212.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Oct/04|4047|USD Sales Oct/04|5055|LC Sales Oct/04|127434|Units Oct/04|951|DOT Oct/04|1588.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Nov/04|4043|USD Sales Nov/04|5251|LC Sales Nov/04|126496|Units Nov/04|944|DOT Nov/04|1576.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Dec/04|3812|USD Sales Dec/04|5107|LC Sales Dec/04|116848|Units Dec/04|872|DOT Dec/04|1456.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jan/05|4457|USD Sales Jan/05|5852|LC Sales Jan/05|135072|Units Jan/05|1008|DOT Jan/05|1683.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Feb/05|2406|USD Sales Feb/05|3131|LC Sales Feb/05|72092|Units Feb/05|538|DOT Feb/05|898.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Mar/05|3853|USD Sales Mar/05|5089|LC Sales Mar/05|114704|Units Mar/05|856|DOT Mar/05|1429.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Apr/05|3968|USD Sales Apr/05|5135|LC Sales Apr/05|119528|Units Apr/05|892|DOT Apr/05|1489.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales May/05|3970|USD Sales May/05|5037|LC Sales May/05|120064|Units May/05|896|DOT May/05|1496.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jun/05|3217|USD Sales Jun/05|3914|LC Sales Jun/05|96624|Units Jun/05|732|DOT Jun/05|1222.4
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jul/05|3335|USD Sales Jul/05|4015|LC Sales Jul/05|100630|Units Jul/05|767|DOT Jul/05|1280.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Aug/05|4838|USD Sales Aug/05|5948|LC Sales Aug/05|143139|Units Aug/05|1091|DOT Aug/05|1821.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Sep/05|4073|USD Sales Sep/05|4992|LC Sales Sep/05|119392|Units Sep/05|910|DOT Sep/05|1519.7
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Oct/05|3439|USD Sales Oct/05|4135|LC Sales Oct/05|102074|Units Oct/05|778|DOT Oct/05|1299.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Nov/05|3577|USD Sales Nov/05|4216|LC Sales Nov/05|104698|Units Nov/05|798|DOT Nov/05|1332.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Dec/05|4010|USD Sales Dec/05|4756|LC Sales Dec/05|116112|Units Dec/05|885|DOT Dec/05|1477.9
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jan/06|4358|USD Sales Jan/06|5276|LC Sales Jan/06|125165|Units Jan/06|954|DOT Jan/06|1593.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Feb/06|3494|USD Sales Feb/06|4174|LC Sales Feb/06|99318|Units Feb/06|757|DOT Feb/06|1264.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Mar/06|3963|USD Sales Mar/06|4765|LC Sales Mar/06|113488|Units Mar/06|865|DOT Mar/06|1444.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Apr/06|5297|USD Sales Apr/06|6496|LC Sales Apr/06|151011|Units Apr/06|1151|DOT Apr/06|1922.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales May/06|5545|USD Sales May/06|7078|LC Sales May/06|156784|Units May/06|1195|DOT May/06|1995.6
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jun/06|5396|USD Sales Jun/06|6833|LC Sales Jun/06|153112|Units Jun/06|1199|DOT Jun/06|2002.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Jul/06|4379|USD Sales Jul/06|5557|LC Sales Jul/06|124574|Units Jul/06|984|DOT Jul/06|1643.2
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Aug/06|5896|USD Sales Aug/06|7552|LC Sales Aug/06|166221|Units Aug/06|1314|DOT Aug/06|2194.3
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Sep/06|5580|USD Sales Sep/06|7106|LC Sales Sep/06|158378|Units Sep/06|1252|DOT Sep/06|2090.8
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0050MG|AMP. 50 MG 10 2 ML|F PARENTERAL ORDINARY|FM PARENT ORD AMPOULES|FMA PARENT ORD AMPOULES|RX BOUND|2002|2002/07|1.67|0.30 G|MONO|RANITIDINE|134|126.5|176.7|EURO Sales Oct/06|5569|USD Sales Oct/06|7026|LC Sales Oct/06|157493|Units Oct/06|1245|DOT Oct/06|2079.1
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Nov/01|270|USD Sales Nov/01|239|LC Sales Nov/01|8961|Units Nov/01|309|DOT Nov/01|772.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Dec/01|180|USD Sales Dec/01|161|LC Sales Dec/01|5829|Units Dec/01|201|DOT Dec/01|502.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jan/02|221|USD Sales Jan/02|196|LC Sales Jan/02|7105|Units Jan/02|245|DOT Jan/02|612.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Feb/02|174|USD Sales Feb/02|151|LC Sales Feb/02|5510|Units Feb/02|190|DOT Feb/02|475
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Mar/02|216|USD Sales Mar/02|189|LC Sales Mar/02|6786|Units Mar/02|234|DOT Mar/02|585
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Apr/02|254|USD Sales Apr/02|225|LC Sales Apr/02|7714|Units Apr/02|266|DOT Apr/02|665
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales May/02|270|USD Sales May/02|248|LC Sales May/02|8264|Units May/02|284|DOT May/02|710
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jun/02|222|USD Sales Jun/02|212|LC Sales Jun/02|6728|Units Jun/02|232|DOT Jun/02|580
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jul/02|372|USD Sales Jul/02|369|LC Sales Jul/02|11078|Units Jul/02|382|DOT Jul/02|955
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Aug/02|326|USD Sales Aug/02|318|LC Sales Aug/02|10034|Units Aug/02|346|DOT Aug/02|865
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Sep/02|317|USD Sales Sep/02|311|LC Sales Sep/02|9570|Units Sep/02|330|DOT Sep/02|825
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Oct/02|228|USD Sales Oct/02|224|LC Sales Oct/02|6989|Units Oct/02|241|DOT Oct/02|602.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Nov/02|273|USD Sales Nov/02|273|LC Sales Nov/02|8381|Units Nov/02|289|DOT Nov/02|722.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Dec/02|335|USD Sales Dec/02|340|LC Sales Dec/02|10411|Units Dec/02|359|DOT Dec/02|897.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jan/03|340|USD Sales Jan/03|361|LC Sales Jan/03|10701|Units Jan/03|369|DOT Jan/03|922.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Feb/03|270|USD Sales Feb/03|291|LC Sales Feb/03|8526|Units Feb/03|294|DOT Feb/03|735
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Mar/03|232|USD Sales Mar/03|251|LC Sales Mar/03|7366|Units Mar/03|254|DOT Mar/03|635
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Apr/03|350|USD Sales Apr/03|380|LC Sales Apr/03|11078|Units Apr/03|382|DOT Apr/03|955
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales May/03|289|USD Sales May/03|335|LC Sales May/03|9077|Units May/03|313|DOT May/03|782.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jun/03|320|USD Sales Jun/03|374|LC Sales Jun/03|10063|Units Jun/03|347|DOT Jun/03|867.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jul/03|358|USD Sales Jul/03|407|LC Sales Jul/03|11397|Units Jul/03|393|DOT Jul/03|982.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Aug/03|308|USD Sales Aug/03|343|LC Sales Aug/03|9947|Units Aug/03|343|DOT Aug/03|857.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Sep/03|396|USD Sales Sep/03|444|LC Sales Sep/03|12818|Units Sep/03|442|DOT Sep/03|1105
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Oct/03|374|USD Sales Oct/03|437|LC Sales Oct/03|11948|Units Oct/03|412|DOT Oct/03|1030
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Nov/03|299|USD Sales Nov/03|350|LC Sales Nov/03|9570|Units Nov/03|330|DOT Nov/03|825
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Dec/03|419|USD Sales Dec/03|514|LC Sales Dec/03|13514|Units Dec/03|466|DOT Dec/03|1165
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jan/04|423|USD Sales Jan/04|533|LC Sales Jan/04|13833|Units Jan/04|477|DOT Jan/04|1192.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Feb/04|380|USD Sales Feb/04|481|LC Sales Feb/04|12499|Units Feb/04|431|DOT Feb/04|1077.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Mar/04|428|USD Sales Mar/04|526|LC Sales Mar/04|14123|Units Mar/04|487|DOT Mar/04|1217.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Apr/04|457|USD Sales Apr/04|547|LC Sales Apr/04|14848|Units Apr/04|512|DOT Apr/04|1280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales May/04|503|USD Sales May/04|604|LC Sales May/04|16095|Units May/04|555|DOT May/04|1387.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jun/04|491|USD Sales Jun/04|596|LC Sales Jun/04|15515|Units Jun/04|535|DOT Jun/04|1337.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jul/04|382|USD Sales Jul/04|469|LC Sales Jul/04|12064|Units Jul/04|416|DOT Jul/04|1040
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Aug/04|452|USD Sales Aug/04|551|LC Sales Aug/04|14297|Units Aug/04|493|DOT Aug/04|1232.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Sep/04|417|USD Sales Sep/04|509|LC Sales Sep/04|13166|Units Sep/04|454|DOT Sep/04|1135
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Oct/04|489|USD Sales Oct/04|611|LC Sales Oct/04|15399|Units Oct/04|531|DOT Oct/04|1327.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Nov/04|390|USD Sales Nov/04|507|LC Sales Nov/04|12209|Units Nov/04|421|DOT Nov/04|1052.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Dec/04|554|USD Sales Dec/04|743|LC Sales Dec/04|16994|Units Dec/04|586|DOT Dec/04|1465
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jan/05|592|USD Sales Jan/05|778|LC Sales Jan/05|17951|Units Jan/05|619|DOT Jan/05|1547.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Feb/05|472|USD Sales Feb/05|615|LC Sales Feb/05|14152|Units Feb/05|488|DOT Feb/05|1220
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Mar/05|622|USD Sales Mar/05|822|LC Sales Mar/05|18531|Units Mar/05|639|DOT Mar/05|1597.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Apr/05|517|USD Sales Apr/05|669|LC Sales Apr/05|15573|Units Apr/05|537|DOT Apr/05|1342.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales May/05|457|USD Sales May/05|580|LC Sales May/05|13833|Units May/05|477|DOT May/05|1192.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jun/05|480|USD Sales Jun/05|584|LC Sales Jun/05|14413|Units Jun/05|497|DOT Jun/05|1242.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jul/05|626|USD Sales Jul/05|753|LC Sales Jul/05|18879|Units Jul/05|651|DOT Jul/05|1627.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Aug/05|524|USD Sales Aug/05|645|LC Sales Aug/05|15515|Units Aug/05|535|DOT Aug/05|1337.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Sep/05|539|USD Sales Sep/05|661|LC Sales Sep/05|15805|Units Sep/05|545|DOT Sep/05|1362.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Oct/05|574|USD Sales Oct/05|690|LC Sales Oct/05|17023|Units Oct/05|587|DOT Oct/05|1467.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Nov/05|498|USD Sales Nov/05|587|LC Sales Nov/05|14587|Units Nov/05|503|DOT Nov/05|1257.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Dec/05|552|USD Sales Dec/05|654|LC Sales Dec/05|15979|Units Dec/05|551|DOT Dec/05|1377.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jan/06|706|USD Sales Jan/06|854|LC Sales Jan/06|20271|Units Jan/06|699|DOT Jan/06|1747.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Feb/06|589|USD Sales Feb/06|703|LC Sales Feb/06|16733|Units Feb/06|577|DOT Feb/06|1442.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Mar/06|633|USD Sales Mar/06|761|LC Sales Mar/06|18125|Units Mar/06|625|DOT Mar/06|1562.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Apr/06|703|USD Sales Apr/06|862|LC Sales Apr/06|20039|Units Apr/06|691|DOT Apr/06|1727.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales May/06|732|USD Sales May/06|935|LC Sales May/06|20706|Units May/06|714|DOT May/06|1785
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jun/06|673|USD Sales Jun/06|853|LC Sales Jun/06|19111|Units Jun/06|659|DOT Jun/06|1647.5
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Jul/06|567|USD Sales Jul/06|720|LC Sales Jul/06|16131|Units Jul/06|566|DOT Jul/06|1415
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Aug/06|730|USD Sales Aug/06|936|LC Sales Aug/06|20590|Units Aug/06|710|DOT Aug/06|1775
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Sep/06|666|USD Sales Sep/06|848|LC Sales Sep/06|18908|Units Sep/06|652|DOT Sep/06|1630
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0075MG|FILM C.TABS 75 MG 10|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|NON-RX BOUND|2001|2001/10|2.50|0.30 G|MONO|RANITIDINE|135|29|40.5|EURO Sales Oct/06|759|USD Sales Oct/06|957|LC Sales Oct/06|21460|Units Oct/06|740|DOT Oct/06|1850
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Nov/01|9638|USD Sales Nov/01|8562|LC Sales Nov/01|320364|Units Nov/01|7281|DOT Nov/01|109215
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Dec/01|8787|USD Sales Dec/01|7846|LC Sales Dec/01|284842|Units Dec/01|6459|DOT Dec/01|96885
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jan/02|10887|USD Sales Jan/02|9614|LC Sales Jan/02|349316|Units Jan/02|7921|DOT Jan/02|118815
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Feb/02|9035|USD Sales Feb/02|7858|LC Sales Feb/02|286915|Units Feb/02|6506|DOT Feb/02|97590
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Mar/02|9371|USD Sales Mar/02|8205|LC Sales Mar/02|293971|Units Mar/02|6666|DOT Mar/02|99990
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Apr/02|10371|USD Sales Apr/02|9187|LC Sales Apr/02|315053|Units Apr/02|7193|DOT Apr/02|107895
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales May/02|10375|USD Sales May/02|9517|LC Sales May/02|317539|Units May/02|7283|DOT May/02|109245
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jun/02|9049|USD Sales Jun/02|8648|LC Sales Jun/02|274043|Units Jun/02|6271|DOT Jun/02|94065
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jul/02|10038|USD Sales Jul/02|9956|LC Sales Jul/02|299068|Units Jul/02|6797|DOT Jul/02|101955
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Aug/02|8681|USD Sales Aug/02|8484|LC Sales Aug/02|267476|Units Aug/02|6079|DOT Aug/02|91185
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Sep/02|9629|USD Sales Sep/02|9440|LC Sales Sep/02|290725|Units Sep/02|6668|DOT Sep/02|100020
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Oct/02|10246|USD Sales Oct/02|10048|LC Sales Oct/02|313592|Units Oct/02|7209|DOT Oct/02|108135
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Nov/02|9308|USD Sales Nov/02|9321|LC Sales Nov/02|285972|Units Nov/02|6559|DOT Nov/02|98385
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Dec/02|8547|USD Sales Dec/02|8686|LC Sales Dec/02|265868|Units Dec/02|6126|DOT Dec/02|91890
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jan/03|10321|USD Sales Jan/03|10962|LC Sales Jan/03|324693|Units Jan/03|7551|DOT Jan/03|113265
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Feb/03|8032|USD Sales Feb/03|8655|LC Sales Feb/03|253958|Units Feb/03|5906|DOT Feb/03|88590
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Mar/03|7951|USD Sales Mar/03|8592|LC Sales Mar/03|252238|Units Mar/03|5866|DOT Mar/03|87990
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Apr/03|8631|USD Sales Apr/03|9361|LC Sales Apr/03|272878|Units Apr/03|6346|DOT Apr/03|95190
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales May/03|7829|USD Sales May/03|9058|LC Sales May/03|245659|Units May/03|5713|DOT May/03|85695
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jun/03|8721|USD Sales Jun/03|10171|LC Sales Jun/03|273867|Units Jun/03|6369|DOT Jun/03|95535
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jul/03|7625|USD Sales Jul/03|8672|LC Sales Jul/03|242804|Units Jul/03|5673|DOT Jul/03|85095
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Aug/03|6595|USD Sales Aug/03|7345|LC Sales Aug/03|212764|Units Aug/03|4948|DOT Aug/03|74220
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Sep/03|8425|USD Sales Sep/03|9437|LC Sales Sep/03|272679|Units Sep/03|6371|DOT Sep/03|95565
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Oct/03|8080|USD Sales Oct/03|9452|LC Sales Oct/03|258298|Units Oct/03|6035|DOT Oct/03|90525
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Nov/03|6919|USD Sales Nov/03|8097|LC Sales Nov/03|221143|Units Nov/03|5179|DOT Nov/03|77685
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Dec/03|6987|USD Sales Dec/03|8576|LC Sales Dec/03|225621|Units Dec/03|5247|DOT Dec/03|78705
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jan/04|7499|USD Sales Jan/04|9459|LC Sales Jan/04|245401|Units Jan/04|5707|DOT Jan/04|85605
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Feb/04|6420|USD Sales Feb/04|8119|LC Sales Feb/04|210915|Units Feb/04|4905|DOT Feb/04|73575
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Mar/04|7258|USD Sales Mar/04|8905|LC Sales Mar/04|239295|Units Mar/04|5565|DOT Mar/04|83475
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Apr/04|7367|USD Sales Apr/04|8832|LC Sales Apr/04|239510|Units Apr/04|5570|DOT Apr/04|83550
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales May/04|7063|USD Sales May/04|8478|LC Sales May/04|225965|Units May/04|5255|DOT May/04|78825
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jun/04|7623|USD Sales Jun/04|9251|LC Sales Jun/04|240972|Units Jun/04|5604|DOT Jun/04|84060
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jul/04|6321|USD Sales Jul/04|7753|LC Sales Jul/04|199391|Units Jul/04|4637|DOT Jul/04|69555
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Aug/04|6168|USD Sales Aug/04|7511|LC Sales Aug/04|195066|Units Aug/04|4547|DOT Aug/04|68205
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Sep/04|6188|USD Sales Sep/04|7558|LC Sales Sep/04|195523|Units Sep/04|4804|DOT Sep/04|72060
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Oct/04|6520|USD Sales Oct/04|8144|LC Sales Oct/04|205296|Units Oct/04|4935|DOT Oct/04|74025
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Nov/04|6729|USD Sales Nov/04|8740|LC Sales Nov/04|210553|Units Nov/04|4908|DOT Nov/04|73620
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Dec/04|6397|USD Sales Dec/04|8571|LC Sales Dec/04|196088|Units Dec/04|4771|DOT Dec/04|71565
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jan/05|7527|USD Sales Jan/05|9882|LC Sales Jan/05|228098|Units Jan/05|5646|DOT Jan/05|84690
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Feb/05|5534|USD Sales Feb/05|7204|LC Sales Feb/05|165842|Units Feb/05|4105|DOT Feb/05|61575
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Mar/05|1557|USD Sales Mar/05|2056|LC Sales Mar/05|46339|Units Mar/05|1147|DOT Mar/05|17205
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Apr/05|398|USD Sales Apr/05|515|LC Sales Apr/05|11999|Units Apr/05|297|DOT Apr/05|4455
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales May/05|7190|USD Sales May/05|9122|LC Sales May/05|217433|Units May/05|5382|DOT May/05|80730
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jun/05|5482|USD Sales Jun/05|6668|LC Sales Jun/05|164630|Units Jun/05|4075|DOT Jun/05|61125
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jul/05|5539|USD Sales Jul/05|6669|LC Sales Jul/05|167135|Units Jul/05|4137|DOT Jul/05|62055
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Aug/05|7068|USD Sales Aug/05|8690|LC Sales Aug/05|209110|Units Aug/05|5176|DOT Aug/05|77640
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Sep/05|6124|USD Sales Sep/05|7505|LC Sales Sep/05|179497|Units Sep/05|4443|DOT Sep/05|66645
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Oct/05|5594|USD Sales Oct/05|6725|LC Sales Oct/05|166004|Units Oct/05|4109|DOT Oct/05|61635
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Nov/05|5527|USD Sales Nov/05|6514|LC Sales Nov/05|161762|Units Nov/05|4004|DOT Nov/05|60060
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Dec/05|4471|USD Sales Dec/05|5302|LC Sales Dec/05|129462|Units Dec/05|3434|DOT Dec/05|51510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jan/06|5341|USD Sales Jan/06|6465|LC Sales Jan/06|153376|Units Jan/06|4123|DOT Jan/06|61845
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Feb/06|4705|USD Sales Feb/06|5622|LC Sales Feb/06|133771|Units Feb/06|3596|DOT Feb/06|53940
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Mar/06|5139|USD Sales Mar/06|6179|LC Sales Mar/06|147163|Units Mar/06|3956|DOT Mar/06|59340
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Apr/06|4738|USD Sales Apr/06|5810|LC Sales Apr/06|135073|Units Apr/06|3631|DOT Apr/06|54465
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales May/06|5980|USD Sales May/06|7633|LC Sales May/06|169074|Units May/06|4545|DOT May/06|68175
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jun/06|5877|USD Sales Jun/06|7442|LC Sales Jun/06|166768|Units Jun/06|4483|DOT Jun/06|67245
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Jul/06|4197|USD Sales Jul/06|5325|LC Sales Jul/06|119388|Units Jul/06|3218|DOT Jul/06|48270
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Aug/06|4786|USD Sales Aug/06|6131|LC Sales Aug/06|134933|Units Aug/06|3637|DOT Aug/06|54555
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Sep/06|5031|USD Sales Sep/06|6407|LC Sales Sep/06|142798|Units Sep/06|3849|DOT Sep/06|57735
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|C.TAB 150 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1997|1997/04|15.00|0.30 G|MONO|RANITIDINE|136|37.1|51.8|EURO Sales Oct/06|5260|USD Sales Oct/06|6637|LC Sales Oct/06|148771|Units Oct/06|4010|DOT Oct/06|60150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Nov/01|22|USD Sales Nov/01|19|LC Sales Nov/01|722|Units Nov/01|1|DOT Nov/01|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jan/02|22|USD Sales Jan/02|19|LC Sales Jan/02|707|Units Jan/02|1|DOT Jan/02|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Feb/02|23|USD Sales Feb/02|20|LC Sales Feb/02|723|Units Feb/02|1|DOT Feb/02|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Apr/02|119|USD Sales Apr/02|105|LC Sales Apr/02|3615|Units Apr/02|5|DOT Apr/02|1250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales May/02|236|USD Sales May/02|217|LC Sales May/02|7229|Units May/02|10|DOT May/02|2500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jul/02|89|USD Sales Jul/02|88|LC Sales Jul/02|2640|Units Jul/02|4|DOT Jul/02|1000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Sep/02|24|USD Sales Sep/02|23|LC Sales Sep/02|723|Units Sep/02|1|DOT Sep/02|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Oct/02|24|USD Sales Oct/02|23|LC Sales Oct/02|723|Units Oct/02|1|DOT Oct/02|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Nov/02|0|USD Sales Nov/02|0|LC Sales Nov/02|0|Units Nov/02|0|DOT Nov/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Dec/02|22|USD Sales Dec/02|23|LC Sales Dec/02|698|Units Dec/02|1|DOT Dec/02|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jan/03|0|USD Sales Jan/03|0|LC Sales Jan/03|0|Units Jan/03|0|DOT Jan/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Feb/03|22|USD Sales Feb/03|24|LC Sales Feb/03|692|Units Feb/03|1|DOT Feb/03|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Mar/03|0|USD Sales Mar/03|0|LC Sales Mar/03|0|Units Mar/03|0|DOT Mar/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Apr/03|0|USD Sales Apr/03|0|LC Sales Apr/03|0|Units Apr/03|0|DOT Apr/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales May/03|0|USD Sales May/03|0|LC Sales May/03|0|Units May/03|0|DOT May/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jun/03|0|USD Sales Jun/03|0|LC Sales Jun/03|0|Units Jun/03|0|DOT Jun/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jul/03|22|USD Sales Jul/03|25|LC Sales Jul/03|692|Units Jul/03|1|DOT Jul/03|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Aug/03|0|USD Sales Aug/03|0|LC Sales Aug/03|0|Units Aug/03|0|DOT Aug/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Sep/03|43|USD Sales Sep/03|48|LC Sales Sep/03|1383|Units Sep/03|2|DOT Sep/03|500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Oct/03|0|USD Sales Oct/03|0|LC Sales Oct/03|0|Units Oct/03|0|DOT Oct/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Nov/03|0|USD Sales Nov/03|0|LC Sales Nov/03|0|Units Nov/03|0|DOT Nov/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Dec/03|0|USD Sales Dec/03|0|LC Sales Dec/03|0|Units Dec/03|0|DOT Dec/03|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jan/04|0|USD Sales Jan/04|0|LC Sales Jan/04|0|Units Jan/04|0|DOT Jan/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Feb/04|0|USD Sales Feb/04|0|LC Sales Feb/04|0|Units Feb/04|0|DOT Feb/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Mar/04|42|USD Sales Mar/04|51|LC Sales Mar/04|1383|Units Mar/04|2|DOT Mar/04|500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Apr/04|21|USD Sales Apr/04|26|LC Sales Apr/04|692|Units Apr/04|1|DOT Apr/04|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales May/04|0|USD Sales May/04|0|LC Sales May/04|0|Units May/04|0|DOT May/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jun/04|22|USD Sales Jun/04|27|LC Sales Jun/04|692|Units Jun/04|1|DOT Jun/04|250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jul/04|0|USD Sales Jul/04|0|LC Sales Jul/04|0|Units Jul/04|0|DOT Jul/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Aug/04|0|USD Sales Aug/04|0|LC Sales Aug/04|0|Units Aug/04|0|DOT Aug/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Sep/04|106|USD Sales Sep/04|130|LC Sales Sep/04|3356|Units Sep/04|5|DOT Sep/04|1250
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Oct/04|85|USD Sales Oct/04|106|LC Sales Oct/04|2684|Units Oct/04|4|DOT Oct/04|1000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Nov/04|0|USD Sales Nov/04|0|LC Sales Nov/04|0|Units Nov/04|0|DOT Nov/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Dec/04|0|USD Sales Dec/04|0|LC Sales Dec/04|0|Units Dec/04|0|DOT Dec/04|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jan/05|0|USD Sales Jan/05|0|LC Sales Jan/05|0|Units Jan/05|0|DOT Jan/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Feb/05|0|USD Sales Feb/05|0|LC Sales Feb/05|0|Units Feb/05|0|DOT Feb/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Mar/05|0|USD Sales Mar/05|0|LC Sales Mar/05|0|Units Mar/05|0|DOT Mar/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Apr/05|0|USD Sales Apr/05|0|LC Sales Apr/05|0|Units Apr/05|0|DOT Apr/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales May/05|0|USD Sales May/05|0|LC Sales May/05|0|Units May/05|0|DOT May/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jun/05|0|USD Sales Jun/05|0|LC Sales Jun/05|0|Units Jun/05|0|DOT Jun/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jul/05|0|USD Sales Jul/05|0|LC Sales Jul/05|0|Units Jul/05|0|DOT Jul/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Aug/05|0|USD Sales Aug/05|0|LC Sales Aug/05|0|Units Aug/05|0|DOT Aug/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Sep/05|0|USD Sales Sep/05|0|LC Sales Sep/05|0|Units Sep/05|0|DOT Sep/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Oct/05|0|USD Sales Oct/05|0|LC Sales Oct/05|0|Units Oct/05|0|DOT Oct/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Nov/05|0|USD Sales Nov/05|0|LC Sales Nov/05|0|Units Nov/05|0|DOT Nov/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Dec/05|0|USD Sales Dec/05|0|LC Sales Dec/05|0|Units Dec/05|0|DOT Dec/05|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jan/06|0|USD Sales Jan/06|0|LC Sales Jan/06|0|Units Jan/06|0|DOT Jan/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Feb/06|0|USD Sales Feb/06|0|LC Sales Feb/06|0|Units Feb/06|0|DOT Feb/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Mar/06|0|USD Sales Mar/06|0|LC Sales Mar/06|0|Units Mar/06|0|DOT Mar/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Apr/06|0|USD Sales Apr/06|0|LC Sales Apr/06|0|Units Apr/06|0|DOT Apr/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales May/06|0|USD Sales May/06|0|LC Sales May/06|0|Units May/06|0|DOT May/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jun/06|0|USD Sales Jun/06|0|LC Sales Jun/06|0|Units Jun/06|0|DOT Jun/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Jul/06|0|USD Sales Jul/06|0|LC Sales Jul/06|0|Units Jul/06|0|DOT Jul/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Aug/06|0|USD Sales Aug/06|0|LC Sales Aug/06|0|Units Aug/06|0|DOT Aug/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Sep/06|0|USD Sales Sep/06|0|LC Sales Sep/06|0|Units Sep/06|0|DOT Sep/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 500|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2000|2000/01|250.00|0.30 G|MONO|RANITIDINE|137|708.2|958.4|EURO Sales Oct/06|0|USD Sales Oct/06|0|LC Sales Oct/06|0|Units Oct/06|0|DOT Oct/06|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Nov/01|0|USD Sales Nov/01|0|LC Sales Nov/01|0|Units Nov/01|0|DOT Nov/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Dec/01|0|USD Sales Dec/01|0|LC Sales Dec/01|0|Units Dec/01|0|DOT Dec/01|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jan/02|0|USD Sales Jan/02|0|LC Sales Jan/02|0|Units Jan/02|0|DOT Jan/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Feb/02|0|USD Sales Feb/02|0|LC Sales Feb/02|0|Units Feb/02|0|DOT Feb/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Mar/02|0|USD Sales Mar/02|0|LC Sales Mar/02|0|Units Mar/02|0|DOT Mar/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Apr/02|0|USD Sales Apr/02|0|LC Sales Apr/02|0|Units Apr/02|0|DOT Apr/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales May/02|0|USD Sales May/02|0|LC Sales May/02|0|Units May/02|0|DOT May/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jun/02|0|USD Sales Jun/02|0|LC Sales Jun/02|0|Units Jun/02|0|DOT Jun/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jul/02|0|USD Sales Jul/02|0|LC Sales Jul/02|0|Units Jul/02|0|DOT Jul/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Aug/02|0|USD Sales Aug/02|0|LC Sales Aug/02|0|Units Aug/02|0|DOT Aug/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Sep/02|0|USD Sales Sep/02|0|LC Sales Sep/02|0|Units Sep/02|0|DOT Sep/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Oct/02|0|USD Sales Oct/02|0|LC Sales Oct/02|0|Units Oct/02|0|DOT Oct/02|0
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Nov/02|13|USD Sales Nov/02|13|LC Sales Nov/02|405|Units Nov/02|5|DOT Nov/02|150
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Dec/02|26|USD Sales Dec/02|26|LC Sales Dec/02|809|Units Dec/02|10|DOT Dec/02|300
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jan/03|44|USD Sales Jan/03|46|LC Sales Jan/03|1375|Units Jan/03|17|DOT Jan/03|510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Feb/03|95|USD Sales Feb/03|102|LC Sales Feb/03|2993|Units Feb/03|37|DOT Feb/03|1110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Mar/03|171|USD Sales Mar/03|185|LC Sales Mar/03|5420|Units Mar/03|67|DOT Mar/03|2010
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Apr/03|159|USD Sales Apr/03|172|LC Sales Apr/03|5016|Units Apr/03|62|DOT Apr/03|1860
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales May/03|116|USD Sales May/03|134|LC Sales May/03|3641|Units May/03|45|DOT May/03|1350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jun/03|216|USD Sales Jun/03|252|LC Sales Jun/03|6796|Units Jun/03|84|DOT Jun/03|2520
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jul/03|254|USD Sales Jul/03|289|LC Sales Jul/03|8090|Units Jul/03|100|DOT Jul/03|3000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Aug/03|206|USD Sales Aug/03|229|LC Sales Aug/03|6634|Units Aug/03|82|DOT Aug/03|2460
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Sep/03|440|USD Sales Sep/03|493|LC Sales Sep/03|14238|Units Sep/03|176|DOT Sep/03|5280
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Oct/03|509|USD Sales Oct/03|595|LC Sales Oct/03|16261|Units Oct/03|201|DOT Oct/03|6030
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Nov/03|982|USD Sales Nov/03|1149|LC Sales Nov/03|31389|Units Nov/03|388|DOT Nov/03|11640
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Dec/03|544|USD Sales Dec/03|667|LC Sales Dec/03|17555|Units Dec/03|217|DOT Dec/03|6510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jan/04|532|USD Sales Jan/04|670|LC Sales Jan/04|17394|Units Jan/04|215|DOT Jan/04|6450
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Feb/04|561|USD Sales Feb/04|710|LC Sales Feb/04|18445|Units Feb/04|228|DOT Feb/04|6840
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Mar/04|685|USD Sales Mar/04|840|LC Sales Mar/04|22571|Units Mar/04|279|DOT Mar/04|8370
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Apr/04|620|USD Sales Apr/04|743|LC Sales Apr/04|20144|Units Apr/04|249|DOT Apr/04|7470
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales May/04|632|USD Sales May/04|759|LC Sales May/04|20225|Units May/04|250|DOT May/04|7500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jun/04|630|USD Sales Jun/04|764|LC Sales Jun/04|19901|Units Jun/04|246|DOT Jun/04|7380
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jul/04|633|USD Sales Jul/04|777|LC Sales Jul/04|19982|Units Jul/04|247|DOT Jul/04|7410
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Aug/04|762|USD Sales Aug/04|928|LC Sales Aug/04|24108|Units Aug/04|298|DOT Aug/04|8940
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Sep/04|328|USD Sales Sep/04|400|LC Sales Sep/04|10355|Units Sep/04|128|DOT Sep/04|3840
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Oct/04|928|USD Sales Oct/04|1158|LC Sales Oct/04|29205|Units Oct/04|361|DOT Oct/04|10830
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Nov/04|695|USD Sales Nov/04|903|LC Sales Nov/04|21762|Units Nov/04|269|DOT Nov/04|8070
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Dec/04|1035|USD Sales Dec/04|1387|LC Sales Dec/04|31734|Units Dec/04|417|DOT Dec/04|12510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jan/05|1116|USD Sales Jan/05|1466|LC Sales Jan/05|33835|Units Jan/05|456|DOT Jan/05|13680
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Feb/05|933|USD Sales Feb/05|1215|LC Sales Feb/05|27968|Units Feb/05|380|DOT Feb/05|11400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Mar/05|247|USD Sales Mar/05|327|LC Sales Mar/05|7360|Units Mar/05|100|DOT Mar/05|3000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Apr/05|2|USD Sales Apr/05|3|LC Sales Apr/05|74|Units Apr/05|1|DOT Apr/05|30
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales May/05|1375|USD Sales May/05|1745|LC Sales May/05|41584|Units May/05|565|DOT May/05|16950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jun/05|1821|USD Sales Jun/05|2215|LC Sales Jun/05|54685|Units Jun/05|743|DOT Jun/05|22290
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jul/05|17|USD Sales Jul/05|21|LC Sales Jul/05|515|Units Jul/05|7|DOT Jul/05|210
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Aug/05|1069|USD Sales Aug/05|1314|LC Sales Aug/05|31617|Units Aug/05|429|DOT Aug/05|12870
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Sep/05|1150|USD Sales Sep/05|1409|LC Sales Sep/05|33709|Units Sep/05|458|DOT Sep/05|13740
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Oct/05|1171|USD Sales Oct/05|1407|LC Sales Oct/05|34739|Units Oct/05|472|DOT Oct/05|14160
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Nov/05|1154|USD Sales Nov/05|1360|LC Sales Nov/05|33782|Units Nov/05|459|DOT Nov/05|13770
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Dec/05|1264|USD Sales Dec/05|1499|LC Sales Dec/05|36594|Units Dec/05|535|DOT Dec/05|16050
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jan/06|1505|USD Sales Jan/06|1821|LC Sales Jan/06|43212|Units Jan/06|644|DOT Jan/06|19320
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Feb/06|1754|USD Sales Feb/06|2095|LC Sales Feb/06|49855|Units Feb/06|743|DOT Feb/06|22290
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Mar/06|1619|USD Sales Mar/06|1947|LC Sales Mar/06|46366|Units Mar/06|691|DOT Mar/06|20730
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Apr/06|1476|USD Sales Apr/06|1810|LC Sales Apr/06|42072|Units Apr/06|627|DOT Apr/06|18810
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales May/06|1449|USD Sales May/06|1849|LC Sales May/06|40959|Units May/06|637|DOT May/06|19110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jun/06|1135|USD Sales Jun/06|1437|LC Sales Jun/06|32208|Units Jun/06|480|DOT Jun/06|14400
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Jul/06|913|USD Sales Jul/06|1159|LC Sales Jul/06|25978|Units Jul/06|386|DOT Jul/06|11580
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Aug/06|1824|USD Sales Aug/06|2337|LC Sales Aug/06|51436|Units Aug/06|770|DOT Aug/06|23100
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Sep/06|1882|USD Sales Sep/06|2397|LC Sales Sep/06|53427|Units Sep/06|801|DOT Sep/06|24030
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|PRO.MED.*|PRO MED|PRO.MED.|RANISAN|0150MG|FILM C.TABS 150 MG 60|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABC ORAL S ORD FILM-COATED TABS|RX BOUND|2002|2002/11|30.00|0.30 G|MONO|RANITIDINE|138|66.7|93.2|EURO Sales Oct/06|1703|USD Sales Oct/06|2148|LC Sales Oct/06|48157|Units Oct/06|722|DOT Oct/06|21660
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Nov/01|3293|USD Sales Nov/01|2925|LC Sales Nov/01|109456|Units Nov/01|2482|DOT Nov/01|37230
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Dec/01|3082|USD Sales Dec/01|2751|LC Sales Dec/01|99892|Units Dec/01|2260|DOT Dec/01|33900
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jan/02|4098|USD Sales Jan/02|3619|LC Sales Jan/02|131495|Units Jan/02|2975|DOT Jan/02|44625
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Feb/02|2904|USD Sales Feb/02|2525|LC Sales Feb/02|92201|Units Feb/02|2086|DOT Feb/02|31290
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Mar/02|3193|USD Sales Mar/02|2796|LC Sales Mar/02|100157|Units Mar/02|2266|DOT Mar/02|33990
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Apr/02|3652|USD Sales Apr/02|3235|LC Sales Apr/02|110942|Units Apr/02|2510|DOT Apr/02|37650
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales May/02|3118|USD Sales May/02|2860|LC Sales May/02|95428|Units May/02|2159|DOT May/02|32385
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jun/02|3217|USD Sales Jun/02|3074|LC Sales Jun/02|97417|Units Jun/02|2204|DOT Jun/02|33060
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jul/02|3271|USD Sales Jul/02|3245|LC Sales Jul/02|97461|Units Jul/02|2205|DOT Jul/02|33075
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Aug/02|2851|USD Sales Aug/02|2786|LC Sales Aug/02|87847|Units Aug/02|1983|DOT Aug/02|29745
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Sep/02|3003|USD Sales Sep/02|2945|LC Sales Sep/02|90682|Units Sep/02|2047|DOT Sep/02|30705
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Oct/02|3474|USD Sales Oct/02|3407|LC Sales Oct/02|106322|Units Oct/02|2433|DOT Oct/02|36495
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Nov/02|3037|USD Sales Nov/02|3041|LC Sales Nov/02|93294|Units Nov/02|2130|DOT Nov/02|31950
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Dec/02|2702|USD Sales Dec/02|2746|LC Sales Dec/02|84055|Units Dec/02|1906|DOT Dec/02|28590
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jan/03|3437|USD Sales Jan/03|3650|LC Sales Jan/03|108116|Units Jan/03|2562|DOT Jan/03|38430
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Feb/03|2489|USD Sales Feb/03|2682|LC Sales Feb/03|78684|Units Feb/03|1896|DOT Feb/03|28440
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Mar/03|2539|USD Sales Mar/03|2744|LC Sales Mar/03|80552|Units Mar/03|1941|DOT Mar/03|29115
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Apr/03|2716|USD Sales Apr/03|2946|LC Sales Apr/03|85864|Units Apr/03|2069|DOT Apr/03|31035
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales May/03|2715|USD Sales May/03|3142|LC Sales May/03|85200|Units May/03|2053|DOT May/03|30795
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jun/03|2545|USD Sales Jun/03|2968|LC Sales Jun/03|79929|Units Jun/03|1926|DOT Jun/03|28890
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jul/03|2768|USD Sales Jul/03|3148|LC Sales Jul/03|88146|Units Jul/03|2124|DOT Jul/03|31860
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Aug/03|2040|USD Sales Aug/03|2272|LC Sales Aug/03|65819|Units Aug/03|1586|DOT Aug/03|23790
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Sep/03|2614|USD Sales Sep/03|2928|LC Sales Sep/03|84614|Units Sep/03|2034|DOT Sep/03|30510
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Oct/03|2452|USD Sales Oct/03|2868|LC Sales Oct/03|78374|Units Oct/03|1884|DOT Oct/03|28260
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Nov/03|2081|USD Sales Nov/03|2435|LC Sales Nov/03|66518|Units Nov/03|1599|DOT Nov/03|23985
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Dec/03|2557|USD Sales Dec/03|3139|LC Sales Dec/03|82576|Units Dec/03|1985|DOT Dec/03|29775
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jan/04|2864|USD Sales Jan/04|3613|LC Sales Jan/04|93725|Units Jan/04|2253|DOT Jan/04|33795
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Feb/04|2027|USD Sales Feb/04|2564|LC Sales Feb/04|66602|Units Feb/04|1601|DOT Feb/04|24015
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Mar/04|2889|USD Sales Mar/04|3545|LC Sales Mar/04|95264|Units Mar/04|2290|DOT Mar/04|34350
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Apr/04|2432|USD Sales Apr/04|2915|LC Sales Apr/04|79058|Units Apr/04|1905|DOT Apr/04|28575
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales May/04|2363|USD Sales May/04|2837|LC Sales May/04|75613|Units May/04|1822|DOT May/04|27330
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jun/04|2460|USD Sales Jun/04|2986|LC Sales Jun/04|77771|Units Jun/04|1874|DOT Jun/04|28110
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jul/04|2236|USD Sales Jul/04|2743|LC Sales Jul/04|70550|Units Jul/04|1700|DOT Jul/04|25500
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Aug/04|2294|USD Sales Aug/04|2793|LC Sales Aug/04|72542|Units Aug/04|1748|DOT Aug/04|26220
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Sep/04|2419|USD Sales Sep/04|2955|LC Sales Sep/04|76443|Units Sep/04|1842|DOT Sep/04|27630
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Oct/04|2238|USD Sales Oct/04|2795|LC Sales Oct/04|70467|Units Oct/04|1698|DOT Oct/04|25470
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Nov/04|2336|USD Sales Nov/04|3034|LC Sales Nov/04|73091|Units Nov/04|1757|DOT Nov/04|26355
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Dec/04|1931|USD Sales Dec/04|2587|LC Sales Dec/04|59182|Units Dec/04|1574|DOT Dec/04|23610
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jan/05|2341|USD Sales Jan/05|3074|LC Sales Jan/05|70950|Units Jan/05|1928|DOT Jan/05|28920
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Feb/05|1909|USD Sales Feb/05|2486|LC Sales Feb/05|57224|Units Feb/05|1555|DOT Feb/05|23325
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Mar/05|2472|USD Sales Mar/05|3265|LC Sales Mar/05|73600|Units Mar/05|2000|DOT Mar/05|30000
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Apr/05|2910|USD Sales Apr/05|3766|LC Sales Apr/05|87658|Units Apr/05|2382|DOT Apr/05|35730
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales May/05|3039|USD Sales May/05|3855|LC Sales May/05|91890|Units May/05|2497|DOT May/05|37455
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jun/05|2909|USD Sales Jun/05|3538|LC Sales Jun/05|87351|Units Jun/05|2413|DOT Jun/05|36195
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jul/05|1851|USD Sales Jul/05|2229|LC Sales Jul/05|55862|Units Jul/05|1518|DOT Jul/05|22770
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Aug/05|2061|USD Sales Aug/05|2534|LC Sales Aug/05|60978|Units Aug/05|1657|DOT Aug/05|24855
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Sep/05|2559|USD Sales Sep/05|3136|LC Sales Sep/05|74998|Units Sep/05|2038|DOT Sep/05|30570
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Oct/05|2353|USD Sales Oct/05|2829|LC Sales Oct/05|69840|Units Oct/05|1903|DOT Oct/05|28545
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Nov/05|3130|USD Sales Nov/05|3688|LC Sales Nov/05|91595|Units Nov/05|2489|DOT Nov/05|37335
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Dec/05|1878|USD Sales Dec/05|2228|LC Sales Dec/05|54388|Units Dec/05|1486|DOT Dec/05|22290
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jan/06|2312|USD Sales Jan/06|2798|LC Sales Jan/06|66392|Units Jan/06|1814|DOT Jan/06|27210
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Feb/06|2233|USD Sales Feb/06|2668|LC Sales Feb/06|63480|Units Feb/06|1725|DOT Feb/06|25875
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Mar/06|2572|USD Sales Mar/06|3093|LC Sales Mar/06|73658|Units Mar/06|2135|DOT Mar/06|32025
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Apr/06|1801|USD Sales Apr/06|2209|LC Sales Apr/06|51356|Units Apr/06|1533|DOT Apr/06|22995
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales May/06|2290|USD Sales May/06|2924|LC Sales May/06|64756|Units May/06|1933|DOT May/06|28995
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jun/06|2340|USD Sales Jun/06|2963|LC Sales Jun/06|66397|Units Jun/06|1982|DOT Jun/06|29730
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Jul/06|1808|USD Sales Jul/06|2294|LC Sales Jul/06|51423|Units Jul/06|1535|DOT Jul/06|23025
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Aug/06|2412|USD Sales Aug/06|3089|LC Sales Aug/06|67994|Units Aug/06|2048|DOT Aug/06|30720
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Sep/06|3036|USD Sales Sep/06|3866|LC Sales Sep/06|86172|Units Sep/06|2580|DOT Sep/06|38700
HOSPITAL MARKET|A0 ALIMENTARY T.& METABOLISM|A02 A-ACID A-FLAT A-ULCERANTS|A02B ANTIULCERANTS|A02B1 H2 ANTAGONISTS|TEVA*|TEVA|IVAX CR|ULCOSAN|0167MG|C.TAB 167 MG 30|A ORAL SOLID ORDINARY|AB ORAL S ORD COATED TABLETS|ABA ORAL S ORD COATED TABLETS|RX BOUND|1991|1991/07|15.00|0.30 G|MONO|RANITIDINE|139|33.4|46.6|EURO Sales Oct/06|1943|USD Sales Oct/06|2451|LC Sales Oct/06|54943|Units Oct/06|1645|DOT Oct/06|24675
